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Abstract 
Colorectal cancer is one of the mostly commonly diagnosed cancers for both men and women in 
the UK, with a poor survival rate compared to other Western countries and other commonly 
diagnosed cancer types. Part of the reason for poor prognosis for patients is the diagnosis of the 
disease at an advanced stage of progression, which has been shown to have a severe impact on 
patient survival rates. Due to this, the signalling events surrounding the adoption of an invasive 
phenotype may provide the opportunity to develop therapies to limit the spread of tumours from 
their original site and improve patient prognosis. 
It has previously been highlighted that the culture of cells in standard two-dimensional (2D) induces 
alterations to gene expression via the imposition of a microenvironment which does not reflect the 
microenvironment experienced by cancer cells in vivo. This limits the accuracy of data obtained 
using 2D migration assays and can help to account for the failure of some anti-migratory 
compounds to be effective in in vivo or clinical screening, after showing promise in conventional 
cell culture tests. 
This project has aimed to develop a novel three-dimensional (3D) migration assay based on 
Alvetex
®
 technology, which provides a more biologically relevant microenvironment in vitro, to 
investigate the role of cell signalling and microenvironment in determining the migratory behaviour 
of colorectal cancer cells. Through extensive optimisation, the 3D culture of two colorectal cancer 
cell lines, SW480 and SW620, was established to allow for the assessment of cell migration via 
histological processing, in addition to the assessment of other behavioural traits via the use of 
commercial biochemical assays. 
Modulation of both the Wnt and Insulin-like Growth Factor (IGF)-I signalling pathways via small 
molecule inhibitors and exogenous protein application has highlighted compounds which alter the 
migratory behaviour of the colorectal cancer cell lines, results which were not reflected in 
counterpart 2D scratch wound assays. This underlines the need to use culturing techniques which 
better reflect the biological system in question, as the anti-migratory applications of these 
compounds have the potential to be missed if subjected to 2D screening only.  
The biological relevance of the model developed here was also increased by altering the culture 
microenvironment by the addition of extracellular matrix (ECM) coatings or co-culture, 
demonstrating that this model can be adapted to recreate a variety of microenvironments 
depending on the aims of the research undertaken. 
Together, the data presented in this thesis demonstrates the suitability of this novel culture system 
to assess the migratory behaviour of colorectal cancer cells in vitro, with the possibility of the 
adaption of this system to assess the behaviour of other cancer types. 
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1 Introduction 
1.1 Cancer is a leading cause of death in the UK 
The incidence of cancer has been steadily rising in the UK, with 431 new cases per 100,000 men 
and 375 new cases per 100,000 women diagnosed in the period 2008-10, compared to 403 and 
343 new cases per 100,000 in 2001-03 respectively [1]. The mortality rates for cancer have not 
followed this trend, with 204 deaths per 100,000 men and 149 deaths per 100,000 women 
recorded in 2008-10, down from 299 and 161 deaths per 100,000 in 2001-03 respectively [1]. 
Despite this decrease in mortality, cancer is currently the largest percentage cause of deaths in 
England and Wales, with 29% of all registered deaths in 2012 attributed to this disease group [2].  
As cancer describes a collection of diseases arising from many tissues in the body, it cannot be 
attributed to changes to a single protein or pathway and there has been much discussion in the 
literature to define the unifying properties of cancers in general. Certain gross properties of the 
disease have been identified for many years, such as the stages of spread of the tumours 
throughout the body [3]. In addition to this, general mechanisms for tumour progression have been 
identified, from the hijacking of the wound healing mechanisms in the body to produce stroma to 
maintain tumour growth [4] to the genetic changes occurring in key oncogenes and genes linked to 
specific cancer types [5]. 
Two landmark reviews by Hanahan and Weinberg, the first in 2000 [6] and a follow up in 2011 [7], 
have gone a long way to outline a framework in which the development of tumours are viewed. In 
these articles, they outlined a total of eight ‘hallmarks of cancer’, six initial ones, namely the 
sustainment of proliferative signalling, resistance of cell death, evasion of growth suppressors, 
enablement of replicative immortality, induction of angiogenesis and activation of invasion and 
metastasis, and two emerging hallmarks, the deregulation of cellular energetics and evasion of 
immune destruction. When these are considered along with the two enabling characteristics of 
tumour promoting inflammation and genome instability and mutation, they provide a description of 
the behaviour of the cells of tumours when taken as a whole, and are not to be taken as the 
characteristics of all cells within tumours at all times [8]. 
The Hanahan and Weinberg articles [6, 7] also stress the complex signalling interactions which 
occur within tumours and the multicellular nature of the tumour microenvironment, with hallmarks 
arising from the perturbation of a variety of pathways and interactions between cell types. 
1.2 Colorectal cancer is the fourth most common cancer in the 
UK 
1.2.1 Colorectal cancer prevalence and survival 
Colorectal cancer was the fourth most commonly diagnosed in England in 2011, after breast, 
prostate and lung, accounting for 12.4% of the total cancer diagnoses [9]. Both the one-year and 
five-year survival rates for this cancer are slowly increasing, with 77.1% of men and 73.1% of 
women diagnosed with colon cancer in 2011 surviving past one year, compared to 66.0% and 
2 
62.6% survival for men and women, respectively, diagnosed with colon cancer in 1996 [10]. 
Additionally, 53.4% of men and 52.3% of women diagnosed with colon cancer in 2006 survived 
past five years, compared to 45.2% and 44.4% survival for men and women, respectively, 
diagnosed with colon cancer in 1996 [10]. 
While this improvement in patient survival is a good sign, the UK still trails behind many of its 
Western neighbours. An analysis of the five-year survival rates for patients diagnosed with 
colorectal cancer in nine European countries and seven states in the USA in the period 1996-98 
demonstrated that most of these obtained a survival rate of 45% or greater, with only Poland falling 
below 40%, with a European average of 50% and a USA average of 58% survival, which out 
performs the 44.8% attained by England for the same time period [11]. Additionally, a comparison 
of the one-year survival rates for colon cancer in Australia, Canada, Denmark, Norway, Sweden 
and the UK for patients diagnosed in 2000-07 demonstrated that the UK attained the lowest 
survival rate out of these countries and this was maintained when a variety of staging methods 
were applied to the patients [12]. 
With this poorer performance in terms of colorectal cancer survival, studies have been undertaken 
to assess the impact that additional factors play in the patient outcomes. A study looking at 
colorectal cancer patients in the North East of England found that deprivation increased the odds of 
a patient receiving a diagnosis of a stage IV tumour and decreased the odds of them receiving any 
treatment for their cancer, with this being more marked for colon cancer than rectal cancer, while 
amount of travel required to receive appropriate healthcare was not a factor [13]. A further study 
covering the whole of England also found that deprivation increased the mortality of patients within 
12 months of diagnosis and this increase was also seen in patients presenting as an emergency 
case or failing to obtain resection surgery as treatment [14]. 
1.2.2 Types of colorectal cancer 
As with many other types of cancer, colorectal cancer can arise as sporadic cases, due to inherited 
susceptibility or as a result of a specific hereditary disease, with inherited genetic factors 
responsible for up to 35% of colorectal cancer cases [15]. The mutations which occur in the 
development of the disease can be broadly divided into two groups, resulting in cancers with 
microsatellite instability (MSI) or chromosomal instability (CIN) [16], in addition to demonstration of 
the CpG Island Methylator Phenotype (CIMP) on tumour suppressor genes in ~40% of colorectal 
cancers [17]. With these, tumours can be classified into one of five subtypes via their molecular 
fingerprint [18], with the subtypes defined as: Type 1 (CIMP-high/MSI-high/BRAF mutation), Type 2 
(CIMP-high/MSI-low or microsatellite stable (MSS)/BRAF mutation), Type 3 (CIMP-low/MSS or 
MSI-low/KRAS mutation), Type 4 (CIMP-negative/MSS) and Type 5 (CIMP-negative/MSI-high). 
1.2.2.1 MSI pathway 
The MSI pathway arises from mutations to DNA mismatch repair genes and this pathway is thought 
to be the underlying cause of ~15% of colorectal cancer cases [19, 20]. While the mutations to 
mismatch repair genes are the driving force behind this type of carcinogenesis, MSI tumours have 
been found to contain a number of mutations to the Wnt signalling pathway [21], a key component 
of the proposed adenoma-carcinoma progression of colorectal cancer. Within this group of 
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colorectal cancers, there is the most common form of hereditary colorectal cancer, Hereditary Non-
Polyposis Colorectal Cancer (HNPCC, also referred to as Lynch syndrome), which accounts for 3% 
of diagnosed colorectal cancer cases [22]. This autosomal dominant disease increases the 
expected lifetime risk of developing colorectal cancer to 50-80% [23], with mutations found in the 
mismatch repair genes MLH1 [24], MSH2 [24], PMS1 [25], PMS2 [25] and MSH6 [26]. 
1.2.2.2 CIN pathway 
The CIN pathway accounts for the remaining 85% of cases not accounted for by the MSI pathway 
[27], with structural changes seen to many chromosomes [28]. The group of CIN tumours contains 
the subset of tumours, less than 1% of the total number of cases [22], formed as a result of the 
autosomal dominant disease familial adenomatous polyposis (FAP), which results in a 100% risk of 
developing colorectal over the average lifetime of patients [23]. The genetic cause of this disease 
was initially narrowed down to a gene found on chromosome 5 [29, 30], with the identification of the 
adenomatous polyposis coli (APC) gene as the one responsible for FAP coming in 1991 [31-34]. 
1.2.2.3 The adenoma-carcinoma progression of colorectal cancer 
Despite the different pathways in colorectal cancer development, there appears to be a sequence 
of key genes which are mutated at various points within the progression of this type of cancer. This 
adenoma-carcinoma progression was first proposed by Fearon and Vogelstein in 1990 [35] and 
has since been reported and refined by other parties [36-38] to incorporate ongoing research, such 
as the contribution of loss of heterozygosity (LOH) mutations to carcinogenesis [39]. The most 
recent adaption of this pathway was presented in Pinto and Clevers in 2005 [40] and is reproduced 
in Figure 1.1. This pathway demonstrates that major components of the Wnt signalling pathway are 
found at the beginning of this progression and that mutations to these genes are critical for the 
development of colorectal cancers. 
1.2.3 Risk factors for colorectal cancer 
While genetic factors can play a large role in determining the risk an individual faces for developing 
colorectal cancer over their lifetime, it has also been shown that lifestyle may affect the occurrence 
of the disease. Many of these are linked to the dietary behaviour of patients, with those adopting a 
‘healthy’ eating pattern with lower meat and increased fruit and vegetable consumption found to 
have a lower risk of developing colorectal cancer [41]. There is also a link between dietary 
diseases and colorectal cancer incidence, with links found between increased body-mass index, a 
sign of obesity, [42] and diabetes [43]. In addition to these risk factors, a clear correlation has been 
demonstrated between smoking [44] or alcohol consumption [45] and the incidence of colorectal 
cancer. 
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Figure 1.1: The adenoma-carcinoma progression of colorectal cancer. The initiation and development of 
colorectal cancer depends on a defined sequence of genetic mutations, adapted from Pinto and Clevers 
(2005) [40]. First hit mutations occur to key proteins in the Wnt signalling pathway to initiate tumour growth 
via aberrant crypt foci, while further mutations to known oncogenes further the progression of the disease 
to a carcinoma with metastatic growth. 
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1.2.4 Staging of colorectal cancer 
The stage at which a cancer is diagnosed has large implications for the treatment of the disease 
and the overall patient prognosis. There are currently two major systems of colorectal cancer 
staging in use, the Dukes system which was first proposed in 1932 [46] and the American Joint 
Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) system which was 
introduced in 1977 [47]. These systems use different criteria for determining the stage of a 
colorectal cancer tumour and are both used in the current literature. Many colorectal cancer cell 
lines were isolated and cultured prior to the introduction of the AJCC/UICC staging system and so 
are given with their Dukes classification, an example being the eleven cell lines established by 
Leibovitz et al in 1976 [48], while more recent work involving patient samples tends to use the 
AJCC/UICC system, such as the 2001 paper by Chan et al [49]. 
1.2.4.1 Dukes staging 
The Dukes staging system was initially proposed for rectal cancer [46] and defined three stages of 
the disease based on the spread of the tumour through the rectum as follows: 
A. Growth limited to the wall of the rectum; 
B. Extension of growth to extra rectal tissues, but no metastases in regional lymph nodes; 
C. Metastases in regional lymph nodes. 
These classifications based on the penetration of the tumour through the tissue layers of the 
rectum, as illustrated in Figure 1.2A, were also seen to have prognostic value, as those patients 
which were determined to have later stages of the disease had a lower probability of surviving for 3 
years after excision of the rectum. 
This system was then adapted by two papers in 1949, the first by Kirklin et al [50] proposed both 
the extension of the Dukes system to the classification of colon cancer and altered the layer of 
tissue penetration required to meet the criteria for each stage. Stage A tumours were defined as 
those confined to the mucosa; B1 tumours as those extending into, but not through, the muscularis 
propria; B2 tumours as those which had extended through the muscularis propria and stage C 
tumours as those stage B tumours which also had lymph node involvement. Meanwhile, 
separately, Dukes proposed a subdivision of stage C rectal tumours into C1 tumours where the 
lymph node involvement is limited to the regional lymph nodes and C2 tumours where distant lymph 
nodes were also involved [51]. These two proposals were combined by Astler and Coller in 1954 
[52] who also demonstrated that these adaptions to the initial staging system proposed in 1932 
were also sufficient to provide clear prognostic indicators for colorectal cancer patients, as the 5-
year survival for patients was decreased in those patients diagnosed with later stages of the 
disease and this observation was separately reported for rectal cancer by Dukes and Bussey in 
1958 [53]. 
[54] 
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Figure 1.2: The staging of colorectal cancer is dependent on the spread of the tumour. The extent of primary 
tumour spread through the tissue layers of the colon, image adapted from Ovalle and Nahirney (2008) [54], is 
used to determine the stage of colorectal cancer under A: the Dukes’ staging system, with the initial Duke’s (1932) 
[46] definitions on the left and the latest Newland et al. (1981) [57] definitions on the right, and B: the AJCC/UICC 
staging system, Edge et al (2011) [47], with the TNM definitions on the left and the prognostic groups on the right. 
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The fourth stage was first introduced in 1967 by Turnbull et al [55], which defined stage D tumours 
as those which had metastasised to the liver, lung or bone or had grown and invaded either the 
abdominal wall or adjacent organs. A method of defining tumours which had grown and become 
adherent to adjacent structures was also proposed by Gunderson and Sosin in 1974 [56] where the 
stages of B3 and C3 were proposed to defined those tumours in the absence and presence of 
lymph node involvement respectively. The proposals of Kirklin et al, Astler and Coller and 
Gunderson and Sosin have been grouped together to form the Modified Astler-Coller system for 
the classification of colorectal cancers. 
The final adaption to the Dukes staging system was proposed in 1981 by Newland et al [57] which 
subdivided the stage A tumours into A1 tumours limited to the mucosa, A2 tumours which had 
extended into the submucosa and A3 tumours which had extended into the muscularis propria. In 
line which these changes, B1 tumours were also redefined to include tumours which had spread 
beyond the muscularis propria and B2 tumours as those involving the serosa. Stage D tumours 
were also subdivided into D1 tumours where the primary tumour was remaining after surgical 
resection and D2 tumours which were present with distant metastases. The system defined here is 
also illustrated in Figure 1.2A and it is clear that over the various changes to the Dukes system, the 
extent of tumour spread in stage A and B tumours is smaller in later versions and the later versions 
have added in a method of defining colorectal cancer cases where distant metastases are present. 
While the staging of colorectal cancer via the Dukes’ system provides a progression for the spread 
of the tumour from the healthy colonic epithelium (Figure 1.3A) to the initial spread of the tumour 
mass (Figure 1.3B) and beyond, the tissue organisation of cancers within each staging group can 
vary. Whilst pathology of Dukes’ Stage B and C tumours demonstrate that both contain epithelial 
(arrows, Figure 1.3C-F) and stromal cells (arrowheads, Figure 1.3C-F), with the epithelial cells 
forming disrupted crypt structures, the proportion of these cell types can vary between patients, 
which has implication for patient prognosis [58]. 
Throughout the different versions of the Dukes’ staging system it has maintained its function as a 
prognostic tool as those patients diagnosed with later stages of the disease are seen to have lower 
survival rates. This is reflected in the latest released data for colorectal cancer cases in England by 
the National Cancer Intelligence Network [59]. This data shows that the 5-year survival rates for 
patients diagnosed between 1996 and 2002 were 93.2, 77.0, 47.7 and 6.6% for patients diagnosed 
with Dukes stage A through D respectively. 
However, due to the large number of alterations made to the Dukes system over the years and the 
lack of clarity in reporting which variant of the Dukes system a research group has employed, there 
can be discrepancies in the staging of tumours between different research groups. This was 
demonstrated by Raraty and Winstanley in 1998 [60] where pathology reports for 14 cases of 
colorectal cancer were distributed to 9 consultants for them to stage. The 9 consultants only 
reached a consensus on 6 of the 14 cases, with a split of 5:4 seen in one of the cases. This 
demonstrates that without a clear indication of which version of the Dukes system is employed at 
the point of diagnosis, the patient could receive an altered diagnosis which could affect the 
treatment options available and the overall patient prognosis. 
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Figure 1.3: Colorectal cancer disrupts the normal organisation of the healthy colon. A: the tissue layers of the 
healthy colon are clearly seen in histological samples and B: tumour growths disrupt these organised tissue 
layers. Examples of pathological samples from C and D: Dukes’ Stage B and E and F: Dukes’ Stage C 
tumours demonstrating the disrupted organisation of the tissue in addition to the varying level of carcinoma 
(arrows) and stromal (arrowheads) involvement in the tumours. Scale bars = 500μm for image A and 200μm 
for images B-F. 
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1.2.4.2 AJCC/UICC staging 
The AJCC/UICC staging system is currently on its 7
th
 edition, with updated staging criteria released 
every 4-7 years [47]. This system stages cancers based on scoring the extent of the primary 
tumour (T), the spread of the tumour to localised lymph nodes (N) and the absence or presence of 
distant metastases, including non-regional lymph node involvement, (M). Together the TNM scores 
are used to define the anatomic stage or prognostic group of the cancer. The general definitions for 
the TNM scores can be applied to all solid cancer types, with more specific definitions given for 
each cancer type. The current, 7
th
 edition, TNM score definitions for colorectal cancer are given in 
Figure 1.4A and illustrated in Figure 1.2B and these demonstrate the progress of the primary 
tumour through the layers of the colon or rectum as the disease progresses. The individual TNM 
scores are then used to grade the cancer from stage I through to stage IV and are given in Figure 
1.4B and illustrated in Figure 1.2B, with subdivisions used to clarify the extent of the spread of the 
primary tumour or the amount of metastatic involvement at each stage. 
While the TNM system provides a clearer system for staging colorectal tumours due to the 
increased detail given to describing the qualifying criteria for each TNM score, clarity in reporting 
this score is important as this system allows for the reporting of cancer staging based on clinical or 
pathological data. Some of these issues were raised by Compton in 2006 [61] which highlights that 
additional data, such as the level of lymphatic or vascular invasion into the primary tumour, is not 
included in the AJCC/UICC staging system but may be relevant for determining treatment options 
of the disease. 
The prediction of prognosis for patients is also not as clear as is seen with the Dukes staging 
system, as the 2005 Surveillance, Epidemiology and End Results (SEER) data from the USA 
demonstrated that patients diagnosed with either stage I and stage IIIA colorectal cancer had 
similar 5-year survival rates [47]. However, recent analysis by Gao et al [62] and Hari et al [63] 
have shown that the 7
th
 edition of the AJCC/UICC classification system is an improvement, in terms 
of predicting patient prognosis, over the 6
th
 edition, although there is still room for improving the 
definitions for each stage to allow for better treatment decisions for those patients diagnosed with 
stage II or stage III colorectal cancer. 
1.3 Cancer migration is a plastic process that leads to 
metastasis 
As seen from the patient survival rates for colorectal cancer of different stages, the further a tumour 
has spread through the body, the worse the prognosis. This demonstrates that the cancer hallmark 
of ‘tissue invasion and metastasis’, as defined by Hanahan and Weinberg [6, 7], represents a key 
tipping point in patient outcomes and is, therefore, of great interest in the arena of cancer research. 
The localised spread of the tumour through the neighbouring tissue, either by expansion through 
growth or collective migration, eventually leads to the dissemination of the tumour through the body 
in the form of metastases. 
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Figure 1.4: The AJCC/UICC staging criteria for colorectal cancer. The system uses A: the scoring of the 
spread of the primary tumour (T) through the localised tissue, the involvement of regional lymph nodes (N) 
and the presence of distant metastasis (M) to determine B: the prognostic groups to stage the disease 
based on its spread throughout the body. 
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1.3.1 Metastasis is a multistep process 
The transition of cancer cells from those in an expanding primary tumour to those forming 
metastases at distant sites relies on the changing behaviour of cells as they disseminate, in 
addition to a permissive microenvironment at the site of metastasis. This was highlighted in Paget’s 
1889 paper [64] which discussed the incidence of secondary tumours in various cancer types and 
noted that there were certain sites in the body which are more likely to be the site of secondary 
tumours based on the location of the original tumour, such as the higher incidence of secondary 
liver tumours in breast cancer patients as opposed to spleen or kidneys. From this observation he 
hypothesised what has become known as the ‘seed and soil’ method of cancer metastases, where 
the process is reliant on the characteristics of the migrating cancer cell, the ‘seed’, and the 
microenvironment of the site of metastasis, the ‘soil’. 
The step-by-step process which is involved in the mechanics of metastasis formation has been 
outlined by many sources, including a 2003 review by Fidler [65]. Here the steps of metastatic 
dissemination are given as the formation of a primary tumour followed by proliferation and 
angiogenesis at this site. Single cells then detach and invade the surrounding tissues and blood 
vessels before being picked up by the circulatory system and transported to distant organs. Within 
the blood vessels of these organs, the cancer cells then attach to the wall of these vessels before 
extravasating into the local tissue, where a permissive microenvironment is established prior to the 
proliferation and vascularisation of the metastatic legion. From this sequence of events, it is clear 
that the cancer cells must adopt a variety of behaviours to navigate each step successfully and one 
of the earliest of these is the adoption of a migratory phenotype. 
1.3.2 Cancer cells can adopt a variety of migratory mechanisms 
The process of cell migration depends on the repeated action of three basic steps to move the 
cells, namely attachment of the leading edge, contraction of the cell body and detachment of the 
trailing edge [66]. The switching between migration modes is mediated by the variable expression 
and distribution of a large number of proteins, from integrins and cadherins regulating cell 
adhesion, matrix metalloproteases (MMP) and cathepsins degrading the surrounding extracellular 
matrix (ECM) and the dynamic behaviour of actin and actin binding proteins to change cell shape 
[67]. 
With this variability in the proteins which can be involved in cell migration, there are three main 
methods of cell migration that cells can employ [68]. Collective, or epithelial-sheet, migration 
(Figure 1.5A) is a commonly occurring process in development and regeneration, particularly in 
epidermal wound healing [69]. In this mode of migration, adherens junctions between the cells are 
retained and the active actin polymerisation and ECM remodelling occurs at the front of the leading 
cells of migration which creates a path for the following cells to move through [68]. 
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Figure 1.5: Migrating cells can adopt one of three modes of migration. A: cells moving via collective 
migration retain cell-cell adhesion sites, with ECM degradation occurring in front of the leading cells, B: 
cells moving via mesenchymal migration do not retain cell-cell adhesion sites but still degrade the ECM in 
front of the migrating cell and C: cells migrating via amoeboid migration do not degrade the local ECM and 
use a dynamic actin cytoskeleton to squeeze through gaps in the ECM, adapted from Sahai (2005) [68]. 
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There are also two forms of single cell migration, mesenchymal and amoeboid [68]. Mesenchymal 
type migration (Figure 1.5B) is similar to the collective cell migration, with the degradation of ECM 
occurring in front of the migrating cell to generate a migration pathway. Cells undergoing this form 
of migration are characterised by a stereotypical elongated shape with the actin remodelling at the 
leading edge of the cell producing a variety of cell protrusions to allow the cells to form attachments 
to the ECM in the wake of the MMP activity. Cells migrating using the amoeboid method (Figure 
1.5C) have a more rounded cell shape and weaker adhesion to the surrounding ECM. These cells 
do not rely on the secretion of MMPs, or similar, to produce a pathway through the ECM and 
instead rely on a dynamic cell shape to squeeze between ECM filaments. 
With these different modes of migration available to cells, the mode of migration employed by the 
cells can be altered by the cells in response to environmental cues, with the physical 
characteristics of the ECM impacting the mode of migration utilised [70]. Cellular migration on 2D 
ECM gels is seen to favour collective migration, whereas the migration of cells through loose 3D 
ECM gels is mainly via amoeboid migration. The switching between the different types of migration 
in response to the environment is mediated by the altered expression of key protein groups, 
namely integrins, proteases and cadherins [71], which allows for the alteration of migration mode to 
suit the environment of the cells. 
1.3.3 The tumour microenvironment can direct migratory behaviour 
It is not just the ECM architecture that can direct the migratory behaviour of cancer cells, other 
factors in the microenvironment of the tumours can also affect cell migration. Larger solid tumours 
develop a hypoxic interior, necessitating the need for angiogenesis to sustain the tumour growth, 
one of the cancer hallmarks described by Hanahan and Weinberg [6, 7]. This oxygen deficient 
environment stimulates the activation of the transcription factor hypoxia-inducible factor (HIF) which 
mediates the cellular response [72]. Failure to adapt to the hypoxic environment via the growth of 
new blood vessels or alterations to cellular metabolism leads to the activation of migration 
associated genes in order to migrate out of the hypoxic environment. Another microenvironment 
trait which is linked to tumour hypoxia is the acidity of the tissue, as the lack of oxygen causes 
increased metabolism resulting in lactic acid and the lack of blood vessels leads to the poor 
removal of this lactic acid and CO2 [73]. Together this reverses the balance of intracellular and 
extracellular pH seen in healthy tissues and can affect the behaviour of proteins including actin-
binding proteins, leading to the activation of a migratory phenotype. 
In addition to the non-cellular factors which can drive migration, additional cell types within the 
tumour can act to progress cancer cells towards a migratory phenotype [74], while the presence of 
immune cells and fibroblasts in tumours have been implicated in poor patient survival [58, 75]. In 
particular, the presence of fibroblasts in cancer models has been shown to increase the level of 
cancer cell migration over that seen in fibroblast free models [76]. Further work looking at the 
mechanism by which the fibroblasts aid migration demonstrated that squamous cell carcinoma 
cells were able to migrate in a collective manner along pathways generated by the fibroblasts in 
ECM gels and that the presence of live fibroblasts aided their migration into the gels [77]. 
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1.3.4 The epithelial-mesenchymal transition is a key step in metastasis 
formation 
The epithelial-mesenchymal transition (EMT) has been implicated in the shifting patterns of gene 
expression seen in cancer cells during the development of a migratory phenotype. This transition 
acts to convert an epithelial cell to a mesenchymal cell and is common in development in order to 
allow the migration of cells to form organ structures [78]. The most basic protein markers for EMT 
are the upregulation of vimentin, coupled with the downregulation of E-cadherin [79], although the 
expression of many other proteins are also altered during EMT inducing the downregulation of 
adhesion proteins such as desmoplakin and occludin and the upregulation of selected MMPs [80]. 
The downstream effects of these changes to gene expression impact the adhesion and migratory 
capabilities of the cells, including the loss of adhesion to neighbouring epithelial cells and increased 
actin remodelling due to the increased activity of Rho [81]. 
It has also been shown that an EMT signature is correlated with the progression of colorectal 
cancer, as the expression of mutated H-Ras in the colorectal cancer cell line CaCo-2 was sufficient 
to induce an alteration in gene expression which correlated with the expected EMT signature in 
terms of vimentin and E-cadherin expression [82]. This EMT signature was also correlated with the 
altered expression of other proteins, such as the transcription factor Slug, which has previously 
been shown to be correlated with the progression of colorectal cancer. Another research group 
also demonstrated that the division of colorectal cancers into those with and without an EMT 
signature was sufficient to be a predictor of prognosis in separate patient cohorts and was 
determined to be a dominant program in the progression of colorectal cancer [79]. 
1.3.4.1 The physical characteristics of the growth environment impacts cell behaviour 
In addition to the changes seen when the dimensionality of the culture environment is altered, the 
physical characteristics of the 3D environment provided to the cells also affects cell behaviour. The 
stiffness of the 3D microenvironment can affect the adhesion of cells, with cells found to spread out 
more and produce larger colonies when cultured on stiffer gels, which is seen in conjunction with 
an increase in actin stress fibres [83]. As the elastic modulus of tissue culture plastic, as used for 
standard 2D culture, is far higher than that seen in healthy or tumorous tissue, this suggests one 
mechanism behind the difference in gene expression between 2D and 3D cultures which is not 
solely reliant on the spatial characteristics of the growth environment. 
Another research group has also demonstrated that the culture of 3D spheroids in a high-stress 
environment, as induced by the variable inclusion of microbeads in the agarose gels, directed the 
growth of the spheroid to form an oblate shape in relation to the stress fracturing of the gel [84]. 
This increase in external stress also induced a significantly higher amount of caspase-3 mediated 
apoptosis in the centre of the spheroids compared to those grown with no or low compressive 
stress. 
With the microenvironment playing a large role in directing the behaviour of cells it has been 
suggested that the application of engineering to tumours to revert the tumorous microenvironment 
back to a healthy microenvironment is one avenue for cancer research to pursue [85], as the 
reversion to a softer ECM environment may provide environment cues to the cancer cells to 
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modulate the expression and localisation of proteins, such as adhesion proteins, which may then 
have an impact on the migratory behaviour of the cells. 
1.4 The Wnt signalling pathway is key in the development of 
colorectal cancer 
Wnt signalling is vital for the development of the healthy colonic epithelium, but it has been shown 
to hold a key place in the development of colorectal cancers as it is consecutive mutations to genes 
in this pathway that forms the initial trigger point in Fearon and Vogelstein’s adenoma-carcinoma 
progression of colorectal cancer [35]. 
1.4.1 The canonical Wnt pathway 
In the canonical Wnt pathway [86], in the absence of a Wnt ligand, the scaffold protein Axin forms a 
complex with APC and glycogen synthase kinase 3β (GSK-3β) (Figure 1.6A). The β-catenin 
binding domains of APC bring the β-catenin protein into contact with GSK-3β, which in turn 
phosphorylates β-catenin and this phosphorylation of β-catenin then targets it for proteasomal 
degradation in the cytoplasm. However, once a Wnt ligand has bound to the Frizzled/lipoprotein 
receptor-related protein (LRP)5/6 co-receptor at the plasma membrane, the Axin/APC/GSK-3β 
complex is distupted as Axin is recruited up to the Frizzled/LRP5/6 co-receptor (Figure 1.6B). As β-
catenin is no longer targeted for proteasomal degradation, it translocates to the nucleus where it 
finds its transcription binding partners which include TCF-4 and LEF-1 [87]. This results in the 
transcription of many genes, including those implicated in EMT and tumour progression [88]. 
1.4.2 Wnt signalling determines cell behaviour in the healthy colonic 
epithelium 
The colonic epithelium is a tightly regulated system where the axis of proliferation vs. differentiation 
must be maintained to ensure a healthy, functional tissue. The cell types of the colonic epithelium 
each have distinct roles which collectively deliver the functionality of the colon. The absorptive 
enterocytes and mucous secreting goblet cells make up roughly 95% of the differentiated cells of 
the epithelium and are responsible for the functionality of the colon in terms of maintaining the 
homeostatic balance of water and electrolytes via the transport of ions including H
+
, Cl
-
, Na
+
 and 
HCO3
-
 across the apical membrane of the cells into and out of the colon lumen [89]. A further 1% of 
the remaining differentiated cells consist of the enteroendocrine cells which regulate the function of 
the gut via hormone secretion [90]. 
In addition to the different cell types found on the surface of the colonic epithelium, there is a 
population of cells, the Paneth cells, which reside at the base of the colonic crypts below the 
population of colonic stem cells [90]. The proteins secreted by these cells have a role in the innate 
immunity of the colon and may help to regulate the healthy gut flora which is found there. The 
differentiation pathways to each of these mature cell types is controlled by a balance of Wnt and 
Notch signalling, with Wnt signalling driving the proliferation vs. differentiation axis, while the Notch 
signalling controls the balance between the secretory and absorptive cell types [90]. 
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Figure 1.6: Schematic of the Wnt signalling pathway. A: In the absence of the Wnt ligand Axin, APC and 
GSK-3β form a complex which targets β-catenin for proteasomal degradation and prevents its 
translocation to the nucleus. B: In the presence of the Wnt ligand, the Axin/APC/ GSK-3β complex is 
disrupted by the recruitment of Axin to the plasma membrane, β-catenin is no longer targeted for 
proteasomal degradation and translocates to the nucleus to find its binding partners TCF-4 and LEF-1 to 
initiate transcription of β-catenin target genes, including those associated with EMT. 
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In mice, inhibition of the Wnt pathway by transgenic overexpression of its protein antagonist 
Dickkopf1 (Dkk1), which interacts with the membrane protein LRP6 [91], inhibits the proliferative 
activity of the cells, as seen by the lack of the proliferation marker Ki-67 or low uptake of the 
synthetic nucleoside Brd-U [92]. This overexpression was also found to disrupt the morphology of 
crypts seen on histological sections, in addition to disrupting the pattern of nuclear β-catenin 
localisation. This aberration of the natural patterning of Wnt leads to a loss to crypt phenotype, as 
visualised by the absence of the crypt marker Enc-1, and the depletion of the three secretory cell 
types of the epithelium, the goblet, enteroendocrine and Paneth cells, while preserving the 
distribution of absorptive enterocytes, as visualised by the alkaline phosphatase (AP), across the 
epithelium. 
Studies on mice which are homozygous negative for the Tcf7l2 gene, which encodes the β-catenin 
binding partner TCF-4, also demonstrate a disruption in intestinal epithelial morphology [93], 
although this study looked at the role in the development of the small intestine as opposed to the 
colon. The lack of TCF-4 disrupted the formation of intestinal crypts in the intervilli regions by 
producing cells which have characteristics of cells found in the villi, such as microvilli and the 
supranuclear arrangement of Golgi bodies. The lack of true crypts led to no detectable 
enteroendocrine cells in the Tcf7l2
-/-
 mice and a lack of detectable cell division, again seen by 
analysing Ki-67 expression and Brd-U uptake, in the latest stages of embryonic development from 
E16.5 onwards. This disruption to cellular organisation was confined to the small intestine and led 
to Tcf7l2
-/-
 pups dying within 24 hours of birth. Other work with TCF-4 null mice has also show that 
the removal of TCF-4 activity removes the expression of β-catenin/TCF-4 transcription targets, 
such as Enc-1, in the prospective crypts while promoting the expression of the differentiation 
markers p21 and FABP2 [94]. 
Downstream targets of Wnt signalling have also been found to drive cellular behaviour [95]. The 
proliferating compartment of the epithelium expresses the tyrosine kinase receptors EphB2 and 
EphB3, while the differentiating cells of the colonic epithelium express the ligands ephrin-B1 and 
ephrin-B2. Null mutations or kinase inactivity in the receptors negatively impacts the rate of cell 
proliferation but does not affect the level of apoptosis seen in the epithelial cells, while 
overexpression of ephrin-B2 causes an increase in observed cell proliferation. The lack of kinase 
activity also affects the distribution of the proliferative and Paneth cells within the crypt. It is thought 
that the inhibition of cell proliferation is caused by a reduction of cells entering the cell cycle as 
opposed to a reduction in size of the stem cell population and that the interaction between the 
ephrin ligands and the Wnt induced EphB receptor defines the domain of proliferation inside the 
colonic crypt. 
1.4.3 Colorectal cancers have abnormal patterns of Wnt signalling 
While Wnt signalling has a key physiological role in the maintenance of a healthy colonic 
epithelium, mutations to proteins within the pathway have been implicated in driving the 
development and progression of colorectal cancer [35]. Analysis by Albuquerque et al of the 
mutations present in the Wnt pathway genes APC, CTNNB1 and AXIN2 in HNPCC in addition to 
sporadic cases [96] was pooled with the data from 12 separate cohorts [21, 97-107] to demonstrate 
that ~90% of colorectal cancers possess a mutation in any of these three genes. 
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Many genes which are found to be upregulated in colorectal cancer are either genes which are 
directly involved in the Wnt signalling pathway, namely APC, LGR6 and TCF7L2, or downstream 
transcription targets of the Wnt pathway, such as MMP2, EPHB6, RET and K61RS3 [108]. 
Additionally, during EMT mediated progression of the disease, the expression Wnt signalling 
transcription mediator β-catenin and Wnt transcriptional target keratins are found to vary, which 
may be a result of Wnt signalling driving the EMT [109]. 
Mutations to APC are common in a variety of colorectal cancer cell lines [110] and tumour samples 
taken from patients with both hereditary and sporadic colorectal cancers [34]. This protein has long 
been one of interest to those studying the genetic causes of colorectal cancer as it was originally 
identified as the mutated gene which causes the autosomal dominant condition FAP. Due to the 
incidence of loss of heterozygosity (LOH) mutations during the progression of colorectal tumours 
[39], the inheritance or the sporadic acquisition of a mutated APC gene is seen as important step 
along the adenoma-carcinoma transition [37, 38]. 
The introduction of a full-length APC protein into the colorectal cancer cell line SW480, which 
possesses a truncated APC protein [110], causes a variety of changes to the cells [111]. The 
change of β-catenin localisation from nuclear in control SW480 cells to peripheral localisation in 
APC transfected cells leads to a change in the cell morphology in 2D cultures, with the APC 
transfected cells producing colonies where the cells had an increasingly epithelial morphology and 
the cells within the colonies were more tightly packed together. This alteration to cell morphology is 
accompanied by an upregulation of E-cadherin expression and its redistribution to the plasma 
membrane. This redistribution of both the β-catenin and E-cadherin does not appear to be 
mediated by the cortical distribution of actin filaments seen in the APC transfected cells, as 
disruption of the actin cytoskeleton via cytochalasin D does not affect the peripheral distribution of 
either. The introduction of APC also decreases the cell proliferation rate of the SW480 cells, 
resulting in smaller colonies formed on soft agar and significantly less tumour growth after injection 
into Balb/c mice. The migratory capacity of the cells is also reduced with fewer single cells moving 
into the wound of a 2D scratch wound assay after 24 hours, as the introduction of the APC protein 
appears to push the cells towards the epithelial sheet form of migration. 
Inhibition of β-catenin/TCF-4 mediated gene transcription by transfection with a dominant negative 
variant of TCF-4 (dnTCF-4) led to a reduction in the proliferation rate of colorectal cell lines and 
induced the expression of the cell cycle regulator p21 [94]. It is thought that the diversion of the 
colorectal cancer cells from a proliferative phenotype to a differentiated phenotype is mediated via 
the downregulation of the Wnt target gene and transcriptional regulator c-MYC lifting the inhibition 
of p21 expression and leading to cell cycle arrest induced differentiation. This data suggests that 
the extended range of nuclear β-catenin localisation in colorectal cancers is a primary driver of the 
excessive proliferation seen in tumours and that targeting the β-catenin/TCF-4 transcriptional 
activity in these cells would cause the spontaneous differentiation of tumours and may be of value 
as a therapeutic strategy. 
When taken with the increased β-catenin mRNA and protein expression at the leading edge of 
invasion in liver metastasis [112], it becomes clear that the transcription of Wnt target genes is 
involved in both driving colorectal cancer formation and its dissemination into distant tissues. This 
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pathway is therefore of interest when investigating colorectal cancer cell migration as disruption of 
Wnt signalling may disrupt the migratory behaviour of the cancer cells. 
1.5 IGF-I signalling has been implicated in the cancerous 
transformation of cells 
Another biological pathway which can feed into the Wnt signalling pathway and affect cell 
behaviour is the IGF-I pathway. 
1.5.1 Biological function of Insulin-like Growth Factor-I 
Insulin-like Growth Factor-I (IGF-I) is a 70 amino acid, 7.649kDa polypeptide with high homology to 
proinsulin [113]. The action of IGF-I is mainly mediated by the IGF-I receptor (IGF-IR), a 
transmembrane receptor tyrosine kinase which shares high homology with the insulin receptor, 85 
and 65% for the cytoplasmic and extracellular domains respectively [114]. Due to the high 
homology between these two receptors, cross-reactivity between insulin and IGF-I and both of their 
receptors has been demonstrated [115]. Additionally, due to the high homology between IGF-I and 
IGF-II [116], there is also binding of IGF-II to the IGF-IR [117] and all of these binding partnerships 
were visualised by the displacement of 
125
I labelled peptides from the receptors. While binding with 
different substrates has been demonstrated, the IGF-IR displays a higher binding affinity for IGF-I, 
with IGF-II and insulin displaying 2- and 100-fold less potency, respectively, at displacing 
125
I 
labelled IGF-I from the IGF-IR binding site than unlabelled IGF-I [118]. 
IGF-I expression is induced by growth hormone (GH), with long and short term effects on mRNA 
and protein levels reported. A single dose of GH led to an increase in mRNA production in liver 
cells without a corresponding increase in the serum protein levels, whereas daily doses over 5 
days significantly increased the serum levels of IGF-I detected via a radioimmunoassay [119]. This 
study also assessed the effect of administering GH on IGF-I related proteins such as IGF-II and the 
IGF binding proteins IGFBP-1, IGFBP-2, IGFBP-3 and ALS, demonstrating that changes in mRNA 
and serum protein levels are different for the different proteins and alter over time. Administration of 
GH to GH-deficient adults over a two week course has also been shown to increase serum levels 
of IGF-I, with the continual infusion of GH via a pump resulting in higher levels than induced by 
single daily injections of the same dose [120]. The changes induced by GH are also seen to have 
longer term effects with continual daily doses injected into patients, as after 3 or 6 months 
treatment the base level of IGF-I, either unbound or total, was increased relevant to the control 
[121]. This increase to the baseline levels did not dampen the immediate response to the 
administration of GH, the level of IGF-I still rose the same amount after the GH dose, however the 
starting value was higher in the samples at 6 months. 
The production of IGF-I has been found to be localised to mesenchymal derived cells in a variety of 
human fetal tissues by histochemical hybridisation analysis [122], which demonstrates the capacity 
for tissue-specific paracrine signalling via IGF-I in addition to secretion into the circulating blood. A 
similar study on rat fetal and adult tissues also demonstrates the wide range of fetal tissues which 
express IGF-I mRNA, although they do not look at the specific tissue components that are 
responsible for this [123]. This paper demonstrates that the abundance of IGF-I mRNA is 
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decreased in the adult tissue comparative to the fetal samples, with the exception of the liver where 
there is a 10-fold increase in the amount of IGF-I mRNA in the adult tissue. The blood serum levels 
of IGF-I have been characterised in different populations [124-126] and shown to peak in childhood 
before declining with age, with slight variation between the levels seen in men and women, 
although it is noted that this may be a product of experimental variation between cohorts [124]. 
The IGF-IR is a homodimer tyrosine kinase receptor which comprises two extracellular α subunits 
and two transmembrane β subunits which possess intercellular kinase domains [114]. Binding of a 
ligand to the extracellular domain of IGF-IR leads to the autophosphorylation of the intercellular 
domains of the β subunits [127] and interaction with further target proteins, insulin response 
substrate-1 (IRS-1) [127, 128] and Shc [129] (Figure 1.7), both of which are signalling mediators 
also activated by the insulin receptor. When activated by the insulin receptor, IRS-1 is 
phosphorylated and has been shown to recruit phosphatidylinositol 3-kinase (PI3K), via the SH2 
domains of the p85 regulatory subunit, in order to stimulate further signalling interactions [130], 
although it has been noted that the p85 subunit of PI3K is not phosphorylated at the tyrosine 
residues after stimulation by insulin and that this is not required for successful activation of PI3K 
[131]. Furthermore, the mitogenic activity stimulated by IGF-I in the human breast cancer cell line 
MCF-7 is mediated by PI3K, as the increase in DNA synthesis, as visualised by 
3
H-thymine 
incorporation, and cyclin D1 mRNA and protein expression, as visualised by Northern and Western 
blots respectively, are all eliminated by the small molecule PI3K inhibitor LY294002 [132]. 
Binding of IGF-I to the IGF-IR causes the phosphorylation of tyrosine residues within the Shc 
protein, causing it to associate with the intercellular domain of IGF-IR [129]. This association 
between the proteins is not mediated by the SH2 domains of Shc [129] and are instead via 
interaction of the amino domain of Shc [133] with the Shc and IRS-1 NPXY binding (SAIN) domain 
of IGF-IR [134]. Although the binding domain on IGF-IR is not within the tyrosine kinase region of 
the protein, the autophosphorylation of IGF-IR is necessary for the binding of Shc, as mutations of 
the tyrosine residues to phenylalanine inhibits this binding [133]. Additionally, while IRS-1 and Shc 
share the same binding site on IGF-IR, there is no detectable interaction between these two 
proteins in vitro [135]. The signalling cascade mediated by the interactions of IGF-IR and Shc is 
continued via the association of Shc with SH2 domain of Grb2 and further signalling cascades via 
Ras [136]. This signalling cascade also affects the mitogenic behaviour of cells as microinjection of 
a Shc antibody or the dominant-negative N17 ras protein into rat fibroblasts inhibited IGF-I induced 
DNA synthesis, visualised via BrdU uptake [129, 137]. 
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Figure 1.7: Schematic of the IGF-I signalling pathway demonstrating the interaction with the Wnt signalling 
pathway. IGF-I binds to the IGF-IR which results in signalling cascades via IRS-1 and Shc. The Shc mediated 
cascade feeds into the Ras/MEK/ERK pathway. The IRS-1 mediated cascade results in the PI3K/PKB 
mediated inhibition of GSK-3β. This results in the accumulation of β-catenin, which translocates to the nucleus 
and mediates transcription of EMT associated genes via interaction with various binding partners. 
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1.5.2 Interaction between the IGF-I and Wnt signalling pathways 
Cross talk between the downstream signalling cascades of IGF-IR and the Wnt signalling pathway 
were first noted by Cross et al in 1994 [138] with a demonstration of the IGF-I inhibition of the 
activity of both GSK-3α and GSK-3β in L6 rat skeletal muscle cells, with GSK-3β being a key 
protein component of the Wnt signalling pathway. This IGF-I mediated GSK-3β inactivation was 
reversed by the pre-incubation of the L6 cells with the potent PI3K inhibitor wortmannin. As 
wortmannin was also shown to inhibit the IGF-I mediated activation of a variety of protein 
components of the MAPK cascade, it was initially suggested that the mechanism of the GSK-3β 
inhibition was via members of this pathway, such as MAPKAP kinase-1β. Further work from this 
group later demonstrated that it was protein kinase B (PKB), a protein found downstream of PI3K 
signalling, which was the signalling mediator of the IGF-I induced GSK-3β inactivity [139] (Figure 
1.7). This was demonstrated via the relative activation half-times for PKB and MAPKAP kinase-1β, 
1 and 5 minutes respectively, compared to the 2 minute half-time for GSK-3β inhibition, in addition 
to its sensitivity to wortmannin and not the MAPK signalling inhibitor PD 98059. 
Further evidence of the role of PKB in the inactivation of GSK-3β was provided by the utilisation of 
a dominant negative PKB mutant which possesses a C-terminal CAAX motif which targets it to the 
plasma membrane [140]. This domain negative mutant was sufficient to reverse the insulin 
mediated inactivation of GSK-3β. This paper also demonstrated that the inhibition of GSK-3β 
activity was via a direct interaction between PKB and GSK-3β, as the two proteins were seen to co-
immunoprecipitate from lysates of a variety of cell lines. 
Following the work examining the inhibition of GSK-3β activity by IGF-I, the effect of IGF-I 
signalling on β-catenin and E-cadherin was examined in a variety of colorectal cancer cell lines 
[141]. This work demonstrated the highly variable expression of the IGF-IRβ subunit mRNA across 
the cell lines, but also demonstrated that the higher levels of expression were correlated with a lack 
of mutation to the APC, β-catenin and E-cadherin proteins. Working on the c10 cell line, which 
expresses wild-type APC, β-catenin and E-cadherin and a high level of IGF-IR, it was 
demonstrated that stimulation of these cells with IGF-I decreased the binding of β-catenin to E-
cadherin. As the IGF-I altered the phosphorylation of E-cadherin bound proteins; the same effect of 
decreased β-catenin was mimicked with the use of the tyrosine phosphatase inhibitor pervanadate. 
This dissociation from E-cadherin led to the relocation of β-catenin from the plasma membrane to 
the cytoplasm of the cells following IGF-I stimulation. Together with the inhibitory effect of IGF-I on 
GSK-3β activity, stimulation of cells with IGF-I doubled the half-life of β-catenin within these cells, 
although this was not sufficient to cause an increase in β-catenin mediated gene transcription and 
required incubation with the GSK-3β inhibitor lithium chloride to induce a transcriptional response. 
While IGF-I stimulation alone was not sufficient to induce β-catenin mediated gene transcription in 
the c10 cell line with wild-type β-catenin, it is sufficient to induce β-catenin mediated gene 
transcription in the HepG2 hepatoma cell line which expresses the wild-type isoform of β-catenin in 
addition to a truncated version which lacks the GSK-3β regulatory subunits [142]. This activation of 
gene transcription relied on PI3K/PKB signalling, as expression of the dominant negative versions 
of PI3K and PKB resulted in a ~90% reduction in the IGF-I induced gene transcription, while the 
expression of constitutively active versions of these proteins both resulted in an increase of 
transcriptional activity of β-catenin target genes in unstimulated cells. The alteration to β-catenin 
23 
mediated gene transcription in the HepG2 cell line was also reliant on the inactivation of GSK-3β, 
as previously seen in the c10 cells, as the expression of the uninhibitable A9GSK-3β mutant 
protein removed the IGF-I induced gene transcription. However, expression of the inactive 
R85GSK-3β mutant displayed an additive effect with IGF-I on the induction of β-catenin mediated 
gene transcription, which implies the role of a second downstream pathway of IGF-I signalling in 
the alteration of gene expression. This additional signalling was identified as the Ras/MEK/ERK 
pathway downstream of Ras activation, as expression of R85GSK-3β along with either activated 
Ha-Ras or constitutively active MEK1 induced a greater level of β-catenin mediated gene 
transcription than R85GSK-3β alone. 
Together these papers demonstrate that signalling via components of the Wnt signalling pathway is 
one means of signal transduction from IGF-I stimulation of cells and from this it is hypothesised that 
the induction of IGF-I signalling would provide cellular responses in line with those seen when there 
is a high level of Wnt signalling. In the context of the experimental work here, it is hypothesised that 
IGF-I signalling would induce a migratory response in cells within a migration assay, while inhibition 
of IGF-I signalling would decrease the amount of cell migration. 
1.5.3 Role of IGF-I in cancer 
With its interaction with a range of downstream signalling mediators, IGF-I signalling has been 
implicated as a pathway with an involvement in cancer development and prognosis. The initial work 
on the role of the IGF-I pathway in the transformation of cells to an immortalised phenotype was 
carried out on mouse embryonic fibroblasts by Sell et al [143], where the group established a 
fibroblast cell line, R
-
 cells, from Igf1r
-/-
 mice. These cells were found to have half the growth rate of 
the wild type (W) cells during adherent culture in standard DMEM supplemented with 10% FCS, 
while being unable to increase in number when the media supplement was a combination of 
platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and IGF-I. Upon transfection 
with a plasmid for the temperature sensitive simian virus 40 large tumor antigen (SV40 TAg tsA58), 
a known transforming agent of mouse cells, W cells show a 2.7-fold increase in cell growth under 
hygromycin selection, whereas the R
-
 cells only display a 30% increase over the same culture 
period. 
In addition to the negative impact on standard in vitro culturing, the homozygous null mutation in 
IGF-IR also retards the ability of the fibroblasts to form colonies on soft agar following transfection 
with SV40 TAg [143]. Only one example of colony formation in an experiment utilising the SV40 
TAg tsA58 transfected R
-
 cells observed, while transfection with the wild-type SV40 TAg resulted in 
no colonies. In comparison, SV40 TAg transfected W cells were capable of forming colonies at all 
seeding densities tested, regardless of if the SV40 TAg plasmid contained the wild-type or 
temperature sensitive variant. Transfection of the R
-
 cells with human IGF-IR cDNA resulted in a 
partial rescue of the wild-type phenotype, with these cells capable of colony formation after SV40 
TAg transfection, although with lower efficacy than demonstrated by W cells. 
Further work by the same group demonstrated that an underlying reason for the alteration in cell 
proliferative behaviour between the W and R
-
 cells was an extension of the length of the cell cycle, 
with R
-
 cells spending longer in all stages of the cycle resulting in a 2.5-fold increase in total 
duration when compared to W cells [144]. Additionally, while the distribution of cells found in each 
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stage of the cell cycle was comparable between the W and R
-
 cells in the early stages of culture, R
-
 
cells were less susceptible to re-entry into S phase following quiescence than their W cell 
counterparts, with only the inclusion of 10% FBS in the growth media capable of inducing DNA 
replication. 
As this work demonstrated a clear alteration to cellular behaviour in cells lacking functional IGF-IR, 
the R
-
 cells were transfected with an activated variant of Ras, as it is a known downstream 
mediator of many tyrosine kinase growth factor receptors, such as IGF-IR, to investigate if this 
could rescue the observed phenotype. This transfection had no effect on the ability of R
-
 cells to 
form colonies in soft agar, even in conjunction with SV40 TAg transfection, thus suggesting that the 
presence of a functional IGF-IR occupies a critical role in the transformation of cells and has since 
been an object of investigation in the arena of cancer research. 
Circulating IGF-I levels have been found to impact the establishment of colorectal cancer tumours 
in mouse models and liver-specific IGF-I deficient (LID) mice have been used to achieve this as 
they have lower levels of serum IGF-I than control mice [145, 146]. Intraperitoneal injection of the 
potent colorectal cancer inducer azoxymethane for a period of 2-4 weeks can be used to induce 
aberrant crypt foci and, subsequently, tumours, with the mice killed at 4 and 26-27 weeks for the 
examination of each respectively [145]. The occurrence of aberrant crypt foci was found to be 
significantly reduced in female LID mice, but not males, compared to the control mice, while the 
incidence of tumours was found to be reduced in LID mice regardless of the gender. At least 85% 
of the tumours produced had progressed from adenoma to adenocarcinoma in both female and 
male, control and LID mice although the tumours from control mice were consistently larger than 
those from LID mice. 
Another study induced tumours by suturing Colon 38 mouse adenocarcinoma tissue to the cecum 
of control and LID mice before harvesting 6 weeks later [146]. Again, it was observed that more 
control mice produced tumours, 57% of control mice compared to 31% LID mice, which were larger 
than those produced in the LID mice and they had a shorter latency period before the growth was 
visible. In addition, the control tumours had a higher abundance of blood vessels, which were 
observed from counts made on histologically prepared samples. Intraperitoneal injection of IGF-I 
into the LID mice raised the serum levels of IGF-I to a level which is comparable to the control mice 
injected with saline. IGF-I injection increased the percentage of mice displaying tumour growth by 
20% in the control mice and by 32% in the LID mice and it also increased the size of these tumours 
in both groups. The effects seen were thought to be due to the differing levels of serum IGF-I 
between the subject groups, as the level of IGF-IR expression within the tumour tissue obtained 
from all four groups was consistent. 
With the growing body of evidence for the involvement of IGF-I signalling in colorectal cancer 
behaviour, there have been multiple studies investigating if plasma levels of IGF-I could be used as 
an indicator of risk for the development of colorectal cancer in patients. The results from these 
studies are variable, with some, a study looking at Cretan men and women and another at US men, 
demonstrating an increased risk for colorectal cancer with elevated plasma IGF-I levels [147, 148], 
while others, one looking at Chinese men and another at European men and women, demonstrate 
no association between plasma IGF-I levels and risk [149, 150]. Similarly, there has been study 
looking at Swedish men and women demonstrating that elevated plasma IGF-I has a role in colon 
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cancer development, but not rectal cancer [151]. Meta-analysis across multiple studies shows a 
small association between elevated plasma IGF-I levels and increased risk of colorectal cancers 
[150, 152], this meta-analysis is a benefit of pooling the data from multiple cohorts, as IGF-I levels 
are known to vary in healthy adults. Additionally, a study into colorectal cancer mortality rates in 
American men found that elevated plasma IGF-I levels are associated with a higher mortality rate 
from colorectal cancer, for age adjusted data as age is also a mortality risk [153]. 
1.6 3D culture models are more relevant to the in vivo biological 
situation 
For many years there has been ongoing work on the development of 3D models in order to capture 
aspects of the in vivo environment, such as the diffusion of molecules through tissues or the effect 
of interstitial fluid flow on the concentration of secreted proteins [154]. The advantages of 3D 
culture methods were identified early in the development of techniques, when tissue explants and 
spheroids were the main methods in use [155], and many reviews have been produced outlining 
the progress of this field, particularly in the arena of 3D cancer models [156-164]. 
1.6.1 Standard 2D culture imparts changes to gene expression in cells 
The emergence and increase of research into the development and characterisation of 3D models 
for cell culture has been carried out in line with increasing evidence supporting the problems with 
standard cell culture in 2D. Alterations to gene expression have been noted in a wide variety of 
cellular functions, such as proliferation and metabolism, with cell lines demonstrating an altered 
gene expression profile when compared back to the tissue of origin [165]. 
A study into the 3D morphology of breast cancer cell lines demonstrated that there was a 
significant alteration to the expression of proteins associated with signal transduction when 2D and 
3D cultures were compared, in addition to differences between cultures with differing 3D 
morphologies [166]. In addition to this change in gene expression, when cultured in 3D, the cell line 
adopted one of four distinct morphologies, round, stellate, mass and grape-like, which did not 
correlate with the morphology of the cells under standard 2D culture on tissue culture plastic. The 
culture of hepatocellular carcinoma cells in a 3D gel also induced alterations to gene expression, 
including the upregulation of a range of MMPs and the focal adhesion proteins paxillin and focal 
adhesion kinase (FAK) [167]. With the protein composition of cell adhesion sites also altered 
between 2D and 3D culture [168], the body of evidence demonstrating a difference in protein 
expression and localisation between 2D and 3D is showing an increased need for 3D culture 
systems. 
With the demonstration that the 3D culture of breast cancer cell lines can alter their response to 
chemotherapy and promote drug resistance [169], the use of 3D cultures to aid drug development 
in the pharmaceutical industry has been proposed as another application of 3D technology in 
addition to more investigative biological research [170]. However, as the authors of this paper note, 
there needs to be a standardisation of 3D culture methods which meet various criteria of the 
industry, such as the scalability of the models and the option for high-throughput screening, before 
the wide spread use of 3D technology as a tool in this industry. 
26 
1.6.2 3D models are becoming more biologically relevant 
The induction of in vivo like characteristics can be achieved through a variety of methods which are 
now available to biological researchers, from the use of perfusion on cell monolayers to mimic 
interstitial fluid flow [171] to the use of 3D culturing techniques. As technology in other fields, such 
as engineering, has progressed, the methods of 3D culture have become more complex in the aim 
to model the microenvironment found in tissues [172]. 
1.6.2.1 Explant cultures 
One of the earliest forms of 3D culture employed was the maintaining of tumour explants in vitro. 
Tumour samples were cut down to explants 1-2mm
3
 in size before placing onto culture plates 
(Figure 1.8A), allowing them to remain viable for long time periods [173] whilst maintaining 
characteristics of the original tumour tissue such as structural characteristics and carcinoembryonic 
antigen production as seen in colorectal cancers [174]. The primary culture of these explants is 
also able to predict the chemosensitivity of tumours, as the response of explant tissue to the 
antimitotic drug SN-38 was comparable to the in vivo response observed in patients [175]. 
As explant cultures are a method of primary culture, these cultures retain many of the 
characteristics of the original tumours and have an application in determining the best course of 
treatment to take for individual patients. However, the tumour samples from which these explants 
are derived need to be prepared immediately after excision to retain the viability of the sample, 
which limits their usage as a laboratory model to those research laboratories with ties to surgical 
departments and with the appropriate licenses to work on primary human tissues. As the excised 
tumours contain a proportion of fibroblast cells, which will outgrow the other cell types in the 
explant, the explants need to be plated in an environment which limits this fibroblast outgrow, such 
as on poly-2-hydroxyethylmetacrylate (PolyHEMA) coated plates [175]. Additionally, these primary 
cultures are prone to infection [174] and require extensive treatment with antibiotics and antifungals 
in order to maintain uninfected cultures. 
1.6.2.2 Spheroids 
Spheroids are another form of 3D cancer cultures which have been around for many years. These 
multicellular aggregates (Figure 1.8B) do not contain many of the structural features prevalent in 
tumour samples, however, they do provide a model for the heterogenic distribution of oxygen, 
nutrients and waste products across a tumour [176]. With a declining supply of oxygen in the centre 
of these in vitro spheroids, the proliferating cells are found in the outer layers of the structure, 
surrounding a necrotic core, which is analogous to the regions of cell necrosis seen in regions 
between capillaries in tumours [177]. This system also permits co-culture, with studies into the 
infiltration of monocytes into spheroids [178] and the interaction between spheroids and collagen 
embedded fibroblasts [179] documented. 
This simple model of cancer has applications for use on many cell lines where the formation of 
aggregates is possible and does permit co-culture with additional cell types to increase the 
complexity of the model. However, from the evidence presented in the literature, the size of the 
generated spheroids has the potential to vary which could give rise to variable results when 
subjected to cellular assays and must be controlled for. 
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Figure 1.8: 3D models of cancer can model different aspects of the tumour microenvironment. A: explant 
cultures retain structural features of the original tumours, B: spheroid cultures model cell-cell interactions 
and the hypoxic interior of tumours, C: ECM gel cultures provide a 3D protein environment for cancer cells, 
D: scaffold cultures provide a 3D environment in the absence of biologically signalling, E: stratified 
organotypic cultures combine a 3D microenvironment with biological signalling from ECM proteins and 
secondary cell types and F: encapsulated organotypic cultures combine the aspects of the stratified 
organotypic cultures with the hypoxic gradients seen in spheroid cultures. 
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1.6.2.3 ECM gel cultures 
The seeding of cancer cells in an ECM gel recreates some of the spatial and protein cues of the 
tumour microenvironment (Figure 1.8C). The protein composition of these gels can be varying to 
study the effect of different ECM components, from how mutations in colorectal or breast cancer 
cells disrupts the formation of crypts [180] or acini [181] in response to basement membrane 
proteins as provided by Matrigel, a commercially available soluble extract of Engelbreth-Holm-
Swarm (EHS) mouse sarcoma tumours which gels at 37
o
C [182]. The presentation of these ECM 
gels can be as large scale gels in well plates, or encapsulated in synthetic hydrogels to provide an 
array for high throughput screening [183]. In addition to gels made from extracted ECM proteins, 
decellularised gels derived from the culture of secondary cell lines, such as fibroblasts, can be 
employed [184]. A variation of collagen gel cultures is the collagen gel droplet embedded culture 
drug sensitivity test (CD-DST), where cells from tumour samples are suspended in collagen and 
plated as 30μl droplets into well plates [185]. This CD-DST method has been used to assess the 
chemosensitivity of human colorectal carcinomas in response to a range of chemotherapy drugs, in 
addition to assessing the effect of the expression of multidrug resistant proteins has on 
chemosensitivity [186]. 
When compared to thin gel coating on tissue culture plastic, these 3D gels have been shown to 
affect the proliferative response and response to chemotherapeutic drugs [184], demonstrating that 
the 3D environment they recreate is affecting cell behaviour. While they also provide a protein 
substrate, in gels which are composed of a single protein, the microenvironment provided is not as 
complex as the in vivo situation, whereas those made from multiple proteins, such as Matrigel 
[182], may lack the organisation of the different protein types seen in vivo, leading to conflicting 
microenvironment cues. These models also lack the interaction between the cancer cells and 
alternative cell types, limiting the intercellular signalling, which can direct cell behaviour. 
1.6.2.4 Synthetic scaffolds 
Another method of introducing a 3D environment to in vitro cultured cells is by the use of synthetic 
scaffolds (Figure 1.8D). These polymer based scaffolds can be made from a wide range of 
materials to highly specialised specifications to produce materials with differing culturing 
characteristics [172]. These materials can be biologically active or inert and can be used with [187] 
or without [188] an ECM coating to promote cellular adhesion. 
When biologically inert scaffolds are employed, they provide the opportunity to observe the effects 
of dimensionality of the culturing environment in the absence of signalling cues which may arise in 
an ECM gel based system. These systems also allow for ECM coatings and co-culture, so they can 
be used to build a step-wise model of cancer to investigate the effect of different components of the 
microenvironment on the behaviour of the cancer cells. If these scaffold systems are commercially 
manufactured and distributed, then the quality control processes would provide a consistent 
product, eliminating variability between experiments and allowing the accumulation of a wide data 
set. However, due to the wide variety of materials and structures available [172], the process of 
optimising the growth of cancer cells on materials would need to occur to ensure consistent, viable 
cultures and the optimal methods for one material may not transfer across to others. 
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1.6.2.5 Organotypic cultures 
The combination of cancer cells, ECM gels and secondary cell types combine to form organotypic 
models. These generally take the form of a collagen gel embedded with fibroblasts which have 
been allowed to establish a stromal equivalent before the addition of the cancer cell line on top 
(Figure 1.8E). Studies using this method have been carried out with colorectal cancer [189, 190] 
and squamous cell carcinoma (SCC) [191] cell lines, with the expression of proteins in the 
organotypic SCC cultures comparable to those seen in primary SCC tumour samples. There have 
also been examples of excised leiomyoma, a benign smooth muscle neoplasm, being used as the 
stromal equivalent for cancer cells, with this inducing a greater amount of cancer cell penetration 
than a collagen and fibroblast based organotypic culture [192]. A variation of these organotypic 
cultures sees an artificial cancer mass (ACM), consisting of cancer cell embedded in a collagen 
hydrogel and compressed to increase the collagen stiffness, encapsulated in a second collagen gel 
containing fibroblasts and/or endothelial cells (Figure 1.8F) [193]. 
These organotypic models allow for interactions between the cancer cells and both ECM 
component proteins and secondary cell types. These allow for the generation of a variety of 
collagen based stromal equivalents by altering the source of fibroblasts or culturing them in 
conjunction with other cell types, such as endothelial cells [193]. The pre-culture of these stromal 
equivalents also allows the secondary cell type to remodel these gels, which usually results in gel 
shrinkage [190], to produce a microenvironment which is closer to that seen in vivo. The 
encapsulation culture combines the hypoxia gradient seen in spheroid cultures with a more 
biologically relevant microenvironment to provide multiple signals to the cancer cells to drive their 
behaviour. However, due to the variable nature of ECM gels which are made in batches or between 
patient samples which are decellularised to provide the ECM environment, this technique may not 
provide a consistent 3D environment for large scale investigations into cellular behaviour. 
1.7 2D and 3D in vitro migration and invasion models assess a 
range of cell behaviours 
With the range of cancer models now available, there are a wide range of in vitro migration and 
invasion assays which can be employed to study cell behaviour and these have been extensively 
reviewed in the literature [194, 195]. These techniques can be used in conjunction with in vivo 
techniques to study migration and metastasis formation, such as the chick embryo chorioallantoic 
membrane (CAM) model [196] or xenografts [197], which provide a complete biological 
microenvironment to direct the behaviour of the cancer cells. 
Each of the techniques discussed require varied techniques and have applications which can be 
more suited to the different modes of migration as described previously. While the increasingly 
complex models provide a more biologically relevant assay environment, the amount of analysis 
and the complexity of techniques required to obtain results is greatly increased over an assay 
which acts on monolayer cultures and there is a trade-off between biological relevance and ease of 
extracting results from the assays. 
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1.7.1 2D models of migration and invasion 
Common 2D models of migration in use in research are based on cells migrating across a flat 
substrate, usually tissue culture plastic, and can be easily assayed by imaging the live cultures and 
performing image analysis to obtain the necessary results. 
1.7.1.1 Outgrowth of explants 
One of the basic forms of assaying cell migration is to view the migration of cells out of a tissue 
explant (Figure 1.9A) [198]. In this system it is possible to view both single migrating cells and cells 
migrating in a collective manner. However, due to the multicellular nature of explants, there is the 
potential for ambiguity regarding the identification of the migrating cells, which could be cleared up 
by the fixing and staining of cell outgrowth at the end of the assay. While the identification of the 
migrating cells would prove straightforward using light microscopy, the preparation and 
maintenance of these cultures would encounter similar problems to the explant cultures, as 
previously mentioned above. 
1.7.1.1 Scratch wound assays 
A commonly used migration assay is the scratch wound assay (Figure 1.9B), which is inexpensive 
and does not require specialist equipment to execute. The assay relies on the growth of a confluent 
2D monolayer of cells which is then wounded using a pipette tip to scrape cells off the plastic. 
Images are taken immediately after wounding and at selected time periods afterwards and can be 
assessed for single cell migration, via the counting of cells which cross into the wound area or 
using cell tracking software, or collective migration, by assessing the closing distance between 
wound edges [199, 200]. While this assay is accessible and can be generated using standard 
laboratory equipment, there is the potential to damage cells when wounding the monolayer culture, 
resulting in unwanted cell signalling occurring during the course of the assay. Additionally, the cells 
are assayed for their migratory behaviour in a highly unnatural environment, with few biological 
cues which would be found in the in vivo situation. 
1.7.1.2 Ring assays 
Another assay which is similar to the scratch wound assay is the ring, or fence, assay (Figure 
1.9C), where the cells are assayed for their migration across a 2D substrate, however the risk of 
cellular damage is removed. The set-up for this assay requires a confluent layer of cells to form 
within a circular ring, which is then removed to allow the cells to migrate out radially [201]. Again, 
this assay is easily analysed via image analysis on the resulting cultures to measure the increased 
area occupied by the migrating cells, although the cells are maintained in an unnatural 
microenvironment. 
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Figure 1.9: 2D migration models provide an easy method of obtaining data on cell migration. Different 2D 
migration assays include A: the migration cells out of explants across a coated 2D surface; B: scratch 
wound assays, where a monolayer culture is ‘wounded’ using a pipette tip and cells migrate to close the 
wound; C: ring assays, where cells are grown in a monolayer inside a ring which is removed and the cells 
migrate out radially; D: colloidal gold particle assays, where cells are seeded onto a 2D surface covered 
colloidal gold, which the cells remove as they travel over it; E: thin ECM gel assays, where single cells 
migrate across an ECM gel coating and digestion of this coating can be viewed via microscopy, and F: 
Dunn chamber for chemotaxis, where cells are seeded in the central chamber and migrate over the bridge 
towards a chemotatic agent in the outer ring. 
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1.7.1.3 Colloidal gold particle assays 
A 2D migration assay which detects the migration of single cells is the colloidal gold particle assay, 
where a 2D substrate is thinly coated with colloidal gold particles which are removed by 
phagocytosis as the cells migrate across them (Figure 1.9D). The tracks produced by the migrating 
cells are clearly visible via microscopy, with cultures where the cells have migrated large distance 
displaying large areas of cleared particles, where the paths of cells have overlapped and the 
individual tracks are no longer visible [202]. This assay requires the use of more complex 
techniques to assay the cellular migration, but does allow for the monitoring of the routes taken by 
individual cells without the need for complex computerised tracking systems. 
1.7.1.4 Thin ECM gels 
The coating of a 2D surface with protein gels can increase the biological relevance of migration 
assays by providing an adhesion substrate which is closer to that seen in vivo (Figure 1.9E). The 
provision of the ECM proteins directs the migrating cells to degrade the coating at the point of cell 
extension, which is a behaviour that is seen in collective and mesenchymal migration. When a 
coating which incorporates a fluorescent tag is used, the points of ECM degradation can be viewed 
via fluorescence microscopy and distinctions between the types of actin protrusions employed 
during migration can be made [203]. Assays of this type begin to introduce more complexity into 
the study of cellular migration, however, the spatial aspect this assay does not match up with in 
vivo tumours as the signalling from ECM proteins is confined to one side of the cell. 
1.7.1.5 Dunn chambers 
A method of analysing 2D cell migration in the presence of a chemotactic gradient is the use of a 
Dunn chamber [204]. This assay uses a modified microscope slide with a central chamber and 
surrounding ring depressed into the slide surface with a raised bridge between them. The cells are 
seeded into the central chamber and the outer chamber is filled with media before the coverslip is 
placed over the chambers and secured such that a small gap over the edge of the outer chamber is 
left. Through this gap, the media in the outer well is drained and media containing the chemotactic 
agent under study is inserted, before sealing the gap over the outer chamber (Figure 1.9F). The 
migration of cells due to chemotaxis can then be observed via microscopic viewing of the bridge 
between chambers. While this method for assaying the migration of single cells adds an element of 
biological relevance by introducing molecules which may direct the migration of these cells, the 
cells remain in a 2D environment without the environmental cues from ECM proteins or other cell 
types. Additionally, the specialised equipment and nature of the set-up required for this assay 
mean it is unsuitable for high throughput studies. 
1.7.2 3D models of migration and invasion 
While 2D migration assays are relativity easy to execute, with little in the way of specialised 
equipment or techniques, they lack the ability to model the correct microenvironment for the cancer 
cells. With the introduction of another spatial dimension in 3D migration assays, the opportunity to 
model interactions between the cancer cells and surrounding ECM proteins or secondary cell types 
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is increased. However, this increasing complexity results in the need for more specialist techniques 
and equipment, with more processing required to obtain results. 
1.7.2.1 Boyden chambers and Transwell
®
 inserts 
A highly adaptable 3D migration assay comes in the form of Boyden chambers [205] and 
Transwell
®
 inserts, which are based on Boyden chambers [206]. The cell culture well is divided into 
two separate chambers by a highly porous filter with defined pore sizes, where the cells are seeded 
on top of the filter and allowed to pass through the pore to the underside of the filter (Figure 1.10A). 
This assay can be adapted to incorporate an element of cell invasion by coating the top side of the 
filter with an ECM gel prior to cell seeding. This assay is also highly adaptable, as chemotactic 
agents can be added to the bottom chamber to assess the cellular migratory response to these 
compounds, or a secondary cell type can be maintained on the bottom of the well plate to 
investigate the paracrine signalling between the two groups of cells. The adaption of the Boyden 
chamber technique to a disposable well insert allows the technology to be available to a wider 
research group and the analysis method of counting the number of cells which have migrated 
through the filter rapidly provides results. 
1.7.2.2 Spheroid Confrontation Assays 
The spheroid method of 3D culture can also be adapted to form a migration assay as a spheroid 
confrontation assay [207]. In this assay, two spheroids of differing cell types are placed in close 
proximity and allowed to migrate into each other to form a single large spheroid (Figure 1.10B). 
This assay can also be adapted to assay the invasion of cells from a single cell suspension into the 
spheroid body, which has applications to model the interactions between tumour cell and the 
immune system. This assay is does not require a large amount of specialist equipment, with the 
results viewable following the histological processing and staining of the samples. However, while 
this assay models cell-cell interactions, it does not model the interaction between cells and an 
extensive ECM network and the role that can play on the migratory behaviour of cells. Additionally, 
quantification of results can be difficult, as there is no distance of migration to measure or clearly 
defined area to count cells from where they have clearly undergone a migration from their starting 
position. 
1.7.2.3 ECM gels 
With the range of ECM proteins that can be purchased from biochemical suppliers, the use of ECM 
gels to generate invasion assays is widespread [208]. Assays of this type can take many forms, 
from cells seeded on the surface of an ECM gel and allowed to invade down into the gel (Figure 
1.10C) [209, 210], to single cells encapsulated in ECM gels and their movement tracked using 
microscopy and cell tracking software (Figure 1.10D) [211, 212]. The encapsulation method has 
been adapted for use with robotics to produce a high-throughput assay, with a plate of 192 
microchannels which are open at both ends [213]. The channel is filled with an ECM gel from one 
end and cells are added to the other and allowed to migrate along the channel, which can be 
monitored using microscopy. This style of assay provides the opportunity of signalling from ECM 
proteins, although it does lack the cell-cell interaction seen with other assays. 
  
34 
  
Figure 1.10: 3D migration models provide a microenvironment which is more biologically relevant. 
Different 3D migration assays include A: Boyden chambers/Transwell
®
 inserts, where cells are seeded on 
top of a thin porous membrane (in the absence or presence of an ECM gel) and allowed to migrate to the 
other side of the membrane; B: spheroid confrontation assays, where two spheroids are placed in close 
proximity and form a single spheroid by invading each other; C: stratified ECM gel invasion assays, where 
the distance invaded vertically into ECM gels is measured; D: encapsulated ECM gel invasion assays, 
where the invasion of single cells through the ECM gel is tracked; E: scaffold assays, where the distance 
invaded vertically into the scaffold is measured, and F: organotypic assays, where the invasion of cancer 
cells into a stromal equivalent is measured. 
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While the larger gels can require specialist microscopy equipment or processing skills to obtain 
results, the technology required to set them up is accessible by many research groups. The 
adaption of this style of assay to a high-throughput method lends itself towards the style of assay 
that would be appealing to drug discovery and development. 
1.7.2.4 Scaffolds 
Despite the large number of scaffold technologies available, either as commercially available 
products or manufactured by individual research groups, there are few examples of the use of them 
in the application of migration assays. The methodology is similar to that used for Boyden 
chambers, with cells seeded on top of a synthetic material and allowed to penetration through it 
(Figure 1.10E) [214, 215]. However, unlike the Boyden chamber, the migrating cells are kept in a 
3D environment for a greater period while migrating due to the greater depth of the scaffolds. While 
the basic form of this type of assay involves cells in a synthetic 3D environment, this technology 
has the potential to be adapted in similar ways to the Boyden chamber assays with the addition of 
ECM coatings or secondary cell types to increase the biological relevance of the model. 
Additionally, the amount of processing required to obtain results from this type of assay is likely to 
be similar to that required for ECM gel and organotypic assay, with histological processing required 
to quantify the level of cell penetration into the material. 
1.7.2.5 Organotypic models 
An invasion assay which recreates many aspects of the 3D microenvironment is the use of 
organotypic models (Figure 1.10F) [76, 216]. This style of assay contains the correct dimensionality 
of the in vivo situation, while incorporating signalling cues from ECM proteins and secondary cell 
types. However, while these systems are still reasonably simple to set up, provided the 
methodologies for the growth of a stromal equivalent are established, the analysis of this type of 
assay is more complex due to the multicellular nature of the culture. Here, tagging of different cell 
lines or staining for appropriate markers must be used to highlight the different cell populations and 
allow for an accurate assessment of the invasive behaviour of the cancer cells. 
Together these demonstrate that there are many different options available for investigating the 
migratory and invasive behaviour of cancer cells. However, some of them do not model the 
microenvironment of tumours, which can lead to results which are not comparable to the in vivo 
situation, while others require specialist equipment or techniques which can prevent them from 
being readily available to researchers. Unfortunately, there appears to be a trend that the more 
biologically relevant a model is, the harder it is to extract results from the system, which hinders the 
development of highly biologically relevant systems into high-throughput systems for use in drug 
discovery. 
1.8 Hypothesised Outcomes 
From the literature reviewed here, the following experimental outcomes are hypothesised: 
 A novel 3D model of colorectal cancer migration can be generated using a synthetic 
scaffold to provide the culturing environment; 
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 The migratory behaviour of colorectal cancer cells within the 3D model will differ from their 
2D migratory behaviour due to the difference in the dimensionality of the culturing 
environment; 
 Inhibition of the Wnt signalling pathway will result in inhibition of the migratory or 
proliferative behaviours of colorectal cancer cells; 
 Modulation of IGF-I signalling will result in alterations to the migratory or proliferative 
behaviours of colorectal cancer cells; 
 Adaption of the 3D model to include ECM proteins or a secondary cell line will also result in 
alterations to the migratory or proliferative behaviours of colorectal cancer cells. 
1.9 Thesis Overview 
This project aims to assess the feasibility of using a commercially available scaffold technology for 
the development of a 3D in vitro migration assay for colorectal cancer cells. This model will then be 
tested by investigating the role of signalling on the migratory behaviour colorectal cancer cells. The 
flexibility of the model will also be examined, with an aim of increasing the biological relevance of 
the model by the introduction of ECM protein coatings and co-culture into the assay. Throughout 
the process of development and testing, the aim is to use commercially available products to 
ensure that the methods employed during this project are available to a wide range of researchers 
and can be replicated and adapted by other research groups. 
Chapter 3 will look at establishing and optimising the 3D culture of colorectal cancer cell lines on 
the 3D material by looking at varying cell seeding density and techniques. Once this has been 
established, the maintenance of viable 3D cell cultures on this material over longer time courses 
will be assessed to allow for the selection of an appropriate time frame for the migration assay. 
Finally, the amount of cell penetration into the different forms of the material will be assessed to 
allow for the selection of the appropriate material for the assay, before a clear protocol for this 
migration assay is defined, which will be followed throughout the rest of this thesis. 
In Chapter 4 the effect of Wnt signalling on the migratory behaviour of colorectal cancer cells will 
be examined using small molecule inhibitions of this pathway. Side-by-side comparisons between 
2D and 3D assays will be made to assess the efficacy of these compounds and to identify where 
the dimensionality of the assay is affecting the outcome. 
Chapter 5 will follow a similar line of investigation to Chapter 4, but instead will focus on the IGF-I 
signalling pathway. Here recombinant IGF-I and a small molecule inhibitor of the pathway will be 
used in 2D and 3D assays to investigate the role this pathway has on cell migration. Interactions 
between the Wnt and IGF-I pathways will also be investigated here by the application of effective 
compounds identified in Chapter 4 to cultures in conjunction with IGF-I. 
Finally, Chapter 6 will look at the feasibility of increasing the biological relevance of the assay. This 
would initially involve the addition of an ECM coating prior to cell seeding to recreate a protein 
environment for invasion. Secondly, the establishment of a stromal equivalent within the 3D 
material will be investigated, in addition to the ability to maintain a culture of colorectal cancer cells 
on top of this stromal equivalent to investigate the paracrine signalling between the different cell 
types.  
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2 Materials and Methods 
2.1 Routine 2D Cell Culture 
2.1.1 Cell Line: SW480 
The human colorectal adenocarcinoma cell line SW480 (ATCC
®
, CCL-228™) was maintained in 
high glucose Dulbecco’s Modified Eagle Medium (DMEM, Lonza) supplemented with 10% v/v heat-
inactivated Foetal Bovine Serum (FBS, Sigma), 2 mM L-glutamine (Lonza) and 100 U/ml 
Penicillin/Streptomycin (Lonza) on Nunc plasticware (Fisher) at 37
o
C in a 5% CO2 environment and 
enzymatically passaged, as outlined in 2.1.6, when cell growth reached 70%. 
2.1.2 Cell Line: SW620 
The human colorectal adenocarcinoma cell line SW620 (ATCC
®
, CCL-227™) was maintained in 
high glucose DMEM (Lonza) supplemented with 10% v/v heat-inactivated FBS (Sigma), 2 mM L-
glutamine (Lonza) and 100 U/ml Penicillin/Streptomycin (Lonza) on Nunc plasticware (Fisher) at 
37
o
C in a 5% CO2 environment and enzymatically passaged, as outlined in 2.1.6, when cell growth 
reached 70%. 
2.1.3 Cell Line: 3T3 
The mouse embryonic fibroblast cell line NIH/3T3 (ATCC
®
, CRL-1658™) was maintained in high 
glucose DMEM (Lonza) supplemented with 10% v/v heat-inactivated FBS (Sigma), 2 mM L-
glutamine (Lonza) and 100 U/ml Penicillin/Streptomycin (Lonza) on BD plasticware (Fisher) at 37
o
C 
in a 5% CO2 environment and enzymatically passaged, as outlined in 2.1.6, when cell growth 
reached 70%. 
2.1.4 Cell Line: 3T3/GFP 
The mouse embryonic fibroblast cell line NIH3T3/GFP (Cell Bio Labs, AKR-214) was maintained in 
high glucose DMEM (Lonza) supplemented with 10% v/v heat-inactivated FBS (Sigma), 2 mM L-
glutamine (Lonza), 100 U/ml Penicillin/Streptomycin (Lonza), 10µg/ml Blasticidin (Invitrogen) and 
0.1mM MEM Non-essential Amino Acids (Sigma) on BD plasticware (Fisher) at 37
o
C in a 5% CO2 
environment and enzymatically passaged, as outlined in 2.1.6, when cell growth reached 70%. 
2.1.5 Growth Curve of Cells Cultured on Conventional 2D Plastic 
All cell lines were seeded into T25 flasks, manufacturer as appropriate to the cell line, at a density 
of 2.5 x 10
5
 cells per flask and cultured for 7 days with media changes every other day. Timepoints 
were taken every other day by putting 3 flasks through the MTT Assay, as described in 2.9.1, and 
trypsinising the cells out of a further 3 flasks, as described in 2.1.6, for the determination of cell 
number, as described in 2.5.1. 
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2.1.6 Routine Passaging and Propagation of Cells 
All cell lines were enzymatically passaged by removal of the growth media, washing of the cell 
monolayer with sterile Magnesium and Calcium free Phosphate Buffered Solution (PBS, Lonza) 
and incubation with Trypsin-Versene (Trypsin-EDTA) (Lonza) at 37
o
C for 1 minute (NIH/3T3 and 
NIH3T3/GFP cell lines) or 5 minutes (SW480 and SW620 cell lines). Following neutralisation with 
complete culturing media, the cells were returned to fresh culture flasks as a single cell 
suspension. 
2.1.7 Cryopreservation of Cells 
All cell lines were cryopreserved at -140
o
C in Nunc cryovials (Fisher) following suspension of cells 
in freezing media at a density of a T75 flask per 3ml. The freezing media for the SW480, SW620 
and NIH/3T3 cell lines comprised 5% v/v Dimethyl Sulfoxide (DMSO, Sigma) in complete culturing 
media. The freezing media for the NIH3T3/GFP cell line comprised 20% v/v FBS (Sigma) and 10% 
v/v DMSO (Sigma) in DMEM (Lonza). 
Cells were retrieved from cryopreservation by defrosting at 37
o
C and diluting the freezing media 
with complete growth media. The resulting cell suspension was centrifuged at 200g for 3 minutes 
using an Eppendorf Centrifuge 5810 R, the supernatant removed and the remaining cell pellet 
resuspended in fresh complete growth media. The cells were transferred to cell culture plasticware 
and incubated to obtain a monolayer culture. 
2.2 Scratch Wound Assays 
2.2.1 Growth of 2D Cultures 
For all experiments, the SW480 and SW620 cells used were taken from flasks within 10 passages 
of each other. The SW480 and SW620 cell lines were seeded into 48-well plates (SLS) and 
allowed to grow to 95% confluency over 5 days with media changes every other day. 
2.2.2 Scratch Wound Assay Set-up 
Scratch Wound Assays were initiated by introducing a scratch wound with a 10μl pipette tip 
(Sarstedt) into the cell monolayer. Cultures were then washed 3 times in sterile PBS and media 
containing media additives at appropriate concentrations added into the wells. The cultures were 
then returned to an incubator at 37
o
C in a 5% CO2 environment for 24 hours. 
2.2.3 Scratch Wound Assay Analysis 
 Images of the wounds were taken at wounding and at 24 hours post wounding using a Leica 
DM13000 B light microscope with an attached Leica DFC310 FX camera at 10x magnification to 
obtain measurements for the movement of the leading edge, which were carried out using the 
Leica Application Suite software (Leica, Version 3.7). At 24 hours the cultures were fixed, as 
described in 2.10.1, stained for Phalloidin and DAPI, as described in 2.13.4, and imaged using a 
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Leica DM13000 B light microscope with an attached Leica DFC310 FX camera at 10x 
magnification to obtain data for single cell migration into the scratch wound. 
2.3 3D Culture 
2.3.1 Preparation of Scaffold Inserts 
The commercially available windowed 6-well insert (Figure 2.1A) format of Alvetex
®
 (Reinnervate, 
AVP004) required no preparation prior to material pre-treatment. The full-sided 6-well insert (Figure 
2.1C) format of Alvetex
®
 required the sterilisation of material and insert with 70% Ethanol prior to 
construction, with the 200µm thick section then clipped between the two halves of the insert. 
For short-term culturing, the well inserts were placed into Greiner 6-well plates, with each well 
supplying 10ml of culture media to a single well insert. For long-term culturing, three well inserts 
were placed into a triplet well insert holder in a deep well Petri-dish (Reinnervate, AVP015); with 
each dish supplying 50ml of culture media to three inserts. 
2.3.2 Media Changes 
Media changes were made by aspirating off the culture media from the gap between the well insert 
and the edge of the well or petri-dish before replenishing the plate with fresh media into the same 
gap as to not disturb the cell growth on top of the material. 
For short-term culturing (up to 7 days) in 6-well plates (Figure 2.2B), the culturing media was 
replaced every 2 days. For long-term culturing in (over 7 days) in deep well Petri-dishes (Figure 
2.2F), the culturing media was replaced every 3-4 days. Additionally, the dishes were replaced to 
remove the build-up of cells growing on the bottom of the plastic at days 7 and 17 of culture, for the 
21 day growth curve experiments, and at day 5 of culture, for the 10 day migration assay 
experiments. For migration assays, any media additives were initially introduced to the cultures at 
day 5 and replenished at the day 7 media change. 
2.3.3 Construction of Co-cultures 
The 3D fibroblast cultures were established for 7 days in a 6-well plate before transferring to a 
deep well Petri-dish. From there the colorectal cancer cell lines were seeded and cultured on top of 
the fibroblast growth as previously described in 2.3.2. Where co-cultures employed the 
NIH3T3/GFP cell line, the co-culture was maintained in the NIH3T3/GFP complete growth media. 
2.4 Media Additives 
2.4.1 Insulin-like Growth Factor-I 
Human Insulin-like Growth Factor-I (IGF-I, Sigma, I3769) was reconstituted in Molecular Biology 
Water (Sigma) to a concentration of 1mg/ml and stored in aliquots at -20
o
C. 
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Figure 2.1: Schematics of the different types of well insert. A: The windowed inserts allow for the free 
exchange of culture media between the top and bottom surfaces of the material via three windows in the 
top half of the insert as highlighted in white. B: this keeps the media composition equal throughout the 
culture well. C: The full-sided inserts keep the culture media on top of the material separate from the 
media under the material by having a continuous top half, as highlighted in white. D: this results in an 
unequal media composition when the media on top of the insert is compared to the media surrounding the 
insert. 
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Figure 2.2: The culture plasticware used for 3D cell culture. For short-term culture, A: a 6-well insert is 
housed in B: the well of a 6-well plate, supplying 10ml of media per well. For long-term culture C: The 
cradle allows for three inserts to be cultured in the same dish and has three heights for positioning of 
inserts within the culture dish. D: The deep well petri dish that houses the cradle and allows for free media 
movement around the cradles. E: The height of the inserts can be selected to allow for different amounts of 
media on top of the scaffold. F: The inserts can be cultured in volumes of media up to 75ml which is shared 
between all three inserts. 
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2.4.2 Small Molecule Inhibitors 
Small molecules were reconstituted in DMSO at the concentrations listed in Table 2.1 and sterile 
filtered prior to storage at -20
o
C. All cultures maintained in media containing small molecule 
additives were compared to a DMSO control. 
Small Molecule Supplier Catalogue Number 
Working Stock 
Concentration 
Cardamonin Sigma C8249 5mM 
ICG 001 Tocris 4505 5mM 
IWR-1 Sigma I0161 10mM 
NVP-AEW541 Cambridge Bioscience CAY13641 1mM 
XAV 939 Tocris 3748 10mM 
Table 2.1: Small molecule additives with suppliers and concentration of stock solutions. 
2.5 Cell Counting 
2.5.1 Neubauer Improved Haemocytometer 
For determination of cell number for calculating the 2D growth curves and seeding into 3D cultures, 
2D cell cultures were trypsinised to a single cell suspension, as described in 2.1.6, and counted 
using a Neubauer Improved Haemocytometer. To ensure the accuracy and consistency of results, 
cell suspensions of the density 0.5-1.5 x 10
6
 were used and suspensions outside of this range were 
resuspended to achieve the appropriate cell density. 
2.5.2 Calculation of Generation Time 
Determination of generation time for cell populations was carried out following the calculations laid 
out in Hayflick’s work on culturing fibroblasts [217]. These equations contain the following 
variables: n, number of generations; N, final population size at time = t2; X0, initial population size at 
time = t0; r, multiplication rate and g, generation time. These equations are: 
n = 3.32(log10 N − log10 X0), 
r = n (t2 − t0)⁄ , 
g = 1 r⁄ . 
2.6 Seeding Method 
2.6.1 Preparation of Cell Suspensions 
For all experiments, the cancer and fibroblast cells used were taken from flasks within 10 passages 
of each other. 2D cell cultures were trypsinised and counted, as described in 2.5.1, before 
centrifugation 200g for 3 minutes using an Eppendorf Centrifuge 5810 R followed by resuspension 
of the cell pellet such that the resulting cell suspension had a cell density of 5 x 10
6
 cells per ml, for 
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the NIH/3T3 and NIH3T3/GFP cell lines, or 10 x 10
6
 cells per ml, for the SW480 and SW620 cell 
lines. 
2.6.2 Seeding Cells by the Concentrated Method 
To seed cells in the concentrated manner, 100μl of the seeding suspension was applied directly to 
the centre of each disc of prepared material (Figure 2.3A). Lids were then placed onto the culture 
dishes and they were placed into a cell culture incubator for 15 minutes to allow cell attachment 
before growth media was added (Figure 2.3B). 
2.6.3 Seeding Cells by the Diffuse Method 
To seed cells in the diffuse manner, the growth media was added to the culture dish prior to the 
application of 100μl of the seeding suspension to the media in the centre of the well insert and 
placement into a cell culture incubator (Figure 2.3C & D). 
2.7 Scaffold Pretreatment 
2.7.1 Ethanol Wetting 
For the ethanol pre-treatment of Alvetex
®
 discs, the discs housed within their well inserts were 
submerged in 70% v/v ethanol for 15 minutes, followed by 3 washes in sterile PBS (Figure 2.4A & 
B). Materials could be stored in sterile PBS until use to prevent them drying out and returning to 
their hydrophobic state. 
2.7.2 Plasma Treatment 
For the plasma pre-treatment of Alvetex
®
 Scaffold, discs were subjected to an oxygen plasma for 5 
minutes at 40W using an Emitech K1050X Plasma Asher (Figure 2.4C & D). For the plasma pre-
treatment of Alvetex
®
 Strata, discs were subjected to an oxygen plasma for 30 minutes at 10W 
using an Emitech K1050X Plasma Asher. 
2.8 Scaffold Coating 
2.8.1 Collagen I Coating 
For the coating of Alvetex
®
 Scaffold, Rat-tail Collagen I (SLS, 354236) was diluted down to a 
concentration of 0.8μg/ml in Molecular Biology Water. 100μl of the Collagen I solution was pipetted 
onto the centre of a plasma pre-treated disc and was allowed to set for 1 hour at room temperature 
before the addition of growth media. 
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Figure 2.3: Schematics of the different methods for cell seeding onto the scaffold. For concentrated 
seeding, A: the 100µl seeding dose is applied to the scaffold in the absence of culture media. After a 15 
minute attachment period, B: the well is filled with media. For diffuse seeding, C: the well is filled with 
enough media to cover the scaffold but without linking the two reservoirs of media. D: the 100µl seeding 
dose is applied to the scaffold through the media on top of the scaffold. After 24 hours the media level is 
topped up to link the two reservoirs of media. 
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Figure 2.4: Schematics of the different scaffold pre-treatment methods. When scaffolds are ethanol pre-
treated, A: the scaffold is full of the PBS when media is introduced to the scaffold, B: this results in the 
slow infiltration of the media into the material. When scaffolds are plasma pre-treated, C: the scaffold is dry 
when media is introduced to the scaffold, D: this results in the instant uptake of media into the material. 
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2.8.2 Fibronectin Coating 
For the coating of Alvetex
®
 Scaffold, Fibronectin from bovine plasma (Sigma, F1141) was diluted 
down to a concentration of 1μg/ml in sterile PBS. 100μl of the Fibronectin solution was pipetted 
onto the centre of a plasma pre-treated disc and was allowed to set for 1 hour at room temperature 
before the addition of growth media. 
2.9 Assays 
2.9.1 MTT Cell Viability Assay 
Each sample to be subjected to the MTT Cell Viability Assay was removed from the well inert, 
washed in sterile PBS and placed into a 12-well plate (Greiner). Each sample was incubated with 
1ml of the MTT solution, 1mg Thiazolyl Blue Tetrazolium Bromide (Sigma, M5655) dissolved per 
1ml of phenol-red free DMEM (Sigma, D1145), for 1 hour in the dark at 37
o
C. The samples were 
then lysed in Acidified Isopropanol, 1μl Hydrochloric Acid (Fisher) per 1ml Isopropanol (Fisher), for 
10 minutes on a rotator plate at 100rpm. 
To read the assay, 20μl of each sample was diluted in 180μl Isopropanol in a flat-bottom 96-well 
plate (Greiner) and read at 570nm on a BioTek ELx800 plate reader. The MTT Cell Viability Assay 
was performed in triplicate for each condition tested. 
2.9.2 Bradford Assay 
2.9.2.1 Protein Extraction 
Each 3D sample for protein lysis was removed from the well insert, washed in sterile PBS 3 times 
and placed into a 1.5ml microcentrifuge tube (Starlabs). Each sample was incubated in 150μl 
Protein Lysis Buffer, 0.85% v/v Igepal CA-630 (Sigma), 42.55μM Tris-Base (Fisher) at pH8.0, 
127.66μM Sodium Chloride (NaCL, Fisher), 0.85μM Magnesium Chloride (MgCl2, Sigma) and 
14.30% v/v 7x Complete Mini Protease Inhibitor Cocktail (Roche Diagnostics, 11 836 153 001), at 
room temperature for 30 minutes with the tubes vortexed half way through. Each sample was 
transferred to a fresh microcentrifuge tube and incubated in 150μl fresh Protein Lysis Buffer at 
room temperature for a further 30 minutes with the tubes vortexed half way through. The discs 
were then discarded and each set of protein lysate combined to give 300μl per sample. The 
samples were subsequently homogenised by passing through a 25G needle (Fisher) and 
centrifuged at 10,000rpm for 5 minutes. The resulting supernatant was transferred to a fresh 
microcentrifuge tube and denatured on a heat block at 95
o
C for 3 minutes; the pellet resulting from 
the centrifugation was discarded. Each sample was stored at -80
o
C until used for the Bradford 
Assay or Western Blot. 
For protein lysis of 2D samples, the same procedure was followed with the lysis steps occurring in 
the well plates containing the cell growth. 
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2.9.2.2 Protein Quantification 
For the Bradford Assay, 20μl of each sample was diluted 1 in 50 in dH20 and placed into a 1.5ml 
microcentrifuge tube (Starlabs). A Bovine Albumin (BSA, Sigma) protein ladder was generated to 
obtain 10 standards ranging for 5mg/ml to 0mg/ml BSA in 0.1% v/v Triton X-100 (Fisher) and these 
were diluted in the same manner as the protein lysates. 250ml Bio-Rad Protein Assay Dye 
Reagent Concentrate (Bio-Rad Labs, 500-0006) was added to each microcentrifuge tube, the 
tubes inverted to mix the samples with the dye and incubated at room temperature for 40 minutes. 
To read the assay, 200μl of each sample pipetted into a flat-bottom 96-well plate (Greiner) and 
read at 595nm on a BioTek ELx800 plate reader. The Bradford Assay was performed in triplicate 
for each condition tested. 
2.9.3 Pico Green dsDNA Assay 
2.9.3.1 Sample Lysis 
Each 3D sample for lysis was removed from the well insert, washed in sterile PBS 2 times, cut into 
smaller pieces and placed into an RNase free 1.5ml microcentrifuge tube (Starlabs). Each sample 
was covered in 1ml RNase-free Pico Lysis Buffer, 10mM Tris-Base (Fisher) at pH8.0, 1mM EDTA 
(Sigma) and 0.2% v/v Triton X-100 (Fisher) in Molecular Biology Water, vortexed and frozen down 
to -80
o
C overnight. Upon defrosting, each lysate was transferred to a fresh microcentrifuge tube 
and the discs discarded. The samples were subsequently homogenised by passing through a 21G 
needle (Fisher) and diluted 1 in 10 in Pico Lysis Buffer. Each sample was stored at -80
o
C until used 
for the Pico Green Assay. 
A ladder was created for each cell line used by trypsinising and counting 2D monolayer cultures, as 
described in 2.5.1, and spinning down cell pellets with 1.25 x 10
5
 to 6.40 x 10
7
 cells in centrifuge 
tubes at 1000rpm for 3 minutes. Each cell pellet was resuspended in 1ml RNase-free Pico Green 
Lysis Buffer, vortexed and frozen down to -80
o
C overnight. From there the lysis procedure is the 
same as described above. 
2.9.3.2 dsDNA Quantification 
For the Pico Green Assay, the Quant-iT™ PicoGreen
®
 dsDNA Assay Kit (Invitrogen, Fisher, 
VXP7589) was used with the appropriate protocol which is summarised below. 10μl of each sample 
and the appropriate ladder was diluted 1 in 10 in RNase-free Pico Green Lysis Buffer in black 
bottom 96-well plates (Fisher). 100μl of the Quant-iT™ PicoGreen
®
 dsDNA Reagent, made up to a 
0.5% v/v solution in 1x TE Buffer, was added to each well and the plate incubated for 5 minutes in 
the dark at room temperature. The plate was subsequently read with excitation 460/40nm and 
emission 540/35nm on a BioTek Synergy H4 Hybrid Multi-Mode Microplate Reader. The Pico 
Green Assay was performed in triplicate for each condition tested. 
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2.10 Fixation of Samples 
2.10.1 2D Monolayer Cultures 
The 2D cultures for fixing were washed 2 times in PBS and covered in a 4% w/v Paraformaldehyde 
(PFA, Sigma) solution pH 7.4 for 30 minutes at room temperature. Samples were washed 2 times 
in PBS prior to staining and could be stored in PBS at 4
o
C until used. 
2.10.2 3D Culture Samples 
Each 3D sample for fixing was removed from the well insert, placed into a 6-well plate (Greiner) 
washed in sterile PBS 2 times and covered in a 4% w/v PFA (Sigma) solution pH 7.4 overnight at 
4
o
C. Samples were washed 2 times in PBS prior to further processing and could be stored in PBS 
at 4
o
C until used. 
2.11 Histological Processing 
2.11.1 Dehydration and Embedding 
The histological processing of cultures grown on Alvetex
®
 discs followed the protocol published by 
Knight et al [218] for the dehydration and embedding of Alvetex
®
 samples and is briefly 
summarised below. PFA fixed samples were washed 2 times in PBS and dehydrated through 15 
minute steps in 30%, 50%, 70%, 80%, 90%, 95% and 100% v/v ethanol at room temperature. Each 
disc was subsequently cut in half along its diameter and placed into Histoclear (Fisher, 12358637) 
at 60
o
C for 15 minutes before an equal volume of liquid paraffin wax (Fisher, 12624077) was added 
for a further 30 minute incubation. The Histoclear/wax mixture was fully replaced with fresh paraffin 
wax for a final hour of incubation before vertical embedding, with the cut surface pointing down, 
into disposable 33x25x13mm embedding moulds (Cellpath Ltd, GAD-5302-02A) topped with 
labelled embedding cassettes (SLS, HIS0029). 
2.11.2 Sectioning 
Wax blocks were sectioned on a Leica RM2125RT microtome using MB Dynasharp Microtome 
Blades (Fisher, 12056679) to a thickness of 10μm for H&E staining of SW480, SW620 and 
NIH/3T3 cultures and consecutive 7μm sections for H&E and DAPI staining of NIH3T3/GFP 
cultures and antibody staining of all cultures. Sections were floated on a 42
o
C water bath, mounted 
onto Superfrost+ microscope slides (Fisher, 10149870) and allowed to dry overnight on slide 
dryers. 
2.12 Pathological Samples 
Pre-sectioned human pathological samples were obtained from the Liverpool Tissue Bank (LTB). 
Prior Ethical Approval and Consent was established by the LTB under its Board of Governance. A 
formal application and research proposal was submitted to access samples in line with the needs 
of this project. The LTB Board of Governance granted approval 4/3/2014, a Material Transfer 
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Agreement was signed, and the specimens were shipped and received. All samples were recorded 
and maintained securely in dedicated storage boxes. The samples were provided as 10 
consecutive 5μm sections on glass slides. A total of 10 tumour samples, 5 from Dukes’ Stage B 
tumours and 5 from Dukes’ Stage C tumours, and 3 corresponding healthy colonic epithelium 
samples were provided for histological and immunohistochemical analysis. 
2.13 Staining 
2.13.1 Haematoxylin and Eosin (H&E) Staining 
For the histological staining of samples, wax was cleared from slides using Histoclear (Fisher, 
12358637) for 5 minutes prior to gradual rehydration through sequential ethanols, 2 minutes at 
100% ethanol and 1 minute for 95% and 70% ethanol and dH2O. The nuclei were stained by a 5 
minute incubation in Mayer’s Haematoxylin (Sigma, H1532) followed by a wash in distilled water 
and blueing of the nuclei in Alkaline Ethanol, 3% Ammonia in 70% Ethanol, for 30 seconds. The 
slides were then dehydrated for 30 seconds in 70% ethanol, followed by 30 seconds in 95% 
ethanol and the cytoplasm was stained in 0.5% Eosin (Sigma, E4009) in 95% ethanol for 1 minute. 
The slides were then further dehydrated in two 10 second washes in 95% ethanol and two washes 
in 100% ethanol, one of 15 seconds and one of 30 seconds. The slides were cleared by two 3 
minute incubations in Histoclear prior to mounting with DPX mounting media (Fisher, 10050080) 
and covered with 50 x 22 mm coverslips (Fisher, 12383138). Once dry, these slides were imaged 
using a Leica DM500 light microscope with attached ICC50 HD camera at 10x and 20x 
magnification using the LAS EZ software (Leica). 
2.13.2 Immunohistochemical Staining 
Immunohistochemical staining, via a horseradish peroxidase (HRP) and 3,3' Diaminobenzidine 
(DAB) reaction, of 5 and 7μm thick consecutive sections was carried out using the IHC select 
HRP/DAB kit (Millipore, DAB150), which contains 20x Rinse Buffer, Blocking Buffer, Secondary 
Antibodies, Streptavidin HRP, DAB Chromogens A and B and Hematoxylin, with the protocol as 
follows. Wax was cleared from slides using Histoclear (Fisher, 12358637) for 5 minutes prior to 
gradual rehydration through sequential ethanols, 2 minutes at 100% ethanol and 1 minute for 95% 
and 70% ethanol and dH2O. 
Antigen retrieval was carried out by microwaving for three 2 minute periods at 800W in 10mM 
Citrate Buffer at pH6 (Fisher, BPE339-500) followed by a cooling period of 20 minutes in the 
heated Citrate Buffer. The samples were permeabilised and endogenous peroxidases quenched by 
incubation in 3% v/v Hydrogen Peroxide (Sigma, 216763) and then washed in 1x Rinse Buffer, 
containing 0.1% v/v Tween 20 (Sigma, P9416). The samples were blocked using the Blocking 
Buffer for 30 minutes and incubated with the primary antibody diluted in PBS at the concentrations 
given in Table 2.2 for 1 hour at room temperature in a humid environment. 
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Antibody Clonality Supplier 
Catalogue 
Number 
Working 
Concentration 
E-cadherin 
(HECD-1) 
Mono Abcam ab1416 1 in 50 
Vimentin Mono Sigma V6630 1 in 40 
Slug Mono 
Cell Signalling 
Technology 
C19G7 1 in 400 
β-catenin Mono Millipore 05-665 1 in 300 
Collagen I Poly Abcam ab34710 1 in 500 
Collagen IV Poly Abcam ab6586 1 in 1000 
Table 2.2: Antibodies for immunohistochemical staining with suppliers and concentrations. 
Samples were washed in 1x Rinse Buffer, incubated with the Secondary Antibody, a combination 
of rabbit and mouse IgG raised in goat, for 1 hour at room temperature and washed again in 1x 
Rinse Buffer. The chromogen reaction was achieved by incubating the slides in Streptavidin for 20 
minutes, followed by a wash in 1x Rinse Buffer followed by 20 minutes in the Chromogen Reagent, 
consisting of a 1:25 ratio of DAB Chromogens A and B, followed by a wash in 1x Rinse Buffer. The 
slides were counterstained for cell nuclei using Hematoxylin for 1 minute and washed for a final 
time in 1x Rinse Buffer. The slides were then dehydrated through distilled water and sequential 
ethanols, 1 minute each for the water, 70% and 95% ethanol and 2 minutes for 100% ethanol, 
before clearing in Histoclear for 5 minutes. The samples were mounted with DPX mounting media 
(Fisher, 10050080) and covered with 50 x 22 mm coverslips (Fisher, 12383138). Once dry, these 
slides were imaged using a Leica DM500 light microscope with attached ICC50 HD camera at 20x 
and 40x magnification using the LAS EZ software (Leica). 
2.13.3 DAPI on Co-cultures 
The counterstaining of nuclei in the sectioned NIH3T3/GFP co-cultures was achieved by clearing 
the wax from slides using Histoclear (Fisher, 12358637) for 5 minutes prior to gradual rehydration 
through sequential ethanols, 2 minutes at 100% ethanol and 1 minute for 95% and 70% ethanol 
and dH2O. The slides were then incubated with Hoescht 33342 (Molecular Probes, H3570), diluted 
1 in 1000 in PBS, for 10 minutes. Slides were then washed for three 10 minutes in PBS on a 
rotating plate at 45rpm before mounting with Vectashield mounting media (Vector Laboratories, H-
1000), covered with 50 x 22 mm coverslips (Fisher, 12383138) and sealed with nail varnish. Once 
dry, these slides were imaged using a Leica DM13000 B light microscope with attached DFC310 
FX camera at 20x magnification using the Leica Application Suite software (Leica, Version 3.7).  
2.13.4 Phalloidin/DAPI on Scratch Wounds 
Scratch wounds were counterstained using Phalloidin to allow the counting of single migrating 
cells. Samples fixed with 4% PFA were washed twice in PBS prior to staining with 14μM Phalloidin 
(Universal Biologicals, PHDG1-A) in PBS, with a 1 in 1000 dilution of Hoescht 33342 (Molecular 
Probes, H3570) to highlight the cell nuclei, for 30 minutes in the dark at room temperature. 
Samples were then washed for three 10 minutes in PBS on a rotating plate at 45rpm and imaged in 
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PBS using a Leica DM13000 B light microscope with attached DFC310 FX camera at 10x 
magnification using the Leica Application Suite software (Leica, Version 3.7). 
2.13.5 Antibody Staining of 2D Monolayer Cultures 
Samples were permeabilised in 0.1% v/v Triton X-100 (Fisher) in PBS for 15 minutes, followed by 
blocking in 1% v/v newborn goat serum (Sigma, G6767), 0.1% v/v Tween 20 (Sigma, P9416) in 
PBS for 30 minutes on ice. Primary antibodies were diluted in the blocking buffer to the dilutions 
given in Table 2.2 and the samples incubated on ice for with them 1 hour. The samples were 
washed for three 5 minutes in blocking on a rotating plate at 45rpm before an hour incubation with 
a 1 in 600 dilution of the secondary antibody Alexa-fluor 488 goat anti-mouse IgG (Fisher, 
1025630) and a 1 in 1000 dilution of Hoescht 33342 (Molecular Probes, H3570) in blocking buffer 
for 1 hour at room temperature. Samples were then washed for three 5 minutes in blocking on a 
rotating plate at 45rpm and imaged in PBS using a Leica DM13000 B light microscope with 
attached DFC310 FX camera at 10x magnification using the Leica Application Suite software 
(Leica, Version 3.7). 
2.14 Measurement of Cell Penetration in 3D Culture Model 
Two methods to analyse the amount of cell penetration were examined to ensure that the method 
selected would provide accurate results which were reflective of the histological data. The ‘linear’ 
method sampled the penetration at 3 separate points of the images and the ‘area’ method took 
data from the full image. Both methods of measuring cell penetration used the ImageJ software 
(NIH, Version 1.46a) to carry out image processing on the central 10 images acquired for each full 
length scaffold. Cell penetration measurements were performed in triplicate for each condition 
tested. 
2.14.1 Linear Method 
Determination of cell penetration via the linear method involved acquiring 3 linear measurements 
from each image, from the left, middle and right of the image, using the ‘Straight Line’ tool. Each 
measurement was made such that it was perpendicular to the top surface of the material and 
expressed as a distance and the 30 measurements were averaged to produce a result for each 
sample (Figure 2.5B). 
2.14.2 Area Method 
Determination of cell penetration via the area method involved determining the area covered by cell 
growth within the material and the total area covered by the piece of material on the image using 
the ‘Freehand Section’ tool. Each cell area measurement was expressed as a percentage of the 
total area measurement and the 10 measurements were averaged to produce a result for each 
sample (Figure 2.5C). 
  
52 
  
Figure 2.5: Methodological schematic for measuring cell penetration of the SW480 and SW620 cell lines 
on Alvetex
®
. A histological image (A) can be assessed for cell penetration by B: the ‘linear’ method, 
which involves taking 3 straight line measurements perpendicular to the top surface of the material down 
to the lowest level of cell penetration at that point (blue arrows), or C: the ‘area’ method, which involves 
determining both the total area of the image taken up by the material (black dotted line) and the total 
area of the image taken up by cells within the material (green dashed line) and subsequently showing 
the area filled with cells as a percentage of the total area of the material. For each replicate of each 
condition examined, this was done for 10 consecutive images and averaged. Both method utilised the 
ImageJ software, the ‘linear’ method utilised the measure length function after straight line selection 
while the ‘area’ method utilised the measure area function after free-hand area selection. 
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2.15 Western Blot Analysis 
2.15.1 Preparing SDS-PAGE Gels 
A 10% Sodium Dodecyl Sulphate (SDS) polyacrylamide gel was cast by mixing 9ml of the 10% gel 
solution, 375mM Tris HCl (Fisher) at pH8.8, 10% v/v Protogel Acrylamide (PAA, Fisher, 12381469) 
and 0.1% w/v SDS (Sigma, L3771), with 22μl 10% Ammonium Persulfate (APS, Sigma, A3678) 
and 10μl Tetramethylethylenediamine (TEMED, Sigma, T9281) to catalyse the polymerisation of 
the PAA. Once set, this gel was topped with a 4% loading gel, made by mixing 3ml of the 4% gel 
solution, 171.53mM Tris HCl at pH8.8, 4% v/v PAA and 1.72% w/v SDS, with 30μl 10% APS and 
16μl TEMED, with a comb inserted to from the wells. 
2.15.2 Running the Gels and Resolving Proteins 
Once the gel had set, the samples and protein ladder (Fisher, 11872124) were loaded into the top 
of the gels and ran for 1-2 hours at 120V in an SDS Running Buffer, 3.03% w/v Tris (Fisher), 14.4% 
w/v Glycine (Sigma) and 1% w/v SDS (Sigma). 
2.15.3 Blotting the Gels and Protein Transfer 
The gel was then transferred to a Polyvinylidene Difluoride (PVDF, Millipore, IPVH00010) 
membrane in Blotting Buffer, 10% v/v Ethanol, 0.3% w/v Tris Base (Fisher), 1.4% w/v Glycine 
(Sigma) and 0.1% w/v SDS (Sigma), at 10V overnight. This was followed by 1.5 hours at 40V the 
following morning to complete the transfer. 
2.15.4 Immunoblotting the Membrane to Examine Protein Expression 
Following transfer from the gel, the PVDF membrane was washed in methanol and allowed to dry. 
The dried membrane was then blocked in 5% milk powder (Sigma, 70166) in PBS for 30-60 
minutes and washed for three lots of 5 minutes in 0.1% Tween 20 (Sigma, P9416) in PBS. The 
primary antibodies were diluted in 5% milk powder in PBS to the concentrations given in Table 2.3 
and the PVDF membrane was incubated in these overnight at 4
o
C on a rotator plate at 45rpm.  
Antibody Supplier Catalogue Number Working Concentration 
E-cadherin (HECD-1) Abcam ab1416 1 in 1000 
Actin Sigma P1951 1 in 600 
Table 2.3: Antibodies for Western Blotting with suppliers and concentrations. 
The PVDF membrane was then washed for three lots of 5 minutes in 0.1% Tween 20 in PBS and 
incubated in the secondary antibody (Goat anti-mouse IgG, Abcam, ab150115) in 5% milk powder 
in PBS at room temperature for 1 hour. The membrane was washed for three lots of 5 minutes in 
0.3% Tween 20 in PBS, followed by three lots of 5 minutes in 0.1% Tween 20 in PBS. The excess 
liquid was removed from the membrane and incubated with the ECL detection solution, 2.51mM 
Luminol (Sigma, 123072), 413.58μM pCoumaric Acid (Sigma, C9008), 103.65mM Tris HCl (Fisher) 
at pH8.5 and 0.01% v/v Hydrogen Peroxide (Sigma), for 1 minute. The membrane was then 
developed onto photographic film (Fisher, 10381544). 
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2.16 Statistical Analysis 
All data presented in graphs within this thesis are averaged from three independent repeats, 
denoted by n = 3 in the figure legends. Statistical analysis of data was carried out using SPSS 
software (IBM, Version 20). Where two experimental groups were compared, the Student’s t-test 
was used. For more than two experimental groups, Univariate Analysis of Variance (ANOVA) was 
used to determine general trends, with the post-hoc analysis of Dunnett’s t-test, where 
experimental groups were compared back to the control only, or Tukey’s test, where all 
experimental groups were compared to each other. The type of statistical analysis used is stated in 
the figure legends of the graphs where the significant statistical differences between groups are 
shown with * representing a statistical difference where p < 0.05, ** where p < 0.01 and *** where p 
< 0.005. 
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3 The Establishment and Characterisation of a Novel 
3D Culture Model to Study Cell Migration in 
Colorectal Cancer 
3.1 Introduction 
3.1.1 Cell migration in cancer is an area of research interest 
3.1.1.1 Cell migration negatively impacts patient survival 
While the survival rates in England for both men and women diagnosed with colon cancer are 
increasing, with five-year survival rates of 53.4% and 52.3%, respectively, for those diagnosed in 
2006 [10], the odds of survival are highly dependent on the stage of the cancer at diagnosis. This 
trend is seen in data from both England [59] and the USA [47], with patients diagnosed with the 
earliest stage of the disease, documented via Dukes staging for the English data and AJCC/UICC 
staging for the American data, seeing a 13-14 fold increase in the probably of surviving for five 
years after diagnosis compared to those patients diagnosed with the latest stage of the disease. 
 Under both methods of colorectal cancer staging, the disease is seen to progress via the 
spreading of the tumour from the original site through the neighbouring tissue of the colon and 
culminates in the formation of metastatic legions in lymph nodes and distant organs [46, 47]. Due 
to this, the change of cellular behaviour required for metastases to form is an area of research 
interest, as disrupting this process may have positive implications for patient survival. 
3.1.1.2 Cell migration can be directed by the culture environment 
One of the events in this multistep process is the invasion of cancer cells into the surrounding 
tissues [65], a complex process which relies on many environmental cues such as cell-cell 
interactions [219]. With such a large number of proteins implicated in the migratory behaviour of 
cancer cells, including the actin regulating Arp2/3 complex [220] and cell adhesion mediating 
integrins [221], and the expression patterns of these proteins directing the mode of migration 
adopted by cells [71], the recreation of an appropriate environment to study these processes in the 
lab is critical. 
One such example which has been highlighted in the literature is the modulation of the expression 
known tumour suppressor CDH1 gene for the cell adhesion protein E-cadherin. The loss of E-
cadherin expression has been linked to increased cell migration and invasion in both 2D and 3D in 
vitro models for squamous cell carcinoma [222], demonstrating that this protein occupies a key 
position in the regulation of cell migratory behaviour. However, it has also been demonstrated that 
in the colorectal cancer cell lines SW480 and HCT116, the expression and localisation of E-
cadherin can be modulated by the density of cell growth in 2D cultures [223]. When grown in 
sparse cultures, with reduced cell-cell contacts, the amount of E-cadherin detected via Western 
blot was reduced compared to dense cultures maintained over the same time period. In addition to 
this, the E-cadherin protein was found to be localised throughout the cytoplasm of the cells in 
sparse cultures, whereas in dense cultures it was predominantly found at the plasma membrane 
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and co-localised with β-catenin, which was itself seen to have a nuclear localisation in sparse 
culture conditions. This change in E-cadherin expression was seen to be negatively correlated with 
the expression of Slug, a transcription factor which is known to be correlated with EMT in colorectal 
cancer cells [82]. The authors of this paper then determined that β-catenin mediated induction of 
Slug expression was a mechanism responsible for the suppression of E-cadherin expression and 
the loss of cell-cell contacts between cells, leading to a more migratory phenotype. Together this 
demonstrates that the migratory behaviour of these cell lines may be modulated by changing the 
culturing environment and therefore it is important to culture them in a manner that accurately 
reflects the in vivo environment. 
The critical nature of recreating a biologically relevant culturing environment is further highlighted 
by the role that the architecture of the surrounding environment, usually in reference to the ECM 
components of this environment, has on directing the mode of migration, with the dimensionality of 
this substrate a factor which can impact cell behaviour [70]. Hence, the use of 2D in vitro migration 
models, such as scratch wound assays [199, 200], provides cells with a culture environment which 
may direct the cells away from behaviours that they would otherwise exhibit in vivo and produce 
results which do not correlate with the observations made from patient data. Therefore, the 
development of a 3D in vitro migration assay which provides more appropriate environmental cues 
to cells would be well placed to bridge the gap between standard 2D in vitro studies and in vivo 
drugs testing to help reduce the high failure rate for anti-cancer treatments [224, 225]. 
3.1.2 The growing field of 3D cell culture 
The expansion in 3D cell culture research in recent years has been reflected in the number of 
papers discussing the use of 3D cancer models, with a PubMed search finding over 500 published 
within the past five years [226, 227]. As this is still a growing area of research, there remains a 
large amount of investigation and optimisation to be carried out to find the methodologies best 
suited to the experimental aims of the field.  
3.1.2.1 3D cell culture models mimic characteristics of tumour microenvironments 
There are a variety of cancer models which are currently employed for research purposes [163] 
which aim to model certain aspects of the tumour environment in an in vitro setting. The main 
benefit each of these models has is the increase in appropriate signalling cues provided to the 
cultured cells, such as the provision of an attachment substrate beyond the planar surface provided 
by standard 2D tissue culture plastic. Each of these have their own advantages and disadvantages, 
with some suitable for adaption for use as an in vitro migration model. 
3.1.2.1.1 Spheroid models provide an oxygen gradient to cancer cells 
One of the 3D cancer models which has been in use the longest is the spheroid model [176]. This 
model relies on the aggregation of cells without the use of ECM protein gels or synthetic scaffolds 
to direct the distribution of cells. This process naturally produces an aggregate with an oxygen 
gradient where the cells the centre of the spheroid are maintained in a hypoxic environment which 
leads to necrosis of the cells found there [177]. Taken along with the diminishing availability of 
nutrients in the core of spheroids, this provides a simple model for poor growth environment found 
in the centre of small tumour legions or in the regions between blood vessels in larger vascularised 
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tumours. As hypoxia is a driver of cell behaviour modification in growing tumours, either directly via 
the action of HIF [72] or through secondary effects such as the lowering of pH [73], it is an 
environmental factor that can push cancer cells towards a migratory phenotype to allow them to 
escape the detrimental growth environment. 
This model also allows for investigations into interactions between multiple cell types, via co-culture 
with either immune cells [178] or fibroblasts [179]. Both of these studies created spheroids from 
colorectal cancer cell lines before being covered in a cell suspension containing either the 
macrophages or fibroblasts. In the study involving the macrophages [178], the spheroids were 
plated on to anti-adherent agarose or adherent collagen I coated plates and cultured in the 
macrophage containing suspension, while in the study involving fibroblasts [179], the fibroblasts 
were introduced to the spheroid surface via centrifugation prior to embedding in a collagen I gel. 
Spheroid cultures have also been used to assay the migratory behaviour of cells in the multicellular 
environment that they provide. This can take the form of observing the migration of cancer cells out 
of the spheroid into a surrounding ECM gel [179] or as a spheroid confrontation assay to observe 
the migration of cancer cells into a spheroid structure formed from a secondary cell type [207].  
3.1.2.1.2 ECM gels provide relevant protein signalling and can support co-culture 
Another common method for obtaining 3D cancer cultures is the use of ECM gels to either 
encapsulate cancer cells [180] or to act as a seeding surface [184]. The gels utilised in these 
cultures can be obtained from the polymerisation of commercially available ECM gels products, 
such as collagen I [185] or Matrigel [182], or the decellularisation of ECM gels generated via the 
culture of a secondary cell type, such as fibroblasts [184]. These cultures provide a 3D protein 
environment for cell culture which allows for signalling to the cells via cell surface receptor, such as 
integrins [168]. They also differ from the culture of cancer cells on 2D gel coatings, as thicker gels 
are more flexible than the thin coatings on tissue culture plastic they recreate the physical cues of 
ECM rigidity more accurately than 2D cultures [83]. This alteration to the rigidity of the 
microenvironment of the cells, in addition to the presentation of ECM protein to a greater proportion 
of the cell surface, has been shown to alter the protein composition of cell-ECM adhesion sites 
[168], which can have knock-on signalling effects as some of those proteins, such as vinculin, are 
known to interact with the actin cytoskeleton and have roles in the modulation the migratory 
behaviour of cells [228]. 
In addition to providing a biologically relevant in vitro protein environment to cells in culture, this 
technique can be adapted to incorporate a secondary cell line, such as fibroblasts, to produce an 
organotypic cancer culture [189]. This results in a more complex culture model with provides 
paracrine signalling from this secondary cell type in addition to the spatial cues from the 3D protein 
gel. The generation of these organotypic models can provide the opportunity for the user to 
construct a culture which reflects the morphology observed in pathology samples to allow for the 
study of cells in an environment which closely mimics the organisation seen in patient tumours to 
provide more accurate results. 
These ECM gel based cultures have also been used to study the migratory behaviour of cancer 
cells. Methodologies include the tracking of single migrating cells encapsulated in a collagen I gel 
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[211] and the vertical invasion of tumour cells into collagen I gels [209] or an organotypic tissue 
construct [216]. 
3.1.2.1.3 Synthetic scaffolds provide a further opportunity for 3D cell culture 
A further methodology for obtaining 3D cell cultures is the use of synthetic scaffolds. With an 
increasing number of materials and fabrication methods available [172], the opportunity to tailor 
scaffolds to a specific culturing application allows this technology to have applications in a wide 
range of research areas. Many scaffold models currently have applications in the modelling of 
functional tissue, such as the hyaluronic acid fibre reinforcement of skin equivalents [229], the 
differentiation of human embryonic stem cells (hESCs) on poly(DL-lactic-co-glycolic acid) (PLGA) 
scaffolds [230] or osteogenesis on mPEG-PCL-mPEG/hydroxyapatite composite scaffolds [231], 
with the physical traits of the materials tested for their ability to support the cell types under 
investigation in each situation. 
This type of model can also have applications for cancer research, although these are less 
common than functional tissue models. Published examples of scaffold use for cancer research 
include the culturing of hemangioendothelioma and angiosarcoma vascular tumour cell lines on a 
polystyrene scaffold [232], a non-small-cell lung cancer cell line on a polyester based scaffold [188] 
and lung cancer cell line on electrospun copolymer scaffolds [233]. This type of model may be 
advantageous over ECM gel based models as the scaffold provides 3D environment for cell culture 
in the absence of biological signals from ECM proteins, which would allow for comparisons with 
standard 2D cultures on uncoated plasticware to assess the impact of the increased dimensionality 
of the culture environment. Additionally, these models can be coated with ECM proteins and 
support multiple cell types [229] which would allow the step-wise development of a more 
biologically realistic model with the ability to assess the impact that each step, increased 
dimensionality or increased biological signalling, has on the behaviour of cells. 
While there are few examples of cancer culture models using synthetic scaffolds, there have been 
attempts to quantify the amount of cell migration attained by cells cultured in the manner by 
assessed the penetration of cancer cells into the material from the seeding surface [215]. A 
synthetic material which has been adapted for use as a migration or invasion assay is the 
Transwell
®
 insert system, which utilises a 10μm polycarbonate filter with 8μm diameter pores to 
provide a barrier which migrating cells must cross [206]. The Transwell
®
 system can be adapted for 
use with ECM protein coatings [234] or co-culture [235] to mimic the biological signals present in 
tumours and provide a simple 3D system for assaying cell migration. 
3.1.2.2 3D migration assays assess cell behaviour in a more realistic microenvironment 
The introduction of 3D culture systems allows for the maintenance of cells in environments which 
are closer replications of the in vivo system than standard 2D methodologies which have been in 
use for many years. In the context of assessing the migratory behaviour of cells, the incorporation 
of features such as increased dimensionality [215], the provision of biological signalling via ECM 
proteins or a secondary cell type [216] or the heterogeneous nature of these cultures [179] 
enhances the behavioural cues in the system, which may direct the cells to adopt a mode of 
migration which reflects the in vivo behaviour of cells more accurately than the mode adopted by 
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cells grown in a highly artificial 2D environment by altering the expression of key proteins involved 
in the migration of cells, such as integrins [168]. 
3.1.2.2.1 Disadvantages of 3D migration assays 
While the biological relevance of models is increasing, the means of extracting data from models is 
becoming increasing complex and sophisticated. The wide range of 2D migration assays provide a 
simple means of measuring cell movement via microscopy, whereas 3D work requires more 
complex methods of cell tracking, as all cells may not be visible in the same plane of focus [194]. 
There is also a trade-off to be made when utilising 3D migration assays between using easy-to-use 
systems that have the potential to cause cellular damage, with systems which are less disruptive 
but more process intensive [195]. Additionally, while the most commonly form of 3D migration 
assay, the Transwell
®
 assay [206], provides a relatively simple method of quantifying cell motility 
via counting the cells which have passed through the filter, when used without an ECM gel coating 
the 10μm thick membrane provides a limited 3D environment which may mean that results 
obtained from this assay may not truly reflect in vivo behaviour. These are all considerations to be 
made when selecting the tools and methodologies to develop a new assay. 
3.1.3 Selection of appropriate tools for 3D cell culture is important 
With the generation of any new system of methodology for scientific research, the tools selected 
play a vital role in ensuring that valuable data is obtained by the experimenter. In the case of 
developing a colorectal cancer migration assay, selection of both the cell lines involved and the 
means of 3D culture will help to shape the subsequent work carried out. 
3.1.3.1 Cancer Cell Lines 
As the aim of this project is to model the migratory behaviour of colorectal cancer in a 3D in vitro 
environment, the selection of cells which reflect the in vivo behaviour of the cancer is vital. While 
the use of cells extracted directly from a primary tumour may provide a closer model to the clinical 
situation there is a large amount of patient variability [79, 186] and tumour heterogeneity [236] 
which may lead to high variation in the results obtained from in vitro experimentation. This is 
particularly problematic during the optimisation of the model, as the lack of a consistent culturing 
profile would make the determination of the optimal conditions for the 3D model harder to visualise. 
Cell lines have a more consistent growth profile in standard 2D in vitro culture, which is 
advantageous trait for the optimisation of a new protocol, so therefore colorectal cancer cell lines 
will be used to assess this model. There are a variety of commercially available cell lines derived 
from colorectal adenocarcinomas at various stages of the tumour progression. The focus of finding 
appropriate cell lines was concentrated on cell lines thought to be representative of the stages of 
colorectal cancer either side of the metastatic progression of the tumour, namely those at Duke’s 
stages B and C [46]. 
A literature search highlighted four cell lines which were confirmed to be derived from Dukes’ stage 
B cancers and initially cultured during the 1970s and 1980s, namely HCA-7 [237], LS123 [238], LS-
174T [239] and SW480 [48]. Each cell line has distinct characteristics when cultured which allow 
for a selection to be made between them subject to the needs of the experimental work. The 
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optimisation process relies on using cells which are representative of the system in question, here 
colorectal cancer and the migratory behaviour it exhibits, and which provide consistent cultures, so 
that conclusions may be accurately drawn from many experiments, hence, these two criteria will be 
used to select the appropriate cell line. 
3.1.3.1.1 HCA-7 
The HCA-7 cell line was initially cultured by Kirkland and Bailey [237] and while this cell line was 
observed to retain some of the characteristics of the original tumour, such as microvilli, the 
morphological features of this cell line decreased with increased time in culture and the cells lost 
much of their adherent properties. 
While this cell line has been used to assess cell migration, via scratch wound and Transwell
®
 
assays [240], or colony formation of sublines of this cell line [241], there is little data in the literature 
regarding the migratory behaviour of this cell line, with PubMed returning just 4 papers [242]. When 
this is taken with the loss of cell adhesion to tissue culture plastic over extended culture periods, 
the HCA-7 is unsuitable for use while optimising a 3D migration assay. 
3.1.3.1.2 LS123 
The LS123 cell line was initially isolated and cultured by Rutzky et al [238], however, this cell line 
failed to demonstrate tumorigenic potential when assayed via tumour formation in xenografts and 
colony formation in soft agar, although they did demonstrate the ability to invade in chick embryonic 
skin assay. The lack of tumorigenic potential has also been confirmed by work from another 
research group [243]. 
The lack of tumorigenic behaviour may contribute to the low number of papers found utilising this 
cell line, a PubMed search only returning 8 papers [244] with none of these in relation to migration 
[245]. This cell line has been used in the literature to assess the adhesion of colorectal cancer cells 
to laminin 5 [246] and derivatised agarose beads [247]. The lack of prior data regarding this cell 
line and its migratory behaviour means that it is an inappropriate choice for use in the optimisation 
of this migration assay and will not be discussed further. 
3.1.3.1.3 LS-174T 
The LS-174T cell line is a trypsinised variant of the LS-180 cell line original established by Tom et 
al [239]. This cell line initially produces monolayer cultures after plating into culture flasks; however, 
the cell morphology was seen to revert back to the tightly packed morphology of the LS-180 cell 
line, which exhibited a tendency to produce multicellular aggregates. 
This cell line is more commonly used than either of the two previously discussed, with 872 entries 
found in the PubMed database [248], and has been documented as used in a variety of migration 
assays, including scratch wound assays [249] and Transwell
®
 migration and invasion assays [250]. 
However, as the morphological properties of this cell line have been documented to alter over 
extended culture periods, this cell line is unlikely to provide a consistent tool for the optimisation of 
a novel model and will not be used here. 
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3.1.3.1.4 SW480 
The final cell line under consideration for this model was the SW480 cell line, which was originally 
established by Leibovitz et al [48], and has been featured in over 1700 journal articles, as found in 
the PubMed database [251], of which nearly 10% were investigating migration [252]. The paper 
describing the initial culture of this cell line cultured them to high passage number and did not note 
any perturbation in cell behaviour, with the exception of a gradual decrease in the generation time 
of the cells [48], which is common as cells adapt to the standard culture conditions and has been 
noted during the isolation of the other Dukes’ stage B colorectal cell lines discussed [237-239]. 
This cell line has been routinely used in standard scratch wound assays [253] and Transwell
®
 
migration [254] and invasion [255] assays, providing a large amount of published data regarding 
the migratory behaviour of this cell line for the results obtained from this model to be compared to. 
Taken with the stability of this cell line over long term in vitro culture, the SW480 cell line has been 
selected as the Dukes’ stage B cell line which will be used to assess the suitability of this 3D 
migration assay. 
A second advantage to the SW480 cell line is that there exists a counterpart Dukes’ stage C cell 
line, the SW620 cell line, which was isolated from a lymph node of the same male patient one year 
after the original surgery [48]. At the time of isolation, subtle differences between the two cell lines 
were noted, such as variations in cell morphology and proliferation rate, with the SW620 cell line 
being comprised of smaller, faster dividing cells. A study in 2000 examined both of these cell lines 
and determined that they have each retained their characteristics over the subsequent years in 
culture and remain a suitable tool for the assessment of changes occurring in colorectal cancer 
during disease progression [256]. Together these cell lines represent states of the tumour either 
side of the metastatic progression of the disease and eliminate any differences seen by gross 
genetic variation between the cell lines.  
Together, the SW480 and SW620 cell lines will reflect different aspects of colon cancer 
progression to allow for investigating how tumour progression alters the way in which cancers react 
to changes to their environment. Additionally, these two cell lines, with their behavioural 
differences, will provide the opportunity to optimise the use of the 3D culture system to provide a 
methodology which has the potential for application to other cell types without the need for 
extensive further optimisation. 
3.1.3.2 Method of 3D culture 
To avoid the variability and difficulty of processing that can be encountered with natural scaffolds 
and gels; a synthetic scaffold was selected for 3D culture. While most of the focus of synthetic 
scaffold use in cell culture is on biologically active materials [257, 258], the commercially available 
highly porous, biologically inactive polystyrene based material, Alvetex
® 
[218], was selected to 
provide a reproducible platform for 3D culture to generate consistent results. The manufacturing 
method for the material is described by Carnachan et al. [259] and the dimensions of the 
characteristics can be altered depending on the additives present during the polymerisation.  
This material is available in two formats, namely Alvetex
®
 Scaffold and Alvetex
®
 Strata, which are 
structurally similar, but have differing microscopic characteristics which lend them to varied 
applications. As these materials are manufactured from materials used to make standard tissue 
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culture plasticware, they are biologically inert and non-biodegradable. These material properties 
lead to a culturing system which is reproducible and will maintain its integrity over long culture 
periods. The biologically inert nature of this system also allows for a step-wise construction of a 3D 
migration model to allow the role of the dimensionality of the culture environment to be assessed, 
as opposed to the assessment made in the presence of ECM proteins as seen with ECM gel and 
organotypic models. 
When working with a 3D system such as Alvetex
®
, it is important to understand the characteristics 
of the material. From the high magnification SEM images in Figure 3.1A & B it is clearly visible that 
gross morphology of the material is consistent between Alvetex
®
 Scaffold and Alvetex
®
 Strata, 
although the morphological features are present at different scales. Both materials are 
approximately 90% porous, with the polymer material surrounding air voids which are linked via 
smaller void interconnects [259, 260]. Alvetex
®
 Scaffold is the larger void-sized variant of the two 
materials, with a modal diameter of 40µm (Figure 3.1C) and interconnect size of 13µm (grey line, 
Figure 3.1E). Alvetex
®
 Strata, on the other hand, has a denser packing of the material, leading to 
modal void diameter of 15µm (Figure 3.1D) and interconnect size of 6µm (black line, Figure 3.1E). 
Each of these materials are presented in a variety of formats, the one selected for this project is the 
22mm diameter, 200μm thick 6-well insert format (Figure 3.1F) as this is the largest size format 
available, which will allow for the maximal collection of data from the cultures, and is surrounded by 
culture media (Figure 3.1G) to aid the maintenance of rapidly proliferating cultures of cancer cell 
lines. From the structural presentation of these materials, it is hypothesised that the cells cultured 
on them will find it easier to move into the Alvetex
®
 Scaffold, as the Alvetex
®
 Strata may provide a 
physical barrier to the migration of the cells. 
Use of this 3D system has also been documented with a wide variety of cell types, including 
adipose tissue-derived stem cells [261], neurons [262], hepatocytes [263], osteoblast-like cells 
[260] and cancer cell lines [232]. These papers also demonstrate the capability of 3D cultures 
grown with this system to be subjected to many forms of analysis to provide a rounded data set in 
order to allow for detailed conclusions to be drawn from experiments. This shows that it is a 
versatile system which has a high probability of producing successful 3D cultures with cell lines 
which have not been previously tested, subject to growth optimisation. 
3.1.4 Aspects of Optimisation of 3D Cell Culture 
The successful generation of 3D cultures relies on methods which have been optimised to obtain 
the best outcome for cell culture by looking at each aspect of the set up process. In the Alvetex
®
 
system, these areas are the pre-treatment and seeding of cells on the material, in addition to the 
parameters used throughout the culturing of cells on the material. 
3.1.4.1 Surface Pre-treatment 
As Alvetex
®
 is a polystyrene based system, it retains the hydrophobic properties of polystyrene 
[264] and requires treatment prior to successful cell culture. The standard preparation of Alvetex
®
 is 
to submerge it 70% v/v ethanol and then wash in sterile PBS prior to use [263]. This leaves the 
user with a pre-wetted scaffold to which a cell suspension can be applied. 
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Figure 3.1: Both Alvetex
®
 Scaffold and Alvetex
®
 Strata possess a highly porous morphology, but on 
different scales. SEM images for A: Alvetex
®
 Scaffold and B: Alvetex
®
 Strata, void diameter distribution (as 
determined from measurements from SEM images) for C: Alvetex
®
 Scaffold and D: Alvetex
®
 Strata and E: 
interconnect size (as determined from mercury intrusion porosimetry) for both materials showing the 
difference in size of the microstructure. F: Both materials are presented as 200μm thick 22mm discs 
housed in a plastic insert, G: this insert fits standard 6-well plates and allows the cells to be cultured with 
media surrounding the insert with the media on top of and under the insert connected. Alvetex
®
 Scaffold 
data supplied by Ross Carnachan and Alvetex
®
 Strata data supplied by Adam Hayward. 
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The other option for surface pre-treatment is to expose the material to an oxygen plasma, as used 
in the preparation of commercial plasticware for cell culture [265]. This procedure changes the 
surface chemistry of the material by adding oxygen into surface functional groups [266], providing 
more sites for cells to attach to. Indeed the amount of oxygen found on the material surface is 
inversely related to the contact angle of the material, as a measure of surface wettability, as 
removal of this oxygen from tissue culture polystyrene by an n-hexane plasma results in an 
increased contact angle [264]. 
The wettability of a surface has a direct impact on the ability of proteins and cells to adhere to the 
surface, as a highly wettable surface will permit stronger adhesion of proteins to the surface than a 
poorly wettable one [267], this in turn leads to an increased cell density on the highly wettable 
surfaces [264]. However, there appears to be a limit on the range of contact angles which result in 
optimal cell adhesion, with the maximal number of cells attached to the surface observed around 
70
o
 and dropping off either side of that [267]. Pre-treatment of Alvetex
®
 with an oxygen plasma 
results in a lowering of the contact angle from 122
o
 to 76
o
 [268], putting it in the optimal range for 
cell adhesion. 
3.1.4.2 Cell Seeding Methodology 
The method by which cells are applied to the pre-treated Alvetex
®
 is another aspect of the set up 
protocol which has the potential to have a large effect on the characteristics of the resulting 3D 
culture. There are a variety of methods which may be used to introduce the cells to the material 
and these can be divided into two groups, static and dynamic techniques. 
Thevenot et al [214] carried out an evaluation of the efficacy of four techniques for cell seeding 
onto 3mm thick PLGA copolymer scaffolds, two static methods, namely surface and injection 
seeding, and two dynamic methods, centrifuge and orbital seeding. These methods produced 
similar levels of cells present in the material after 7 days of culture, although the centrifuge method 
resulted in a greater percentage of dead cells found 3 hours post seeding. The main difference 
between the techniques was seen in the profile of cell distribution throughout the scaffolds, with 
surface seeding resulting in the greatest number of cells found at the extremities of the scaffold, 
while injection seeding results in a higher density of cells toward the bottom of the scaffold. The two 
dynamic methods, centrifuge and orbital seeding, both resulted in the greatest density of cells 
residing in the centre of the scaffolds. 
As the endpoint of the research question addressed here is to investigate the migratory capacity of 
colorectal cancer cells in a 3D environment, the employment of a seeding method which causes 
cells to become evenly distributed throughout the depth of material would hinder the analysis of 
cultures to determine if the migratory behaviour alters when the cultures are exposed to different 
conditions. Due to this two static, surface seeding methods will be investigated, the concentrated 
and diffuse seeding methods. Both apply cells to the uppermost surface of the material; however 
the concentrated method applies the cells directly to the surface via a small seeding dose, while 
the diffuse method allows the cells within the seeding dose to settle out onto the surface of the 
material through the culture media in the dish. A comparison of these should highlight if they have 
an effect on the lateral distribution of cells across the material and if that has an effect on the 
cultures they produce. 
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3.1.4.3 Period of Growth 
It is expected that the culturing of cells in a 3D environment will affect their protein expression and, 
in turn, their behaviour. One such example of this is FAK and phosphorylated FAK, which is known 
to be altered when cells form different types of adhesion sites and specifically decreased at 3D 
adhesion sites [168], the expression of which has been shown to affect the growth rates of 
colorectal cancer cell lines in vitro, with higher FAK expression correlated with higher rates of 
proliferation [269]. As it has also been demonstrated that the increase in the dimensionality of 
collagen I gels reduces the proliferation of human breast epithelial cells [270], it is expected that the 
proliferation of cells in the 3D cultures would be reduced compared to 2D cultures. 
With the a reduction in cell proliferation expected, the model must be examined to ascertain how 
long Alvetex
®
 can support viable cultures as this time period is likely to be longer than that seen in 
2D and the culture of cells for an extended period may provide the opportunity to make a more 
accurate assessment of the migratory behaviour of the cells. 
3.1.4.4 Protein Coating of Materials 
It has been demonstrated that the ECM environment of cells can direct the migratory behaviour of 
cells [271] and is also correlated to the progression of tumours [272]. The inclusion of ECM 
coatings in the model under development here represents a more advanced model by the 
increasing of the biological relevance of the model and will be discussed fully in Chapter 6. 
3.1.4.5 Utilisation of a Co-culture Model 
The involvement of stromal cells in tumour development has implications for cancer cell migration 
[273] and overall patient survival [58, 274]. Again, as with the inclusion of ECM coatings, the 
inclusion of a secondary cell line to form a stromal equivalent represents a more advanced model 
by the increasing of the biological relevance of the model and will be discussed fully in Chapter 6. 
3.1.4.6 Medium Type 
An end goal of this project is to produce a co-culture of these cell lines with fibroblasts, therefore, 
the selection of a suitable growth medium for both cell types is critical. The paper which 
documented the original culturing of the SW480 and SW620 cell lines used supplemented L-15 
media [48], however, the original isolation of the NIH/3T3 cell line which will be used for co-culture, 
see Chapter 6, shows that this was carried out in Dulbecco's modification of Eagle's medium 
(DMEM) [275]. A search of the literature has demonstrated that since their initial isolation both the 
SW480 and SW620 cell lines have been successfully maintained in DMEM and subjected to a 
variety of experimental procedures [276, 277]. Due to this, DMEM has been selected as the growth 
media for these experiments to allow the model to be assessed for the ability to support a co-
culture model without the need for extensive re-optimisation. 
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3.2 Chapter Aims 
This Chapter aims to assess the suitability of a novel polystyrene scaffold for use in a 3D migration 
assay for colorectal cancer and to develop a standard protocol for this assay. To achieve this, the 
lateral distribution of cells across the material should be maximised to increase the opportunities for 
data collection. Additionally, the optimisation process should result in cultures which have little 
variation in the distribution of the cells across the depth of the material. 
3.2.1 Objectives 
 To assess the 2D growth characteristics of the two colorectal cancer cell lines; 
 To assess the impact of seeding methodology, scaffold preparation and scaffold presentation 
on 3D cultures of two colorectal cancer cell lines; 
 To assess the long term viability of 3D cultures on different sized variants of the material; 
 To assess the amount of cell movement into the materials and develop an appropriate method 
to quantify cell migration in a 3D system. 
  
67 
3.3 Results 
3.3.1 The SW480 and SW620 cell lines display different characteristics 
when grown in standard 2D culture 
Although both the SW480 and SW620 cell lines were isolated from the same patient at different 
stages of the disease progression, characteristics of the cells in standard 2D culture differ. The two 
cell lines possess distinct morphology which allows for easy distinction between the two lines.  
3.3.1.1 Both the SW480 and SW620 cell lines possessed a mixed morphology in 2D culture 
Both cell lines culture as mixed morphologies, as noted in the original paper at their isolation [48], 
with both of them containing populations with an elongated bipolar phenotype (arrows, Figure 3.2B 
& D), although the size of these individual cells is larger in the SW480 cell line, roughly 36μm by 
13μm, than the SW620 cell line, roughly 26μm by 10μm. The SW480 cell line also had a population 
of larger cells, roughly 36μm by 23μm, which grew with a triangular shape and possess a more 
epithelial phenotype (solid arrowheads, Figure 3.2B). Whereas the SW620 cell line contained a cell 
population with a smaller rounded morphology, roughly 11μm in diameter (outline arrowheads, 
Figure 3.2D). Within both cell lines, the different cell morphologies were found with equal 
distribution throughout the cultures and together, along with the differences in cell size, these allow 
for the easy identification of the cell lines in standard 2D in vitro culture. 
3.3.1.2 Both the SW480 and SW620 cell lines retained a rapidly proliferating phenotype 
At the original derivation of these two cell lines, they were noted as having population doubling 
times which characterised them as two of the faster growing cell lines discussed in the paper. Their 
generation times were listed as 50 and 30 hours for SW480 and SW620 respectively for the higher 
passage numbers documented [48]. It was also noted that many of the cell lines generated in this 
collection underwent a shortening of generation time as their passage number increased, as they 
adapted to in vitro culturing conditions.  
When these cell lines were seeded at a density of 0.5 million cells per T25 culture flask, they 
maintained the rapidly dividing phenotype noted in the original article (Figure 3.3). When 
trypsinised cells were manually counted at the end of the seven day culture period, the SW480 cell 
line reached a final population of 16.90 x 10
6
 while the SW620 appeared to retain the faster 
dividing phenotype and had increased to a final population of 20.75 x 10
6
 cells per flask. However, 
the subsequent years of cell culture maintenance appear to have led to the two cell lines 
developing a shorter generation time and displaying a comparable generation time of 28 and 26 
hours for SW480 and SW620 respectively, the calculations for these made using the experimental 
data and Hayflick’s formula as stated in his 1973 paper on subculturing fibroblasts [217] and 
subsequently used by Leibovitz et al. to calculate the original values for the generation time [48]. 
68 
  
Figure 3.2: Both the SW480 and SW620 cell lines display distinct mixed morphologies of cells in standard 
2D culture, with the SW480 cell lines having larger cells than the SW620 cell line. Phase contrast images 
of the A and B: SW480 and C and D: SW620 cell lines at low and high magnification respectively, with 
both cell lines having a bipolar type cell (arrow) The SW480 cell line also has an epithelial type cell (solid 
arrowhead) while the SW620 cell line has a spherical type cell (empty arrowhead). Scale bars = 100µm for 
all images. 
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Figure 3.3: Both the SW480 and SW620 cell lines expand rapidly in 2D culture over 7 days, with the 
SW620 cell line maintaining a faster rate of division than the SW480 cell line as seen by the final cell 
counts. Cell counts from trypsinised monolayer cultures in T25 culture flasks with 0.5 x10
6
 cells at initial 
seeding for A: SW480 and B: SW620 cells. Data represent mean, n = 3, ±SEM for both graphs. 
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Furthermore, the cultures of both the SW480 and SW620 cell lines were found to retain cell viability 
(Figure 3.4) throughout the complete seven day culture period. This suggests that the speed of 
population doubling across the culture period was not constrained by limited nutrient supply from 
the media or limited space to accommodate the newly generated biomass. 
Together these data display that the two cell lines both retain a rapidly dividing phenotype, which 
will need to be accounted for when optimising the protocols for their growth in the 3D culture 
system. However, as it has been previously noted that the culturing of cells in a 3D environment 
reduces their rate of cell division [270], it is expected that the proliferation rate of the SW480 and 
SW620 cell line will be reduced compared to the rate observed in 2D. Additionally, the distinct 
morphologies of each cell line when maintained in standard 2D culture have the potential to result 
in a distinct 3D growth pattern on the material. 
3.3.2 Pilot assay to determine whether the SW480 and SW620 cell lines 
can be maintained in a 3D culture system 
The SW480 and SW620 cell lines were cultured on Alvetex
®
 Scaffolds provided in a standard 6-
well insert format. Each 22mm diameter, 200µm thick disc of material was housed in an insert 
which is suspended in a well of a 6-well culture plate. The material was ethanol pre-treated to 
prepare the Scaffold for culture, as per the manufacturer instructions and standard protocol used in 
previously published research papers [263], and each cell line was subsequently seeded in a 
concentrated manner at a density of 1 million cells per scaffold. Scaffolds were incubated for 15 
minutes to allow for cell adhesion before the remaining media was added to each of the wells. 
3.3.2.1 The SW480 and SW620 cell lines demonstrated different cell distributions when 
culture on Alvetex
®
 Scaffold 
From the histological data presented in Figure 3.5, Alvetex
®
 Scaffold can support the culture of 
both the SW480 and SW620 cell lines for up to 7 days. The composite images in Figure 3.5A, for 
SW480, and Figure 3.5B, for SW620, demonstrate that the growth of the cell lines was found 
across the entire 22mm diameter of the material after 7 days in culture. When higher magnification 
images of the cultured material are viewed, it is clear that both cell lines had moved into the 
material over the culture period. 
At 4 days culture, the SW480 cell line (Figure 3.5C) was found distributed at low density within the 
polymer material, with few cells growing on top. However, by 7 days culture (Figure 3.5D), the cell 
growth had increased in density. The majority of this increase was seen by the thickening of the 
cell layer found at the surface of the material, with a modest increase in the density of the cells 
distributed within the material. 
In contrast, the SW620 cell line did not have a cell layer on the top of the material after 4 days 
culture (Figure 3.5E) and only presented a layer that is one or two cells thick by 7 days culture 
(Figure 3.5F). Instead, this cell line appeared to enter the material and to continue to proliferate 
within it, producing a higher density of internal cell growth by the end of the culture period when 
compared back to the SW480 cell line. 
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Figure 3.4: The SW480 and SW620 cells maintain similar increasing levels of cell viability when 
maintained in 2D culture over 7 days. Absorbance at 570nm of monolayer cultures in T25 culture flasks 
with 0.5 x10
6
 cells at initial seeding for A: SW480 and B: SW620 cells as determined by the MTT Cell 
Viability Assay. Data represent mean, n = 3, ±SEM for both graphs. 
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Figure 3.5: The SW480 and SW620 cell lines have different growth characteristics when cultured for 4 or 7 
days on Alvetex
®
 Scaffold. Both cell lines also display an increase in cell growth when left to grow for 7 days 
when compared to 4 days culture. H&E stained full scaffold images of 7 day cultures with A: SW480 and B: 
SW620 cells and high magnification images of scaffolds cultured with C: SW480 for 4 days, D: SW480 for 7 
days, E: SW620 for 4 days and F: SW620 for 7 days. Scale bars = 500µm for images A and B, 100µm for 
images C-F. 
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Furthermore, the manner in which the cells grow in the 3D culture varies between the two cell lines. 
The SW480 cell line was more likely to be found as groups of cells both on top of and within the 
material, whereas the SW620 cells filled the material as a culture of loosely associated individual 
cells, without packing together in tightly associated groups. 
3.3.2.2 SW480 and SW620 cultures on Alvetex
®
 Scaffold remained viable for up to 7 days 
From the cell viability data (Figure 3.6), it was seen that the extension of the culturing period from 4 
days to 7 days results in a significant increase in the viability of the SW480 3D cultures (Figure 
3.6A). As the assay used is based on the metabolic activity of the cells within a given culture, this 
increase may be correlated with the increased cell population seen in the material at 7 days. 
However, such a viability increase was not seen in the SW620 cultures (Figure 3.6B), even with the 
visible increase in the amount of cell growth within the cultures between the two time points (Figure 
3.6E & F). 
This data demonstrated that both the SW480 and SW620 cell lines could be maintained on 
Alvetex
®
 Scaffold for up to 7 days without a loss of cell viability. Therefore, a 7 day culture period 
was selected to assess further aspects of the optimisation of the 3D cultures, as this extended 
culture period would allow any differences in the cultures resulting from the different setup 
protocols tested to be more apparent than a 4 day culture. 
3.3.3 Seeding method affects the viability of 3D SW620 cultures 
One possible variable in the setup of 3D cultures is the method by which cells are applied to the 
culture material [214]. To investigate the effect of seeding method on the growth characteristics of 
3D SW480 and SW620 cultures, two different methodologies were selected for comparison, here 
termed the concentrated and diffuse seeding methods. For consistency across other variables, the 
cells were applied to an ethanol pre-treated material in a seeding dose of 100µl, which contained 1 
million cells in a single cell suspension. 
The concentrated seeding method applies the cells directly to the material before the addition of 
culture media. A seeding dose was pipetted into the centre of pre-treated discs (Figure 2.3A), after 
which the 6-well plates were placed in a cell culture incubator at 37
o
C, 5% CO2 for 15 minutes to 
allow the cells to attach to the material. Following the attachment period, media was added to each 
culture well such that the reservoir of media on top of the material, which is within the top part of 
the well insert, links with the reservoir of media found surrounding the well insert via the cut-away 
sides of the well insert (Figure 2.3B). 
When the diffuse seeding method is employed, the cells are introduced to the material after the 
addition of the culture media. The well was filled with media such that the material is covered by 
media, but the two reservoirs of media, one directly over the material and the other between the 
insert and the well wall, are not linked via the cut-away sides of the well insert (Figure 2.3C) to 
prevent cells from settling onto the bottom of the well plate The seeding dose was added into the 
media sitting above the material (Figure 2.3D) and the 6-well plates placed into a cell culture 
incubator to allow the cells to settle onto the material over time, in a manner similar to standard 2D 
culture. The wells were topped up with media after the initial 24 hours to allow cell attachment. 
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Figure 3.6: The viability of the SW480 cell line increases according to time cultured on Alvetex
®
 Scaffold, 
while the viability of the SW620 cell line was unaffected, when 1 million cells were seeded in a 
concentrated manner and cultured for 4 or 7 days. Absorbance at 570nm of A: SW480 and B: SW620 cells 
as determined by the MTT Cell Viability Assay, with corresponding histological images for each condition. 
Data represent mean, n = 3, ±SEM for both graphs, ** p < 0.01 by a Students t-test. 
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3.3.3.1 Diffuse seeding provided a more even cell distribution 
When 3D cultures of the SW480 cells seeded by the two methods are compared, it was seen that 
the diffuse seeding protocol produces a culture which is evenly distributed across the entire width 
of the material, as seen in the composite image in Figure 3.7A, which was comparable to the 
results from applying the concentrated seeding protocol (Figure 3.5A). However, the 7 day culture 
after concentrated seeding resulted in a build-up of cells on the top surface of the material (Figure 
3.7C), diffuse seeding did not lead to a build-up of cells, while still maintaining a cell population 
within the material (Figure 3.7D). 
The alteration of seeding method also affects the behaviour of the SW620 cell line during 3D 
culture. Again, cell distribution after 7 days of culture was even across the width of the material with 
both the concentrated (Figure 3.5B) and diffuse (Figure 3.7B) seeding protocols. When viewed at a 
higher magnification, differences were visible between the two cultures. While cultures seeded by 
the concentrated protocol had a low build-up of cells at the top surface of the material, with most 
cells found distributed within the material (Figure 3.7E), in the cultures produced by seeding the 
cells by the diffuse protocol the cells were distributed towards the top surface of the material, with a 
thicker layer of cells at the top surface (Figure 3.7E). 
3.3.3.2 Diffuse seeding increased the viability of SW620 cultures 
Additionally, the viability of SW480 cultures was unaltered by the seeding method employed 
(Figure 3.8A), suggesting that there is no distinct advantage or disadvantage to applying either 
method to this cell line. The same was not seen in the SW620 cultures, where the diffuse seeding 
protocol resulted in increased viability over the concentrated seeding protocol (Figure 3.8B), 
suggesting that an advantage could be gained from seeding these cells using the diffuse method. 
Whilst this data shows that there minimal differences in cell distributions in 3D culture, when 
viewed via histological images, when the method of seeding cells is varied, the viability data 
displayed a significant difference for the SW620 cell line. The increase in viability seen in diffusely 
seeded SW620 cultures, which did not appear to be correlated with an observable increase in the 
number of cells distributed throughout the material, suggesting that this culture method is 
preferable for the 3D culture of SW620 cells. As the use of the diffuse seeding method did not have 
a negative impact on the viability of SW480 cultures, both cell lines will continue to be seeded via 
the diffuse method for further optimisation of this 3D system. 
3.3.4 The method of scaffold pre-treatment affects cell distribution in 3D 
cultures 
As previously mentioned, the material used to provide the 3D culturing environment for this 
research is a polystyrene based scaffold. Whilst having a porosity of 90% due to the large number 
of voids found within the material [260], and therefore having the capacity to take up comparatively 
large volumes of liquid when compared to a similar material with a lower porosity, the material itself 
is hydrophobic and requires a pre-treatment before it will absorb aqueous solutions, such as cell 
culture media. 
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Figure 3.7: Diffuse seeding of 3D cultures onto Alvetex
®
 Scaffold affects the distribution of the SW480 and 
SW620 cell lines. The SW480 cell line displays a smaller amount of growth on top of the material, whereas 
SW620 cell line displays a more consistent layer of growth across the whole scaffold when diffusely seeded. 
H&E stained full scaffold images of diffusely seeded cultures with A: SW480 and B: SW620 cells and high 
magnification images of scaffolds seeded with C: SW480 in a concentrated manner, D: SW480 in a diffuse 
manner, E: SW620 in a concentrated manner and F: SW620 in a diffuse manner. Scale bars = 500µm for 
images A and B, 100µm for images C-F. 
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Figure 3.8: The viability of the SW620 cell line is increased when diffusely seeded onto Alvetex
®
 Scaffold, 
while the viability of the SW480 cell line was unaffected, as compared to cells seeded in a concentrated 
manner when 1 million cells were cultured for 7 days. Absorbance at 570nm of A: SW480 and B: SW620 
cells as determined by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs, * 
p < 0.05 by a Students t-test. 
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Alvetex
®
 Scaffold can be pre-treated in one of two different ways to prepare it for cell culture, either 
by an ethanol wash or an oxygen plasma. For the ethanol wash procedure, discs were submerged 
in a 70% ethanol solution and subsequently washed in PBS to remove the ethanol from the voids, 
after which they remain hydrophilic until they dry out. This means that when an aqueous liquid is 
applied to the top surface of the material, it spreads across the surface of the material before it is 
absorbed (Figure 2.4A & B), as the voids of the material are filled with PBS, preventing the rapid 
uptake of the liquid. 
Oxygen plasma pre-treatment instead results in a hydrophilic material which is still dry. Application 
of liquid to the top surface of the material leads to a rapid uptake of the liquid (Figure 2.4C & D), as 
the voids do not contain a different liquid which needs to be displaced. For ethanol pre-treated 
discs, the media is slower to flow through the material to the internal part of the well insert, which 
may result is it floating in the culture media until sufficient media has come through the material, or 
the cut-away sides of the well insert, to equilibrate the media levels inside and outside the well 
insert. In contrast, the media flows straight through a plasma pre-treated disc and the insert is not 
dislodged from its position in the well temporarily. 
3.3.4.1 SW480 and SW620 cells grew in a less clustered manner on plasma pre-treated 
scaffold 
The method of pre-treatment of the Alvetex
®
 Scaffold prior to seeding with either SW480 or SW620 
cells had an impact on the distribution of cells within the material after a 7 day growth period. Both 
cell lines demonstrated an increased cell penetration across the entire length of the material 
(Figure 3.9A & B) when cultured on scaffolds which had a plasma pre-treatment when compared to 
scaffolds that were ethanol pre-treated (Figure 3.7A & B). 
When cultured on plasma pre-treated scaffolds, the SW480 cells grew in a spread out distribution 
within the material (Figure 3.9D), whereas on ethanol pre-treated scaffolds the cell growth within 
the material tended to be found in clusters of densely packed cells (Figure 3.9C). Additionally the 
plasma pre-treatment produced a larger build-up of cells on the top surface of the material, which 
was a feature seen across the full length of the material. 
Culturing the SW620 cells on plasma pre-treated scaffolds also lead to a difference in cell 
distribution after 7 days of growth. On ethanol pre-treated scaffolds, the cells were mostly confined 
to the upper half of the material and usually found as loosely associated collections of cells (Figure 
3.9E). Plasma pre-treatment of scaffolds resulted in the SW620 cells adopting a distribution 
throughout the depth of the material, with more cells found as isolated cells within the material 
(Figure 3.9F). 
3.3.4.2 Plasma pre-treatment increased the viability of SW480 cultures 
The method of pre-treatment of the scaffolds also affected the viability of the resulting SW480 
cultures, with cells grown on plasma pre-treated scaffolds displaying increased cell viability when 
compared to cells grown on ethanol pre-treated scaffolds (Figure 3.10A). In contrast there was no 
significant advantage to either scaffold pre-treatment method in the viability of SW620 cultures over 
the same time scale (Figure 3.10B). 
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Figure 3.9: Both the SW480 and SW620 cell lines display deeper cell penetration when seeded on plasma 
pre-treated Alvetex
®
 Scaffolds. H&E stained full scaffold images of plasma pre-treated scaffolds with A: 
SW480 and B: SW620 cells and high magnification images of scaffolds with C: SW480 on an ethanol pre-
treated scaffold, D: SW480 on a plasma pre-treated scaffold, E: SW620 on an ethanol pre-treated scaffold 
and F: SW620 on a plasma pre-treated scaffold. Scale bars = 500µm for images A and B, 100µm for images 
C-F. 
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Figure 3.10: Plasma pre-treatment of Alvetex
®
 Scaffold increases the viability of the SW480 cell 
line, but not the SW620 cell line, as compared to ethanol pre-treatment when 1 million cells were 
diffusely seeded scaffolds and cultured for 7 days. Absorbance at 570nm of A: SW480 and B: 
SW620 cells as determined by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM 
for both graphs, * p < 0.05 by a Students t-test. 
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Collectively, these data show that the method of scaffold pre-treatment had a significant effect on 
the resulting 3D cultures of colorectal cancer cell lines. Plasma pre-treatment of scaffolds resulted 
in cultures which had cells distributed throughout a larger proportion of the material than those 
grown on ethanol pre-treated scaffolds. The cells were also more likely to be found as individual 
cells within the material when it has been plasma pre-treated, as compared to the clusters seen in 
ethanol pre-treated scaffolds. Taking into account this and the data showing that plasma pre-
treatment of scaffolds had a slight increase in the cell viability of SW480 cultures without negatively 
impacting SW620 cultures, plasma pre-treatment of scaffolds will be employed for further 3D 
culturing experiments. 
3.3.5 The presentation of the 3D culture does not significantly affect the 
cell growth 
The presentation of the material within the well is another variable which has the potential to affect 
the behaviour of the 3D cultures. The format of Alvetex
®
 Scaffold well insert employed so far during 
this investigation was the windowed insert where a 22mm diameter disc is held between the top 
and bottom halves of the well insert which subsequently sat inside the well of 6-well plates (Figure 
2.1A). This design allows for the free exchange of media from on top of the material with media 
from underneath by passing through the three windows cut into the sides of the insert. This results 
in a more homogeneous media composition throughout the well [278] (Figure 2.1B). 
A second style of insert for the 22mm disc format of Alvetex
®
 Scaffold is the full-sided insert. This 
insert does not have the windows cut into the top half of the walls, resulting in a solid ring which 
surrounds the media on top of the material (Figure 2.1C). This full-sided insert segregates this 
reservoir of media from the media underneath/surrounding the material, meaning that any 
exchange of media occurs via movement through the Scaffold and any cells found in culture there, 
resulting in two reservoirs of media with varying media composition within the well [278] (Figure 
2.1D). 
It has been shown that while the amount of glucose and lactic acid in the media is consistent both 
above and below the windowed insert, the full-sided insert provides a barrier to media mixing 
between these compartments that results in an unequal distribution of lactic acid, with higher lactic 
acid concentrations seen in the media compartment above the scaffold [278]. This increased 
concentration of lactic acid when using the full-sided insert may prove beneficial to the culturing of 
cancer cells, as this may mimic the hypoxic interior of unvascularised tumours and induce a 
migratory response in the cancer cells in response to this environmental cue [72]. 
3.3.5.1 The use of the full-sided insert produced a more even distribution of SW480 cells 
Alteration of the insert style when culturing the SW480 cell line produced a difference in the 
distribution of cells at the end of the culturing period, as the SW480 cells grew in a more even 
distribution across the width of the material when cultured used a full-sided insert (Figure 3.11A). In 
contrast, the overall distribution of the SW620 cell line across the width of the material did not alter 
when the style of well insert is changed (Figure 3.11B). 
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Figure 3.11: Both the SW480 and SW620 cell lines display similar distribution profiles when cultured on 
Alvetex
®
 Scaffolds placed in full-sided inserts, when compared to culturing in the standard windowed insert. 
H&E stained full scaffolds cultured in a full-sided insert cultured with A: SW480 and B: SW620 cells and high 
magnification images of scaffolds with C: SW480 in a windowed insert, D: SW480 in a full-sided insert, E: 
SW620 in a windowed insert and F: SW620 in a full-sided insert. Scale bars = 500µm for images A and B, 
100µm for images C-F. 
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When viewed at higher magnification, SW480 cells grown in a full-sided insert did not penetrate as 
far into the material as seen with the windowed insert, with the cell growth confined to the upper 
half of the material (Figure 3.11C & D). Additionally, the growth on top of the material was found to 
be more consistent across the culture, with fewer gaps between areas of cell growth and the cells 
growing at a similar thickness across the width of the material. 
Such changes in cell behaviour are not seen with the SW620 cell line when the style of insert was 
altered. When cultured with either insert type, the SW620 cells were found to be distributed 
throughout the depth of the material, with a mixture of individual cells and cells growing in clusters 
with others (Figure 3.11E & F). 
3.3.5.2 Cell viability was not affected by the well insert style 
The alteration of the style of well insert did not have a significant effect on the viability of the 7 day 
3D cultures of either the SW480 or SW620 cell lines (Figure 3.12). Whilst this was not unexpected 
with the SW620 due to the consistency of growth patterns when either insert type was used, the 
viability data suggested that the change in insert type only altered the growth pattern of the SW480 
cells without diminishing their capacity to produce viable cultures. 
These data show that the style of insert did not have a significant effect on the behaviour of SW620 
cultures, but changed the distribution of the SW480 found both within and on top of the material. As 
the aim of this optimisation process is to produce cultures with a minimum of internal variation 
within the sample to allow for accurate data retrieval, the full-sided insert is selected over the 
windowed insert. The use of the full-sided inserts results in more consistent SW480 cultures, 
without a detrimental effect on the consistency of cell distribution in SW620 cultures. 
3.3.6 Alvetex® Scaffold allows for more viable long term cultures than 
Alvetex® Strata 
This optimisation process has resulted in a set of conditions for the experimental set up of 3D 
colorectal cancer cultures using Alvetex
®
 Scaffold which result in consistent, viable cultures after 7 
days of growth. The diffuse seeding of 1 million cells per plasma pre-treated scaffold housed in a 
full-sided insert provided conditions which are suited to short term culture of the SW480 and 
SW620 cell lines. This protocol will now been assessed for its suitability for the maintenance of 
long term cultures of both SW480 and SW620 cells on both Alvetex
®
 Scaffold and Alvetex
®
 Strata. 
To facilitate this, the cultures will be maintained in deep-well petri dishes (Figure 2.2) instead of the 
6-well plates previously used. This system allows for the culture of three well inserts in the same 
dish with 50ml of culture media shared between them. This provides better long term viability of 
cultures by allowing the cells access to a larger reservoir of nutrients, leading to less fluctuation in 
media composition over the culture period [218]. 
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Figure 3.12: The viability of the SW480 and SW620 cell lines is not altered by the insert type for 
the presentation of Alvetex
®
 Scaffold when 1 million cells were diffusely seeded onto plasma 
treated scaffolds and cultured for 7 days. Absorbance at 570nm of A: SW480 and B: SW620 
cells as determined by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both 
graphs, no significance by a Student’s t-test. 
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3.3.6.1 The SW620 cell line penetrated Alvetex
®
 Scaffold quicker than the SW480 cell line 
over 21 days 
When the SW480 cell line is seeded onto Alvetex
®
 Scaffold, it can be maintained in culture for up 
to 21 days (Figure 3.13). Over this time course, the cell growth began as sparsely distributed cells 
confined to the top half of the material for the first 7 days of culture (Figure 3.13B). Once this 
culture was established, the cells built up a thicker layer of growth on top of the material over the 
next 11 days, while maintaining their distribution within the top half of the material only (Figure 
3.13E). It was only in the final days of this culture period that the cells then penetrated down into 
the material and were found to be distributed throughout the entire depth of the material (Figure 
3.13F). 
In contrast the SW620 cells line could not be maintained on Alvetex
®
 Scaffold for the full 21 day 
culture period (Figure 3.14). As with the SW480 cells, the SW620 cells had a 7 day establishment 
period with cells found to be sparsely distributed throughout the depth of the material with no cell 
growth found at the surface (Figure 3.14B). However, after this establishment period, the cell 
growth expanded rapidly to fill the majority of the available space within the material by 11 days of 
culture (Figure 3.14C). This pattern of cell growth was then maintained for a further week (Figure 
3.14E) before cell death, as seen by changes in cell morphology and a decreased cell density 
within the material, by day 21 (Figure 3.14F). 
3.3.6.2 The viability of SW480 and SW620 cultures decreased after the first 11 days of 
culture on Alvetex
®
 Scaffold 
The differing behaviour of each cell line in terms of cell distribution within Alvetex
®
 Scaffold is also 
reflected in the viability of each cell line over the culture period. The viability data for the SW480 
cell line showed that there is a steady level of viability for the first 11 days of the culture period, 
followed by a small increase between 11 and 18 days before a crash in viability at 21 days (Figure 
3.15A). In contrast, the SW620 cell line displayed a steady increase in the viability of the culture for 
the first 11 days, followed by a progressive decline after that until the end of the culture period 
(Figure 3.15B). 
3.3.6.3 Long term cultures of SW480 and SW620 demonstrated increasing protein content 
This viability data was not reflected in the amount of protein for long term cultures of either cell line 
on Alvetex
®
 Scaffold. Both the SW480 and SW620 cells displayed a general trend of increasing 
protein content over the course of the culture period. The protein content of the SW480 cultures 
appeared to increase in staggered jumps, such as between 11 and 14 days, with a period where 
the level remains steady between jumps, such as between 7 and 11 days (Figure 3.16A). Whereas 
the increase in protein content in the SW620 cultures was more gradual over the full 21 day culture 
period (Figure 3.16B). Together this data would suggest that SW480 cells can be maintained in 
long term cultures on Alvetex
®
 Scaffold for longer than the SW620 cell line without compromising 
the viability of the culture. 
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Figure 3.13: The SW480 cell line can be maintained in 3D culture on Alvetex
®
 Scaffold for up to 21 days. 
The cell growth starts as a layer at the top surface of the material and penetrates the material as the cell 
growth builds up over the full 21 day culture period. H&E stained images of scaffolds which had been 
cultured for A: 4 days, B: 7 days, C: 11 days, D: 14 days, E: 18 days and F: 21 days. Scale bars = 200µm 
for all images. 
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Figure 3.14: The SW620 cell line does overgrow when maintained in 3D culture on Alvetex
®
 Scaffold for 
up to 21 days. Cells quickly penetrate into the material and the build-up of cells expands from these initial 
penetrating cells until 18 days culture, at which point the culture over grows the material as seen by the 
apparent cell death at 21 days culture. H&E stained images of scaffolds which had been cultured for A: 4 
days, B: 7 days, C: 11 days, D: 14 days, E: 18 days and F: 21 days. Scale bars = 200µm for all images. 
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Figure 3.15: The SW480 and SW620 cell lines remain viable cultures for different culture 
periods when maintained on Alvetex
®
 Scaffold for up to 21 days, with the SW480 cells 
remaining viable for up to 18 days, while the SW620 cells remain viable up to 11 days. 
Absorbance at 570nm of A: SW480 and B: SW620 cells as determined by the MTT Cell 
Viability Assay. Data represent mean, n = 3, ±SEM for both graphs. 
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Figure 3.16: The SW480 and SW620 cell lines produce different amounts of proteins when maintained on 
Alvetex
®
 Scaffold for up to 21 days, with both displaying a slight increase over the total culture period. 
Protein content in mg/ml of A: SW480 and B: SW620 cells as determined by the Bradford Assay. Data 
represent mean, n = 3, ±SEM for both graphs. 
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3.3.6.4 The distribution of SW480 and SW620 cells on Alvetex
®
 Strata is limited compared 
to Alvetex
®
 Scaffold 
Long term culture on Alvetex
®
 Strata was also investigated for only 14 days due to the 
observations in Alvetex
®
 Scaffold suggesting a longer culture period would be detrimental to cell 
viability. The growth of SW480 cells on Alvetex
®
 Strata resulted in a culture in which cells adopted 
a distribution that is distinct from cultures grown on Alvetex
®
 Scaffold, as the cells did not penetrate 
into the material to the same extent (Figure 3.17). The density of cells found on the top surface of 
the material was established within the 4 days of culture (Figure 3.17A), with this level of cell 
growth maintained through to 7 days of culture (Figure 3.17B). It was only after the initial culturing 
period that SW480 cells began to move into the material, with the small amount of cell growth 
found within the material by day 14 confined to the upper quarter (Figure 3.17D). Throughout the 
culturing period, the cell growth on the top surface did not increase beyond the level seen by day 4, 
unlike the long term cultures on Alvetex
®
 Scaffold (Figure 3.13). 
Similarly, the SW620 cell line displayed an impaired ability to grow on Alvetex
®
 Strata (Figure 
3.18). Unlike cultures on Alvetex
®
 Scaffold, SW620 cultures on Alvetex
®
 Strata did not initially 
penetrate into the material and form a small layer of growth at the top surface (Figure 3.18A). Cells 
were seen to penetrate into the material by later time-points (Figure 3.18C); however, once again 
they were confined to the top quarter of the material. It also appeared that the cells found in the 
material by day 11 are cells which had migrated into the material as the build-up of cells inside the 
material was correlated with a loss of cell from the top surface of the material at day 7 (Figure 
3.18B). By day 14 most of the cell growth both within and on top of the material had been lost 
(Figure 3.18D), suggesting an inability of Alvetex
®
 Strata to maintain long term culture of the 
SW620 cell line. 
3.3.6.5 Cultures on Alvetex
®
 Strata demonstrated poor viability 
Histological analysis reflected the data for both the viability and protein content of the cultures 
grown on Alvetex
®
 Strata. Both the SW480 and SW620 cultures displayed a steady level of viability 
over the first 11 days of culture, with a drop by the end of the 14 day culturing period (Figure 3.19). 
This viability data was also more variable that the viability data from cultures grown on Alvetex
®
 
Scaffold, as viewed by comparing the error bars with Figure 3.15, suggesting that culture on 
Alvetex
®
 Strata did not produce consistent samples at any time-point in culture. 
3.3.6.6 Cultures on Alvetex
®
 Strata had a lower protein content than those on Alvetex
®
 
Scaffold 
Similarly, the protein content data for Alvetex
®
 Strata cultures differed from the data for Alvetex
®
 
Scaffold cultures. The protein content of the SW480 cultures on Alvetex
®
 Strata was seen to 
decline over the 14 day culture period (Figure 3.20A), while the protein content of the SW620 
cultures on Alvetex
®
 Strata was found not to vary across all time-points (Figure 3.20B). For both 
cell lines, the amount of protein found in the Alvetex
®
 Strata cultures was at a much lower level 
than found in the Alvetex
®
 Scaffold cultures. 
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Figure 3.17: The SW480 cell line can be maintained in 3D culture on the top layer of Alvetex
®
 Strata 
for up to 14 days with fewer cells visible than seen when cultured on Alvetex
®
 Scaffold. Cells maintain 
a layer of growth on top of the material with little penetration into the material over the culture period. 
H&E stained images of scaffolds which had been cultured for A: 4 days, B: 7 days, C: 11 days and D: 
14 days. Scale bars = 200µm for all images. 
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Figure 3.18: The SW620 cell line shows a poor ability to be maintained in 3D culture on the top layer 
of Alvetex
®
 Strata for up to 14 days. The initial cell attachment to the top surface of the material is lost 
over the culture period, with few cells penetrating the material. H&E stained images of scaffolds which 
had been cultured for A: 4 days, B: 7 days, C: 11 days and D: 14 days. Scale bars = 200µm for all 
images. 
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Figure 3.19: Low levels of cell viability of cells cultured on Alvetex
®
 Strata for up to 14 days reflects the low 
low amount of cell growth build up for both the SW480 and SW620 cell lines. Absorbance at 570nm of A: 
SW480 and B: SW620 cells as determined by the MTT Cell Viability Assay. Data represent mean, n = 3, 
±SEM for both graphs. 
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Figure 3.20: Low levels of protein extracted from cells on Alvetex
®
 Strata for up to 14 days reflects the low 
amount of cell growth build up for both the SW480 and SW620 cell lines. Protein content in mg/ml of A: 
SW480 and B: SW620 cells as determined by the Bradford Assay. Data represent mean, n = 3, ±SEM for 
both graphs. 
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Collectively, this data suggests that Alvetex
®
 Scaffold is a better choice of material for long term 
culture of both the SW480 and SW620 colorectal cancer cell lines as it could support the growth of 
cells at a high density before there was a decrease in their viability. This is not without limitations, 
as each cell line reaches a point of declining cell viability at different timepoints throughout the 
growth period. In comparison, Alvetex
®
 Strata did not appear to provide either cell line with a 
growth environment which encourages the maintenance or expansion of cultures, even at the 
shortest timepoint investigated. 
3.3.7 Culturing colorectal cancer cells in 3D changes the expression of 
E-cadherin 
The data presented so far has demonstrated that there were differences in the cell distribution 
profile of each cell line in 3D cultures on Alvetex
®
 Scaffold; furthermore this distribution altered over 
extended culture periods. Protein lysates from 2D and 3D cultures of both cell lines were compared 
to investigate if this difference in cell distribution and cell density had an effect on the protein 
expression profile of these cells. To assess this, the expression of E-cadherin and vimentin were 
examined as the expression of these key proteins can be used to identify which cells have 
undergone EMT [79] and have developed a more migratory phenotype via the alteration of a wide 
range of proteins [80]. 
Immunostaining of 2D and 3D SW480 and SW620 cultures for E-cadherin showed clear 
differences between the two cell lines, in addition to variation due to the cell density (Figure 3.21A). 
E-cadherin expression in the SW480 cell line appeared to be dependent of the culture conditions, 
with staining seen in both 2D cultures and in the more densely packed 3D culture (Figure 3.21A). 
This was reflected in the Western blot analysis, where a band was found at 110kDa in both of the 
samples taken from moderately and densely packed 2D monolayer cultures (Figure 3.21B, lanes 1 
& 2). In the 3D cultures, the band was found to be absent in 7 day cultures (Figure 3.21B, lane 3) 
where the cells were sparsely packed into the scaffold (Figure 3.13B) with the band present in the 
sample taken from 11 day cultures (Figure 3.21B, lane 4) where the cells were more densely 
packed at the top surface of the scaffold (Figure 3.13C). 
In contrast, the SW620 cell line did not appear to express E-cadherin at any of the cell densities 
investigated in either 2D or 3D cultures when analysed by both immunostaining (Figure 3.21A) and 
Western blots (Figure 3.21B, lanes 5, 6, 7 & 8). This corresponds to cells which have undergone 
EMT during metastatic tumour progression and have lost any E-cadherin expression that the 
original tumour had. 
Additional immunostaining analysis was carried out to determine the expression of vimentin in the 
2D and 3D cultures of these cell lines. Both the SW480 and SW620 cell lines were seen to express 
vimentin regardless of the density or dimensionality of the in vitro culture conditions (Figure 3.21A). 
Together this shows that the expressional behaviour of certain proteins in certain cell lines, such as 
E-cadherin in the SW480 cell line, may be altered by the dimensionality of the culture environment. 
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Figure 3.21: The conditions of cell culture alter the expression levels of E-cadherin but not vimentin in 
SW480 and SW620 cells. A: Immunocytochemical and immunohistochemical staining for E-cadherin and 
vimentin in 2D and 3D cultures of SW480 and SW620 cells, demonstrating the absence of E-cadherin 
expression in the SW620 cell line and in the lower density 3D SW480 cultures. B: Western blot analysis of 
E-cadherin expression in SW480 cells grown in 2D at lane 1: medium and lane 2: high density and in 3D 
for lane 3: 7 days and lane 4: 11 days and SW620 cells grown in 2D at lane 5: medium and lane 6: high 
density and in 3D for G: lane 7 days and lane 8: 11 days. Scale bar = 50μm for all images. 
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3.3.8 Long term culture on Alvetex ® Scaffold provides the basis for a 3D 
cell migration assay 
As the aim of this Chapter is to generate and optimise a 3D migration assay for the assessment of 
the impact of signalling events and culture microenvironment on the behaviour of colorectal cancer 
cells, the migratory behaviour of both the SW480 and SW620 cell lines on both Alvetex
®
 Scaffold 
and Alvetex
®
 Strata were assessed to establish the most appropriate time point to use for the 
assessment of this behaviour. 
Two methods of analysing the level of cell penetration into the material will be compared to 
determine which provides the most accurate results for use in a migration assay. Each method 
utilises the histological images taken from processed samples from each time-point of the culturing 
period (Figure 2.5A). The images used for analysis were the 10 consecutive images encompassing 
the central portion of the material; this ensures that the analysis was not skewed by the areas of 
lower cell density found towards the edge of the material. 
The first method of analysis, the ‘linear’ method, samples the depth of penetration at 3 points on 
each image by taking straight line measurements from the top surface of the material 
perpendicularly downwards to the greatest depth of penetration at that point (blue arrows, Figure 
2.5B). An alternative method was also assessed and is referred to as the ‘area’ method. This 
method takes the area of the material filled with cell growth (green dashed line, Figure 2.5C) as a 
percentage of the total area of the material (black dotted line, Figure 2.5C). When the cell 
penetration of the Alvetex
®
 Scaffold and Alvetex
®
 Strata cultures with both cell lines were assessed 
using the two methods, both methods produced results with similar trends, which reflected the 
histological images seen in Figure 3.13, Figure 3.14, Figure 3.17 and Figure 3.18. 
3.3.8.1 The SW620 cell line penetrated further into Alvetex
®
 Scaffold than the SW480 cell 
line over 14 days 
When the SW480 cultures on Alvetex
®
 Scaffold are assessed by the linear method, the cell 
penetration was seen to peak at 88µm by 11 days into the culturing period (Figure 3.22A), however 
assessment by the area method showed a maximal penetration of 22%, equivalent to 44µm, by the 
same time-point (Figure 3.22B). This reflected the distribution of cells as seen at the relevant time-
point images in Figure 3.13, as the amount of cells visible within the material increased between 7 
and 11 days, without filling the whole of the material. 
Similar trends in data generated by each method are seen when the SW620 cells were cultured on 
Alvetex
®
 Scaffold. The area method detected a lower level of cell penetration than the linear 
method for the same data set. Assessment via the linear method of these cultures showed a 
continual increase in the level of cell penetration which peaks at 185µm by 14 days (Figure 3.22C), 
whereas the area method put the maximal penetration at 70%, equivalent to 140µm, with a smaller 
increase in penetration seen between days 11 and 14 (Figure 3.22D). Again, this was a good 
reflection of the histological images presented in Figure 3.14, with the amount of cell growth found 
within the material shown to increase over the culturing period to 14 days. 
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Figure 3.22: 3D culture of cells on Alvetex
®
 Scaffold for up to 14 days demonstrates a difference in cell 
penetration ability between the SW480 and SW620 cell lines, with the SW620 cells achieving a greater 
penetration over the culture period. Cell penetration of A and B: SW480 and C and D: SW620 cells as 
determined by the linear method, expressed in μm, and by the area method, expressed as percentage, 
respectively. Data represent mean, n = 3, ±SEM for all graphs. 
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3.3.8.2 Both the SW480 and SW620 cell lines demonstrated impaired penetration into 
Alvetex
®
 Strata 
The results from the Alvetex
®
 Strata cultures show that the two cell lines exhibited different 
migratory behaviours on this material. Linear assessment of the SW480 cultures showed a gradual 
increase in cell penetration over the full 14 days of the culturing period with it peaking at 51µm 
(Figure 3.23A). Use of the area method did not show an increase in penetration over the 14 day 
culturing, with it remaining at 6%, equivalent to 12µm, throughout (Figure 3.23B). With these 
assessments, it was the cell penetration detected by the linear method that best reflects the 
histological data as presented in Figure 3.17, as these images showed a gradual movement of 
cells into the upmost part of the material. 
The penetration of the SW620 cell line into Alvetex
®
 Strata was also found to be at a much lower 
level than the penetration seen into Alvetex
®
 Scaffold. A gradual increase in penetration was 
detected by both the linear and area methods, although again the area method detected a lower 
level. The linear method detected a maximum penetration of 55µm at 14 days (Figure 3.23C), while 
the area method only placed the maximum penetration at 18%, equivalent to 36µm (Figure 3.23D). 
These numbers again reflected the histological data seen in Figure 3.18, with only a small amount 
of cell penetration seen by the end of the culture period. 
From these assessments of cell penetration, the linear method produced results which appear to 
be a more accurate reflection of the cell distribution seen in the corresponding histological images. 
This main reason for this seems to be that the area method tended to under estimate the level of 
cell penetration within a sample as it works on the assumption that the cells migrate down through 
the material as a solid block, whereas it was clearly seen in the histological data presented 
throughout this Chapter that it is not the case with the two cell lines assessed here. 
Additionally, due to the increased amount of user input required to obtain results using the area 
method over using the linear method, the potential for introducing errors into the data obtained was 
greatly increased when using the area method and may lead to incorrect conclusion being drawn 
from the data. Therefore, for the assessment of cell penetration in the migration assay, the linear 
method will be used as it is more sensitive to small alterations in cell penetration that the area 
method does not detect. 
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Figure 3.23: 3D culture of cells on Alvetex
®
 Strata for up to 14 days limits the amount of cell penetration 
for both the SW480 and SW620 cell lines. Cell penetration of A and B: SW480 and C and D: SW620 cells 
as determined by the linear method, expressed in μm, and by the area method, expressed as percentage, 
respectively. Data represent mean, n = 3, ±SEM for all graphs. 
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3.4 Discussion 
This Chapter has sought to assess the suitability of a 3D cell culture system, Alvetex
®
, for use in a 
3D cell migration assay for colorectal cancer. This system was selected as there is currently a lack 
of synthetic scaffold based 3D migration assays and it has already been shown to support a wide 
variety of cell lines [232, 260-263]. The optimisation process examined the outcome of altering 
different aspects of the preparation of the cultures on the cell distribution, as assessed from 
histologically processed samples, and cell viability, as assessed using the MTT Cell Viability Assay. 
The outcomes of the four areas examined, namely seeding method, scaffold pre-treatment, well 
insert format and Alvetex
®
 format, are summarised in Table 3.1. 
Work carried out here has demonstrated that the standard method of pre-treatment, ethanol 
wetting, is sufficient to allow cultures of the SW480 and SW620 cell lines to grow in 3D, as has 
previously been demonstrated for a variety of other cell lines [232, 260-263]. However the data 
from plasma pre-treated samples demonstrates that this is also sufficient for cultures to be 
maintained on Alvetex
®
. Using side-by-side comparisons of cultures grown on ethanol and plasma 
pre-treated material (Figure 3.9 and Figure 3.10); it is shown that the plasma pre-treated 
membranes provided the opportunity for a more consistent growth profile in the resulting cultures. 
As more consistent cultures would remove internal variation in the cell distribution within the 
material and would provide the homogeneous environment throughout the culture, this would lead 
to less variation in the protein expression [223], in turn the migratory behaviour of the cells will be 
more consistent, leading to more reliable penetration data. 
Table 3.1: Summary of the outcomes of protocol optimisation for growing SW480 and SW620 cells 
on Alvetex
®
. 
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The two methods of cell seeding, concentrated and diffuse, were equally effective at introducing 
the cell lines to the material and both led to successful cultures. The choice of static seeding 
methods minimises damage to both cells and the substrate that can be seen in dynamically seeded 
cultures by introducing excessive forces to the system [214]. The other advantage of investigating 
these methods is that they do not require specialist equipment to carry out the protocol and are 
relatively quick to complete. The alteration in seeding method had a large effect on the SW480 cell 
line by eliminating the thick layer of cell growth seen on top of the material (Figure 3.7C & D) 
without having a negative effect on the overall viability of the culture. While the SW620 cultures did 
not appear to have an altered cell distribution with a change in cell seeding method, the change 
from concentrated to diffused seeded cultures increased the viability of the cultures (Figure 3.8B). 
As with the selection of material pre-treatment, the selection of the diffuse seeding method 
achieved cultures which have a more consistent growth profile to provide reliable results. 
Changing the culturing environment by altering the well insert did not have an effect on the viability 
of the cultures of either cell line (Figure 3.12), while only effecting the distribution of the SW480 
cells (Figure 3.11). However, it has previously been demonstrated that the use of the full-sided 
insert leads to increased lactic acid build up in the reservoir of media above the scaffold compared 
to the media below it [278]. While this is not desirable for most cultures, this may prove 
advantageous for use in a migration assay as it may provide a simple way of mimic the hypoxic 
interior of tumours and produce biological cues which drive cell migration in a manner to that seen 
in vivo [72]. Additionally, with the culture media divided into two separate compartments within the 
well, there is the potential for introducing media additives to either compartment to produce a 
concentration gradient to alter the migration of the cells during 3D culture and this is a method that 
is often used in other migration protocols during standard 2D culture [204, 279]. 
From the Western blot presented in Figure 3.21, it was clear that the 3D culture environment has 
an effect on the protein expression profile of cells. The data for the expression of E-cadherin is in 
agreement with previously published studies. The SW480 cell line has been found to have variable 
levels of expression depending on the confluency of the 2D cultures from which the protein was 
extracted [223]. This carries over to culturing the SW480 cell line in a 3D system, as the lower 
density culture of these cells expressed E-cadherin at a lower level than the higher density culture. 
The lack of bands for E-cadherin from the SW620 cell lysates has also been previous noted in the 
literature, with multiple sources finding no detectable expression via Western blots and only limited 
expression when probed via immunohistochemistry [280, 281]. This variation seen in protein 
expression profile could have a knock-on effect when it comes to comparing the migration of the 
cell lines in 2D and 3D cultures, particularly as the loss of E-cadherin is one of the defining factors 
in determining whether cells have undergone EMT and have an increase metastatic potential [79]. 
The comparison between Alvetex
®
 Scaffold and Alvetex
®
 Strata has demonstrated that their 
morphological characteristics have a large impact on the behaviour of the SW480 and SW620 cell 
lines during 3D culture. The smaller void and interconnect size of Alvetex
®
 Strata appeared to limit 
the number of cells which can attach to the material in the first instance, as seen when MTT data 
was compared to that from Alvetex
®
 Scaffold cultures (Figure 3.15 and Figure 3.19), and provides 
an environment where it was more difficult for the cells to remain attached to maintain the viability 
of the cultures (Figure 3.19). This led to a smaller volume of cells moving into the material over the 
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14 day culture period when compared to the counterpart Alvetex
®
 Scaffold cultures. This agrees 
with the original hypothesis that Alvetex
®
 Strata may provide a physical barrier to cell migration into 
the material and, therefore, is not an appropriate material for a 3D migration assay with these cell 
lines and so all further studies will work solely with Alvetex
®
 Scaffold. 
From the viability and penetration data for long term cultures of the SW480 and SW620 cells on 
Alvetex
®
 Scaffold, an overall methodology for a 3D migration assay has been established (Figure 
3.24). The timescales for this protocol were determined by the behaviour of both cell lines over the 
21 day culture period tested. The endpoint of 10 days was selected due to the behaviour of the 
SW620 cell line, as these cells had penetrated 185μm into the 200μm thick scaffold by 14 days 
(Figure 3.22C). This would make visualising differences in cell penetration more difficult in cases 
where media additives increase the level of migration, whereas the penetration depth of 166μm by 
11 days would allow for more opportunity to visualise these differences. Additionally, viability of the 
long term cultures of SW620 dropped off after 11 days in 3D culture, so using a culturing period 
which is shorter than this ensures that the migration assay is being carried out on healthy cells and 
the results obtained would not be affected by cell death. A 10 day culture of the SW480 and 
SW620 cell lines still demonstrated a similar level of distinction between the amount of cell 
penetration demonstrated by each cell line as previously seen at 11 days (Figure 3.25). 
Furthermore, the selection of an even number of days for the total assay period allows for an even 
split between the establishment and assessment periods of the assay. Histology data for both cell 
lines demonstrated that both of them have established cultures by 4 days (Figure 3.13A and Figure 
3.14A), so the introduction of media additives at day 5 would lead to them acting on cells which 
have already adapted to the scaffold environment and would not alter the outcome of the assay by 
affecting cell attachment. 
As with all assays, a control needs to be included in order to validate the results obtained and to 
allow for the best possible conclusion to be drawn from the data available. As the role of the Wnt 
signalling pathway in colorectal cancer is the biological focus of this project, the control aspect is 
particularly important in this assay, as the Wnt pathway plays a crucial role in the proliferative 
behaviour and differentiation of cells in the colonic epithelium [94] and disruption of the pattern of 
Wnt signalling causes major disruption to the final organisation of the epithelial cells in the colon 
[92]. The control selected for this migration assay is the Quant-iT™ PicoGreen® dsDNA Assay, 
which is a fluorescence assay which quantifies the amount of double-stranded DNA [282], which in 
turn provides the user with either the concentration of dsDNA or the cell number within a sample. 
This will allow the assessment of the effect of any media additives to ensure that the any alteration 
seen in the penetration of cells into the scaffold is due to changes in cell migratory behaviour and 
not proliferative behaviour. 
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Figure 3.24: Schematic for the 3D cell migration assay using Alvetex
®
 Scaffold, a novel polystyrene 
scaffold. This experimental outline allows for an establishment period for cell growth before the 
introduction of media additives to influence cell penetration during the second phase of the culture period. 
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Figure 3.25: The SW620 cell line shows a greater capacity than the SW480 cell line to penetrate into 
Alvetex
®
 Scaffold over the time course of the migration assay. H&E stained images of scaffolds which had 
been cultured for 10 days with A: SW480 and B: SW620 cells showing an average penetration (n=3) of 
51±7µm and 98±5µm respectively. Scale bars = 200µm for both images. 
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Together, this work will aim to investigate cancer cell migration in a setting that has not been 
examined in great detail in the literature, which is using a synthetic scaffold to provide a 3D cell 
culture environment. Using this variety of system has advantages over other methods of obtaining 
3D cancer cultures, such as spheroids or ECM gel based cultures. Spheroids have been used for 
many years as a method of obtaining 3D multi-cellular cultures [176] and naturally provide an 
oxygen and nutrient gradient which mimics the intravascular regions of tumours. However, it has 
been demonstrated that the size of these spheroids needs to be tightly regulated, the behaviour of 
cells is affected by spheroid size and this can affect experimental outcomes [155]. The system 
under development here provides a platform for producing consistent 3D cultures, removing some 
of the variability in cell behaviour and experimental outcomes seen with spheroids. Additionally, 
with the employment of the full-sided well insert, the 3D culture can be subjected to a lactic acid 
concentration gradient [278], providing a simple way of modelling the gradient seen in tumours. 
ECM gels are another commonly used method for obtaining 3D cancer cultures, with the cancer 
cells cultured on top of [209] or encapsulated by the gel [211] and with the option of co-culturing 
with a secondary cell type to form an organotypic model [216]. While these systems provide a 3D 
microenvironment which is highly biologically relevant, the determination of biological responses 
which are due to biological signalling from the protein environment or the increased dimensionality 
of the culture environment may be complex. As the Alvetex
®
 system is polystyrene based [259], the 
same material used for tissue culture plasticware [265], it provides an opportunity to study the role 
that the increased dimensionality has in the alteration of cell behaviour in the absence of the 
increased biological cues from the ECM gel. Additionally, as the culture of cells on ECM coated 
Alvetex
®
 Scaffolds has been demonstrated [283], it provides the opportunity for the stepwise 
building of a biologically relevant 3D model to examine the effect of each component individually. 
The closest model to the Alvetex
®
 system which is routinely used to assay cell migration and 
invasion is the Transwell
®
 model [206], which is used with or without an ECM coating to investigate 
cell invasion or migration respectively. The Transwell
®
 system also works on the concept of utilising 
well inserts to allow the rapid set up of experiments which require little in the way of specialist 
equipment, which may account for their widespread usage in the literature. However, Transwell
®
 
insert membranes are only 10μm thick, which, when used to assay cell migration, provides a 
limited 3D environment for the cells to migrate through, while the 200μm thickness of Alvetex
®
 
Scaffold provides a 3D environment to the migrating cells for a longer period of their migration, 
which more accurately reflects the in vivo tissue morphology. Additionally, the relatively short time 
periods that Transwell
®
 assays are run for, in the region of hours as opposed to days [284], may 
fail to identify compounds of interest if their effects work over a longer time period. It is proposed 
that the Alvetex
®
 system is a more advanced migratory system than the Transwell
®
 system by 
providing a more biologically relevant 3D microenvironment than the Transwell
®
 system. 
This migration assay will now be utilised for investigating the role of Wnt signalling in modulating 
the migratory behaviour of colorectal cancer cells and if the nature of the 3D culture environment 
has an effect by looking at ECM protein coatings and co-culture with fibroblasts to mimic the 
stromal compartment of tumours. 
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4 Inhibition of Wnt Signalling in Colorectal Cancer 
Cells Alters Cell Migratory Behaviour 
4.1 Introduction 
This Chapter will seek to investigate the role of Wnt signalling in mediating cell migration within 
colorectal cancer models. From roles in controlling the proliferation vs. differentiation axis of colonic 
epithelial cells [92, 93] to the positioning of cells to form crypts [92] or the functional intercrypt 
epithelium [95], the Wnt signalling pathway has been shown to be fundamental to the maintenance 
of the healthy colonic epithelium. With ~90% of colorectal tumours possessing a mutation to key 
proteins within this pathway [96], Wnt signalling also plays a key role in the initiation of colorectal 
cancers, leading to it holding a position of interest within the field over many of the other signalling 
pathways which have been implicated in cancer development [6]. 
As the protein interactions within the Wnt signalling pathway were fully identified in the 1990s [285-
287], there has been the opportunity to develop a range of molecular tools to manipulate the 
activity of this pathway. As the Wnt pathway is found to be inappropriately activated in colorectal 
cancers, as demonstrated by the high levels of nuclear β-catenin [288], it is the search for 
antagonists of this pathway that have the potential to provide the basis for the treatment of this 
disease. While there is Dkk1, a protein antagonist of the Wnt pathway [91], there are also a range 
of small molecules which act as antagonists to the Wnt signalling pathway by targeting different 
protein interactions (Figure 4.1). 
4.1.1 Small molecule inhibition of the Wnt signalling pathway 
A screen of the literature has highlighted four commercially available Wnt antagonists, cardamonin, 
ICG 011, IWR-1 and XAV 939, for testing in the migration assay optimised in Chapter 3 to evaluate 
their effect on the migration of colorectal cancer cell in in vitro migration assays. 
4.1.1.1 Cardamonin 
Cardamonin (Figure 4.1A) belongs to the chalcone family of compounds and has been isolated 
from a variety of plant species, including Boesenbergia pandurata [289] and Alpinia henryi [290]. It 
is one of a group of plant derived compounds termed ‘nutraceuticals’ which have been implicated 
for roles in cancer prevention and treatment due to their interaction with a variety of signalling 
pathways which are crucial to cancer initiation and development [291, 292]. 
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Figure 4.1: Chemical structure of small molecule Wnt inhibitors and schematic of their interaction with the 
Wnt signalling pathway. Chemical structure of A: cardamonin, B: ICG 001, C: IWR-1 and D: XAV 939. E: 
both XAV 939 and IWR-1 stabilise the Axin/APC/GSK-3β complex, leading to β-catenin phosphorylation 
even when the Wnt ligand is present. F: cardamonin decreases the levels of free β-catenin in a GSK-3β 
independent manner, while ICG 001 inhibits β-catenin/TCF-4 mediated transcription by interaction with 
transcriptional coactivators. The inhibition of Wnt signalling leads to a decrease in the transcription of EMT 
associated genes. 
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4.1.1.1.1 Cardamonin inhibits NF-κB target gene activation 
Work carried out on RAW 264.7 macrophages has shown that cardamonin inhibits bacterial 
lipopolysaccharide stimulated NF-κB target gene activation, including inflammatory associated 
proteins such as COX-2, iNOS [293] and TNF-α [294]. The reduction seen in Cox-2 and iNOS 
protein levels leads to a decrease in the production of prostaglandin E2 and NO2
-
 respectively 
[295]. The proposed mechanism for this action is the inhibition of IKK, the protein complex 
responsible for the phosphorylation of I-κBα. The inhibition of this phosphorylation process leads to 
the cytosolic accumulation of the unphosphorylated form of I-κBα, masking the nuclear localisation 
signal of NF-κB, preventing nuclear translocation and transcriptional activation of target genes 
[295]. 
Cardamonin has also been shown to have an inhibitory effect on the migration of a variety of 
cancer cell lines, including breast cancer, neuroblastoma and fibrosarcoma cell lines [296]. This 
work was carried out looking at both migration and invasion assays, using multi-well chambers and 
Matrigel coated Transwell
®
 units respectively with FBS as a chemoattractant. Cardamonin dose 
dependently inhibited migration and invasion via the NF-κB mediated suppression of 
transglutaminase-2 expression, in addition to suppression of the activity of the matrix 
metalloproteinases MMP-2 and MMP-9, both in the presence and absence of the invasion inducer 
TPA. 
4.1.1.1.2 Cardamnonin decreases β-catenin protein levels independently of the Wnt 
signalling pathway 
In addition to its role as an anti-inflammatory compound, cardamonin has also been shown to 
inhibit Wnt signalling. In human melanocytes, cardamonin has been shown to decrease the levels 
of β-catenin protein in a dose dependent manner without altering the level of β-catenin mRNA 
[297]. Further to this, the decrease of β-catenin protein levels was found to be independent of the 
Wnt pathway, as it was unaffected by the presence of the Wnt3a ligand or BIO, a Wnt signalling 
agonist. The action of cardamonin was blocked by addition of the proteasome inhibitor MG-132, 
indicating that the mechanism by which the compound acts on β-catenin is via proteasome-
mediated degradation (Figure 4.1F). In the melanocytes, decreased levels of β-catenin led to 
decreased melanin production in response to the Wnt3a ligand by lowering the levels of tyrosinase 
and microphthalmia-associated transcription factor, both of which are required to catalyse tyrosine 
into melanin. 
Cardamonin has also been used to investigate the role that Wnt signalling has to play in control 
cardiac function [298]. Using the murine derived atrial-like cells HL-1, cardamonin was used to 
determine the mode of action by which MSC conditioned tyrodes affected the conduction velocity of 
the cells. Application of cardamonin in addition to the conditioned tyrodes lead to a decrease in 
Cx43 protein expression and, due to its role in synchronised contraction of cardiac tissue, a 
decrease of the conduction velocity of the cells. As this complemented data using the GSK3-β 
inhibitor lithium chloride, this lead to the conclusion that the signalling pathway activated to control 
the conduction velocity was the canonical Wnt signalling pathway. 
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4.1.1.1.3 The cardamonin mediated decrease in β-catenin suppresses the proliferation of 
colorectal cancer cells 
More recently, cardamonin has been shown to suppress the proliferation of a variety of colorectal 
cancer cell lines, including the SW480 cell line, in standard 2D monolayer cultures [299]. Again, 
this action was found to be via the proteasome mediated degradation of the β-catenin protein 
without affecting the mRNA levels, as seen in melanocytes [297]. This decrease in β-catenin 
protein level led to the decreased expression of cyclin D1 and c-myc [299], both of which are β-
catenin target genes, with a knock-on effect to the viability of cell lines upon exposure to the 
compound. Together the data for the interactions between cardamonin and the Wnt signalling 
pathway suggests that it has potential as a therapeutic agent for targeting cancer, along with other 
compounds which modulate the transcriptional activity of β-catenin [300]. 
4.1.1.1.4 Cardamonin sensitises cancer cells to TRAIL mediated apoptosis 
In addition to the interactions with NF-κB and the Wnt pathway, cardamonin has been shown to 
sensitise a variety of cancer cells to TRAIL mediated apoptosis by down regulating various anti-
apoptotic proteins such as Bcl-2 and survivin [301]. While the authors of the paper eliminated p53 
involvement in this process, they did not confirm the signalling pathway which the cardamonin was 
interacting with to mediate this result. 
While the action of cardamonin is not limited to interactions with the Wnt pathway, the evidence 
linking it to roles in mediating cell migration and invasion shows that it has potential in a novel 
migration assay, although the migration data obtained should be viewed in light of cell number data 
to determine whether that the compound is primarily affecting the migratory or proliferative 
behaviour of the cells. 
4.1.1.2 ICG 001 
4.1.1.2.1 ICG 001 inhibits tumour growth 
ICG 001 (Figure 4.1B) is an organic compound which interacts with CBP, a transcriptional 
coactivator of β-catenin, in a dose dependent manner (Figure 4.1F). First utilised by Emami et al 
[302], it has shown to be effective in both in vitro and in vivo colorectal cancer studies by directly 
inhibiting the binding between β-catenin and CBP without inhibiting the binding of β-catenin to the 
CBP homolog p300. As the IC50 of ICG 001 is raised from the initial 3µM seen in SW480 cells by 
transfection of CBP into the cell line, this demonstrates that ICG 001 actively competes with β-
catenin as a binding partner for CBP and, by blocking the β-catenin/CBP interaction, switches the 
balance of β-catenin binding towards transcriptional complexes with p300. ICG 001 downregulates 
the expression of survivin and cyclin D1, both β-catenin/TCF transcriptional targets, which in turn 
results in an inhibition of growth of the colorectal cancer cell lines SW480 and HCT116 without 
effect the growth of the normal colonic epithelial cell line CCD-841Co in vitro. In vivo studies using 
SW620 xenografts into Balb/c nude mice and the Min mouse model of human FAP reflect the in 
vitro data regarding survivin expression and inhibition of tumour cell growth, suggesting that ICG 
001 may have clinical applications. 
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4.1.1.2.2 ICG 001 suppresses gene expression, including EMT associated genes 
Application of ICG 001 to in vitro cultures alters the expression of a range of genes, including the 
downregulation of survivin expression in various colorectal cancer cell lines mediated by the lack of 
CBP binding to the gene promoter [303] and was also seen in a variety of hepatic [304], breast and 
prostate [303] cancer cell lines tested. This downregulation was seen found without alteration to the 
levels of either β-catenin or TCF proteins found at the promoter [303]. In addition to the blocking of 
CBP from the survivin promoter, ICG 001 mediated the recruitment of the transcriptional repressors 
HDAC6 and SUMO-1 to the promoter, further enhancing the inhibition of expression [303]. When 
utilised with the MCF-7 breast cancer cell line, ICG 001 was found to repress leptin mediated EMT 
by supressing the levels of Snail, Zeb2 and Slug expression when compared to treatment with 
leptin alone, resulting in monolayer cultures with cellular phenotypes resembling the untreated 
controls [305]. 
4.1.1.2.3 ICG 001 inhibits Wnt signalling in response to dietary fibre breakdown 
ICG 001 has been used to investigate the signalling events that mediate the effect of butyrate, a 
histone deactylase inhibitor (HDACi) breakdown product of dietary fibre, on the behaviour of 
colorectal cancer cells. ICG 001 inhibited butyrate induced Wnt signalling in both the HCT-116 and 
SW620 cell lines, which in turn had a variable effect on the induction of apoptosis in these cell lines 
with ICG 001 increasing the apoptotic response, as visualised by caspase activity, in the HCT-116 
cells while inhibiting the level of apoptosis seen in the SW620 cells [306]. In addition to affecting 
apoptosis induction, ICG 001 and butyrate have a negative impact on the proliferation rate of the 
two cell lines tested, when used individually and in combination, with the expression levels of both 
p21 and survivin supressed by ICG 001 treatment. Further work from the same group has shown 
that ICG 001 mediates similar effects on the level of Wnt activity of the p300 deficient colorectal cell 
lines HCT-R and HCT-15 in response to butyrate [307]. The authors of these papers suggest that 
with further investigations into the action of β-catenin/p300 on cell proliferative and apoptotic 
behaviours, joint therapies of ICG 001 and HDACis may have a role in the treatment of p300 
deficient patients where treatment with butyrate alone does not elicit the desired cellular response. 
A further role for ICG 001 in joint therapies has been suggested for the treatment of multidrug 
resistant hepatoblastoma, as is has been shown that combinatorial therapy with either the MET 
kinase inhibitor SU11274 or common hepatoblastoma chemotherapy agent cisplatin had a greater 
decrease on the cell viability of 2D monolayer cultures than any compound used in isolation [308]. 
4.1.1.2.4 ICG 001 has application in the modulation of Wnt signalling in different cell types 
The documented use of ICG 001 in the literature is not limited to studies looking at the behaviours 
of cancer, as it has been used to look at the effect of inhibiting β-catenin/CBP mediated gene 
transcription in rat epicardial cells following induced myocardial infarction [309]. ICG 001 was found 
to upregulate the Gdf15, Ctgf and Nppa genes which are associated with healthy cardiac function 
and this causes an increase in contractile function of the left ventricle. Additionally, inhibition of the 
Wnt pathway via ICG 001 is able to upregulate the expression of the cartilage specific collagen 
COL2A1 gene after injury to the growth plate of hind legs of rats and this effect can accentuate the 
increase caused by the chondrogenesis enhancer TGF-β1 [310]. By 10 days post injury, the 
application of ICG 001 increased the proportion of cartilaginous tissue and decreased the 
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proportion of bony trabecular whilst leaving the proportions of mesenchymal tissue and bone 
marrow unaffected in the sampled population. 
With ICG 001 displaying a wide variety of uses both in vitro and in vivo models, from those 
discussed here to models of neuron outgrowth [311] and pulmonary fibrosis [312], it has 
demonstrated its capacity to modulate the regulation of Wnt target genes and it has potential for 
use with the novel 3D migration model under testing here. 
4.1.1.3 IWR-1 
4.1.1.3.1 IWR-1 modulates Wnt signalling by stabilising the β-catenin degradation complex 
IWR-1 (Figure 4.1C) is one of a group of organic small molecules termed ‘inhibitors of Wnt 
response’ capable of inhibiting Wnt signalling via promoting the stability of the β-catenin 
degradation complex comprising of Axin, APC and GSK-3β (Figure 4.1E) [313], in addition to being 
a potent inhibitor of tankyrase (TNKS) 2 [314]. Application of IWR-1 to the colorectal cell line DLD-1 
results in the upregulation of the Axin2 protein relative to DMSO treated controls and this is not 
mirrored by changes to the protein levels of other components of the Wnt pathway such as APC, 
GSK-3β, β-catenin and Dvl. The upregulation of Axin2 is not mediated by upregulation of AXIN2 
gene, as IWR-1 downregulates the expression of the AXIN2 gene, or inhibit the action of the 
proteasome; neither does it alter the localisation of Axin2 within the cells or its affinity for β-catenin. 
This paper also demonstrates the ability of IWR-1 to modulate the activity of the Wnt pathway in 
cell lines with a mutated APC protein, as is found in many colorectal cancers. 
4.1.1.3.2 IWR-1 has been used to downregulate Wnt signalling in development models 
IWR-1 has been utilised to investigate the role of Wnt signalling in various developmental 
processes in zebrafish and Xenopus. It is found to retard the regrowth of amputated caudal fin and 
inhibit the regeneration of the lining of the gastrointestinal tract of six-month old zebrafish, as 
visualised by the lack BrdU uptake in the base of intestinal folds [313]. In addition to those effects 
of Wnt signalling inhibition in zebrafish, the use of IWR-1 retards swimbladder development in the 
developing embryo [315, 316]. The smaller swimbladder is also associated with a lack of smooth 
muscle, visualised by the lack of acta2 expression, in addition to disrupted tissue layers, as 
visualised by disrupted hb9, has2 and elov1a expression. In Xenopus embryos, application of IWR-
1 reduced the expression of AXIN2, as well as the markers for blood development hba1 and lmo2 
[317]. 
4.1.1.3.3 IWR-1 had been shown to be effective in non-cancer models 
There has also been work carried out utilising IWR-1 as a modulator of Wnt signalling in 
mammalian culture experiments. When used in conjunction with BMP2 on mouse dental papilla 
cells, IWR-1 is capable of reversing the BMP2 induced increase in DMP1, Dspp and β-catenin 
expression and reduces the level of AP activity induced after a 48 hour exposure to BMP2 [318]. 
Inhibition of the Wnt signalling pathway in human iPSCs can switch the differentiation pathway from 
alveolar epithelial type II (AETII) to alveolar epithelial type I (AETI) cells by increasing the gene 
expression levels of caveolin-1, AQ5 and T1α, all of which are markers of the AETI phenotype 
[319]. During hESC differentiation into cardiomyocytes via exposure to BMP-4 and activin A, 
inclusion of IWR-1 in the induction media increased the percentage of cardiomyocytes produced 
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over a DMSO control [320], with IWR-1 producing a greater proportion of atrial cells over 
ventricular cells, as visualised by the relative gene expression of the MYL7 and MYL2 respectively. 
IWR-1 has had limited usage so far in the area of cancer research, however it has been used on a 
variety of murine and human lung cancer cell lines [321]. Across all cell lines tested, IWR-1 dose 
dependently decreased the viability of the 2D monolayer cultures, an effect which could be 
reversed by the overexpression of β-catenin in the cells. As this paper also demonstrated the 
inhibition of Wnt signalling by IWR-1, this molecule has the potential to affect the migratory 
outcome of Wnt signalling in a colorectal cancer model. 
4.1.1.4 XAV 939 
4.1.1.4.1 XAV 939 also stabilises the β-catenin degradation complex 
XAV 939 (Figure 4.1D) is another small molecule which has the capability to stabilise the 
Axin/APC/GSK-3β destruction complex by stabilising axin2 (Figure 4.1E), which results in an 
increase in the protein levels of phosphorylated β-catenin and a decrease the level of Wnt 
dependent gene transcription [322]. The action of XAV 939 is mediated by the inhibition of TNKS1 
and TNKS2 and it is the inhibition of these which in turn stabilise the axin2 protein levels, as 
treatment of SW480 with TNKS1/2 siRNA also increased the levels of axin2. TNKS1 and TNKS2 
add several ADP-ribose units to their targets, a process called poly-ADP-ribosylation 
(PARsylation). PARsylation of axin2 targets it for ubiquitin mediated proteasomal degradation, as 
demonstrated by the exposure of XAV 939 treated SW480 cells to the proteasome inhibitor 
MG132, which leads to a build-up of PARsylated and ubiquitinated axin2 relative to untreated 
controls. When the DLD-1 colorectal cancer cell line was exposed to XAV 939, it caused a 
decrease in colony formation relative to untreated controls. As IWR-1 is also a TNKS2 inhibitor 
[314], it is possible that its action to stabilise axin2 is also mediated by TNKS2. 
4.1.1.4.2 XAV 939 inhibits Wnt signalling in development models 
Like IWR-1, XAV 939 has also been used to look at developmental processes in Xenopus 
embryos, where it reduced the expression of AXIN2, as well as the markers for blood development 
hba1 and lmo2 [317]. XAV 939 has also been used to investigate the role of Wnt signalling in 
cardiomyogenesis of mouse ES cells [323], with the application of XAV 939 to embryoid bodies 
(EBs) during days 3 through 5 of differentiation producing a greater proportion of spontaneously 
beating EBs by day 10. The increase in XAV 939 induced spontaneously beating EBs is 
comparable to the increase induced by the Wnt antagonist Dkk1. The increase in spontaneously 
beating EBs was accompanied by gene upregulation of the cardiac markers Myh6 and Nkx2.5 as 
well as upregulation of α-actinin protein levels at the expense of gene expression of Gata1, Myh11, 
and KDR, which are hematopoietic, smooth muscle and endothelial markers respectively. 
4.1.1.4.3 XAV 939 sensitises cancer cells to apoptosis and decreases viability 
XAV 939 has been used to investigate the role of Wnt signalling in a variety of cancer types. As 
with IWR-1, XAV 939 also dose dependently decreased the viability of 2D monolayer cultures of a 
variety of murine and human lung cancers cell lines, an effect which could be reversed by the 
overexpression of β-catenin in the cells [321]. When the human neuroblastoma cell line SK-N-SH is 
exposed to XAV 939 in conjunction with the chemotherapy agent Doxorubicin (DOX), the 
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percentage of live cells is lower than when the cells are exposed to DOX alone for 24 hours [324]. 
Additionally, the use of XAV 939 equalises the effect of DOX on the CD133
+
 and CD133
-
 
populations within the cell line, as DOX causes a larger drop in live cells in the CD133
-
 population 
than the CD133
+
 population, the putative stem cell compartment of the tumour cell populations. 
In colorectal cancers, XAV 939 has been shown to increase apoptosis mediated by the PI3K 
inhibitors LY-294002 and BKM120 or the PKB inhibitor API-2 in spheroid cultures of cells from 
patient samples with high levels of nuclear β-catenin [325]. However, the same effect was not seen 
in dual treatment with the chemotherapy agents 5-FU or oxaliplatin. As the Wnt signalling pathway 
is disrupted in many colorectal cancers, there have been many review articles suggesting that XAV 
939 has the potential to be effective in the treatment of colorectal cancers by switching the balance 
of β-catenin behaviour within the cells [326-328], hence its selection as a Wnt signalling antagonist 
to be assessed for its potential to reduce colorectal cancer cell migration in a 3D model. 
Based on the available literature when this study was initiated, XAV 939 was selected as the first 
small molecule to be screened for effectiveness in the 3D migration model developed here. This 
selection was based on characteristics of all four of the small molecules. Cardamonin was 
discounted as it has been shown to interact with multiple signalling pathways and so its mechanism 
of activity is not confined to the Wnt pathway. Hence, any results obtained using this molecule 
would need to be assessed to determine which pathways were responsible for any changes in 
behaviour observed. 
As ICG 001 acts to inhibit the binding of β-catenin and CBP, not p300, it does not uniformly block 
Wnt signalling and appears to favour inhibiting the proliferative activity of cells. As the aim of this 
study is to investigate the migratory behaviour of the cancer cells, this molecule was also 
discounted as there is evidence to suggest that it would target a wider range of cellular behaviour 
beyond migration. 
The two remaining small molecules, IWR-1 and XAV 939, both work to stabilise the 
Axin/APC/GSK-3β degradation complex to decease the available amount of β-catenin, which 
decreases the expression of Wnt target genes. Of these, IWR-1 has had limited applications in 
cancer research and, therefore, was not selected for initial study. 
While XAV 939 has been used with a variety of cancer types, it was the effect on cell viability, not 
migration, which was investigated. As its effect on β-catenin mediated gene transcription is well 
documented, it is hypothesised that it would decrease Wnt mediated cell migration. However, any 
data obtained would need to be assessed in conjunction with cell number data to ensure that the 
molecule is not affecting cell viability as previously noted. 
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4.2 Chapter Aims 
This Chapter aims to assess the role of the Wnt signalling pathway in modulating the behaviour of 
colorectal cancer cells by utilising small molecule inhibitors of the Wnt pathway in both 2D and 3D 
cell migration assays. Screens of these molecules will highlight whether they have an inhibitory 
effect on the cell migration whilst also considering their influence on the proliferative behaviour of 
the cells. 
4.2.1 Objectives 
Overall, the aims of the small molecule assessment in this Chapter will be met by: 
 Screening a selection of small molecule Wnt signalling inhibitors to assess their impact on the 
migration and proliferation of colorectal cancer cells in the 3D model; 
 Performing counterpart assessments on the efficacy of the small molecule Wnt signalling 
inhibitors for inhibiting colorectal cancer cell migration in standard 2D scratch wound assays; 
 Obtaining the optimum concentration for usage of any small molecule Wnt signalling inhibitors 
which demonstrate their ability to inhibit colorectal cancer cell migration in the 3D model. 
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4.3  Results 
4.3.1 XAV 939 is a Wnt signalling inhibitor which is ineffective in this 3D 
cell migration model 
Due to previous examples of the effectiveness of XAV 939 in colorectal cancer cell lines [322, 324, 
325], in particular the SW480 cell line which is in use during this study [322], it was selected as the 
first small molecule to be screened for its ability to inhibit Wnt mediated cell migration. The IC50 
value of XAV 939 is 11nM and 4nM for TNKS1 and TNKS2 respectively [322] and it has previously 
been used at concentrations for 5nM [324] through to 20μM [322]. Therefore, a selection of 
concentrations within this range were used for the initial screen, clustered around the commonly 
used lower concentrations found in the literature, namely 1, 3 and 5μM [322, 323, 325, 329]. 
4.3.1.1 Low concentrations of XAV 939 do not effect cell migratory behaviour 
The addition of the low concentrations of XAV 939 to the 3D migration assay after culture 
establishment did not cause any clearly visible alterations to the cell distribution of either of the 
SW480 or SW620 cell lines throughout Alvetex
®
 Scaffold after the 10 day total culture period 
(Figure 4.2). The SW480 cultures produced after exposure to either XAV 939 or the DMSO (0μM 
XAV 939) control had the majority of the cell growth in the uppermost section of the scaffold, with 
the cells found to be growing in clusters (Figure 4.2A, C, E & G). The SW620 cells were also found 
to be distributed in the same manner as seen in previous experiments, with the cells found 
individually throughout a greater depth of the scaffold (Figure 4.2B, D, F & H). 
When the cell penetration within each condition was analysed using the ‘linear’ method of 
measurement, neither cell line displayed a significant difference in cell penetration in the presence 
or absence of XAV 939 at concentrations of 5μM and below (Figure 4.3), with the SW620 cell line 
penetrating the scaffold roughly twice as much as the SW480 cell line, ANOVA, F(1,19)=116.440, 
p<0.001. 
4.3.1.2 Low concentrations of XAV 939 affect the viability and proliferation of SW480 
cells but not SW620 cells 
While it does not affect the cell penetration at these concentrations, XAV 939 did have an overall 
effect on cell viability, ANOVA, F(3,19)=3.259, p=0.044, and significantly so on the viability of the 
3D SW480 cultures (Figure 4.4A), with all concentrations of XAV 939 tested increasing the 
apparent cell viability of the whole culture when compared to the DMSO control using the MTT Cell 
Viability Assay. The greatest and most significant increase in viability was seen when XAV 939 was 
used at 1μM, with the increases seen at 3 and 5μM also being significant over the control. This 
change to cell viability was not seen with the SW620 cell line at any of the concentrations of XAV 
939 tested (Figure 4.4B). 
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Figure 4.2: Neither cell line displayed an alteration in the build-up of cells when the Wnt inhibitor XAV 939 
was present at concentrations of 5µM and below. H&E images of 10 day cultures with A and B: 0µM XAV 
939 (DMSO control), C and D: 1µM XAV 939, E and F: 3µM XAV 939 and G and H: 5µM XAV 939 for both 
cell lines. Scale bars = 200µm for all images. 
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Figure 4.3: The 3D cell penetration of the both the SW480 and SW620 cell lines remained unaffected by 
the presence of XAV 393 at 5μm and below. Cell penetration in µm of A: SW480 and B: SW620 cells as 
determined by the linear measurement method. Data represent mean, n = 3, ±SEM for both graphs, no 
significance by a Dunnett’s t-test. 
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Figure 4.4: The 3D cell viability of the SW480 cell line increased when XAV 939 was present, while the 
viability of the SW620 cell line was unaffected. Absorbance at 570nm of A: SW480 and B: SW620 cells as 
determined by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05, 
0.05, *** p < 0.005 by a Dunnett’s t-test. 
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The increase in cell viability seen in the SW480 cell line was only correlated with an increase in cell 
number, as obtained by use of the Quant-iT™ PicoGreen® dsDNA Assay, at 5μM XAV 939, with 
all other concentrations failing to cause a change in cell number after the 10 day culture period 
(Figure 4.5A). There was also no significant alteration to cell number in the SW620 cell line after 
exposure to XAV 939 at concentrations up to 5μM (Figure 4.5B), although the SW620 cultures 
were found to have a significantly higher cell number than the SW480 cultures, ANOVA, 
F(1,19)=196.740, p<0.001. 
4.3.1.3 The 2D migratory behaviour of the SW480 and SW620 cell lines was unaffected 
by low XAV 939 concentrations 
As a comparison, these concentrations of XAV 939 were also utilised in a standard 2D scratch 
wound assay on uncoated tissue culture plastic. The scratch wounds were monitored over a 24 
hour period, with the data obtained from images taken at 24 hours post wounding presented here 
within this thesis. At 24 hours post wounding both cell lines had moved into the wound from the 
wound edges at either side (Figure 4.6), although the SW620 also appeared to have a greater 
number of single cells within the wound which are not attached to either wound edge (Figure 4.6B, 
D, F & H). The scratch wound assay was quantified by two methods in order to assess the different 
forms of cell migration that cells can undertake. Measuring the distance between the two wound 
edges measured epithelial-sheet migration, where cells maintain E-cadherin cell-cell adhesion, 
whereas counting the number of single cells within the wound measured the mesenchymal-type 
migration, where each cell moves individually. 
When the wound closure in terms of distance moved by the wound edges was quantified, the 
application of XAV 939 did not affect the amount of migration obtained by either cell line (Figure 
4.7). Additionally, when quantified in this manner, the two cell lines appeared to migrate at similar 
rates in this 2D migration assay which was not seen in the 3D migration assay. For the single cell 
counting, the scratch wounds were fixed and stained with DAPI, to show individual nuclei, and 
fluorescently tagged Phalloidin, an actin binding molecule, to ease in determining if cells were 
attached to either wound edge. This staining confirmed that the SW620 cell line has more single 
cells present within the wound at 24 hours than the SW480 (Figure 4.8), which was further 
confirmed by the quantification of these cells (Figure 4.9), as the SW620 cell line had ~10 times the 
number of single cells in the wound after 24 hours than seen with the SW480 cell line, ANOVA, 
F(1,16)=158.583, p<0.001. These data also show that the application of XAV 939 at concentrations 
of up to 5μM did not inhibit single cell migration in this 2D model (Figure 4.9). 
4.3.1.4 Cell migration was unaffected by high XAV 939 concentrations in 3D 
As XAV 939 has been shown to be ineffective at curtailing the migratory behaviour of either the 
SW480 or SW620 cell lines in 2D and 3D migration assays at concentrations of 5μM and below, it 
was then screened for effectiveness at higher concentrations as it has been used at concentrations 
of up to 20μM in other models [321, 322, 329]. A range of higher XAV 939 concentrations, namely 
10, 20 and 50μM, were selected to encompass the higher end of concentrations previously used in 
the literature. 
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Figure 4.5: The number of SW480 cells in the 3D material increased when XAV 939 was present at a 
concentration of 5µM, while the number of SW620 cells was unaffected. Cell number in millions of cells of 
A: SW480 and B: SW620 cells as determined by the Pico Green dsDNA Assay. Data represent mean, n = 
3, ±SEM for both graphs, ** p < 0.01 by a Dunnett’s t-test. 
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Figure 4.6: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay 
with concentrations of the Wnt inhibitor XAV 939 of 5µM and below. Phase images of 24 hours post 
wounding, with 0 hours post wounding shown inset, with A and B: 0µM XAV 939 (DMSO control), C and D: 
1µM XAV 939, E and F: 3µM XAV 939 and G and H: 5µM XAV 939 for both cells lines.  Scale bars = 
200µm for all images. 
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Figure 4.7: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance moved 
by the edges of the 2D scratch wound in the presence of XAV 939 at concentrations of 5μM and below. 
Wound closure in µm of A: SW480 and B: SW620 cells as determined by measuring the width of the 
wound. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test. 
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Figure 4.8: The SW620 cell line had more single migrating cells than the SW480 cell line during a scratch 
wound assay with concentrations of the Wnt inhibitor XAV 939 of 5µM and below. DAPI and Phalloidin 
(inset) images of 24 hours post wounding with A and B: 0µM XAV 939 (DMSO control), C and D: 1µM XAV 
939, E and F: 3µM XAV 939 and G and H: 5µM XAV 939 for both cells lines.  Scale bars = 200µm for all 
images. 
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Figure 4.9: Neither the SW480 and SW620 cell lines showed a significant alteration in the number of 
single migrating cells within the 2D scratch wound in the presence of XAV 939 at concentrations of 5μM 
and below. Number of single migrating cells in A: SW480 and B: SW620 scratch wounds as determined 
from cell counts. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test.  
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When used in the 3D migration assay, there was no alteration to the distribution of the cell growth 
for either the SW480 or SW620 cell lines upon exposure to the higher concentrations of XAV 939 
(Figure 4.10). As expected, the SW480 cell line maintained a distribution of cells towards the 
seeding surface of the scaffold, with the cells found to be clustered together (Figure 4.10A, C, E & 
G), while the SW620 cells maintained their distribution pattern as individual cells throughout a 
greater depth of the scaffold (Figure 4.10B, D, F & H). These cell distribution patterns in the 
histological data were confirmed by the measurement of cell penetration into the scaffold, with the 
addition of XAV 939 at any of the concentrations tested resulting in no alteration to the level of cell 
penetration displayed by either the SW480 or SW620 cell lines (Figure 4.11), although, as 
previously seen, the SW620 cell line achieved a greater level of cell penetration, ANOVA, 
F(1,19)=25.59, p<0.001. 
4.3.1.5 The viability and proliferation of the SW480 cell line only was affected by high 
concentrations of XAV 939 
As with the lower concentrations of XAV 939, there was an overall effect of XAV 939 addition on 
cell viability, ANOVA, F(3,19)=6.868, p=0.003. There was also a specific impact of the cell viability 
of SW480 with the addition of XAV 939 when compared to the DMSO control (Figure 4.12A). 
However, unlike the response to low concentrations of XAV 939, the cell viability of the 3D cultures 
was decreased when XAV 939 was present at concentrations of 20 and 50μM, while the presence 
of XAV 939 at 10μM did not affect the cell viability. The SW620 cell line did not display any 
response to the addition of XAV 939 at concentrations of 10μM and above (Figure 4.12B), which 
reflects what was seen with the addition of XAV 939 at lower concentrations (Figure 4.4B). The 
decrease in apparent cell viability when XAV 939 was present at concentrations of 20 and 50μM is 
accompanied by a decrease in the number of SW480 cells within the 3D cultures after 10 days 
(Figure 4.13A), whereas XAV 939 did not induce a change in the cell number of the SW620 cell 
line at any concentration tested (Figure 4.13B), with the SW620 cultures producing a greater 
number of cells over the growth period, ANOVA, F(1,19)=195.303, p<0.001. 
4.3.1.6 Higher concentrations of XAV 939 also failed to affect 2D migration 
When these higher concentrations were used in a 2D scratch wound assay, XAV 939 failed to 
inhibit the migration of cells over a 24 hour period (Figure 4.14). The distribution of each cell line 
relative to the initial wound was comparable to the previous scratch wound assays with XAV 939 at 
a lower concentrations, with the movement of SW480 cells mostly confined to the wound edge 
(Figure 4.14A, C, E & G), whereas the SW620 cultures had more single cells within the wound after 
24 hours (Figure 4.14B, D, F & H). The black particles seen at 24 hours in the wells which 
contained XAV 939 at 50μM (Figure 4.14G & H) were most likely to be the XAV 939 precipitating 
out into the culture media as opposed to an infection of the cultures as these were viewed in all 
cultures, both 2D and 3D, which contained 50μM XAV 939 across multiple independent 
experiments. When the wound closure was looked at in terms of the movement of the wound 
edges over 24 hours, XAV 939 did not have an impact on the amount of epithelial sheet migration 
achieved by either the SW480 or SW620 cell line (Figure 4.15). 
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Figure 4.10: Neither cell line displayed an alteration in the build-up of cells when the Wnt inhibitor XAV 
939 was present at concentrations of 10µM and above. H&E images of 10 day cultures with A and B: 0µM 
XAV 939 (DMSO control), C and D: 10µM XAV 939, E and F: 20µM XAV 939 and G and H: 50µM XAV 
939 for both cells lines.  Scale bars = 200µm for all images. 
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Figure 4.11: The 3D cell penetration of both the SW480 and SW620 cell lines remained unaffected by 
XAV 939 present at concentrations of 10µM and above. Cell penetration in µm of A: SW480 and B: SW620 
SW620 cells as determined by the linear measurement method. Data represent mean, n = 3, ±SEM for 
both graphs, no significance by a Dunnett’s t-test. 
129 
  
Figure 4.12: The 3D cell viability of the SW480 cell lines decreased when XAV 939 was present at 
concentrations of 20µM and above, while the viability of the SW620 cell line was unaffected. Absorbance 
at 570nm of A: SW480 and B: SW620 cells as determined by the MTT Cell Viability Assay. Data represent 
mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Dunnett’s t-test. 
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Figure 4.13: The number of SW480 cells in the 3D material decreased when XAV 939 was present at 
concentrations of 20µM and above, while the number of SW620 cells was unaffected. Cell number in 
millions of cells of A: SW480 and B: SW620 cells as determined by the Pico Green dsDNA Assay. Data 
represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Dunnett’s t-test. 
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Figure 4.14: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay 
with concentrations of the Wnt inhibitor XAV 939 of 10µM and above. Phase images of 24 hours post 
wounding, with 0 hours post wounding shown inset, with A and B: 0µM XAV 939 (DMSO control), C and D: 
10µM XAV 939, E and F: 20µM XAV 939 and G and H: 50µM XAV 939 for both cells lines. The black 
particles seen in the cultures with 50μM XAV 939 present were assumed to be the XAV 939 precipitating 
out of solution as they were observed with all 50μM XAV 939 cultures, both in 2D and 3D.  Scale bars = 
200µm for all images. 
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Figure 4.15: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance 
moved by the edges of the 2D scratch wound in the presence of XAV 939 at concentrations of 10μM and 
above. Wound closure in µm of A: SW480 and B: SW620 cells as determined by measuring the width of 
the wound. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test. 
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The images of the DAPI and Phalloidin stained cultures confirmed that scratch wounds to the 
SW620 cultures resulted in a greater number of single cells within the wound than was seen in the 
SW480 cultures (Figure 4.16), ANOVA, F(1,16)=33.304, p<0.001. Counts of these individual cells 
demonstrated that the application of XAV 939 to the 24 hour scratch wounds did not affect the 
number of these cells seen in either cell line (Figure 4.17). 
Together these experiments demonstrate the XAV 939 is a Wnt signalling inhibitor which is 
ineffective in mediating the migratory behaviour of colorectal cancer cells in both 2D and 3D 
migration models and it is therefore an unsuitable candidate for further investigation. 
4.3.2 Further 3D small molecule screens highlight an effective Wnt 
signalling inhibitor 
With XAV 939 ruled out for use in investigating the role of the Wnt pathway in the migratory 
behaviour of colorectal cancer cells in in vitro models, the remaining three candidate small 
molecule inhibitors were screened. A single concentration was selected for each small molecule 
based on previous usage in the literature. The IC50 value of IWR-1 against Wnt signalling activity 
has been found to be 0.18μM when used in L-Wnt-STF cells [313], with the standard concentration 
of usage being 10μM [313, 315-317, 320, 321], hence the concentration of 10μM was selected for 
the screening process. 
There has not been an IC50 value established for the action of cardamonin on β-catenin 
degradation, with the closest approximation coming from Cho et al demonstrating that β-catenin 
mediated Wnt signalling is inhibited in the presence of cardamonin at concentrations of 5μM and 
above [297] and other papers using concentrations of 10μM [298] or 20 to 80μM [299]. For the 
screening of compounds, the concentration of 10μM was selected for cardamonin as it sits in the 
midrange of concentrations used in a variety of models. 
The small molecule ICG 001 has an IC50 value of 3μM for binding to the transcription co-activator 
CBP [302] and has been used at a variety of concentrations from 1μM [330] through to 100μM 
[302, 303, 307, 308], although it has been shown to have a negative impact on cell viability at 
higher concentrations [308]. For these reasons, ICG 001 was tested in the small molecule screen 
at a concentration of 5μM. 
4.3.2.1 The distribution of colorectal cancer cells was affected by the inclusion of 
small molecule Wnt inhibitors 
When these three small molecules were screened in a 3D migration assay, the distribution of the 
SW480 and SW620 cell lines was still found to display the same broad characteristics as before, 
with the SW480 cells growing in clusters towards the top of the material and the SW620 cells 
distributed as single cells (Figure 4.18). However, in this screen there were differences seen in the 
depth distribution of the two cell lines with some of the candidate molecules. When exposed to 5μM 
ICG 001, the SW480 cell line had a tighter distribution of cells, with more appearing to grow as 
clusters and fewer single cells found between the clusters (Figure 4.18G). Additionally, the 
distribution of the SW620 cells did not extend as far down into the scaffold as in the DMSO control 
in cultures treated with either 10μM IWR-1 (Figure 4.18D) or 5μM ICG 001 (Figure 4.18H). 
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Figure 4.16: The SW620 cell line had more single migrating cells than the SW480 cell line during a 
scratch wound assay with concentrations of the Wnt inhibitor XAV 939 of 10µM and above. DAPI and 
Phalloidin (inset) images of 24 hours post wounding with A and B: 0µM XAV 939 (DMSO control), C and 
D: 10µM XAV 939, E and F: 20µM XAV 939 and G and H: 50µM XAV 939 for both cells lines.  Scale bars 
= 200µm for all images. 
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Figure 4.17: Neither the SW480 and SW620 cell lines showed a significant alteration in the number of 
single migrating cells within the 2D scratch wound in the presence of XAV 939 at concentrations of 10μM 
and above. Number of single migrating cells in A: SW480 and B: SW620 scratch wounds as determined 
from cell counts. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test.  
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Figure 4.18: The application of Wnt inhibitors alters the distribution of SW480 and SW620 cells in 3D. The 
SW480 cell line displayed a decrease in the build-up of cells when 5µM ICG 001 was present, while the 
SW620 cell line displayed a decrease in the build-up of cells when either 10µM IWR-1 or 5µM ICG 001 were 
present. H&E images of 10 day cultures with A and B: DMSO control, C and D: 10µM IWR-1, E and F: 10µM 
cardamonin and G and H: 5µM ICG 001 for both cells lines.  Scale bars = 200µm for all images. 
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The alteration in the distribution of the SW480 cells in the presence of 5μM ICG 001 was not 
reflected in the cell penetration observed under this condition (Figure 4.19A). This data confirms 
that none of the three small molecules tested were effective in altering the penetration behaviour of 
the SW480 cell line in this 3D model. In contrast, the cell penetration data for the SW620 cell line 
did show that molecules screened impact the behaviour of the cells in this model. Application of 
either 10μM IWR-1 or 5μM ICG 001 had a negative impact on the cell penetration achieved by the 
SW620 cell line after the 10 day culture period, while cardamonin failed to induce a significant 
change in cell behaviour (Figure 4.19B). Additionally, the SW620 cell line continued to demonstrate 
a greater ability to penetrate the scaffold than the SW480 cell line, ANOVA, F(1,19)=15.94, 
p=0.001. 
4.3.2.2 Small molecule inhibition of Wnt signalling inhibited cell viability and 
proliferation 
The viability data from this experiment also showed that the small molecules have a variable effect 
on both cell lines, ANOVA, F(3,19)=7.573, p=0.002. The application of either 10μM IWR-1 to the 
SW480 cell line or 10μM cardamonin to the SW620 cell line led to a decrease in cell viability, while 
culturing the SW620 cell line in the presence of 5μM ICG 001 resulted in an increase in the viability 
(Figure 4.20). While the addition of small molecules had an overall effect on the number of cells 
observed in the 3D cultures, ANOVA, F(1,19)=106.315, p<0.001, the decreased cell viability of 
SW480 cultures in response to 10μM IWR-1 was not mirrored by a decrease in cell number (Figure 
4.21A), unlike the correlation seen between cell viability and cell number in the SW480 cell line in 
response to XAV 939 (Figure 4.4, Figure 4.5, Figure 4.12 & Figure 4.13). However, there was a 
decrease in the number of SW480 cells found in the 3D cultures after 10 days when the cultures 
have been exposed to 5μM ICG 001. The only alteration to cell number seen with the SW620 cell 
line was in cultures which have been exposed to 10μM cardamonin, with the other small molecules 
leaving cell number unaffected (Figure 4.21B). Despite the reduction in cell number mediated by 
10μM cardamonin, the SW620 culture were found to contain more cells than the SW480 cultures, 
ANOVA small molecule, F(3,19)=4.656, p=0.013. 
4.3.2.3 The single cell migration of SW620 cells was altered by small molecule 
inclusion 
The counterpart 2D scratch wound screen of IWR-1, cardamonin or ICG 001 demonstrated that 
none of these small molecules fully inhibited the migration attained by 24 hours in this model 
(Figure 4.22). This is reflected in the wound closure data, where the distance moved by the wound 
edges was not significantly altered by the addition of any of the small molecules tested (Figure 
4.23). 
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Figure 4.19: The 3D cell penetration of the SW620 cell line decreased in the presence of 10µM IWR-1 or 
5µM ICG 001, but remained unaffected by 10µM cardamonin, while the penetration of the SW480 cell line 
remained unaffected by all small molecules. Cell penetration in µm of A: SW480 and B: SW620 cells as 
determined by the linear measurement method. Data represent mean, n = 3, ±SEM for both graphs, * 
p<0.05 by a Dunnett’s t-test. 
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Figure 4.20: The 3D cell viability of the SW620 cell line increased in the presence of 5µM ICG 001, but 
decreased in the presence of 10µM cardamonin, while the viability of the SW480 cell line decreased in the 
presence of 10µM IWR-1. Absorbance at 570nm of A: SW480 and B: SW620 cells as determined by the 
MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Dunnett’s t-
test. 
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Figure 4.21: The number of SW480 cells in the 3D material decreased when 5µM ICG 001 was present, 
while the number of SW620 cells decreased when 10µM cardamonin was present. Cell number in millions 
of cells of A: SW480 and B: SW620 cells as determined by the Pico Green dsDNA Assay. Data represent 
mean, n = 3, ±SEM for both graphs, * p < 0.05, *** p<0.005 by a Dunnett’s t-test. 
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Figure 4.22: Both the SW480 and SW620 cell lines exhibied wound closing during a scratch wound assay 
with small molecule Wnt inhibitors. Phase images of 24 hours post wounding, with 0 hours post wounding 
shown inset, with A and B: DMSO control, C and D: 10µM IWR-1, E and F: 10µM cardamonin and G and H: 
5µM ICG 001 for both cells lines. Scale bars = 200µm for all images. 
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Figure 4.23: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance 
moved by the edges of the 2D scratch wound in the presence of various small molecule inhibitors of the 
Wnt signalling pathway. Wound closure in µm of A: SW480 and B: SW620 cells as determined by 
measuring the width of the wound. Data represent mean, n = 3, ±SEM for both graphs, no significance by 
a Dunnett’s t-test. 
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The DAPI and Phalloidin staining demonstrated that while the SW620 cell line produced more 
single cells in the wound after 24 hours than the SW480 cell line, the number of these appeared 
reduced in the cultures which have been exposed to either 10μM cardamonin or 5μM ICG 001 
(Figure 4.24F & H). The quantification data for the number of single cells within the wound reflected 
this observation, as the numbers seen for the SW480 cell line were lower than those seen for the 
SW620 cell line, ANOVA cell line, F(1,16)=667.283, p<0.001, and were not altered by any of the 
small molecules. Whereas the SW620 scratch wounds maintained in the presence of either 10μM 
cardamonin or 5μM ICG 001 produced significantly fewer single cells in the wound after 24 hours 
(Figure 4.25) and the addition of small molecules was found to have an overall effect on single cell 
migration, ANOVA small molecule, F(3,16)= 61.270, p<0.001. 
When viewed together, this small molecule screen highlights a clear candidate, IWR-1, for further 
use as it caused a decrease in the penetration of the SW620 cell line without adversely affecting 
the number of cells seen in the 3D cultures. As the aim of this project is to investigate the role of 
the Wnt pathway in modulating migratory behaviour of colorectal cancer cells and not the 
proliferative or apoptotic behaviour, neither cardamonin nor ICG 001 are suitable candidates for 
further use in this model, as they have a negative impact on the number of cells found in 3D 
SW620 and SW480 cultures respectively. 
4.3.3 IWR-1 is only effective at inhibiting SW620 migration in 3D 
As it has been demonstrated that IWR-1 is effective at limiting the amount of cell penetration 
achieved by the SW620 in the 3D migration assay at a concentration of 10μM, it was subsequently 
screened to observe its effectiveness at lower concentrations. The concentrations of 0.1 and 1μM 
were selected, as 0.1μM falls below the IC50 value for IWR-1 it was expected that this concentration 
would fail to induce a response in the assay. 
4.3.3.1 SW620 cell distribution was disrupted by higher concentrations of IWR-1 
When utilised in the 3D migration assay, the distribution of the SW480 cell line was unaltered within 
the scaffold in the presence of IWR-1 at any concentration (Figure 4.26A, C, E & G). In contrast, 
the distribution of the SW620 cell line was limited to the upper half of the scaffold when IWR-1 was 
present at concentrations of 1 or 10μM (Figure 4.26F & H), whereas there was not a clear 
difference in the cell distribution of cultures with 0.1μM IWR-1 and a DMSO (0μM IWR-1) control 
(Figure 4.26B & D). The alteration in the depth distribution of cells in response to the higher 
concentrations of IWR-1 was not correlated with a change to the clustering behaviour of the cells, 
as they were still found as individuals within the scaffold. 
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Figure 4.24: The SW620 cell line had more single migrating cells than the SW480 cell line during a scratch 
wound assay, with the numbers affected by small molecule Wnt inhibitors. DAPI and Phalloidin (inset) 
images of 24 hours post wounding with A and B: DMSO control, C and D: 10µM IWR-1, E and F: 10µM 
cardamonin and G and H: 5µM ICG 001 for both cells lines. Scale bars = 200µm for all images. 
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Figure 4.25: The SW620 cell line showed a significant alteration in the number of single migrating cells 
within the 2D scratch wound in the presence of 10µM cardamonin and 5µM ICG 001, whereas the SW480 
cell line was not affected. Number of single migrating cells in A: SW480 and B: SW620 scratch wounds as 
determined from cell counts. Data represent mean, n = 3, ±SEM for both graphs, *** p < 0.005, by a 
Dunnett’s t-test. 
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Figure 4.26: The SW620 cell line displayed a decreased build-up of cells when the Wnt inhibitor IWR-1 is 
present at a concentration of 1µM and above, while the SW480 cell line remained unaffected. H&E images 
of 10 day cultures with A and B: 0µM IWR-1 (DMSO control), C and D: 0.1µM IWR-1, E and F: 1µM IWR-1 
and G and H: 10µM IWR-1 for both cells lines.  Scale bars = 200µm for all images. 
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4.3.3.2 IWR-1 affected cell penetration without affecting viability or proliferation 
In line with the histological data, the SW620 cell line was found to attain a greater depth of cell 
penetration than the SW480 cell line, ANOVA, F(1, 19)=20.376, p<0.001. The cell penetration of 
SW480 cell line into the scaffold was not altered by the addition of IWR-1 at any concentration 
(Figure 4.27A). Use of IWR-1 at a concentration of 0.1μM was also insufficient to induce a change 
in cell penetration in the SW620 cell line, whereas 1 and 10μM were both sufficient to significantly 
reduce the level of cell penetration seen in the SW620 cell line (Figure 4.27B). Application of IWR-1 
did not alter the viability of either the SW480 or SW620 cell line for any of the concentrations tested 
(Figure 4.28). Additionally, there was no difference in cell number for either of the two cell lines 
after exposure to IWR-1 at any concentration (Figure 4.29), with a greater cell number measured 
for the SW620 cultures, ANOVA, F(1,19)=126.167, p<0.001. 
4.3.3.3 2D migration was unaffected by IWR-1 at any concentration 
As expected from the initial small molecule screen, addition of IWR-1 into the culture media for 2D 
scratch wounds did not have an effect on the appearance of the cellular distribution after 24 hours 
for either of the cell lines (Figure 4.30). This resulted in no significant alteration to the distance 
moved by either of the wound edges for either cell line upon exposure to IWR-1 (Figure 4.31). The 
DAPI and Phalloidin staining also confirmed that there was also a consistent pattern of single cell 
distribution within the wound after 24 hours for either cell line in the presence and absence of IWR-
1 (Figure 4.32) and the quantification of these cells showed that the amount of them did not alter in 
the presence and absence of IWR-1 (Figure 4.33), although there were more SW620 cells 
observed in the wound, ANOVA, F(1,16)=101.217, p<0.001. 
Together, these data show that IWR-1 is a small molecule inhibitor of Wnt which is an effective 
inhibitor of migration in a 3D model of colorectal cancer, without affecting the number of cells found 
in the material by the end of the culture period, but which is not effective in a standard 2D scratch 
wound model at the same concentrations. 
4.3.4 IWR-1 suppresses β-catenin expression in the SW620 cell line 
With this identification of IWR-1, which is capable of causing a 17% decrease in cell penetration in 
a 3D migration model, the effect of this molecule on the expression of key EMT and signalling 
proteins was examined. The proteins selected for investigation via immunohistochemistry were E-
cadherin and vimentin, both key identifiers of cancer cells which have gone through EMT [79], β-
catenin, the transcriptional mediator of Wnt signalling [86], and Slug, a transcriptional suppressor 
which mediates the effect of β-catenin on E-cadherin expression [223]. Together these proteins 
should provide information about the migratory capacity of the cells and the role of Wnt signalling in 
directing the migratory behaviour of the cells. 
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Figure 4.27: The 3D cell penetration of the SW620 cell line was decreased when IWR-1 was present at 
concentrations of 1µM and above, while penetration of the SW480 cell line remained unaffected. Cell 
penetration in µm of A: SW480 and B: SW620 cells as determined by the linear measurement method. 
Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Dunnett’s t-test. 
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Figure 4.28: The 3D cell viability of both cell lines remained unaffected by IWR-1 present at 
concentrations of 10µM and below. Absorbance at 570nm of A: SW480 and B: SW620 cells as determined 
by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs, no significance by a 
Dunnett’s t-test. 
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Figure 4.29: The number of cells present in the 3D material remained unaffected by IWR-1 present at 
concentrations of 10µM and below for both the SW480 and SW620 cell lines. Cell number in millions of 
cells of A: SW480 and B: SW620 cells as determined by the Pico Green dsDNA Assay. Data represent 
mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test. 
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Figure 4.30: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay 
with concentrations of the Wnt inhibitor IWR-1 of 10µM and below. Phase images of 24 hours post 
wounding, with 0 hours post wounding shown inset, with A and B: 0µM IWR-1 (DMSO control), C and D: 
0.1µM IWR-1, E and F: 1µM IWR-1 and G and H: 10µM IWR-1 for both cells lines.  Scale bars = 200µm for 
for all images. 
 
152 
  
Figure 4.31: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance 
moved by the edges of the 2D scratch wound in the presence of IWR-1 at concentrations of 10μM and 
below. Wound closure in µm of A: SW480 and B: SW620 cells as determined by measuring the width of 
the wound. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test. 
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Figure 4.32: The SW620 cell line had more single migrating cells than the SW480 cell line during a 
scratch wound assay with concentrations of the Wnt inhibitor IWR-1 of 10µM and below. DAPI and 
Phalloidin (inset) images of 24 hours post wounding with A and B: 0µM IWR-1 (DMSO control), C and D: 
0.1µM IWR-1, E and F: 1µM IWR-1 and G and H: 10µM IWR-1 for both cells lines.  Scale bars = 200µm for 
for all images. 
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Figure 4.33: Neither the SW480 and SW620 cell lines showed a significant alteration in the number of 
single migrating cells within the 2D scratch wound in the presence of IWR-1 at concentrations of 10μM and 
below. Number of single migrating cells in A: SW480 and B: SW620 scratch wounds as determined from 
cell counts. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test.  
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The immunohistochemical staining of 10 day 3D SW620 cultures in the absence and presence of 
10μM IWR-1 demonstrated that the inclusion of this small molecule did affect the protein 
expression profile of these cells. When cultured in the absence of IWR-1, the SW620 cell line did 
not express E-cadherin (Figure 4.34A) or Slug (Figure 4.34G) and did express vimentin (Figure 
4.34C) and β-catenin (Figure 4.34E), with the staining for vimentin appearing to be stronger than 
the staining for β-catenin, with more cells demonstrating more intense positive staining. When IWR-
1 was included in the culture media, the expression of E-cadherin (Figure 4.34B), vimentin (Figure 
4.34D) and Slug (Figure 4.34H) in the SW620 cell line did not appear to alter. However, the 
expression of β-catenin was seen to decrease, with fewer cells demonstrating positive staining and 
that positive staining being less intense(Figure 4.34F), compared to the majority of cells seen to 
express β-catenin in the control cultures (Figure 4.34E). 
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Figure 4.34: The inclusion of the Wnt inhibitior IWR-1 in culture media suppresses β-catenin expression in 
the SW620 cell line in 3D cultures. Immunohistochemical images of antibody staining for A and B: E-
cadherin, C and D: Vimentin, E and F: β-catenin, G and H: Slug and I and J: no primary control on 10 day 
3D cultures of SW620 cells in the absence and presence of 10µM IWR-1, where the brown precipitate 
(arrows) indicates positive staining.  Scale bars = 25µm for all images. 
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4.4 Discussion 
The primary effects on the small molecule Wnt inhibitors screened in this Chapter on both the 
SW480 and SW620 cell lines in the 3D migration model is summarised in Table 4.1. This 
demonstrates the range of effects that these molecules can have upon cells as the Wnt pathway is 
known to have roles in cell proliferation, differentiation and migration [90, 95].  
Additive Concentration SW480 SW620 
XAV 939 Up to 50µM No effect on cell 
penetration, but 
variable changes 
to cell number 
No effect on 
cell penetration 
IWR-1 10µM No effect Up to 26% 
decrease in cell 
penetration 
with 
concentrations 
of 1µM and 
greater 
Cardamonin 10µM No effect No effect on 
cell 
penetration, but 
40% decrease 
in cell number 
ICG 001 5µM No effect on cell 
penetration, but 
25% decrease in 
cell number 
26% decrease 
in cell 
penetration 
Table 4.1: Summary of the primary effect of small molecule Wnt inhibitors on cell culture in the 3D migration 
assay. 
Of the small molecules tested, the TNKS inhibitor XAV 939 was found to have a variable effect on 
cell number, increasing the number of SW480 cells found after 10 days 3D culture at 5µM (Figure 
4.5A) and decreasing those found when applied at 20 and 50µM (Figure 4.13A). The different 
responses of the 3D SW480 cultures to high and low concentrations of XAV 939 may be due to 
paradoxical activation of signalling mediators of the Wnt signalling pathway. This phenomenon was 
initially documented in Raf signalling, where the application of a Raf inhibitor resulted in an 
increase in c-Raf activation compared to control cells [331]. This effect was found to be due to the 
self-reactivation of Raf following inhibition. So far there have been no reports in the literature of 
instances of paradoxical activation of the Wnt signalling pathway by Wnt inhibitors, however, this 
does not rule out the possibility of it occurring in the 3D system under investigation here. 
This XAV 939 data  partially correlates with the effect on colorectal cancer cell behaviour previously 
reported, with inhibited colony formation by the DLD-1 cell line in the presence of XAV 939 [322]. 
Additionally, this molecule did not have any effect on the cell migration of either cell line tested in 
either of the 3D or 2D migration models used here (Figure 4.3, Figure 4.7, Figure 4.9, Figure 4.11, 
Figure 4.15 & Figure 4.17). When this is taken with the lack of published data regarding the effect 
of XAV 939 on cell migration, it would suggest that the downstream effects of this molecule result in 
alterations to cell viability and that it may be better placed to reduce the growth of tumours via 
limiting cell proliferation and increasing apoptosis than by inhibiting cell migration. 
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Cardamonin was also found to be an unsuitable candidate for a small molecule inhibitor of 
colorectal cancer migration as it failed to elicit a change in the migratory behaviour of either the 
SW480 or SW620 cell lines in the 3D model (Figure 4.19), despite significantly decreasing the 
amount of single cell migration observed in the 2D SW620 scratch wounds (Figure 4.25). With its 
negative impact on the number of SW620 cells found in the 3D cultures (Figure 4.21B), 
cardamonin demonstrates that cellular responses that it elicits are not limited to cell migration. This 
correlates with the published data for this molecule, as cardamonin has been shown to inhibit cell 
migration, via NF-κB signalling [296], and cell proliferation, via β-catenin suppression [299]. The 
data presented here failed to demonstrate a reduction in the cell number in the SW480 cell line 
(Figure 4.21A), which had been previously observed [299]. However, a reduction in the number of 
SW620 cells upon exposure to cardamonin was demonstrated (Figure 4.21B). This difference in 
the observed behaviour of the SW480 cell line may be due to the dimensionality of the cultures, as 
Park et al. assessed cells in 2D monolayer cultures and here the cell number was obtained for 3D 
cultures only. 
The small molecule ICG 001 showed promise as an anti-migratory compound, as was able to 
inhibit the migration of the SW620 cell line in both 3D (Figure 4.19B) and 2D models (Figure 
4.25B). However, it also had a negative impact on the number of SW480 cells found after 3D 
culture (Figure 4.21A). The inhibition of migration in the SW620 cell line may be due to a 
repression of EMT via suppression of Snail, Zeb2 and Slug expression, as previously seen in MCF-
7 cells [305]. The negative impact of ICG 001 on the number of cells in 3D SW480 cultures also 
correlates with previously published data, where ICG 001 downregulated survivin and cyclin D1 in 
the SW480 cell line, resulting in an inhibition of 2D growth [302]. 
While IWR-1 is also a TNKS inhibitor like XAV 939 [314], it caused a different cellular response in 
the migration models tested here, as it affected the 3D migration of the SW620 cell line (Figure 
4.19B) without affecting the cell number of either cell line (Figure 4.21). The initial screen 
demonstrated its effectiveness at a concentration of 10μM (Figure 4.19B), which is the most 
commonly used concentration in a variety of studies utilising this molecule [313, 321], and further 
experiments also demonstrated its effectiveness at the lower concentration of 1μM (Figure 4.27B). 
An exhaustive search of the published literature demonstrated that the application of this small 
molecule to 2D cultures of lung cancer cells decreased cell viability [321]. However, no mentions of 
a role for this small molecule as an anti-migratory compound were found, suggesting that the data 
presented here for the effect of IWR-1 on the 3D migration of SW620 cells represents a novel 
experimental result. 
The immunohistochemical staining of 3D SW620 cultures grown in the absence and presence of 
IWR-1 also highlighted its mechanism of action, as the inclusion of IWR-1 decreased the amount of 
β-catenin staining compared to the control (Figure 4.34E&F), which correlates with other papers 
demonstrating the mechanism of IWR-1 on 2D cultures [313]. When taken with the cell penetration 
data, this would suggest that the action of IWR-1 is mediated by a decrease in β-catenin 
availability, which would in turn affect the downstream transcriptional targets of the Wnt signalling 
pathway. This mechanism appears to be independent of pathways involving the Slug mediated 
downregulation of E-cadherin, as the expression of both of these proteins was unaffected by the 
inclusion of IWR-1 in the culture media. 
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Together these data demonstrate that IWR-1 is a small molecule which can inhibit the 3D migration 
of the SW620 cell line while leaving the viability of cells unaffected in multiple cell lines. This small 
molecule may be of use in limiting the spread of later stage cancers, while avoiding the negative 
impact on cell proliferation in a wide range of cell types, as seen with conventional chemotherapy 
agents. However, the results presented here are drawn from observations of the behaviour of the 
cell cultures. A more direct assessment of Wnt signalling, via a TOPFLASH assay to assess TCF 
mediated gene transcription [329], would provide clearer information regarding the inhibition of Wnt 
signalling by the small molecules tested in this Chapter. 
These data demonstrate the need to screen large numbers of compounds in order to identify those 
which have the potential to be of clinical significance in the treatment of cancers. From the 
previously published literature, it would be a reasonable hypothesis that IWR-1 and XAV 939 would 
elicit the same response in a 3D cancer migration model as they are both TNKS inhibitors [314] 
and produce similar phenotypes when utilised in Xenopus development models [317]. However, 
when used in 2D and 3D models of colorectal cancer cell migration these two compounds produce 
different responses; with IWR-1 affecting the 3D migration while XAV 939 did not and instead 
affected the cell number. This difference in cell response could arise from a variety of causes, from 
the difference in binding interactions with target proteins to differences in IC50 and molecular 
stability when reconstituted in culture media, and highlights the difficulties in accurately predicting 
experimental outcomes in different models. 
However, many high-throughput screening methods rely on 2D culture models, as more complex 
3D models are unsuitable for use in a high-throughput format, although there are examples of the 
adaption of these 3D models for use in compound screening [183, 225]. This reliance on 2D culture 
methods to carry out initial compound screens with further validation in 3D models has the potential 
to identify compounds which do not prove to be effective in further testing, or to fail to identify 
compounds of interest that have an effect in a more complex model, as demonstrated here by the 
lack of IWR-1 activity in 2D scratch wounds (Figure 4.31 and Figure 4.33) while causing a 
significant reduction in 3D cell migration (Figure 4.27). 
Additionally, this data highlights the problems with using 2D models which have already been 
discussed. With a high rate of failure during drug discovery, the discussion in the literature is 
turning towards the accuracy of 2D in vitro models in identifying targets and drug development 
[332], with 3D models offered as a more biologically relevant alternative [157, 159]. Of the three 
compounds tested here which elicited a response in terms of the migratory behaviour of the cells, 
only one, ICG 001, was effective in both the 2D and 3D models. Cardamonin was only effective at 
inhibiting single cell migration in the 2D scratch wound and only affected cell number in 3D, 
whereas the effectiveness of IWR-1 in the 3D model was not mirrored in the 2D model at any of the 
concentrations tested. This correlates with previously published data demonstrating that the JIMT1 
breast cancer cell line displayed differing responses to antineoplastic agents when assayed in 2D 
and 3D culture conditions [333]. This highlights the need for more biologically relevant models to 
guide the development of treatments for diseases, as 2D in vitro data alone can falsely identify 
targets of interest. 
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5 Use of Insulin-like Growth Factor-I Increases the 
Biological Relevance of a 3D Migration Assay 
5.1 Introduction 
This Chapter will aim to assess the role that the growth factor IGF-I plays in the migratory 
behaviour of colorectal cancer cells. The secretion of IGF-I by mesenchymal cells, predominantly 
from the liver [123], allows for both paracrine and endocrine signalling. The blood serum levels of 
the protein follows a characteristic pattern over the human lifespan, with a peak during puberty and 
tailing off in later life [124], while an elevation of these levels is correlated with an increased risk of 
developing colorectal cancer [150]. As the downstream signalling processes of IGF-IR are 
mediated by the signalling intermediaries PI3K [130], which subsequently feeds into the Wnt 
signalling pathway [141], and Ras [136] (Figure 5.1B), IGF-I signalling appears well placed as a 
target subject for cancer research. This is confirmed from published literature in the area of cancer 
cell migration, as in vitro exposure of colorectal cancer cells to IGF-I results in an increase in cell 
migration and invasion [334], while the induction of xenograft colorectal tumours in LID mice results 
in a lower rate of metastasis formation [146]. 
5.1.1 Role of IGF-I in cancer 
5.1.1.1 IGF-I signalling provides a small protective effect against apoptosis in 
colorectal cancer cells 
IGF-I has been shown to modulate cellular response in the human colon carcinoma cell line DiFi by 
reducing the level of apoptosis which is induced upon exposure to mAb 225, a ligand blocking 
antibody to EGF receptor, by reducing the activity of caspase-3, caspase-8 and caspase-9 [335]. 
However this reduction of apoptosis was only effective in the short term, as longer exposure to 
mAb 225, here up to 72 hours, in the presence of IGF-I still resulted in a decrease in cell number 
relative to the control cells which were exposed to neither, although it did provide a small protective 
effect at this time point relative to cells exposed to mAb 225 in the absence of IGF-I. IGF-I was also 
ineffective in inhibiting the mAb 225 induced G1 cell cycle arrest, as the reversal of the mAb 225 
induced PI3K/PKB inhibition was limited to the initial hours after exposure and the level of IGF-I 
activation of the MAPK pathway was not sufficient to overcome the apoptosis. 
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Figure 5.1: Chemical structure of the small molecule inhibitor of the IGF-IR, NVP-AEW541, and schematic 
of its interaction of the IGF-I signalling pathway. A: chemical structure of NVP-AEW541. B: NVP-AEW541 
competitively binds the receptor, blocking IGF-I interaction and inhibiting IGF-I signalling, leading to a 
decrease in the transcription of EMT associated genes. 
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5.1.1.2 Inhibition of IGF-I signalling limits colorectal cancer cell proliferation 
With the increased expression of IGF-IR in colorectal cancer [336], IGF-I has also been found to 
influence the proliferative behaviour of colorectal cancer cell lines in a variety of in vitro and in vivo 
experiments. Transfection of a dominant negative variant of IGF-IR (dnIGF-IR) in the HT29 
colorectal cancer cell line results in lower levels of vascular endothelial growth factor (VEGF) being 
induced in the cells after stimulation with IGF-I in addition to a decrease in the levels of 
phosphorylated IRS-1 and ERK1/2 when compared to control cells [337]. This group again 
observed a decrease in cell proliferation in standard 2D culture conditions and severe inhibition of 
colony formation on soft agar as has been seen with mouse fibroblasts [143]. When the dnIGF-IR 
cells were used in xenograft experiments in nude mice subcutaneous tumours were observed after 
25 days, although these tumours were significantly smaller and lighter than control tumours 
generated from untransfected or mock transfected HT29 cells. The dnIGF-IR cells also showed a 
compromised ability to form tumours when directly injected into the livers of nude mice, with 30% of 
mice producing significantly smaller tumours than those produced in 88% of the control mice after 
30 days. Histological analysis of the subcutaneous dnIGF-IR tumours showed decreased staining 
for proliferating cell nuclear antigen (PCNA), VEGF and CD31, an endothelial cell marker, while 
displaying an increased number of TUNEL positive cells, an apoptosis indicator. Manual counts of 
the CD31 stained blood vessels in these tumours showed that the dnIGF-IR tumours had a 
reduced number of vessels compared to controls which demonstrates that impaired IGF-I signalling 
affects angiogenesis within tumours in addition to the proliferative behaviour of the tumour cells. 
Inhibition of IGF-I signalling can also be obtained via transfection with siRNA and produces similar 
results in terms of cell proliferation of the SW480 cell line, with a ~35% reduction in cell number 
observed over a 72 hour period [338]. This method of inhibiting IGF-IR function was also used to 
investigate the effect it has on the sensitivity of the SW480 cell line to doses of radiation ranging 
from 1 to 20Gy over a 72 hour period [339]. Transfection with the IGF-IR siRNA increased the 
cellular sensitivity to all radiation doses over the time course when compared to mock transfected 
cells, with the maximal radiation dose of 20Gy inhibiting cell growth by 35%, 70% and 95% at 24, 
48 and 72 hours, respectively, in IGF-IR siRNA transfected cells while only achieving 13%, 23% 
and 63% inhibition in the mock transfected cells. From the data it was calculated that the ID50 at 72 
hours required for the control cells was 8.3Gy, compared to the 4.3Gy for the IGF-IR siRNA 
transfected cells, demonstrating the level of increased sensitivity that IGF-IR inhibition causes. 
5.1.1.3 IGF-I signalling modulates migration and metastasis formation 
In addition to affecting the establishment and growth of colorectal cancers, IGF-I signalling also 
affects the migratory behaviour of colorectal cancer cells, as exposure of the colorectal cancer cell 
line KM12L4 to IGF-I over 48 hours results in a 17.5-fold increase in migration in a standard 
Transwell
®
 assay and a 1.8-fold increase in invasion in a Matrigel coated Transwell
®
 assay [334]. 
This increase in migratory behaviour appeared to be mediated by the urokinase plasminogen 
activator (uPA)/uPA receptor (uPAR) system, as treatment with antibodies to either uPA or uPAR 
inhibited both migration, by 85% and 92% respectively, and invasion, by 75% and 85% 
respectively. Use of the uPA inhibitor amiloride, in conjunction with IGF-I also reduced the 
migration and invasion observed by 92% and 75% respectively. 
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The effect of IGF-I is not limited to localised migration, as it also has been shown to have an impact 
on the development of metastasis in in vivo models. In addition to the investigation into 
adenocarcinoma establishment carried out in LID mice as described preivously [146], this paper 
also looked at the effect of circulating IGF-I on liver metastasis. It was found that the control mice 
had a higher incidence of metastasis, 44% compared to 31% of LID mice, and the number of 
metastatic nodes per liver was increased. Additionally, the intraperitoneal injection of IGF-I 
increased the metastasis rate in both groups, as well as the frequency of metastatic nodes found in 
the control mice. 
Direct blockade of the IGF-IR also inhibits the metastatic growth colorectal cancer [340]. 
Application of the cytotoxic chemotherapy agent oxaplatin or the IGF-IR targeting monoclonal 
antibody AVE1642 to 2D cultures of the colorectal cancer cell lines HT29 and KM12L4 significantly 
inhibits the growth of both cell lines, with the greatest effect observed when both oxaplatin and 
AVE1642 are used together. These agents also have an impact on cell growth when HT29 cells 
are directly injected into the livers of nude mice. Intraperitoneal injection of oxaplatin with a control 
antibody did not significantly decrease the tumour volume observed after 54 days, however it did 
increase the level of cell apoptosis observed and decrease the level of BrdU uptake in the last 16 
hours prior to tumour harvest. Intraperitoneal injection of AVE1642 was found to be effective, both 
with and without administration of oxaplatin; the tumours from these mice were smaller, with a 
higher level of apoptotic cells and lower BrdU uptake. As with the in vitro work, the application of 
oxaplatin and AVE1642 had a synergistic effect on the growth of xenograft tumours. 
5.1.2 Small molecule inhibition of IGF-I signalling 
With the body of evidence for the role of IGF-I signalling in the development of cancers, targeting 
this pathway has been viewed as a viable method for controlling the behaviour of cancer cells and 
providing chemotherapy treatments for a wide range of cancers. There are different methodologies 
for this targeting which are currently undergoing experimentation, these consist of antibody 
targeting of IGF-I or IGF-IR, or small molecule tyrosine kinase inhibition of the receptor. In the 
pursuit of this line of investigation, a wide range of compounds that been isolated and are 
undergoing further testing in various stages of preclinical and clinical trials, the status of some of 
these are reviewed by Ewing and Goff [341] and Gao et al [342]. 
One of the small molecules identified for its role in modulating IGF-I signalling via the IGF-IR is 
NVP-AEW541 [343] (Figure 5.1A). This molecule is highly selective for both the IGF-IR and the 
insulin receptor over a range of other tyrosine kinase receptors, with IC50 values of 0.15μM and 
0.14μM respectively when used on purified GST-fusion recombinant proteins. However, when 
tested on cell lines expressing the receptors, the selectivity for the IGF-IR far outweighed the 
selectivity for the insulin receptor, with the compound obtaining an IC50 value of 0.086μM against 
IGF-IR expressed on NWT-21 cells and 2.3μM against insulin receptors on A14 cells, a 27-fold 
selectivity for the IGF-IR. 
With the confirmation of the selectivity of NVP-AEW541 for the IGF-IR, it has subsequently been 
used on a variety of cancer cell lines to examine its effect on cellular behaviour. These include 
cancers originating from epithelial cells, such as hepatocellular carcinomas [344, 345], colorectal 
cancer [345-347] and pancreatic cancer [345, 348, 349], in addition to musculoskeletal tumours 
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[350, 351], neural-tissue derived tumours [352-355], acute myeloid leukaemia (AML) [356, 357] and 
multiple myeloma cells [358]. The effects of NVP-AEW541 have been shown to be consistent 
across many of this cell lines, demonstrating the specificity of its targeting. 
Application of NVP-AEW541 has been shown to inhibit the phosphorylation of various protein 
signalling mediators of IGF-IR signalling, without affecting the overall level of protein expression. 
These include IGF-IR itself [345, 348, 352-354, 356, 358], in addition to the downstream signalling 
mediators IRS-1 [348, 353], PKB [343, 345, 347-353, 356, 358-361], ERK [345, 348, 350, 351, 353, 
358, 361], MEK [348], MAPK [343] and GSK-3β [353, 356]. There was also an inhibition of 
phosphorylation of signal transducer and activator of transcription 3, STAT3, [348, 354] and the 
associated downregulation of protein levels of HIF1α [354], suggesting that inhibition of IGF-IR 
signalling via NVP-AEW541 affects the response of glioblastoma cells to hypoxic conditions. 
5.1.2.1 NVP-AEW541 inhibits cell proliferation 
NVP-AEW541 affects the behaviour of the cells tested by limiting the cell growth in standard 2D 
cultures [343-345, 347, 348, 350-352, 357], although this effect appears to be dependent on the 
endogenous expression of the IGF-IR exhibited by the cells [346]. One of the mechanisms for the 
lower cell survival appears to be the arrest of the cell cycle at the transition between G1 and S 
phase [343, 344, 352, 353, 358, 359]. The observed decrease in phosphorylated GSK-3β in AML 
cells is associated with an increased level of phosphorylated cyclin D1 [356]. This provides a 
potential mechanism for the G1 arrest seen after exposure of cells to NVP-AEW541 as cyclin D is 
targeted for degradation upon phosphorylation and cannot initiate the transition into S phase and 
results in a lower proliferation rate. This limitation to the proliferation rate can be seen as either 
lower 
3
H-thymidine incorporation [361] or reduced uptake and metabolic conversion of MTT 
reagent [358]. 
In a reflection of the work carried out on R
-
 cells from Igf1r
-/-
 mice [143], the use of NVP-AEW541 
has also been used to retard the growth of cells on semisolid agar. This effect has been seen 
across cancer cell lines deriving from a variety of source tissues, including the mouse 
medulloblastoma cell line BsB8 and the two human medulloblastoma cell lines D364 and Daoy 
[353] and a variety of gastrointestinal tract cancer cell lines, including the colorectal cancer cell line 
HT29, esophageal squamous cell carcinoma cell line TE1, pancreatic adenocarcinoma cell line 
BxPC3 and hepatocellular carcinoma cell line PLC/PRF/5 [345]. In the study of AML, NVP-
AEW541 is also effective in preventing the CD34
+
 bone marrow cells, the stem cell population of 
the bone marrow, from forming colonies on soft agar [357]. 
5.1.2.2 NVP-AEW541 can inhibit cell growth by the induction of apoptosis 
Another mechanism of NVP-AEW541 in limiting the rate of cell growth is the induction of apoptosis 
[355], as seen by a lower number of Trypan Blue excluding cells upon cell counting [353] or a 
higher number of Annexin V positive cells, a marker of apoptotic DNA changes [358]. This 
induction in apoptosis is linked with the NVP-AEW541 induction of caspase-3, caspase-7 and 
caspase-8 activity [344, 345, 357], in addition to downregulating the expression the anti-apoptotic 
proteins Bcl-2, Bax and survivin [344], leading to the stereotypical changes to cell shape 
associated with apoptotic induction. 
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5.1.2.3 The apoptosis of cells after exposure to chemotherapeutic agents can be 
enhanced by NVP-AEW541 
When used in conjunction with standard chemotherapeutic agents, NVP-AEW541 has been shown 
to enhance the cytotoxic effect of some of them. NVP-AEW541 is effective at augmenting the 
effects of vincristine, actinomycin D and ifosfamide on the Ewing’s sarcoma cell line TC-71 in vitro, 
but not doxorubicin and cisplatin and was also seen to augment the effect of vincristine on 
decreasing the size of TC-71 xenografts [350]. Similarly, NVP-AEW541 displayed a synergistic 
effect on the cell survival of biliary tract cancer cells when used in combination with gemcitabine, 
but only an additive effect when used with 5-fluorouracil (5-FU) and the PI3K inhibitor BI 2536 
[359]. The downregulation of cell growth of multiple myeloma MM1S cells by the drugs 
lenalidomide, dexamethasone, bortezomib and melphalan was enhanced with the addition of NVP-
AEW541, when each drug was used alone or in conjunction with dexamethasone, and a similar 
enhancement of apoptotic induction was seen with the use of NVP-AEW541 and dexamethasone 
or bortezomib [358]. The synergistic effect that NVP-AEW541 has on the cell death of HL60AR 
AML cells with etoposide is reflected when NVP-AEW541 is used in conjunction with etoposide on 
cells from chemoresistant patients, where the use of NVP-AEW541 sensitises the cells to the 
actions of the chemotherapy agent [356]. 
5.1.2.4 The migratory behaviour of cancer cells can be inhibited by NVP-AEW541 
Application of NVP-AEW541 to cultures can also inhibit the migratory behaviour of the cells, with 
the compound able to inhibit the in vitro migration of the Ewing’s sarcoma cell lines TC-71 and SK-
N-MC [351], the pancreatic cancer cell line HPAF-II [348] and the colorectal cancer cell line HT29 
[345]. This inhibition is seen even in the presence of IGF-I, suggesting that this compound may 
have use in a migration model for looking at cell migratory behaviour in response to IGF-I. In 
addition to the inhibited migration behaviour of the HT29 cells, NVP-AEW541 is also capable of 
inhibiting the invasion of these cells in Matrigel-coated Boyden Chambers and is associated with a 
downregulation of the matrix metalloproteinase-7 (MMP-7) protein, but not MMP-2 or MMP-9 [349]. 
5.1.2.5 NVP-AEW541 inhibits xenograft tumour formation in mice 
The described in vitro behaviours of cells in response to exposure to NVP-AEW541 are reflected in 
the xenograft experiments which have been carried out with this compound. NVP-AEW541 has 
been shown to limit the size of xenograft tumours when administered to mice, without affecting the 
overall weight of the subject [343, 345], and this has also been used to augment the effects of 
chemotherapy agents on the size of tumours [345, 350]. The smaller xenograft tumours display 
protein phosphorylation profiles which are similar to those seen in vitro, with the NVP-AEW541 
tumours demonstrating lower positive staining for phosphorylated IGF-IR [348], PKB [345, 349] and 
ERK [345, 348]. 
The smaller size of the xenograft tumours could be due to a variety of factors. The cells within the 
tumours have a higher number of pyknotic nuclei, where the DNA condenses prior to apoptosis 
[352], suggesting that apoptosis may be one of them. The level of vascularisation within the 
tumours is decreased [351, 352], with fewer CD31 positive cells detected [348]. This lack of 
vascularisation is seen in conjunction with lower levels of VEGF mRNA [348, 352] and protein [348, 
351, 354] and limited metastatic spread of the xenograft tumours from their original site [351, 352]. 
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While the work with NVP-AEW541 has shown the capability of this compound to modulate IGF-IR 
signalling, the overall experimental work targeting IGF-IR signalling to obtain a viable clinical 
treatment has not produced the results that were initially hoped for when IGF-I signalling was first 
identified as a pathway of interest for cancer research. In their 2013 review, Baserga discusses 
some of the underlying reasons for this lack of success and suggests that the targeting of signalling 
via the IGF-IR is not a successful strategy for single target cancer therapy, it still has the potential 
for use in supplementing current chemotherapy agents as the compounds can produce a 
synergistic effect on cell viable when used together [362]. 
The evidence that both IGF-I and NVP-AEW541 can modulate the migratory behaviour of a variety 
of cancer cell lines, with IGF-I increasing migration [334] and NVP-AEW541 decreasing migration 
[345], demonstrates that manipulation of IGF-I signalling is the 3D model in use here is likely to 
produce a change in migratory behaviour. However, as there is also extensive evidence that 
decreased IGF-I signalling decreases cell proliferation [143] while application of NVP-AEW541 
inhibits cell proliferation [347], an assessment must be made to ensure that any changes in the 
amount of cell penetration seen with either cell line are not due to changes in cell number. 
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5.2 Chapter Aims 
This Chapter aims to assess the role of IGF-I signalling via the IGF-IR in modulating the behaviour 
of colorectal cancer cells by utilising recombinant IGF-I and a small molecule inhibitor of IGF-IR in 
both 2D and 3D migration assays.  
5.2.1 Objectives 
Overall, the aims of the small molecule assessment in this Chapter will be met by: 
 Assessing the impact of IGF-I addition on the migration and proliferation of colorectal cancer 
cells in the 3D model; 
 Performing counterpart assessments of IGF-I addition on colorectal cancer cell migration in 
standard 2D scratch wound assays; 
 Assessing the effectiveness of a small molecule IGF-IR inhibitor in affecting the IGF-I induced 
changes in migration and proliferation of colorectal cancer cells in the 2D and 3D models; 
 Assessing the effect that the Wnt signalling inhibitor IWR-1 has on the IGF-I induced changes 
in migration and proliferation of colorectal cancer cells in the 2D and 3D models. 
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5.3 Results 
5.3.1 IGF-I interacts with the Wnt pathway to induce a migratory 
response in this 3D model 
As the levels of circulating IGF-I can vary within healthy populations, it is important to select a 
biologically appropriate range of IGF-I concentrations for testing in this 3D migration model. Many 
studies which have determined the circulating concentration of IGF-I, which is in the region of 100 – 
200ng/ml [119, 124, 126], examine the total IGF-I which includes IGF-I which is bound to IGFBPs 
or ALS and is therefore inactive. It is the concentration of the unbound, or free, IGF-I which is of 
importance as it is this subset of the total IGF-I which has the capacity to bind to the IGF-IR and 
induce a cellular response. In a selection of healthy volunteers used as a control for a study into 
the levels of serum IGF-I and IGF-II in hormone disorders, the blood serum concentration of free 
IGF-I was found to range from 0.22 – 1.20ng/ml [363]. In another study into the effect of GH 
administration on the blood serum levels of IGF-I and other associated proteins, the baseline level 
of free IGF-I was found to be 0.26ng/ml, with it rising to 1.02ng/ml within the 24 hours after GH 
administration [121]. After 6 months of daily doses of GH, the base level of free IGF-I is 2.96ng/ml, 
which is still a small proportion of the total IGF-I, and rises up to 5.33ng/ml after GH administration. 
Together these data sets provide a biologically relevant range of IGF-I concentrations for testing in 
the 3D model used here, with the concentrations of 0.1, 1.0 and 10.0ng/ml selected here. 
5.3.1.1 IGF-I enhanced the penetration of the SW480 cell line but not the SW620 cell line 
Use of IGF-I at these concentrations in this 3D migration model affected the two colorectal cancer 
cell lines SW480 and SW620 differently. When added to the SW480 cultures, IGF-I altered the 
distribution of the cells within the scaffold (Figure 5.2). In the absence of IGF-I, the SW480 cells 
were found to be in the top quarter of the scaffold (Figure 5.3A), which was also seen when IGF-I 
added at a concentration of 0.1ng/ml (Figure 5.2C). However, when IGF-I was present at 
concentrations of 1 and 10ng/ml, the distribution of the cells was altered, with the cells found at a 
greater depth into the scaffold (Figure 5.2E & G). When the cell distribution was altered by the IGF-
I, it is not only the depth at which the cells are found which was altered, as the cells were found in 
tighter association with other cells in the material when the IGF-I is present at 1ng/ml (Figure 5.3B) 
than when it was absent (Figure 5.3A). In contrast, the addition of IGF-I did not produce a clearly 
visible alteration to the cellular distribution of the SW620 within the scaffold (Figure 5.2B, D, F & H). 
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Figure 5.2: The SW480 cell line displayed an increased build-up of cells when IGF-I was present at 
concentrations of 1ng/ml and above, while the SW620 cell line remained unaffected. H&E images of 10 
day cultures with A and B: 0ng/ml IGF-I, C and D: 0.1ng/ml IGF-I, E and F: 1ng/ml IGF-I and G and H: 
10ng/ml IGF-I for both cells lines. Larger images of this data are presented in Figure 5.3. Scale bars = 
200µm for all images. 
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Figure 5.3: The use of IGF-I at 1ng/ml on the SW480 cell line produced a clear change in the observed cell 
distribution. H&E stained images of 10 days cultures of SW480 cells with A: 0ng/ml and B: 1ng/ml IGF-I 
showing an average penetration (n=3) of 51±3µm and 78±8µm respectively and SW620 cells with C: 
0ng/ml and D: 1ng/ml IGF-I showing an average penetration (n=3) of 98±5µm and 100±8µm respectively. 
Scale bars = 200µm for all images. 
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When the cell depth was measured using the ‘linear’ method of cell penetration quantification, it 
was confirmed that the addition of IGF-I did affect the penetration of the SW480 cells in the scaffold 
but did not affect the penetration of the SW620 cells (Figure 5.4). The addition of IGF-I at a 
concentration of 0.1ng/ml did not cause a significant increase in the amount of cell penetration 
observed, however, when added at concentrations of 1ng/ml and above IGF-I did cause a 
significant increase in the level of cell penetration (Figure 5.4A). When added at a concentration of 
1ng/ml, IGF-I induced a 54% increase in the level of cell penetration attained by the SW480 cell 
line, while the addition of IGF-I at a concentration of 10ng/ml induced a 50% increase in 
penetration. While the level of penetration attained by the SW620 cell line was unaffected by IGF-I 
at all concentrations tested (Figure 5.4B), although, as previously observed, it was found to be 
significantly higher than the penetration attained by the SW480 cell line, even in the presence of 
IGF-I, ANOVA, F(1,19)=43.413, P<0.001. 
5.3.1.2 IGF-I did not affect the viability or proliferation of the SW480 cell line 
As IGF-I is known to have an effect on the proliferative behaviour of cancer cells [337], it is 
important to check if the observed increase in cell penetration demonstrated by the SW480 cell line 
was due to an alteration in the migratory behaviour of the cells and not due to an alteration in the 
proliferative behaviour resulting in an increased number of cells within the material. When the 
viability of the 3D cultures was measured using the MTT Cell Viability Assay, the addition of IGF-I 
did not induce an alteration in the cell viability of either cell line at any of the concentrations 
screened (Figure 5.5). Additionally, when the number of cells within the material after 10 days of 
culture was quantified using the Quant-iT™ PicoGreen® dsDNA Assay, it was found to be 
unaltered by the presence of IGF-I in the culture media (Figure 5.6), although the number of 
SW620 cells was significantly higher than the number of SW480 cells, as previously observed 
ANOVA, F(1,19)=113.399, p<0.001. Together these suggest that the alteration in cell penetration 
seen in the SW480 cells cultured in the presence of IGF-I at concentrations of 1ng/ml and above 
was due to an alteration of the distribution of the cells as caused by a change in the migratory 
behaviour of the cells as opposed to the distribution of an increased number of cells within the 
material. 
5.3.1.3 The 2D migratory behaviour was unaffected by IGF-I 
With this data, the 2D migratory behaviour of colorectal cancer cells in the presence and absence 
of IGF-I at a concentration of 1ng/ml was examined. The phase contrast images of the scratch 
wounds at 24 hours post wounding showed that both cell lines display migratory behaviour, as 
seen with the alteration of the wound shape relative to initially after the wound was made (Figure 
5.7). There was no clear visual difference between the cells cultured with or without the IGF-I, as 
the SW480 cells demonstrated partial closing of the wound (Figure 5.7A & C) and the SW620 cells 
demonstrated partial wound closing and the clear migration of single cells into the wound (Figure 
5.7B & D). When the wound closure was quantified, it was found that IGF-I had no effect of the 
distance that the leading edges of migration move for either cell line (Figure 5.8). 
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Figure 5.4: The 3D cell penetration of the SW480 cell line was increased when IGF-I was present at 
concentrations of 1ng/ml and above, while penetration of the SW620 cell line remained unaffected. Cell 
penetration in µm of A: SW480 and B: SW620 cells as determined by the linear measurement method. 
Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Dunnett’s t-test. 
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Figure 5.5: The 3D cell viability of both the SW480 and SW620 cell lines was unaffected by the presence 
of IGF-I. Absorbance at 570nm of A: SW480 and B: SW620 cells as determined by the MTT Cell Viability 
Assay. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test. 
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Figure 5.6: The number of SW480 and SW620 cells in the 3D material was unaffected when 
IGF-I was present at a concentrations up to 10ng/ml. Cell number in millions of cells of A: 
SW480 and B: SW620 cells as determined by the Pico Green dsDNA Assay. Data represent 
mean, n = 3, ±SEM for both graphs, no significance by a Dunnett’s t-test. 
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Figure 5.7: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay 
with in the presence and absence of 1ng/ml IGF-I. Phase images of 24 hours post wounding with A and B: 
0ng/ml IGF-I and C and D: 1ng/ml IGF-I for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.8: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance moved 
by the edges of the 2D scratch wound in the presence of IGF-I at concentrations of 1ng/ml. Wound closure 
in µm of A: SW480 and B: SW620 cells as determined by measuring the width of the wound. Data 
represent mean, n = 3, ±SEM for both graphs, no significance by a Student’s t-test. 
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When the number of single migrating cells was highlighted using DAPI and Phalloidin staining, 
there were fewer cells visible in the SW480 wounds (Figure 5.9A & C) than observed in the SW620 
wounds (Figure 5.9B & D), which was consistent with previous observations, although there was no 
obvious difference between the cultures grown with or without 1ng/ml IGF-I. Quantification of these 
cells confirmed that the SW620 cell line has more single cells within the scratch wound after 24 
hours than the SW480 cells line and that these numbers were not altered by the addition of IGF-I 
for either cell line (Figure 5.10). 
Together these data show that IGF-I is capable of altering the migratory behaviour of the colorectal 
cancer cell line SW480 in a 3D migration model but not a 2D migration model, whilst having no 
effect on the migratory behaviour on the counterpart cell line SW620. It also demonstrates the an 
IGF-I concentration of 1ng/ml is sufficient to produce the observed migratory response in the 3D 
model. 
5.3.2 NVP-AEW541 inhibits the IGF-I induced migratory response only 
and is ineffective when IGF-I is absent 
As it has been demonstrated that IGF-I increases the migration of the SW480 cell line in a 3D 
migration model, the effect of the IGF-IR inhibitor NVP-AEW541 was then examined. The original 
paper describing the activity of NVP-AEW541 gives the cellular IC50 value of the molecule against 
the IGF-IR as 0.086μM, with it inducing cellular effects in a variety of cell lines at concentrations of 
0.105 – 1.640μM [343]. When used in in vitro migration and invasion assays, NVP-AEW541 has 
been shown to inhibit the invasion of neuroblastoma cells through Matrigel at concentrations as low 
as 0.5μM [352]. With gastrointestinal tract tumour cells, including the colorectal cancer cell line 
HT29, use of NVP-AEW541 at 1μM is sufficient to decrease the migration by at least 50% [345, 
348]. From these data the concentrations of 0.01, 0.10 and 1.00μM were selected as those which 
would be subjected to screening with the 3D migration model, as this was predicted to provide a 
concentration that is below effective concentrations noted in the literature and a concentration that 
has previously been shown to be effective, in addition to an intermediary one. 
5.3.2.1 The migratory behaviour of both SW480 and SW620 cells lines was inhibited by 
NVP-AEW541 
When the histological data of the 3D cultures in the screen for the effectiveness of NVP-AEW541 
on inhibiting the action of IGF-I on the migratory behaviour of the colorectal cancer cells was 
examined, there was no clear difference in the distribution of either cell line (Figure 5.11). The 
SW480 cells were found to be distributed in the uppermost proportion of the material, with many of 
the cells found in distinct clusters and few cells found as individual cells (Figure 5.11A, C, E, G & I). 
The SW620 cells were once again found to be distributed as single cells throughout a greater 
proportion of the depth of the material (Figure 5.11B, D, F, H & J).   
178 
  
Figure 5.9: The SW620 cell line had more single migrating cells than the SW480 cell line during a 
scratch wound assay in the presence and absence of 1ng/ml IGF-I. DAPI and Phalloidin (inset) images of 
24 hours post wounding with A and B: 0ng/ml IGF-I and C and D: 1ng/ml IGF-I for both cells lines. Scale 
bars = 200µm for all images. 
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Figure 5.10: Neither the SW480 and SW620 cell lines showed a significant alteration in the number of 
single migrating cells within the 2D scratch wound in the presence or absence of IGF-I. Number of single 
migrating cells in A: SW480 and B: SW620 scratch wounds as determined from cell counts. Data 
represent mean, n = 3, ±SEM for both graphs, no significance by a Student t-test.  
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Figure 5.11: Both cell lines displayed a decreased build-up of cells when the IGF-I inhibitor NVP-AEW541 
was present at a concentration of 1µM. H&E images of 10 day cultures with A and B: DMSO control, C and 
D: 1ng/ml IGF-I and DMSO control, E and F: 1ng/ml IGF-I and 10nM NVP-AEW541, G and H: 1ng/ml IGF-I 
and 100nM NVP-AEW541 and I and J: 1ng/ml IGF-I and 1µM NVP-AEW541 for both cells lines. Scale bars 
= 200µm for all images. 
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The quantification of the cell penetration again confirmed that more SW620 cells were present in 
the scaffold at 10 days than SW480 cells, ANOVA, F(1, 24)=91.04, p<0.001. This quantification 
also demonstrated that the inclusion of NVP-AEW541 significantly altered the penetration of cells 
into the scaffold, ANOVA, F(4,24)=3.949, p=0.013. NVP-AEW541 caused a significant decrease in 
the penetration for both cell lines when used at a concentration of 1µM in the presence of 1ng/ml 
IGF-I (Figure 5.12). Used on the SW480 cell line, the significant decrease seen with 1µM NVP-
AEW541 was seen relative to the DMSO control (Figure 5.12A), whereas with the SW620 cell line, 
this decrease was seen relative to the 1ng/ml IGF-I control (Figure 5.12B). However, the increase 
in cell penetration induced by IGF-I in the SW480 cell line seen previously (Figure 5.4A) was not 
replicated here (Figure 5.12A), although this may be due to the use of different batches of IGF-I 
and the result presented in Figure 5.4 was replicated by other experiments presented later in this 
thesis. 
5.3.2.2 NVP-AEW541 also affected cell viability and proliferation 
The use of IGF-I with or without NVP-AEW541 was found to have no effect on the cell viability of 
the 3D SW480 cultures (Figure 5.13A); whereas the addition of 1ng/ml IGF-I without the presence 
of NVP-AEW541 at any concentration was found to increase the cell viability of the SW620 cultures 
(Figure 5.13B). However, as with the SW480 cell line, the addition of NVP-AEW541 did not alter 
the cell viability relative to the DMSO control (Figure 5.13B). In agreement with previous 
observations, when the number of cells within the material was quantified, there are more SW620 
cells found per scaffold than SW480 cells (Figure 5.14), ANOVA, F(1,24)=350.186, p<0.001. Here 
it was observed that there was a small but significant increase in the observed cell number in 
SW480 cultures when 1ng/ml IGF-I was present in the absence of NVP-AEW541, compared to the 
DMSO control, (Figure 5.14A) and there was a significant increase in the number of SW620 cells 
when 1ng/ml IGF-I was present with 0.01µM NVP-AEW541 over the DMSO control (Figure 5.14B). 
Together these data show that at the concentration where NVP-AEW541 was effective in inhibiting 
the cell penetration into the material, this compound is not affecting the proliferative behaviour of 
the cultures, suggesting that the changes seen are due to NVP-AEW541 affecting the cellular 
migratory behaviour of the cells. 
5.3.2.3 The combination of IGF-I and NVP-AEW541 did not affect the 2D migration of cells 
When utilised in a 2D scratch wound assay, use of NVP-AEW541 did not completely inhibit the 
migration of the cells, as seen by the changes to the wound edges in the first 24 hours post wound 
(Figure 5.15). Quantification of the distance moved by the leading edges of migration demonstrated 
that none of the combinations of media additives tested were effective in significantly altering the 
amount migration attained by either cell line (Figure 5.16), although there was a difference 
observed between the two cell lines, ANOVA, F(1,20)=8.703, p=0.008. Fluorescent staining of the 
scratch wounds at 24 hours post wounding highlighted the number of single cells which have 
migrated into the wounds over 24 hours under each condition, as the SW620 cell line 
demonstrated a greater number of observed single cells than the SW480 cell line (Figure 5.17). 
The quantification of these cells confirmed that the SW620 cell line produces more of them over the 
24 hour period than the SW480 cell line, ANOVA, F(1, 20)=40.786, p<0.001, with the media 
additives causing no alteration to the numbers observed within each cell line (Figure 5.18).  
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Figure 5.12: The 3D cell penetration of both the cell lines decreased when 1ng/ml IGF-I and 1µM NVP-
AEW541 were present, relative to a DMSO control for the SW480 cells and a 1ng/ml IGF-I control for the 
SW620 cells. Cell penetration in µm of A: SW480 and B: SW620 cells as determined by the linear 
measurement method. Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Tukey’s test. 
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Figure 5.13: The 3D cell viability of the SW620 cell line increased when 1ng/ml IGF-I was present in the 
absence of NVP-AEW541, while the viability of the SW480 cell line was unaffected. Absorbance at 570nm 
of A: SW480 and B: SW620 cells as determined by the MTT Cell Viability Assay. Data represent mean, n = 
3, ±SEM for both graphs, * p < 0.05 by a Tukey’s test. 
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Figure 5.14: The number of SW480 cells in the 3D material increased when IGF-I only was present at a 
concentration of 1ng/ml and was unaffected by the presence of NVP-AEW541 at all concentrations, while 
the number of SW620 cells increased in the presence of 1ng/ml IGF-I and 0.01µM NVP-AEW541 and was 
unaffected by all other NVP-AEW541 concentrations. Cell number in millions of cells of A: SW480 and B: 
SW620 cells as determined by the Pico Green dsDNA Assay. Data represent mean, n = 3, ±SEM for both 
graphs, * p < 0.05 by a Tukey’s test. 
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Figure 5.15: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay 
in the presence of 1ng/ml IGF-I with and without the IGF-I inhibitor NVP-AEW541. Phase images of 24 
hours post wounding with A and B: DMSO control, C and D: 1ng/ml IGF-I and DMSO control, E and F: 
1ng/ml IGF-I and 10nM NVP-AEW541, G and H: 1ng/ml IGF-I and 100nM NVP-AEW541 and I and J: 
1ng/ml IGF-I and 1µM NVP-AEW541 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.16: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance 
moved by the edges of the 2D scratch wound in the presence of IGF-I with and without NVP-AEW541. 
Wound closure in µm of A: SW480 and B: SW620 cells as determined by measuring the width of the 
wound. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Tukey’s test. 
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Figure 5.17: The SW620 cell line had more single migrating cells than the SW480 cell line during a 
scratch wound assay in the presence of 1ng/ml IGF-I with and without the IGF-I inhibitor NVP-AEW541. 
Phase images of 24 hours post wounding with A and B: DMSO control, C and D: 1ng/ml IGF-I and DMSO 
control, E and F: 1ng/ml IGF-I and 10nM NVP-AEW541, G and H: 1ng/ml IGF-I and 100nM NVP-AEW541 
and I and J: 1ng/ml IGF-I and 1µM NVP-AEW541 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.18: Neither the SW480 and SW620 cell lines showed a significant alteration in the number of 
single migrating cells within the 2D scratch wound in the presence of IGF-I with and without NVP-AEW541. 
Number of single migrating cells in A: SW480 and B: SW620 scratch wounds as determined from cell 
counts. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Tukey’s test.  
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5.3.2.4 The presence of NVP-AEW541 alone had no effect on cell penetration 
As it has been demonstrated that 1µM NVP-AEW541 is capable of inhibiting 3D migration of 
colorectal cancer cells in the presence of IGF-I, the effectiveness of NVP-AEW541 in inhibiting 
migration in the absence of IGF-I was then examined. Upon histological examination of the 3D 
cultures grown with and without IGF-I and NVP-AEW541, the SW480 cell line displayed the build of 
cells previously observed when IGF-I alone is present (Figure 5.19C) when compared to the DMSO 
control (Figure 5.19A). The presence of NVP-AEW541, either with (Figure 5.19G) or without 
(Figure 5.19E) the presence of IGF-I, produced cultures where the cellular distribution is 
comparable to the DMSO control. The distribution of SW620 cells within the scaffold did not appear 
to be altered by the presence of either IGF-I or NVP-AEW541 (Figure 5.19B, D, F & H). 
The quantification of cell penetration demonstrated that the SW620 cell line attained a greater 
depth of penetration than the SW480 cell line, ANOVA, F(1,19)=14.317, P=0.001, in addition to 
demonstrating that the inclusion of NVP-AEW541 also significantly affected the cell penetration, 
ANOVA, F(3,19)=5.02, p=0.01.The average penetration of SW480 cells into the scaffold was 
increased in the presence of 1ng/ml IGF-I and returned to a level comparable to the DMSO control 
when 1µM NVP-AEW541 was also present, as the presence of 1µM NVP-AEW541 alone failed to 
produce a significant alteration in cellular penetration when compared to the DMSO control (Figure 
5.20A). In conjunction with the observation made from the initial assessment of the histological 
images, the cell penetration demonstrated by the SW620 cell line remained unaltered in the 
presence of the media additives examined here (Figure 5.20B).  
5.3.2.5 The viability and proliferation of colorectal cancer cell lines was not affected by 
NVP-AEW541 
Assessment of the cell viability of the 3D cultures showed that the addition of 1ng/ml IGF-I or 1µM 
NVP-AEW541 to the culture media did not have an effect on the viability of either cell line (Figure 
5.21). The number of cells present in the cultures with either cell line was also unaltered by the 
addition of 1ng/ml IGF-I or 1µM NVP-AEW541 to the culture media, with the SW620 cultures 
yielding a higher cell number than the SW480 as previously observed (Figure 5.22), ANOVA, 
F(1,19)=495.973, p<0.001. These data showed that in the 3D migration model, NVP-AEW541 was 
effective in inhibiting the IGF-I induced cell migration and not the base-line cell migration observed, 
while leaving the proliferative behaviour of the cells unaffected. 
5.3.2.6 The combination of IGF-I and NVP-AEW541 only effects 3D migration and did not 
affect 2D migration 
The phase contrast images for the counterpart 2D scratch wound assays showed that the cell 
distribution after 24 hours was broadly similar to that previously observed in other experiments and 
shows no clear difference between each of the conditions tested (Figure 5.23). The quantification 
of the wound closure attained by these cultures confirmed the lack of significant variation in wound 
closure in the presence of 1ng/ml IGF-I or 1µM NVP-AEW541 for either the SW480 or SW620 cell 
line (Figure 5.24). 
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Figure 5.19: Neither cell line displayed an alteration in the build-up of cells when the IGF-I inhibitor NVP-
AEW541 was present in the absence of IGF-I. H&E images of 10 day cultures with A and B: DMSO control, C 
and D: 1ng/ml IGF-I and DMSO, E and F: 1µM NVP-AEW541 and G and H: 1ng/ml IGF-I and 1µM NVP-
AEW541 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.20: The 3D cell penetration of the SW480 cell line increased when IGF-I alone was present and 
decreased relative to this when 1µM NVP-AEW541 was present in the presence of 1ng/ml IGF-1, the 
penetration of both cell lines was unaffected when 1µM NVP-AEW541 alone was present. Cell penetration 
in µm of A: SW480 and B: SW620 cells as determined by the linear measurement method. Data represent 
mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Tukey’s test. 
192 
  
Figure 5.21: The 3D cell viability of both the SW480 and SW620 cell lines was unaffected by the presence 
of IGF-I or NVP-AEW541. Absorbance at 570nm of A: SW480 and B: SW620 cells as determined by the 
MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs, no significance by a Tukey’s 
test. 
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Figure 5.22: The number of cells present in the 3D material was unaffected by the presence of IGF-I or 
NVP-AEW541 for both the SW480 and SW620 cell lines. Cell number in millions of cells of A: SW480 and 
B: SW620 cells as determined by the Pico Green dsDNA Assay. Data represent mean, n = 3, ±SEM for 
both graphs, no significance by a Tukey’s test. 
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Figure 5.23: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay in 
the presence of IGF-I or the IGF-I inhibitor NVP-AEW541. Phase images of 24 hours post wounding with A and 
B: DMSO control, C and D: 1ng/ml IGF-I and DMSO, E and F: 1µM NVP-AEW541 G and H: 1ng/ml IGF-I and 
1µM NVP-AEW541 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.24: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance 
moved by the edges of the 2D scratch wound in the presence of IGF-I or NVP-AEW541. Wound closure in 
µm of A: SW480 and B: SW620 cells as determined by measuring the width of the wound. Data represent 
mean, n = 3, ±SEM for both graphs, no significance by a Tukey’s test. 
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The DAPI and Phalloidin staining of the scratch wounds did not reveal any clear alteration to the 
number of single cells within the scratch wound at 24 hours post wounding within the cultures for 
each cell line (Figure 5.25). A count of these cells confirmed that there is no significant alteration in 
the presence of 1ng/ml IGF-I or 1µM NVP-AEW541, with the SW620 cultures consistently resulting 
in a higher number of single cells within the wound after 24 hours than the SW480 cultures (Figure 
5.26), ANOVA, F(1,16)=122.785, p<0.001. These data confirmed that the effect of IGF-I and NVP-
AEW541 in altering the migratory behaviour of colorectal cancer cells was only effective in the 3D 
model and not the 2D scratch wound model used here. 
5.3.3 Inhibition of the Wnt signalling pathway with IWR-1 can block the 
IGF-I induced migratory response of cells in the 3D model 
As it has now been demonstrated that independent manipulation of both the IGF-I and Wnt 
signalling pathways can be used to alter the cell migratory behaviour of colorectal cancer cells in a 
3D migration model, the interaction between these pathways was then examined. For this, IGF-I 
and IWR-1 were used in conjunction at the effective concentrations determined previously in this 
Chapter, 1ng/ml for IGF-I, and in Chapter 4, 10μM for IWR-1. 
5.3.3.1 IWR-1 counteracts the effect of IGF-I on the penetration of SW480 cells 
Histological processing of the 3D cultures grown in the presence of 1ng/ml IGF-I or 10μM IWR-1 
shows a difference in the response of each cell line to the media additives. Culturing the SW480 
cell line in the presence of IGF-I led to the cells being present in a greater proportion of the depth of 
the scaffold (Figure 5.27C) than when cultured in the presence of DMSO alone (Figure 5.27A), 
while there were no clear differences between the distribution of cells in the control cultures and 
those when IWR-1 was present (Figure 5.27E & G). The H&E images of the SW620 cultures did 
not display an alteration of cellular distribution within the scaffold in the presence of either of the 
media additives (Figure 5.27B, D, F & H). In confirmation of the histological data, the addition of 
media additives was found to alter the cell penetration achieved by the SW480 cell line, but not the 
SW620 cell line (Figure 5.28), although the SW620 cell line was found to penetrate a greater depth 
than the SW480 cell line, ANOVA, F(1,19)=19.327, p<0.001. The amount of cell penetration found 
in the SW480 cultures grown in the presence of IGF-I was found to be significantly greater than 
those cultures grown under any of the other conditions (Figure 5.28A). 
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Figure 5.25: The SW620 cell line had more single migrating cells than the SW480 cell line during a scratch 
wound assay in the presence of IGF-I or the IGF-I inhibitor NVP-AEW541. DAPI and Phalloidin (inset) images of 
24 hours post wounding with A and B: DMSO control, C and D: 1ng/ml IGF-I and DMSO, E and F: 1µM NVP-
AEW541 G and H: 1ng/ml IGF-I and 1µM NVP-AEW541 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.26: Neither the SW480 and SW620 cell lines showed a significant alteration in the number of 
single migrating cells within the 2D scratch wound in the presence of IGF-I or NVP-AEW541. Number of 
single migrating cells in A: SW480 and B: SW620 scratch wounds as determined from cell counts. Data 
represent mean, n = 3, ±SEM for both graphs, no significance by a Tukey’s test.  
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Figure 5.27: The SW480 cell line displayed a decrease in the build-up of cells when both IGF-I and the Wnt 
inhibitor IWR-1 were present, relative to those seen when IGF-I alone was present, while the SW620 cell line 
did not display a decrease under these conditions. H&E images of 10 day cultures with A and B: DMSO 
control, C and D: 1ng/ml IGF-I and DMSO, E and F: 10µM IWR-1 and G and H: 1ng/ml IGF-I and 10µM IWR-1 
for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.28: The 3D cell penetration of the SW480 cell line was increased when 1ng/ml IGF-I alone was 
present relative to all other conditions, while the penetration of the SW620 cell line remained unaffected. 
Cell penetration in µm of A: SW480 and B: SW620 cells as determined by the linear measurement 
method. Data represent mean, n = 3, ±SEM for both graphs, ** p < 0.01, *** p < 0.005 by a Tukey’s test. 
201 
5.3.3.2 The viability of 3D cultures was unaffected while the final cell population was 
affected 
The use of IGF-I or IWR-1, either on their own or in conjunction with each other, did not cause a 
significant variation in the viability of cultures grown with either cell line (Figure 5.29). When the cell 
numbers within the cultures was assessed, the SW620 cell line was found to have more cells in the 
scaffold than the SW480 cell line, ANOVA, F(1,19)=213.238, p<0.001. There was a small but 
significant increase in the number of SW480 cells present in the scaffolds cultured with IGF-I when 
compared to the DMSO (Figure 5.30A), while inclusion of media additives did not affect the final 
cell numbers found in the SW620 cultures (Figure 5.30B). Although in this case the inclusion of 
IGF-I in the culture media caused a 23% increase in the number of SW480 cells after 10 days of 
3D culture, this increase was unlikely to wholly account for the 48% increase in cell penetration 
seen in these cultures. Additionally, as there was no significant difference between the cell number 
in the IGF-I and the IGF-I with IWR-1 cultures, but there was a significant difference in the depth of 
cell penetration attained by the cells found in each culture, it is thought that the addition of IWR-1 in 
the culture media inhibits the IGF-I induced cell migration in the SW480 cell line. 
5.3.3.3 The inclusion of both IWR-1 and IGF-I did not affect 2D migration 
When IGF-I and IWR-1 are included in the culture media of 2D scratch wounds, the appearance of 
the cultures containing both did not grossly differ from those cultures grown with either or neither of 
them (Figure 5.31). In conjunction with previously observed results, the inclusion of either IGF-I or 
IWR-1 on their own did not have an effect on the distance moved by the leading edges of the 
wound and the addition of both of them did not cause a significant alteration either (Figure 5.32). 
The quantity and distribution of single cells within the scratch wound in the presence of IGF-I or 
IWR-1 appeared similar to those previously seen in the fluorescently stained samples, with little 
deviation from the DMSO control (Figure 5.33). Quantification of these cells confirmed that IGF-I 
and IWR-1 had no effect on the migratory behaviour of the SW480 cells in a 2D scratch assay 
(Figure 5.34A), with fewer cells observed than for the SW620 cell line, ANOVA, F(1, 16)=57.400, 
p<0.001. The number of single cells observed in the SW620 cultures grown with 1ng/ml IGF-I and 
10μM IWR-1 was significantly lower than the DMSO control (Figure 5.34B), but as all cell counts 
were lower than the control and there was no significant difference between the IGF-I only and 
IGF-I with IWR-1 cell counts, it was likely that the control count was unusually high and therefore 
IWR-1 was unable to alter any effect that the addition of IGF-I is having on the 2D scratch wounds. 
Together these data shows that the manipulation of the migratory behaviour of the colorectal 
cancer cell line SW480 and SW620 using IGF-I and IWR-1 is only effective in the 3D model used 
here and not in the counterpart 2D scratch wounds. 
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Figure 5.29: The 3D cell viability of both cell lines was unaffected by the presence of IGF-I or IWR-1. 
Absorbance at 570nm of A: SW480 and B: SW620 cells as determined by the MTT Cell Viability Assay. 
Data represent mean, n = 3, ±SEM for both graphs, no significance by a Tukey’s test. 
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Figure 5.30: The number of SW480 cells in the 3D material increased when IGF-I alone was present, 
while the SW620 cell line was unaffected by all conditions. Cell number in millions of cells of A: SW480 
and B: SW620 cells as determined by the Pico Green dsDNA Assay. Data represent mean, n = 3, ±SEM 
for both graphs, * p < 0.05 by a Tukey’s test. 
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Figure 5.31: Both the SW480 and SW620 cell lines exhibited wound closing during a scratch wound assay 
in the presence IGF-I or the Wnt inhibitor IWR-1. Phase images of 24 hours post wounding with A and B: 
DMSO control, C and D: 1ng/ml IGF-I and DMSO, E and F: 10µM IWR-1 and G and H: 1ng/ml IGF-I and 
10µM IWR-1 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.32: Neither the SW480 and SW620 cell lines showed a significant alteration in the distance 
moved by the edges of the 2D scratch wound in the presence of IGF-I or IWR-1. Wound closure in µm of 
A: SW480 and B: SW620 cells as determined by measuring the width of the wound. Data represent mean, 
n = 3, ±SEM for both graphs, no significance by a Tukey’s test. 
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Figure 5.33: The SW620 cell line had more single migrating cells than the SW480 cell line during a scratch 
wound assay in the presence IGF-I or the Wnt inhibitor IWR-1. DAPI and Phalloidin (inset) images of 24 
hours post wounding with A and B: DMSO control, C and D: 1ng/ml IGF-I and DMSO, E and F: 10µM IWR-
1 and G and H: 1ng/ml IGF-I and 10µM IWR-1 for both cells lines. Scale bars = 200µm for all images. 
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Figure 5.34: The SW620 cell line showed a significant decrease in the number of single migrating cells 
within the 2D scratch wound in the presence of IGF-I and IWR-1, while the SW480 cell line remained 
unaffected. Number of single migrating cells in A: SW480 and B: SW620 scratch wounds as determined 
from cell counts. Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Tukey’s test. 
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5.3.4 Manipulation of IGF-I signalling affected protein expression in both 
the SW480 and SW620 cell lines 
In this Chapter, media additives which manipulate the IGF-I signalling pathway and effect the 
migratory behaviour of colorectal cancer cell lines in a 3D migration model have been identified, 
namely IGF-I and NVP-AEW541. The effect of these media additives on the key proteins identified 
in Chapter 4, E-cadherin, vimetin, β-catenin and Slug, was assessed to determine the underlying 
pathways involving in the altered migratory behaviour of the colorectal cancer cells. 
5.3.4.1 IGF-I increases β-catenin expression in the SW480 cell line 
The immunohistochemical staining of 10 day 3D SW480 cultures in the absence and presence of 
1ng/ml IGF-I demonstrated that the inclusion of this growth factor did affect the protein expression 
profile of these cells. When cultured in the absence of IGF-I, the SW480 cell line did not express E-
cadherin (Figure 5.35A) or Slug (Figure 5.35G) and did express vimentin (Figure 5.35C) and β-
catenin (Figure 5.35E), with the staining for vimentin appearing to be stronger than the staining for 
β-catenin. When IGF-I was included in the culture media, the expression of E-cadherin (Figure 
5.35B), vimentin (Figure 5.35D) and Slug (Figure 5.35H) in the SW480 cell line did not appear to 
alter. However, the expression of β-catenin was seen to increase, with stronger staining seen in the 
cells (Figure 5.35F) when compared to the control cultures (Figure 5.35E). 
5.3.4.2 NVP-AEW541 affects the expression of different proteins in different cell lines 
The analysis of 3D cultures of both colorectal cancer cell lines cultured with IGF-I and NVP-
AEW541 via immunohistochemistry also demonstrated that the inclusion of NVP-AEW541 in the 
culture media affected protein expression. When cultured in the presence of IGF-I with DMSO, the 
SW480 cell line retained the same expression profile as previous seen, with no E-cadherin (Figure 
5.36A) or Slug (Figure 5.36G) expression and vimentin (Figure 5.36C) and β-catenin (Figure 
5.36E) expression. When 1μM NVP-AEW541 was included in addition to the IGF-I, the expression 
of E-cadherin (Figure 5.36B) and Slug (Figure 5.36H) in the SW480 cell line did not appear to alter. 
However, the expression of vimentin was entirely suppressed (Figure 5.36D) and the expression of 
β-catenin was seen to decrease, with less intense staining observed in the cells (Figure 5.36F). 
The pattern of protein expression in the SW620 cell line in response to the addition of NVP-
AEW541 was observed to differ from that seen in the SW480 cell line. When cultured in the 
presence of IGF-I with DMSO, the SW620 cell line retained the same expression profile as 
previous seen, with no E-cadherin (Figure 5.37A) or Slug (Figure 5.37G) expression and vimentin 
(Figure 5.37C) and β-catenin (Figure 5.37E) expression. When 1μM NVP-AEW541 was included in 
addition to the IGF-I, the expression of vimetin (Figure 5.37D), β-catenin (Figure 5.37F) and Slug 
(Figure 5.37H) in the SW620 cell line did not appear to alter. However, the expression of E-
cadherin was seen to increase (Figure 5.37B) relative to the IGF-I control. 
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Figure 5.35: The inclusion of IGF-I in culture media enhances β-catenin expression in the SW480 cell line. 
Immunohistochemical images of antibody staining for A and B: E-cadherin, C and D: vimentin, E and F: β-
catenin, G and H: Slug and I and J: no primary control on 10 day 3D cultures of SW480 cells in the 
absence and presence of 1ng/ml IGF-I, where the brown precipitate (arrows) indicates positive staining. 
Scale bars = 25µm for all images. 
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Figure 5.36: The inclusion of NVP-AEW541 with IGF-I in culture media suppresses vimentin and β-
catenin expression in the SW480 cell line. Immunohistochemical images of antibody staining for A and B: 
E-cadherin, C and D: vimentin, E and F: β-catenin, G and H: Slug and I and J: no primary control on 10 
day 3D cultures of SW480 cells in the absence and presence of 1μM NVP-AEW541 with 1ng/ml IGF-I, 
where the brown precipitate (arrows) indicates positive staining. Scale bars = 25µm for all images. 
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Figure 5.37: The inclusion of NVP-AEW541 with IGF-I in culture media enhances E-cadherin expression 
in the SW620 cell line. Immunohistochemical images of antibody staining for A and B: E-cadherin, C and 
D: vimentin, E and F: β-catenin, G and H: Slug and I and J: no primary control on 10 day 3D cultures of 
SW620 cells in the absence and presence of 1μM NVP-AEW541 in the presence of 1ng/ml IGF-I, where 
the brown precipitate (arrows) indicates positive staining. Scale bars = 25µm for all images. 
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5.3.4.3 IWR-1 reverses the effect of IGF-I on β-catenin expression 
As the inclusion of IWR-1 along with IGF-I in 3D SW480 cultures has been shown to inhibit the 
IGF-I mediated increase in cell migration, the effect of the combination of these additives on protein 
expression profile of the SW480 cell line was investigated. The immunohistochemical staining of 10 
day 3D SW480 cultures with combinations of IGF-I and IWR-1 added to the culture media 
demonstrated that the inclusion of IWR-1 did affect the IGF-I induced protein expression profile of 
these cells. The control and IGF-I SW480 cultures displayed the same protein expression profile as 
seen in (Figure 5.35), with E-cadherin (Figure 5.38A & B) and Slug (Figure 5.38J & K) not 
expressed and vimentin (Figure 5.38D & E) and β-catenin (Figure 5.38G & H) expressed. When 
IWR-1 was included in the culture media along with IGF-I, the expression of E-cadherin (Figure 
5.38C), vimentin (Figure 5.38F) and Slug (Figure 5.38L) in the SW480 cell line did not appear to 
alter. However, the expression of β-catenin was seen to decrease, with few, if any, cells 
demonstrating positive staining (Figure 5.38I), compared to the majority of cells seen to express β-
catenin in the control and IGF-I cultures (Figure 5.38G & H). 
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Figure 5.38: The inclusion of IWR-1 with IGF-I in culture media suppresses β-catenin expression in the 
SW480 cell line. Immunohistochemical images of antibody staining for A, B and C: E-cadherin, D, E and F: 
vimentin, G, H and I: β-catenin, J, K and L: Slug and M, N and O: no primary control on 10 day cultures of 
SW480 in the absence and presence of 1ng/ml IGF-I without and with 10µM IWR-1, where the brown 
precipitate (arrows) indicates positive staining. Scale bars = 25µm for all images. 
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5.4 Discussion 
Following the application of the model developed here to investigate the role of Wnt signalling in 
directing the migratory behaviour of colorectal cancer cells, this 3D model was then used to 
analyse the role of IGF-I. The commercial availability of human recombinant IGF-I and the small 
molecule NVP-AEW541 has provided a useful set of tools for investigating the role of the IGF-I 
signalling pathway via the IGF-IR in the 3D migration model under development in this project. In 
both cases, the addition of these compounds to the culture media yielded results in the 3D 
migration assay but not the counterpart 2D studies and these are summarised in Table 5.1. This 
highlights that although IGF-I signalling is known to have an effect on the proliferative behaviour of 
cancer cells [338], in the model used here the action of IGF-I signalling has only affected the 
migratory behaviour of the cells. 
Additive Concentration SW480 SW620 
IGF-I 1ng/ml 54% increase in 
cell penetration 
No effect 
NVP-AEW541 1µM 16% decrease in 
cell penetration, 
only when 1ng/ml 
IGF-I is also 
present 
13% decrease 
in cell 
penetration, 
only when 
1ng/ml IGF-I is 
also present 
IWR-1 10µM Reduces the 
54% increase in 
cell penetration 
induced by 
1ng/ml IGF-I 
down to control 
levels 
Up to 26% 
decrease in cell 
penetration 
Table 5.1: Summary of the primary effect of growth factors and small molecules on cell culture in the 3D 
migration assay. 
IGF-I was found to induce a 50% increase in the observed cell migration of the SW480 cell line 
when used at concentrations of 1ng/ml and above in the 3D model (Figure 5.3A), which resulted in 
changes in cellular distribution clearly visible in the histological images of the cultures (Figure 5.2A, 
E & G), but was unable to produce a response in the 2D model when either epithelial sheet (Figure 
5.7A) or single cell (Figure 5.9A) migration was measured. The effect on the SW480 cell line was 
not mirrored by its counterpart cell line, SW620, as IGF-I failed to induce a migratory response 
when used on this cell line in 2D (Figure 5.7B & Figure 5.9B) or 3D (Figure 5.3B) models. This data 
correlates with previously published data, as the exposure of the colorectal cancer cell line KM12L4 
to exogenous IGF-I resulted in increased migration and invasion in uncoated and Matrigel coated 
Transwell
®
 assays [334]. This role of IGF-I in enhancing colorectal cancer cell migration is not 
limited to in vitro studies, as the intraperitoneal injection of IGF-I into both control and LID mice 
resulted in an increase in metastasis formation [146]. 
In contrast, the data regarding cell number obtained here does not correlate with previously 
published data, as manipulation of IGF-I signalling did not affect the overall cell number of cancer 
cells in the 3D model tested, this may be due to differences in experimental protocols, as cell 
proliferation in 2D cultures [143] and xenografts [340] have been assessed in the literature, 
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whereas a 3D model was assessed here. Additionally, the published studies looked at the effect of 
the manipulation of IGF-I signalling via inhibition of IGF-IR activity via transfection of a dominant 
negative variant of IGF-IR [337] or IGF-IR siRNA [338] as opposed to the addition of IGF-I into 
culture media. As the cell lines used here are derived from cancers, it is likely that their rate of 
proliferation is already elevated due to genetic mutations and signalling alterations within the cells, 
resulting in the cells having an impaired capacity to respond to elevated IGF-I signalling. 
The alteration of protein expression mediated by the addition of IGF-I into the culture media also 
correlates with previously published data. An increase in β-catenin expression in response to IGF-I 
has previously been noted by Desbois-Mouthon et al. [142], which correlates with the increased 
staining presented here (Figure 5.35E & F). It has also been noted that exposure to IGF-I also 
changes the location of both E-cadherin and β-catenin in the colonic adenocarcinoma cell line 
HT29-D4, from a distribution based predominantly at the plasma membrane in the absence of IGF-I 
to a distribution through the cytoplasm in the presence of IGF-I [364]. 
The introduction of the small molecule inhibitor NVP-AEW541 at a concentration of 1μM was 
successful in inhibiting 3D cell migration in the presence of IGF-I (Figure 5.11), while failing to elicit 
a response when IGF-I was absent (Figure 5.19). Again, this manipulation of IGF-I signalling did 
not alter the migratory behaviour of either the SW480 or SW620 cell line in 2D (Figure 5.15, Figure 
5.17, Figure 5.23 & Figure 5.25). Again, this data is not fully in correlation with the published data 
for this small molecule, as NVP-AEW541 has been shown to limit cell growth in the 2D cultures of a 
variety of cell types [345, 357]. However, the data presented here does correlate with the published 
data regarding the effect of NVP-AEW541 on cell migration, with NVP-AEW541 inhibiting the 
migration of both SW480 and SW620 cells in the presence of IGF-I, although in the literature this 
inhibition was also seen in the absence of IGF-I [351], which was not observed here. In terms of 
the effect of NVP-AEW541 on protein expression, no published data was found regarding the 
effects of NVP-AEW541 on any of the protein targets assessed here. However, the downregualtion 
of vimetin and β-catenin in SW480 cells (Figure 5.36C, D, E & F) and the upregulation of E-
cadherin in SW620 cells (Figure 5.37A & B) would correlate with the decreased motility observed in 
the 3D model if the main mechanism of action of IGF-I is via the Wnt signalling pathway in this 
system. 
As there is a known interaction between IGF-I signalling and the Wnt signalling pathway [141], the 
mechanism of the action of IGF-I in the induction of migration in the 3D cultures of the SW480 cell 
line was examined using the small molecule Wnt signalling inhibitor IWR-1. It has previously been 
demonstrated that use of IWR-1 at a concentration of 10μM is capable of causing a 26% reduction 
in the observed cell migration of the SW620 cell line (Figure 4.27B), while leaving the SW480 
unaffected (Figure 4.27A). When used in conjunction, the addition of IWR-1 to the cultures with 
IGF-I resulted in the complete inhibition of the IGF-I induced 3D cell migration of the SW480 cell 
line (Figure 5.28A). As there is no evidence in the literature of IGF-I and IWR-1 being used in 
conjunction on cell cultures, there is no previous data to compare these results to. However, the 
increase in SW480 cell migration in response to IGF-I has been consistent across all experiments 
and correlates with published data [334], in addition to the effect of IWR-1 correlating with 
previously noted migratory inhibition which has not been recorded in any published data. This 
provides evidence that the main signalling cascade responsible for mediating the migratory 
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response of the SW480 cell upon exposure to IGF-I is acting via the Axin/APC/GSK-3β destruction 
complex, as this is the point in the Wnt signalling pathway at which IWR-1 interacts by stabilising 
axin2 [313]. Additionally, the observed reduction in IGF-I induced β-catenin expression seen in 
SW480 cells cultured in the presence of IWR-1 (Figure 5.38E & F) correlated with the previously 
seen decrease in β-catenin expression in SW620 cells (Figure 4.34E & F), although there is no 
evidence in the literature regarding the effect of IWR-1 on the expression of the proteins assessed 
in this study. 
When taken with the cell penetration data, this immunohistochemical data would suggest that the 
downstream signalling action of IGF-I interacts with the Wnt signalling pathway. This interaction is 
likely to be via the PKB mediated inhibition of GSK-3β [139], as inclusion of exogenous IGF-I 
increased β-catenin expression, which would in turn affect the downstream transcriptional targets 
of the Wnt signalling pathway. In addition to this, inhibition of IGF-I signalling via the small molecule 
NVP-AEW541 appears to mediate changes to the cell migratory behaviour by affecting the 
expression of the key EMT indicators E-cadherin and vimentin. Along with the inhibition of the IGF-I 
mediated increase in migration in the SW480 cell line by the small molecule Wnt inhibitor IWR-1, 
this demonstrates that the IGF-I pathway can interact with the Wnt signalling pathway, a critical 
pathway for the development of colorectal cancer [96], to induce a migratory response in the model 
under investigation here. 
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6 Increasing the biological relevance of cell invasion 
models in vitro by utilising ECM coatings and co-
culture 
6.1 Introduction 
The provision of a 3D environment for in vitro cultures is an important step towards mimicking the 
in vivo environment of cells in order to produce more accurate biological models. The 
microenvironment of extracellular matrix (ECM) proteins and secondary cell types have also been 
identified as important in the development and behaviour of cancers [365, 366]. Modification of the 
3D migration assay in use herein to include ECM and co-culture components will be addressed in 
this Chapter and open opportunities for novel cell invasion models which reflect the tumour 
microenvironment more accurately (Figure 6.1). 
6.1.1 The ECM has a role in modulating cellular behaviour 
6.1.1.1 ECM proteins alter cellular behaviour both in vivo and in vitro  
The in vivo ECM provides a wide variety of biochemical and mechanical information to cells and 
alterations to this environment can have a significant impact on the behaviour of cells and tumours. 
This also applies to cells cultured in vitro with the provision of an ECM substrate altering the 
biochemical and physical properties of the culturing environment. 
6.1.1.1.1 The mechanical stiffness of the ECM alters during cancer and affects cell behaviour 
Changes to the mechanical stiffness of the growth substrate of cells in vitro have been shown to 
alter the morphology and migration of cells [367]. The seeding of the rat kidney cell line NRK-52E 
or Swiss mouse 3T3 fibroblasts onto polyacrylamide (PA) gels with increasing bis-acrylamide 
content altered their morphology, as the higher the bis-acrylamide content gels were stiffer and 
allowed for the better spreading of cells. The softer substrates resulted in greater fluctuation of the 
lamellipodia of the NRK-52E cells and a faster rate of motility of the 3T3 cells, demonstrating that 
these cell lines appear to be more motile on the softer gels. 
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Figure 6.1: The tumour microenvironment is a complex multicellular environment which requires accurate 
in vitro modelling. A: H&E image of a Stage C colorectal cancer with B: a schematic representation of the 
components of the microenvironment. This microenvironment can be modelled via C: 2D culture, providing 
a limited microenvironment to model cancer behaviour, with limited cell-cell contacts, D: 3D culture on 
synthetic scaffolds, increasing the level of cell-cell interactions in the absence of ECM protein or cancer-
stroma interactions, E: 3D culture with ECM, providing cell-protein interactions to direct cell behaviour, and 
F: 3D co-culture, providing a range of multicellular and protein interactions. Scale bar = 200µm. 
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The stiffness of protein matrices has been shown to have an effect on breast cancer cells, in both 
in vivo and in vitro studies. A study using the MMTV-Neu mouse model of breast cancer 
demonstrated that the stiffness of the mammary gland tissue increases with increasing tumour 
progression and that this stiffness also spreads to the stromal tissue adjacent to the invading 
tumour [368]. This increased stiffness is thought to be due to a combination of increased collagen 
expression and increased linearisation and cross-linking of these fibres. The increased detection of 
the collagen cross-links was also seen in correlation with an increase of lysyl oxidase (LOX), an 
amine oxidase which acts as a collagen cross-link initiator. The cross-linking of in vitro collagen 
gels with L-ribose also resulted in an increase in gel stiffness which was sufficient to disrupt the 
tissue organisation of non-malignant MCF10A acini and to increase the size of the observed 
colonies within the 3D gel. However, without the malignant activity of ErbB2, the stiffening of the 
collagen gels was not sufficient to induce the invasion of the mammary epithelial cells (MECs). 
The authors of this study then went on to investigate the role of the LOX modulation of tissue 
stiffness in the initiation and progression of breast tumours [368]. The replacement of the native 
cells of the mammary fat pads of NOD/SCID mice with fibroblasts which express normal or 
elevated levels of LOX allowed the experimenters to prime the mice prior to the injection of 
MCF10AT MECs to induce premalignant legions. The elevated LOX expression resulted in stiffer 
glands with a higher linearised collagen content which promoted the growth and invasion of the 
injected MECs without directly affecting the behaviour of the MECs themselves, as the application 
of the LOX inhibitor β–aminopropionitrile (BAPN) did not affect the tumour growth. A 
complementary study treating five month old MMTV-Neu mice either BAPN or a LOX inhibiting 
antibody for a period of one month followed by a month recovery was sufficient to reduce the LOX 
activity levels and decrease amount of fibrillar collagen, crosslinks and the linearisation of fibres. 
This resulted in fewer, smaller tumours produced in the LOX inhibited mice and they took longer to 
appear. These tumours were found to express lower levels of proliferating cell nuclear antigen 
(PCNA) and were generally a lower grade of tumour when compared to the untreated MMTV-Neu 
mice. 
LOX has also shown to have a role in the progression of colorectal tumours, as the injection of 
SW480 cells stably overexpressing LOX into nude mice resulted in an increased tumour volume 
and increased stiffness of the tumours produced when compared to either control mice or those 
expressing catalytically inactive LOX [369]. However, this model did not observe the increase in 
collagen as was observed in the mouse model described above as the collagen content was 
comparable across all conditions. The expression of active LOX in the SW480 cells was sufficient 
to promote the phosphorylation of focal adhesion kinase (FAK), while the culturing of unmodified 
SW480 cells on collagen I gels treated with either LOX or ribose to promote cross-linking and 
increase stiffness was also sufficient to promote FAK phosphorylation. Histological staining of the 
subcutaneous SW480 tumours also highlighted that expression of LOX increases the amount of 
phosphorylated Src, suggesting that the mechanism of signal transduction from the stiffened matrix 
via a FAK/Src signalling cascade. Application of either FAK or Src inhibitors to LOX expressing 
SW480 cells grown in collagen gels was sufficient to reduce the proliferation and invasion of these 
cells back to levels comparative to those seen with controls, with the FAK inhibitor reducing the 
proliferation of both the control and LOX mutant cells. 
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While both of these papers utilised cell lines which demonstrated increased growth and motility on 
stiffer matrix substrates, cancer cells have varied growth profiles on substrates of differing rigidity 
[370]. A variety of cell lines were assessed for their ability to grow on collagen coated PA gels with 
elastic moduli ranging from 150 to 9600 Pa, which covers the stiffness of normal lung or mammary 
tissue, breast tumours and striated muscle. Those which were found to grow better on the stiffer 
gels were termed rigidity-dependent and those which had a consistent growth profile across all gel 
were termed rigidity-independent, with no correlation between the growth patterns and the tumour 
origin or stage observed. Rigidity-dependent cell lines were found to have a cell-cycle blockade 
preventing entry into S phase or increased apoptosis, or a combination of the two, when cultured 
on softer gels which accounts for the decreased cell number overall as the attachment of cells to 
the range of gels remained comparable. The alteration of gel stiffness also affected the ability of 
the rigidity-dependent cells to spread on the substrate and to migrate through the gels. Altogether, 
these traits meant that the rigidity-dependent cell lines were less effective at generating xenograft 
tumours in soft lung tissue than rigidity-independent cell lines under the same conditions and 
highlight that the mechanical properties of ECM can play a large part in directing the initial growth 
and spread of tumours. 
SW480 cells seeded onto soft collagen I gels, as opposed to collagen I coated glass or a hard 
collagen I gels, exhibited an inhibited ability to spread, which appeared to be under the control of 
receptor-type tyrosine-protein phosphatase alpha (RPTPα) [371]. While RPTPα expression 
reversed this inhibition in the soft gels and knock-down of RPTPα expression in cells grown on the 
harder substrates mimicked the inhibition seen on the soft gels. This process of spreading is Src 
dependent, as the transfection of C-terminal Src kinase (CSK), which acts to activate Src where 
RPTPα inactivates Src, is sufficient to decrease the amount of spreading on the hard gels when 
expressed alone and counteracts the effect of RPTPα when both proteins are expressed together. 
The authors demonstrated that cellular spread is also mediated via myosin light chain kinase 
(MLCK) but not via Rho-kinase (ROCK), as application of the MLCK inhibitor ML-7 was sufficient to 
inhibit the effect of RPTPα expression completely but the application of the ROCK inhibitor Y-
27632 only resulted in a partial inhibition of the response to RPTPα. The expression of RPTPα also 
controls the invasion of SW480 across the chorioallantoic membrane (CAM) of eggs, as knock-
down of RPTPα expression reduced the number of eggs exhibiting invasion of the membrane by 
the SW480 from ~75% seen in controls to ~20%, while overexpression of RPTPα resulted in a 
small increase in instances of invasion. 
Together these data demonstrate that the mechanical properties of the microenvironment, in terms 
of its rigidity, can drive cell behaviour and the interaction of cells with ECM with differing rigidity can 
direct cancer progression and spread. The inclusion of an ECM substrate in the 3D model under 
development here may alter the rigidity of the 3D in vitro microenvironment, providing the cells with 
a culture environment which is closer to the in vivo situation. 
6.1.1.1.2 ECM proteins can direct cell migratory behaviour 
Modulation of the migratory behaviour of cells by ECM protein components has also been 
observed, with both collagen I and fibronectin facilitating the migration of cells in in vitro and in vivo 
assays. The remodelling interaction between cells and the ECM can also direct the mode of 
migration utilised in the 3D environment [271], as the inhibition of the protease degradation of ECM 
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forces cells to adopt a more amoeboid mode of migration to maintain migration speed. Using a 
Fluorescein Isothiocyanate (FITC) release assay, the migration of membrane type-1 matrix 
metalloproteinase (MT1-MMP, also known as MMP-14) overexpressing HT-1080 fibrosarcoma 
cells (HT-1080/MT1 cells) on FITC-labelled collagen matrices was examined in the presence of 
protease inhibitors. The addition of the broad spectrum matrix metalloproteinase (MMP) inhibitor 
BB-2516 was sufficient to cause an 80% reduction in the amount of FITC released from the matrix 
by collagen degradation over a 40 hour period, while the application of a protease cocktail which 
induced cathepsin and serine protease inhibitors in with BB-2516 increased this inhibition to 95%. 
This significant reduction in matrix degradation was not accompanied by a decrease in the 
migratory speed of the cells, with both the control and cocktail treated HT-1080/MT1 cells 
maintaining a median speed of ~0.5μm per minute across the 15 hours they were tracked. The lack 
of speed loss in the presence of the protease cocktail appears to be due to a shift in the migratory 
mode utilised by these cells, observed as a significant change from elongated mesenchymal type 
cells to spherical amoeboid type cells in the presence of the cocktail. This change was also seen in 
the breast cancer cell line MDA-MB-231, although the shift in the ratio of mesenchymal and 
amoeboid in the presence and absence of the protease cocktail was not significant, in addition to a 
lower inhibition of FITC release in the MDA-MB-231 cultures in the presence of the protease 
cocktail. This in vitro data was mirrored by the injection of HT-1080/MT1 cells into mouse dermis as 
those cells which were pre-treated with the protease cocktail exhibited a greater ability to 
disseminate throughout the dermal tissue, with the cells also maintaining a more spherical 
amoeboid shape. 
The interactions of cancer cells with ECM components leads to alterations to their organisation as 
visible through histological analysis and has led to the identification of a series of tumour-
associated collagen signatures (TACS) which are correlated with the disease progression [272]. 
The first of these signatures, TACS-1, is seen as a build-up of dense collagen deposits in the 
stromal tissue surrounding the initial site of tumour growth and can be used to local small tumours 
within a tissue sample. TACS-2 is associated with larger tumours and characterised by stretched, 
elongated collagen fibres found around the tumour boundary, with the angle between the tumour 
boundary and the fibres being 0
o
. The authors of this study hypothesise that this alteration in 
collagen organisation is due to the expansion of the tumour exerting an outward force on the dense 
collagen deposits of TACS-1, causing the stretching of the individual fibres. The final signature, 
TACS-3, is associated with invasive tumours, as the smooth collagen organisation seen in TACS-2 
is disrupted by the local invasive fronts of the tumour to a formation which is irregular and most 
commonly perpendicular to the tumour boundary. As these signatures were observed in fixed 
mammary tumours from MMTV-Wnt-1 mice, a common mouse breast tumour model, the study 
then looked at the remodelling of in vitro collagen gels by tumour explants from another common 
mouse breast tumour model, the MMTV-polyoma middle-T (PyVT) model where cells express the 
oncogenic middle antigen of the polyoma virus. Imaging of these gels after polymerisation but 
before the addition of the tumour explants highlights the randomly orientated collagen fibres, while 
imaging of gels after 8 hours of culturing with the explants shows a radically altered collagen 
organisation close to the explants. Collagen morphology analogous to TACS-2 was observed 
around the tumour boundary, while morphology analogous to TACS-3 was seen in areas where the 
222 
explant had begun to invade into the collagen gel, demonstrating that tumours are able to remodel 
the organisation of collagen fibres to promote the localised invasion of the tumours. 
The deposition of collagen seen in the earlier stages of the mammary tumours may also have a 
role in the migration of tumours as it has been shown that glioblastoma spheroids attain a greater 
distance of invasion over a 12 hour period on gels with a higher content of collagen I [372]. 
Deposition of fibronectin may also increase the cell migration of both normal and transformed cells, 
as seen via the colloidal gold migration assay where cells remove the gold coating from coverslips 
as they migrate across the surface [202]. The addition of 50μg/ml of fibronectin at the time of cell 
plating enhanced the migration of both normal and transformed NIL8 hamster and 3T3 mouse 
fibroblasts in the initial two days after cell seeding. The migration of the NIL8 cells transformed by 
the hamster sarcoma virus (NIL8-HSV cells) was observed over the initial 24 hours after plating 
and the extent of this migration was dependant on the concentration of fibronectin present, as 
lower concentrations of fibronectin resulted in smaller areas cleared of their gold particle coating. 
The change in behaviour seen in response to fibronectin could also be directly observed from the 
cell morphology, as the NIL8-HSV cells adopted a spindle like morphology and were more spread 
out in the presence of 50μg/ml fibronectin, whereas they grew in tight colonies in the absence of 
fibronectin. 
The presence of fibronectin can also increase the ability of cells to migrate across a collagen I 
substrate, as demonstrated in vitro with Chinese hamster ovary (CHO) cells [373]. The seeding of 
CHO cells on to 3D collagen I gels in the absence of fibronectin resulted in delayed attachment to 
the substrate as cells retained a spherical morphology over the initial two hours post seeding, 
whereas those seeded in the presence of fibronectin had adopted the characteristic spread out 
morphology of the cell line. This difference in cell attachment was lost by 24 hours post seeding, 
with the 3D cultures with or without fibronectin producing cells with comparable morphologies. This 
alteration in attachment behaviour did not lead to a significant alteration in the proliferative 
behaviour of the CHO cells over the first 3 days of culture post seeding, with the initial 2.5 x 10
4
 
cells expanding to 5.5 x 10
5
 and 5.0 x 10
5
 cells, with and without fibronectin in the serum 
respectively. However the migratory capacity of the CHO cells cultured on the 3D collagen I gels 
varied depending on the presence of fibronectin. After the initial 3 days of culturing, 12.4% of the 
CHO cells where found within the collagen gels when fibronectin was present in the serum, 
whereas the use of fibronectin depleted serum resulted in only 6.1% of the cells migrating into the 
gels. 
While the presence of fibronectin has implications for the migration of cancer cells in vitro, the 
expression of fibronectin has been shown to not fully correlate to the metastatic behaviour of breast 
cancer cells [374]. Using mammary tumour clones generated from 7,12-dimethylbenz(α)anthracene 
(DMBA) induced tumours in rats, the group identified three clones taken from legions within the 
mammary tissue which exhibited a varied capacity to produce lung metastasis when xenografted 
into the mammary fat pads of further rats. Two lung metastases were also cloned and shown to 
have different capacities for metastasis formation in a xenograft model, with the more metastatic of 
these two also able to produce lymph node metastases which were not viewed with any of the 
other clones examined. Analysis of in vitro cultures on glass coverslips showed that both of the 
metastatic clones did not demonstrate any cell surface expression of fibronectin, regardless of the 
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confluency of cell growth, whereas the three clones from primary tumours did have surface 
fibronectin expression which was shown to increase with increased cell confluency. The same 
trend was observed with fibronectin secreted into the growth medium, with both the metastatic 
clones secreting ~2.5μg per 1 x 10
6
 cells when in confluent cultures compared to the 26.7 - 77.0μg 
per 1 x 10
6
 cells secreted by the confluent cultures of the primary clones. This pattern of 
expression of fibronectin was maintained in vivo, with xenograft tumours produced from the 
metastatic clones producing a much lower amount of fibronectin than those produced from the 
primary clones and this trend remained when either the primary mammary xenograft tumour or 
metastases were examined. As the authors of this paper found no clear correlation between the 
expression of fibronectin and the metastatic potential of the mammary tumour clones it is thought 
that any role that fibronectin may play in the metastatic progression of tumours is not as simple as 
changing expression levels of the protein. 
6.1.1.1.3 The ECM can direct other aspects of cancer behaviour 
While the ECM can modulate the migratory behaviour of cancer cells, other aspects of cancer 
behaviour and progression can also be affected by these proteins. The collagen content of 
subcutaneous xenograft tumours affects the elasticity of the tumours, with those containing a 
higher amount of collagen taking longer to relax after compression [375]. This difference in 
elasticity was seen in tumours generated from cancer cell lines originating from a variety of tissues 
and was not correlated to the glycosaminoglycan (GAG) content of the xenografts, as this was 
comparable across the four cell lines examined. The higher collagen content also affects the 
diffusion of macromolecules, as examined with a non-binding antibody, with those tumours with a 
lower collagen content attaining a diffusion rate of ~1.930 x 10
-7
 cm
2
 per second as opposed to the 
~0.915 x 10
-7
 cm
2
 per second obtained in the tumours with a higher collagen content, 
demonstrating that the collagen content of tumours may be preventing the diffusion of 
chemotherapy agents into the centre of the tumour mass and limiting the effectiveness of these 
treatments. The treatment of these high collagen tumours with collagenase was able to increase 
the rate of diffusion by up to 100% and provides a potential solution to the problem of drug delivery 
if the collagenase can be appropriately targeted to the tumour mass and not disrupt the 
organisation of other tissues. 
The regulation of collagen I can also affect angiogenesis in response to basic fibroblast growth 
factor (bFGF) and vascular endothelial growth factor (VEGF) [376]. Using a modified CAM assay 
where a collagen I gel is implanted into the membrane and the angiogenesis of the chick embryo 
into the collagen is observed, the addition of bFGF, either with or without VEGF, was sufficient to 
increase the amount of vascularisation of the collagen I gel, while the application of VEGF alone 
did not result in a significant increase in vascularisation. This increase in vascularisation was 
shown to be dependent on the action of MMPs degrading the collagen I gel as the inclusion of 
either the synthetic MMP inhibitor BB-3103 or the natural MMP inhibitor tissue inhibitor of 
metalloproteinase (TIMP)-1, here used in its C-terminally truncated form, were sufficient to reduce 
at least 60% of the angiogenesis activity. Immunofluorescence and polymerase chain reaction 
(PCR) analysis of the collagen gels demonstrated that the degradation of the gel was facilitated by 
a combination of MMP proteins, namely MMP-2, MMP-9, MMP-13 and MMP-16. This highlights 
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that the ECM can have roles in tumour progression which are not limited to modulating the 
migratory behaviour of the cells. 
6.1.1.2 The distribution of ECM proteins in colonic tissue is altered during cancer 
progression 
6.1.1.2.1 Collagen I and fibronectin are found in healthy colonic tissue 
The composition of the colonic ECM in terms of major protein components has been documented 
in the literature for many years. As with most other tissues, one of the major components of the 
ECM is type I collagen, the most abundant of the fibrillar collagens, which comprises of 68% of the 
fibrillar collagens present in healthy intestinal samples [377] and is localised at the basement 
membrane found below the epithelial cells and within the stromal tissue of the colon [378]. 
Additionally the basement membrane marker, collagen IV, is also present in healthy colon and is 
mainly found at the basement membrane around the colonic epithelium [379] in addition to 
surrounding blood vessels within the stromal layer [378]. Another common ECM component, 
fibronectin, is distributed throughout the stromal layer of the colon [379]. As both collagen I and 
fibronectin are abundant ECM proteins and have documented effects on cancer cell behaviour they 
will be the two ECM components which will be focused on during this chapter. 
Like many other aspects of normal cell behaviour, the expression and distribution of ECM 
components is found to be disrupted during cancer progression. However, as each cancer case is 
different, there is variation in the data presented in the literature, although some trends remain 
once all of the data is taken into account. 
6.1.1.2.2 Collagen I expression is increased in the stromal compartment of tumours 
Assessments of the variable expression of proteins in cancer have been made using the serial 
analysis of gene expression (SAGE) technique, which is capable of analysing large number of 
gene transcripts simultaneously, and has been applied to pancreatic [380-382], colorectal [381, 
382], ovarian [382] and breast [382-384] cancers. Use of this technique has identified the variable 
expression of collagen I between normal and cancerous colonic tissue, Ryu et al. found that the 
expression of both the α1 and α2 collagen I chains is increased in tissue obtained from primary 
colorectal tumours compared to normal mucosa, but this increased expression is not maintained in 
the colorectal cancer derived cell lines CaCo-2 or SW837 [382]. This is comparable to results seen 
for breast cancer, with the collagen I α1 transcript found to be elevated during the later stages of 
disease progression when compared to normal mammary tissue [383], while the breast cancer cell 
line libraries LacZ, MCF70 h, and MDA453 did not show this elevated expression [384]. This result 
has been mirrored using microarray analysis of gene expression between primary and metastatic 
solid tumours which found an elevation of collagen I α1 and α2 expression [385]. 
Proteomic analysis of colorectal cancer tissue via mass spectrometry has also identified a variation 
in both collagen I α1 and α2 expression across all stages of the disease progression [386]. The 
mRNA and protein expression levels for both collagen I chains were found to be elevated at all 
stages compared to normal mucosa, with the elevation seen in stages I and II significantly greater 
than that in stages III and IV and stage II tumours consistently demonstrating the highest levels for 
all. Enzyme-linked immunosorbent assay (ELISA) analysis of the serum levels of the 
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carboxyterminal propeptide of type I collagen (PICP) and the C-terminal telopeptide of type I 
collagen (CTx) provide further information regarding the dynamics of collagen I processing across 
the progression of colorectal cancer. PICP is a marker of collagen I synthesis and found to be 
elevated in the serum of patients exhibiting all stages of the disease when compared to healthy 
patients. CTx is a marker of collagen I degradation and also found to be elevated in the serum of 
cancer patients, although this elevation increased with increasing progression of the disease. 
Kaplan-Meier analysis of the survival rates demonstrated that there is a correlation between 
elevated serum CTx levels and poor patient progression, as visualised by examining the 3-year 
disease free survival rates. 
Immunohistochemical analysis of primary colorectal tumours highlights increased stromal 
distribution of collagen I in tumours when compared back to normal tissue from the same patient 
[378] and this change in collagen I distribution was seen regardless of tumour site within the colon 
or grade of tumour. When pre- and post-metastatic colorectal cancers are compared in this 
manner, there is a higher collagen I expression in the reactive stroma of the metastatic disease 
than the non-metastatic disease, with the expression of collagen I in tumour cells remaining 
comparable [387]. Additionally, when two different forms of metastatic growth patterns were 
compared, the level of collagen I expression was found to vary at the tumour border but not in the 
interior of the tumour. Metastasis displaying a desmoplastic growth pattern, that is metastasis 
formation separated from the liver parenchyma by a layer of stromal tissue [388], expressed a 
higher level of collagen I than metastasis displaying a pushing growth pattern [387], where the 
metastasis and liver tissue are found next to each other without the formation of a stromal layer 
[388]. 
Together this data shows that collagen I is an ECM component which is abundant in the stromal 
compartment of tumours, with the expression of both primary protein chains, collagen I α1 and α2, 
elevated relative to normal tissue. The proteomic analysis also demonstrated an increase in 
collagen I turnover in the later metastatic stages of colorectal cancer, which accounts for the 
highest expression seen in stage II of the disease, and this degradation is linked to decreased 
patient survival. 
6.1.1.2.3 Fibronectin expression is increased in colorectal cancer 
Fibronectin is commonly produced by fibroblasts and secreted to a pericellular localisation around 
many cell types [389]. This localisation of fibronectin is commonly lost during transformation of cells 
to a malignant cell type and has been demonstrated in gliomas [390], rhabdomyosarcoma and 
transformed fibroblasts [391], however it was noted that this loss is not due to an inhibition of 
fibronectin production. 
Indeed, an increase in fibronectin expression has been noted in different types of cancer, with a 
6.53-fold increase noted in a study which compared microarray analysis of pancreatic cancer cell 
lines and primary tumours to the SAGE data for healthy pancreatic tissue [392]. There have also 
been studies made on colorectal cancer which have detected increases in the expression of 
fibronectin. SAGE analysis of two primary colorectal tumours highlights an 11-fold increase in 
fibronectin expression over normal colonic tissue, while comparisons between normal tissue and 
the colorectal cancer cell lines SW837 and CaCo-2 shows a 28-fold increase in fibronectin 
expression in the cell lines over the normal tissue [381]. 
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The analysis of protein expression carried out via mass spectrometry that detected an increase in 
the expression of both collagen I α1 and α2 also detected a smaller, but still significant, increase in 
fibronectin expression across stages I, II and III of the disease [386]. Microarray analysis of colon 
cancers which were sorted into epithelial-type and mesenchymal-type cells using the citeria of high 
E-cadherin/low vimentin expression to denote an epithelial-like gene expression pattern and low E-
cadherin/high vimentin expression to denote a mesenchymal-like gene expression pattern also 
identified a change in fibronectin expression [79]. This identification criteria was sufficient to identify 
genes which are associated with the epithelial-mesenchymal transition (EMT) in colorectal cancer 
and fibronectin was found to be upregulated in cells displaying the mesenchymal phenotype over 
the epithelial phenotype and therefore a gene which is correlated with EMT. 
This result from Loboda et al. appears to be a contradiction of data previous obtained by Smith et 
al. which found that the amount of fibronectin found within and secreted by cells was reduced in 
cell lines derived from metastatic tumours when compared to cell lines derived from primary 
tumours [393]. However, together these data may mean that the cells which make up the 
metastatic tumours from which the six cell lines tested were derived have gone through the reverse 
process of EMT, namely mesenchymal-epithelial transition (MET), whereby cells regain a more 
epithelial phenotype and this may account from the drop in fibronectin expression in the metastatic 
tumours. 
In addition to the variation in the expression level of fibronectin between normal and cancerous 
colonic tissue, there is also a variation in the specific isoforms of fibronectin that are present too. 
One of the means of generating isoform differences in the fibronectin protein is by alternate splicing 
at a 270 nucleotide long splice site, the ED splice site [394], which results in the ED-A
+
 and ED-B
+
 
isoforms [395]. It is the ED-A
+
, not the ED-B
+
, isoform which is present in healthy human colonic 
tissue, whereas the ED-B
+
 isoform is only found in colorectal cancer tissue. The amount of the ED-
A
+
 isoform appears to be increased in cancer, as the immunohistological staining for this isoform 
was stronger in the cancer samples than in the healthy tissue. The source of these isoforms of 
fibronectin is from both the colorectal cancer cells and tumour-associated myofibroblasts, as 
demonstrated by both Northern and Western blot analysis of the colorectal cancer cell line CaCo-2 
and primary rat tumour-associated myofibroblasts. 
Together these data show that there is generally an increase in the production of fibronectin at the 
primary site of tumour growth which is correlated with an altered extracellular distribution of the 
protein. This increase in expression is also correlated with other EMT associated genetic changes 
and may be part of the metastatic process of colorectal cancer cells. 
6.1.2 Solid tumours are comprised of multiple cell types 
While the protein environment in terms of the localised ECM is clearly important in the development 
and progression of colorectal cancers, the stromal compartment of tumours also plays a role in the 
disease and the addition of stromal components into in vitro assays can increase the biological 
relevance of the models. 
 
227 
6.1.2.1 Tumours are multicellular environments 
6.1.2.1.1 The stromal compartment of tumours can comprise of a variety of cell types 
Over the years many different types of stromal cell have been identified in cancers, including 
vascular endothelial cells [396, 397], fibroblasts [398] and immune cells such as T-cells [75] and 
macrophages [399]. As each of these cell types can have differing protein expression profiles and 
each may originate from different populations of healthy cells [400], together these add a great deal 
of complexity to understanding the precise mechanisms involved at any point during cancer 
progression.  
6.1.2.1.2 The stromal content of tumours is a marker of prognosis 
While the involvement of stromal tissue in cancerous tumours has been under investigation for 
many years, a study into the role of stromal content of colorectal cancers in terms of predicting 
patient prognosis was published in 2007 by Mesker et al. [58], with a follow up study published in 
2009 [274]. The amount of stromal tissue within the tumour was scored from histological samples 
from human colorectal cancers graded from I to III under the AJCC classification system and 
designated as either the carcinoma percentage (CP) or stroma ratio, with a low CP equivalent to a 
high stromal ratio and vice versa. The initial study found that a CP of 50%, that is a tumour which is 
comprised of cancerous tissue and stromal tissue in equal parts, was a sufficient cut off point to 
provide a significant variation in the patient prognosis, visualised by both the disease-free and 
overall survival [58]. The initial study set used in this paper demonstrate that patients with CP-low 
tumours had a worse prognosis for both disease-free and overall survival, 1.36 and 1.40 years 
respectively vs 4.82 and 5.40 years for CP-high tumours, with the validation series providing a 
similar trend. This difference in survival prospects is as significant as when the T-stage, N-stage or 
overall tumour grade is used as a factor of prognosis and remains valid when the microsatellite 
instability (MSI) status or stage of the tumours is considered. The follow up study from this group, 
which drew data from a larger study group, confirmed the finding of the initial study that the CP is a 
marker of patient prognosis [274]. Here they demonstrated that in addition to there being a 
statistically significant difference in the disease-free and overall survival between CP-low and CP-
high group, there is also a significant difference in the metastasis-free survival, again with the CP-
high patients faring better than the CP-low patients. In addition, this study also showed that the 
expression of the transcription factor SMAD4 could be used as a further marker of prognosis in CP-
low tumours. The expression of SMAD4 had no effect in CP-high tumours, but in CP-low tumours 
the expression of SMAD4 correlated to an increase in the disease-free and overall survival rates. 
This work was backed up by the use of a different patient cohort, again demonstrating that 
colorectal cancer patients with CP-low grade II or III tumours had a poorer prognosis in terms of 
both disease-free and overall survival [401]. The relationship between CP and the T- and N-stages 
of tumours was also examined, with the percentage of CP-high tumours decreasing from 100.0% of 
T1 tumours down to 55.0% of T4 tumours. Similarly, a drop in CP-high tumours is seen when 
lymph nodes are metastasised, with 76.1% of N0, lymph node negative, tumours falling into the 
CP-high classification compared to ~64.7% of N1-2, lymph node metastasised, tumours. This 
scoring via analysis of histologically stained samples demonstrates the value of the stromal 
compartment of tumours as a diagnostic tool and the authors of these papers suggest that this 
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could be used to identify high-risk patients that could benefit from further treatment after surgical 
resection of the initial tumour mass. 
6.1.2.1.3 The production of proteins by cancer associated stroma can affect patient 
prognosis 
While the volume of stromal tissue within tumours has been shown to have implications for patient 
survival, the production and secretion of proteins by this stromal compartment can also have a 
value as a marker of patient prognosis. A variety of research groups have published data 
demonstrating that high protein expression of vimentin [402] and toll-like receptor 4 (TLR-4) [403] in 
the stroma is linked to poor patient prognosis in terms of disease-free survival, and overall survival 
in the case of vimentin. Conversely, stromal expression of the MMP-related disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTS)-12 protein, a known inhibitor of tumour 
growth which acts via modulation of the ERK signalling pathway, correlates with improved patient 
prognosis for both disease-free and overall survival and this improvement is seen with the 
increasing percentage of positively staining stromal cells [404]. The mRNA expression of fibroblast 
activation protein-α (FAP-α) and stromal cell-derived factor-1 (SDF-1) are both associated with 
cancer-associated fibroblasts (CAFs) and are poor prognostic markers for distant recurrence of the 
cancer and survival, while the blood serum levels for these two proteins do have a prognostic 
significance [405]. 
It is not just the expression of proteins in the stromal compartment of the primary tumour which can 
affect patient outcome. The expression of a range of MMPs, growth factors and other pro-
angiogenic proteins varies between the tumour and stromal compartments of primary colorectal 
cancers, liver and lung metastases [406]. Some proteins such as angiopoietin-2 were found at a 
higher concentration in the stromal compartment of all locations analysed, while others such as 
MMP-9 were elevated in the tumour compartment of liver metastases with no variation at the other 
sites. While this information can provide clues to the role of these proteins in the vascularisation of 
tumours at the primary and metastatic sites, the variation in expression can also be used as 
prognosis markers. In the primary tumours and lung metastases, high stromal expression of MMP-
2 and MMP-3 correlated with a better overall survival rate while not being significantly correlated 
with survival in liver metastases. 
6.1.2.2 Fibroblasts involvement in tumours affects cancer behaviour 
A major component of the stromal portion of tumours is the CAFs and these have been shown to 
produce proteins which can direct the progression of the disease. 
6.1.2.2.1 Recruitment of CAFs alters their protein expression 
Interactions between the tumour cells and the recruited CAFs result in alteration of the protein 
expression profile of the CAFs. Culturing of fibroblasts derived from human skin, colon and lung in 
the presence of tumour cell-derived collagenase-stimulatory factor (TCSF), derived from the cell 
membranes of the LX-1 human lung carcinoma cell line, induced an increase in mRNA expression 
and protein secretion of MMP-1, MMP-2 and MMP-3 [407]. These MMPs target a variety of ECM 
proteins and have been implicated in the progression of colorectal cancer [408]. The 
overexpression of MMPs by CAFs has also been assessed via in situ hybridisation of colon cancer 
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samples [409]. While the overexpression of MMP-14 was seen in both the populations of tumour 
cells and CAFs, the overexpression of MMP-2 and type-1 procollagen was confined to the 
fibroblast compartment of the tumour mass. 
It is not only the expression of secreted ECM proteins and MMPs in fibroblasts which is altered 
during cancer progression, the expression of cytoskeletal proteins is also altered [410]. When the 
expression of cytoskeletal proteins is examined via immunohistochemistry, there is an increase of 
staining in the nonpericryptal stroma of the diseased tissue when compared to the normal mucosa. 
While the expression of vimentin does not alter across the tissues examined, there is focal 
expression of the muscle specific intermediate filament, desmin, in the diseased colonic tissue 
which is absent from the healthy nonpericryptal stroma. Additionally, the expression of α-SMA and 
the associated actin motor protein smooth muscle myosin (SMM) is also increased in the diseased 
tissues, with the adenomatous polyps displaying a greater intensity of staining than the non-
tumorous hyperplastic polyps examined. 
It is not just the recruited CAFs at the site of the primary tumours which have an altered protein 
expression profile relative to the healthy colonic fibroblasts, the recruited CAFs at the site of 
metastatic legions in the liver also have an altered expression profile [411]. Microarray analysis of 
mRNA extracted from subcultured fibroblasts isolated from metastatic colorectal cancer legions in 
the liver and counterpart healthy liver fibroblasts from the same patients reveals that there is a wide 
variety of genes which are either up- or downregulated in the CAFs. While some of the genes were 
unidentified, the majority of genes which were found to be downregulated in the CAFs were 
transcription factors or transcription regulators. The upregulated genes were found to come from a 
variety of cellular processes including cell signalling pathways, migration and cell proliferation. 
The matter of altered protein expression profile in CAFs is further complicated by the variable 
expression of proteins depending on the origin of the colorectal cancer [412]. This study examined 
the expression of the focal adhesion protein four and a half LIM domain protein-2 (FHL2) in 
sporadic and HNPCC cases of colorectal cancer with or without lymph node involvement. This 
protein is absent from the stromal tissue of tumour samples which have been 
immunohistochemically stained and present in the peritumoural fibroblasts found within the centre 
of the tumour mass. The expression of FHL2 was also seen to be variable in the fibroblasts in the 
invasive margin of the tumours. When the amount of FHL2 expression was quantified in each of 
the four types of cancer, either sporadic or HNPCC, with or without lymphatic involvement, it is 
seen that positive FHL2 expression is significantly correlated with lymphatic involvement in 
sporadic tumours and significantly inversely correlated in HNPCC cases. 
One of the pathways which has been implicated in the mechanism of expression alteration in CAFs 
is the TGFβ signalling pathway [413]. Culturing of the colorectal cancer cell lines HT29 and 
HCT116 produces conditioned media which is high in TGFβ, with the HCT116 cultures producing a 
higher amount of TGFβ than the HT29 cultures. When this conditioned media is subsequently used 
to culture CAFs isolated from colorectal cancer patients, it was able to induce a similar pattern of 
expression induction to that seen when cultured with human recombinant TGFβ. Some of the 
proteins which were analysed include MMP-2, MMP-3 and MMP-14, which were seen to increase 
the most with the conditioned media from the HCT116 cell line, which is in line with the amount of 
TGFβ these cultures secreted into the culture media. 
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With the alteration of protein expression in the recruited CAFs of colorectal tumours, there is a 
greater potential for the behaviour of cancers to also be altered via paracrine signalling. 
6.1.2.2.2 CAFs alter cancer behaviour 
The recruitment of CAFs to colorectal cancer tumours, both primary and metastatic, has been 
shown to affect different aspects of the tumour progression, including tumour growth and 
dissemination. The activation of fibroblasts in the tumour microenvironment can be visualised by 
the expression of FAP-α on the cell surface and inhibition of this protein has been shown to limit 
tumour growth in a murine lung carcinoma model [398]. The cross breeding of BALB/c LSL–K-
ras
G12D
 mice, a model which produces lung adenoma when infected with an adenovirus expressing 
Cre recombinase, with FAP-deficient mice produced a collection of animals which either had two 
functional copies of the FAP gene, two non-functional copies or one of each. The induction of 
tumours in these animals highlighted the role the stromal compartment has on the establishment of 
the tumours, with tumours occurring more readily in the mice which had at least one functional 
copy of the FAP gene than those without a functional copy of the gene. This difference was also 
visualised by the decreased area of tumour growth observed on histologically stained slides and 
the decreased expression of Ki67 in the homozygous null mice. This result was also mirrored in a 
xenograft model where the colorectal carcinoma cell line CT26 was subcutaneously injected into 
FAP
+/+
 and FAP-null mice, where the tumour size and number of proliferative cells were 
significantly lower in the FAP-null mice. 
With this demonstration that FAP-α plays a role in tumour establishment, the potential of this 
protein as a diagnostic marker has been examined [414]. A study of human colorectal cancer 
samples obtained from tumour resections examined the expression of FAP-α in both the tumour 
centre and invasive front, with a negative correlation seen between the level of FAP-α staining and 
the TNM grading of the tumour. However, when the survival data was examined for these patients 
it was seen that FAP-α expression at the tumour front did not have a correlation with the cancer-
specific survival rates. However, it was observed that higher levels of FAP-α expression in the 
tumour centre were correlated with a significant decrease in the cancer-specific survival rates of 
patients diagnosed with colon cancer, but not rectal cancer. 
The expression of FAP mRNA has also been shown to be correlated with the expression of SNAI1 
mRNA in colorectal CAFs, as CAFs were show to express higher levels of SNAI1 than normal 
fibroblasts and detection of SNAI1 expression in tumour samples was positively correlated with 
FAP expression [254]. The expression of SNAI1 also has an effect on tumour growth in a xenograft 
model where the colorectal cancer cell line HT29-M6 was subcutaneously injected into mice with 
fibroblasts which were either the wild-type cells or knock-outs for SNAI1 expression. Tumours 
obtained from mice injected with both the cancer and knock-out fibroblasts were smaller and had 
fewer proliferative cells than tumour obtained from mice injected with either HT29-M6 cells alone or 
with wild-type fibroblasts.  
The source of fibroblast cells can have a significant effect on proliferative activity of cancer cells, as 
has been demonstrated by the culture of gastric cancer cell lines with varying states of 
differentiation with conditioned media from the growth of fibroblast cell lines derived from a variety 
of human tissues [415]. It was observed that the poorly differentiated cell lines exhibited enhanced 
proliferation in the presence of conditioned media from stomach fibroblast cell lines when 
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compared to serum free media and that the use of conditioned media from fibroblasts with a 
different tissue of origin did not enhance the proliferation over the levels seen in the control 
cultures. Meanwhile the proliferation of the well differentiated cancer cell lines did not alter with the 
addition of conditioned media, regardless of the source of the fibroblasts. The tissue source of 
fibroblast also affects the migratory behaviour of cancer cells, as demonstrated by the co-culture of 
the colorectal cancer cell line KMl2SM on monolayers of primary mouse fibroblasts [416]. While the 
monolayer co-culture did not affect the proliferation of the KMl2SM cells, the cancer cells were 
seen to migrate through colon derived fibroblasts grown on 0.8μm pore filters at a greater rate than 
cultures of skin or lung derived fibroblasts or filters without fibroblasts. 
The origin of CAFs from different stages of tumours also affects the behaviour of cancer cells in 
vitro [417]. The culturing of the DLD1 colorectal cancer cell line in the presence of conditioned 
media obtained from either normal fibroblasts or CAFs obtained from primary tumours (CAF-PT) or 
liver metastases (CAF-LM) increased the colony formation observed compared to cultures grown 
with normal media. Additionally, the rate of colony formation was increased in the cultures grown 
with conditioned media from either of the CAF populations compared to normal fibroblasts, 
although there was no significant difference between them. However, prolonged culturing with the 
CAF-LM conditioned media resulted in a decreased number of cells from a variety of colorectal 
cancer cell lines when compared to culturing with standard media, while culturing with the CAF-PT 
conditioned media resulted in cultures which had cell counts which were similar to or greater than 
the controls. However, this decrease in cell number was not due to increased apoptotic activity, as 
the level of caspase-3 activity was reduced in cultures grown with either type of CAF conditioned 
media, and the authors hypothesised that this decrease in cell number was due to an induction of 
cell necrosis. In addition to the effect that the conditioned media had on cell proliferation and 
survival, it also had an effect on the migration and invasion of colorectal cancer cell lines. The 
DLD1 cell line was found to exhibit a significant increase in migration in both scratch wound and 
Transwell
®
 assays in response to culturing with the CAF-LM media, whereas the SW480 cell line 
showed enhanced invasion through basal membrane extract coated Transwell
®
 inserts in response 
to the CAF-LM media, regardless of the concentration of the coating. 
One of the means by which CAFs can direct the migratory behaviour of colorectal cancer cells is by 
the secretion of the glycoprotein stanniocalcin-1 (STC1) [418]. Platelet-derived growth factor 
(PDGF) stimulation of the BJhTERT immortalised fibroblasts elevated STC1 mRNA expression and 
increased the migration and invasion of the LIM1215 colorectal cancer cell line in co-culture models 
using Transwell
®
 inserts without or with a Matrigel coating. Similarly a decrease in cell invasion was 
observed for a variety of colorectal cancer cell lines co-cultured with STC1-deficient fibroblasts. 
Xenograft experiments, where mice were injected with HCT116 colorectal cancer cells with 
fibroblasts which were either wild-type or STC1-deficient, demonstrate that STC1 expression 
affects tumour volume and metastatic potential, as the tumours formed in the mice injected with the 
STC1-deficient fibroblasts were both significantly smaller and spread to fewer sites throughout the 
body. 
Another protein which is upregulated in CAFs and has an effect on cell migration is the actin 
binding protein transgelin (TGALN) [273]. Co-cultures of the gastric cancer cell line MKN-45 with 
CAFs showed a greater ability to migrate and invade in modified Boyden chambers than cultures 
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with fibroblasts derived from tissue adjacent to tumours or fibroblasts from healthy tissue. As the 
CAFs expressed a significantly higher level of TAGLN than either of the non-CAF fibroblast types, 
the role of TAGLN in the migratory behaviour was examined using siRNA. The knockdown of 
TAGLN expression by the siRNA was sufficient to reduce the observed level of TAGLN expression 
in the three types of fibroblasts and to also significantly reduce the migration and invasion of the 
MKN-45 cells in the co-cultures, compared to control siRNA. 
6.1.2.2.3 Xenograft tumour formation is altered when the behaviour of CAFs is altered 
With CAFs affecting many areas of cell behaviour, it is not surprising that altering the fibroblast 
compartment of tumours in in vivo xenograft models can have a large impact on the outcomes of 
these experiments. A study published in 1993 by Noël et al. demonstrated that the subcutaneous 
injection of human skin fibroblasts with human breast carcinoma cell lines increased both the 
instance of tumour growth and the size of the resulting tumours [419]. With the MCF7 breast 
cancer cell line, injections which had neither fibroblasts nor Matrigel failed to produce tumours at 
either the low or high cell number injected, whereas the inclusion of fibroblasts produced tumours 
in 60% of cases with a latency period of 65-70 days. When Matrigel was included in the injections, 
those without fibroblasts produced tumours in 67% and 80% of cases, for low and high cell 
numbers respectively, with respective latency periods of 36 and 22 days. The inclusion of both 
Matrigel and fibroblasts increased the tumorigenicity of the injections to 100% tumour formation 
with a latency period of 20 days. A similar decrease in latency time and increase in tumour size at 
any given time point was also observed when the MDA-MB-231 cell line was injected with Matrigel 
and fibroblasts, as compared to with Matrigel alone. It was hypothesised that the mechanism by 
which the fibroblasts were affecting the tumour growth was due to soluble factors secreted from the 
fibroblasts, as the repeated, weekly injection of conditioned media from 2D culture of fibroblasts 
into the inoculation site produced a similar increase in tumorigenicity that the repeated injection of 
fibroblasts into the inoculation site produced. 
Another study demonstrated that the characteristics of the fibroblasts included in the inoculation 
injection also affect the tumorigenic potential of the cells used in the xenograft models [420]. 
Injection of either the human epidermal keratinocyte cell line HaCAT or its tumorigenic derivative 
Ha(Pk) into the dorsal flap of nude mice did not produce any tumours over the initial 40 days post 
injection when injected without fibroblasts. When presenescent WI-38 lung fibroblasts were 
included in the injections, both cell lines were able to produce tumours in a small number of mice. 
However the greatest change was seen when the WI-38 fibroblasts were used when they were 
senescent, with over half the mice used producing tumours which were larger than the tumours 
produced in mice injected with presenescent fibroblasts. A similar trend was mirrored when the 
mammary epithelial cell line SCp2 was injected into the nipple region of nude mice, with the 
injection of these cells on their own or with presenescent fibroblasts failing to produce tumours 
within 120 days. Again, when this cell line was injected with the senescent fibroblasts, large 
tumours were produced within the observation period in more than 50% of the mice. 
Blocking the action of CAFs has been investigated in a xenograft model to assess the impact this 
has on tumour development and response to treatment [421]. The oral pre-immunisation of BALB/c 
mice with a DNA vaccine for FAP-α prior to subcutaneous injection of the colorectal carcinoma cell 
line CT26 or injection of the breast carcinoma cell line D2F2 into the mammary fat pads 
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significantly reduced the size of the tumours formed in this xenograft model. It was further noted 
that this reduction was not enhanced by the complementary vaccination against the chemokine 
CCL21 or IL-2, an inducer of T-cell proliferation. The oral immunisation against FAP-α was also 
sufficient to reduce the occurrence of lung metastases after the intravenous injection of CT26 cells, 
where the vaccination was carried out after the introduction of the cancer cells. When this 
immunisation was carried out in conjunction with doxorubicin (Dox) treatment, a synergistic effect 
was seen, with the size of tumours drastically reduced when the mice were pre-immunised against 
FAP-α and treated with Dox after the injection of the D2F2 cells compared to either of the two 
treatments given separately. In a therapeutic model where the FAP-α immunisation was delivered 
after the intravenous introduction of the D2F2 cells, again the combined therapy of immunisation 
and Dox treatment resulted in a significant increase in survival when compared to the single 
treatment mice, although these single treatment groups themselves had a better outcome than the 
control group. While there was a marked effect on tumour growth, the treatment of mice with the 
FAP-α vaccine did not affect the speed of wound closure in the back skin of these mice, suggesting 
that it is targeting the fibroblasts within the tumours and not the healthy fibroblasts populations 
elsewhere in the body. 
These studies provide evidence to suggest that the inclusion of fibroblasts to provide a stromal 
equivalent in in vitro cancer models would increase the biological relevance of these models and 
lead them to produce results which are more easily translated into cancer treatments. 
6.1.2.3 The immune system can also affect cancer behaviour 
6.1.2.3.1 The infiltration of regulatory T-cells into tumours is a marker of patient prognosis 
T-cells are one of the many immune cell types that have been implicated in tumour progression 
and this group of cells is composed of various subsets which can be identified by their cell surface 
markers. The influence of these different subsets of colorectal cancer patient survival was 
examined using the CD3, CD8 and CD45RO cell surface markers and the transcription factor 
FOXP3 to identify all T-cells, cytotoxic T-cells (Tc cells), memory T-cells and regulatory T-cells 
(Tregs) respectively [75]. This study found that the amount of tumour infiltrating CD3
+
 cells did not 
affect either the disease-specific and overall survival, while higher levels of CD8
+
, CD45RO
+
 and 
FOXP3
+
 cells were correlated with better patient survival. Furthermore, it was also found that that 
there was a correlation between the infiltration of CD45RO
+
 cells and the other three cell types 
examined. 
Another study looking specifically at the correlation between Tregs and patient prognosis also 
found associations between the number of Tregs observed within the tumours and the T-stage of 
the primary tumour, the involvement of the lymphatic system and the overall disease grading [422]. 
The tumours with a lower grading or lacking lymphatic involvement were found to have a 
significantly higher number of Tregs within the tumour. The expression of FOXP3 in the nuclei of 
the cancer cells was also negatively correlated with lymphatic invasion and tumour grading, with 
higher levels of expression seen in patients with less developed examples of the disease. In 
addition to these correlations with tumour grading, this study also demonstrated a correlation with 
overall patient survival. A higher number of tumour-infiltrating Tregs, a lower number of Tregs in the 
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tumour epithelium and normal mucosa and a lower level of FOXP3 expression in the cancer cells 
were all correlated with increased patient survival when evaluated via Kaplan-Meier analysis. 
6.1.2.3.2 Macrophages can play a role in metastasis development 
Another type of immune cell which has been implicated in cancer is macrophages. Depletion of 
colony-stimulating factor-1 (CSF-1), a hematopoietic growth factor which directs macrophage 
differentiation, via anti-sense oligonucleotides is sufficient to limit the growth of embryonal 
carcinoma xenograft tumours in the testicles of SCID mice [423]. Of the three oligonucleotides 
tested, each of them demonstrated a different capacity to limit CSF-1 production and this inhibition 
was directly correlated with the inhibition of tumour growth of seen by either testicular weight or the 
area of tumour tissue visible on processed slides. The lower levels of CSF-1 expression were also 
correlated with lower levels of vascularisation of the xenograft and lower expression of the 
angiogenesis associated proteins VEGF, VEGF receptor 2 (VEGFR-2) and angiopoietin 1 (Ang-1). 
When these oligonucleotides were tested in a colorectal carcinoma xenograft model, the same 
pattern of decreased CSF-1 expression and tumour size was also observed. Survival analysis 
demonstrated that oligonucleotide treatment increased the survival rate, as all control animals has 
died by 65 days and over 50% of the treated mice survived past 6 months. 
Depletion of the liver specific Kupffer cells, a specialised type of macrophages found lining the 
sinusoids of the liver, also affects the development of liver metastases in a rat xenograft model 
[424]. This depletion was mediated by intravenous injection of clodronate encapsulated in 
liposomes and was sufficient to completely eliminate the Kupffer cells in the liver. The rat colon 
carcinoma cell line CC531 was subsequently injected into the hepatic portal vein to induce the liver 
metastases and the animals were sacrificed at day 14. The tumours produced in the Kupffer cell 
depleted rats were larger and occurred at a higher frequency than in the control rats, while the 
tumours produced in the control rats had a higher amount of immune cell infiltration and 
desmoplastic reaction from the surrounding tissue. 
Like T-cells, the number of macrophages observed within clinical samples of colorectal cancer has 
been found to be inversely correlated with various markers of tumour progression [425]. The 
presence of macrophages in the tumour stroma and borders was assessed via expression of the 
macrophage marker CD68. Higher numbers of CD68
+
 macrophages in the tumour stroma were 
observed in tumours with a lower histological grading, those which had no distant metastases and 
those with a higher level of inflammatory response at the invasive front. These correlations were 
also seen when the number of macrophages at the tumour border was assessed and there were 
further correlations between high number of macrophages in this location and those tumours with 
low TNM grading, no vascular or lymphatic invasion or localised lymph node metastases. The 
correlation between high macrophage density in the tumour border and the characteristics listed 
here translate into a correlation with patient survival, with 50% of patients surviving for ~28 months 
after surgery when a low macrophage number is observed and over 50% of patients surviving over 
the ~40 month follow up period when a high macrophage number is observed. 
The secretion of proteins from tumour infiltrating macrophages is also correlated with colorectal 
cancer progression. The secretion of the anti-angiogenic MMP-12 is correlated with better patient 
prognosis, with a 3-year survival rate of 75.86% for those patients with a higher level of MMP-12 
compared to 36.00% of those patients with lower MMP-12 expression [426]. This survival analysis 
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was accompanied by an analysis of the correlation between MMP-12 mRNA levels and 
clinicopathologic characteristics of the tumours examined. Minimal invasion from the initial tumour 
site and low levels of lymphatic and vascular invasion were all significantly correlated with higher 
MMP-12 levels and while fewer microvessels were observed in the low MMP-12 tumours, this 
decrease was not significant. 
6.1.2.3.3 Immune cell involvement has the potential for use in cancer classification 
It has recently been proposed that the involvement of the immune system in cancers could be used 
as a method of classification of the disease, in a similar way that information about the 
differentiation of cells within the tumour or the mutation status of key genes is used to supplement 
the AJCC/UICC classification, and a proposal has been made following research on the prognostic 
importance of T-cells infiltration into tumours [427]. Some of the research drawn on by this article 
includes studies which have confirmed that high Treg infiltration is positively correlated with patient 
survival [75, 428, 429] and that low Tc cell involvement is correlated with patient relapse [430]. 
Taken together with the general correlation between high numbers of T-cells and patient survival, 
as assayed by CD3 staining [429, 431], Galon et al. propose that an ‘immunoscore’ devised from 
the staining of histopathological samples for a combination of CD3, CD8 and CD45RO to 
determine the density of T-cells and specifically Tc and Treg cells within different areas of the 
tumour has the potential to be a simple diagnostic tool to be used in conjunction with the standard 
TNM grading system to provide a clearer picture of patient prognosis. 
6.1.2.4 In vitro co-cultures highlight the biological relevance of stromal cells to cancer 
models 
With the emergence of data highlighting the influence that secondary cell types have on tumours, 
there have been developments in in vitro research to develop models which incorporate these 
additional cells in order to increase the biological relevance of the models. 
6.1.2.4.1 In vitro models can utilise conditioned media to examine the role of soluble factors 
in the directing of cancer cell behaviour 
One of the easiest ways of modelling the interactions between two cell populations is to investigate 
the role that secreted factors have on the behaviour of the cell type of interest. There are many 
examples of conditioned media being used to determine the effect that additional cell types can 
have on tumour cells in in vitro culture. One such example is the use of conditioned media from 
human pancreatic stellate cells (HPSCs) to culture human pancreatic cancer cell lines and examine 
for any resulting change in cell behaviour [432]. It was observed that the addition of the HPSC 
conditioned media resulted in dose dependent increase in the proliferation, invasion through 
Matrigel and colony formation on soft agar of the cells, over the serum free media controls. In some 
cases, the increase seen with the addition of the highest concentration of conditioned media was 
comparable with the increase induced by the addition of 10% FCS to the culturing medium. 
However, in other examples, such as the invasion of the Panc1 cell line, there was a significant 
difference between the conditioned media and the FCS media, with the conditioned media inducing 
a higher invasive response than the FCS. The apoptotic response of the BxPC3 cell line in 
response to chemotherapy treatment gemcitabine or radiation treatment was also measured when 
236 
the cells were cultured in serum free or conditioned media, with the conditioned media providing 
protection against apoptosis in both cases. 
Another method of analysing the soluble factors involved in cell-cell interactions is to grow the two 
cell lines as segregated co-cultures, with the cell lines usually separated by a Transwell
®
 insert or 
similar. This method has been used to access the impact of MSC co-culture on the characteristics 
of colorectal cancer cell lines [235]. The cancer cells grown in the co-cultures have a different 
morphology compared to the cancer cells which had been cultured in media alone, with the 
HCT116 and HT29 cell lines adopting an elongated shape in response to the MSCs, while the 
LS180 cells formed spheroid-like structures in the co-cultures. Regardless of the morphological 
response, the expression levels of proteins which are associated with EMT were found to be 
significantly altered by the introduction of the MSCs, with E-cadherin expression downregulated 
and the upregulation of the EMT associated transcription factors Twist, Snail1 and Slug in all three 
cancer cell lines. As a result, the colorectal cancer cells which had been maintained as co-cultures 
were found to be more invasive in a Matrigel-coated Transwell
®
 model. It was further noted that 
these alterations in cell behaviour were due to an increase in surface bound TGF-β on the cancer 
cell lines after co-culture, as alterations to gene expression induced by the co-culture were 
reversed by the use of TGF-β inhibitors latency-associated peptide or SB431542. 
Opposite trends in terms of cell migratory behaviour were observed with the segregated co-culture 
of the hepatocellular carcinoma cell line Bel-7402 with either the endothelial cell line RF/6A or the 
normal liver cell line HL-7702 [433]. After co-culturing with either of these two cell lines, the Bel-
7402 cells were removed from the 0.4μm pore inserts and subjected to migration and invasion 
assays on 8μm Transwell
®
 insert in the absence and presence of a Matrigel coating. In all cases, 
the migratory capacity of the Bel-7402 was significantly inhibited after co-culture and this inhibition 
was seen after the co-cultures had been maintained for a variety of time periods. Protein analysis 
via Western blots and immunofluorescence staining demonstrated that the co-cultured Bel-7402 
cells expressed a greater amount of E-cadherin and a decreased amount of F-actin, which the 
authors of this paper considered was sufficient to account for the impaired motility of these cells. In 
contrast, the culture of the Bel-7402 cell line with conditioned media from the lung fibroblast cell 
line MRC-5 induced a distinct change in Bel-7402 cell morphology, with the cells adopting a more 
rounded phenotype. These cells demonstrated a significant increase in motility when subjected to 
Transwell
®
 assays and immunofluorescence analysis highlighted that the actin cytoskeleton in 
these cells had adopted a morphology more commonly seen in highly motile cells with many 
protrusions from the main cell body. The authors of this paper hypothesise that the MRC-5 cells 
were able to induce EMT in the Bel-7402 cells due to their production of HGF, which was not seen 
with either the RF/6a or HL-7702 cell lines. 
The segregated co-culture of the colonic fibroblast cell line CCD-18Co with the two colorectal 
cancer cell lines SW480 and SW620 showed that the presence of the cancer cell lines could also 
affect the behaviour of the fibroblast cell line [434]. In standard monolayer culture, the CCD-18Co 
cells had a mixed morphology of spindle-like and rounded cells, with the amount of spindle-like 
cells decreasing over the 72 hour culture period which was coupled with a significant reduction in 
cell viability when compared to the viability at 24 hours of culture. In contrast, when maintained in 
co-culture, a higher percentage of the CCD-18Co cells had the spindle-like morphology and 
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retained this throughout the culture period. The co-culture was also beneficial to the viability of the 
fibroblasts, as this did not significantly alter over the 72 hour culturing period. The improved 
maintenance of the fibroblast cultures was due to a decrease in cells undergoing apoptosis when 
maintained in co-culture and an increase in the percentage of cells found in the G1 phase of the 
cell cycle. In addition to the changes in the proliferative behaviour of the CCD-18Co cells, the co-
culture also induced changes in the expression of VEGF mRNA in these cells. While the CCD-
18Co cells expressed a higher level of VEGF mRNA in monolayer cultures than either the SW480 
or SW620 cell line, this expression was significantly increased in the co-cultures, with the SW620 
cell inducing a greater increase than the SW480 cell lines. In contrast, only the SW620 cells 
demonstrated a more modest increase in VEGF mRNA expression in co-cultures when compared 
to the monolayer cultures. 
These experiments using conditioned media or segregated co-cultures demonstrate that soluble 
factors secreted from both cancer and secondary cell types can influence many aspects of cell 
behaviour. However, cancers occur in a microenvironment where they grow along side and in 
contact with secondary cell types and so modelling the physical interactions between these cells 
would provide a more relevant model. 
6.1.2.4.2 In vitro models utilising gels in addition to co-culture can develop structures which 
mimic the in vivo situation 
While experiments which utilise the soluble factors produced by additional cell types to influence 
cancer cell behaviour model a more complex cellular environment, these experiments are generally 
carried out in standard 2D culture conditions, which mean that cells are still subjected to the 
unnatural culture conditions that this imposes. Another approach is to adapt 3D models of cancer 
to incorporate a co-culture element. One example of this is the adaption of the tumour spheroid 
model to allow two spheroids, one consisting of breast tumour cells, the other of fibroblasts, to 
invade into each other [435]. However, as observed from the phase-contrast and 
immunohistochemical images presented in this paper, the result of this appears to be the engulfing 
of one spheroid by the other so that when the cells are stained for fibronectin to highlight the 
fibroblasts or cytokeratin 18 to highlight the breast cancer cells, the two stains are not found to 
overlay each other and there is a distinct boundary between the expressing and non-expressing 
cells. However, this paper does highlight that different breast cell lines exhibited varying behaviour 
in terms of the infiltration of the fibroblast spheroids. 
Another model which mimics a 3D environment to study the migratory ability of cancer cells is one 
which supplements collagen I gels with Swiss 3T3 fibroblasts and plates the cancer cells either 
directly on top of the gel/fibroblast base or on top of an intervening collagen I layer [436]. This 
model was used to demonstrate that the oral epithelial cancer cell lines YD-10B and YD-38 would 
only infiltrate the collagen I gel when fibroblasts were present within it. This behaviour was seen in 
conjunction with an increase in expression of both MMP-2 and MMP-9 mRNA when the oral cancer 
cell lines were co-cultured adjacent to fibroblast containing collagen I, as opposed to cell-free 
collagen I gels or those where there was an intervening layer of collagen I. This change in MMP 
expression levels in 3D co-cultures was mimicked in the mixed and segregated 2D co-cultures of 
these cell lines, with the mRNA expression of both MMP-2 and MMP-9 found to be higher in the co-
cultured YD-10B and YD-38 cells than in the monolayer cultured YD-10B or YD-38 cells. This data 
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supports the hypothesis that the fibroblast compartment of tumours plays a vital role in the 
migration of cancer cells by inducing changes in the expression of genes within the cancer cells. 
An extension of this method using collagen I gels is the study by Nyga et al. which documents the 
creation of an artificial cell mass (ACM) and the subsequent culture of this in a collagen I hydrogel 
containing fibroblasts and/or endothelial cells [193]. The ACM was generated by suspending HT29 
colorectal carcinoma cells in a collagen I hydrogel and then compressing this gel to increase the 
stiffness of the collagen so that it more closely mimicked the denser collagen I fibres seen in 
tumours. The ACMs were then cut to a standard size of 5.5 x 10 x 10 mm and embedded into 
collagen I gels with or without a secondary cell type. When subjected to this type of 3D culture, the 
centre of the ACM reached hypoxic conditions faster than the outer edges of the ACM and the 
growth of the HT29 cells was decreased compared to standard 2D monolayer cultures. Over the 
course of 21 days culture in an acellular collagen I gel, the HT29 initially migrated towards the edge 
of the ACM before breaking into the surrounding collagen I gel as tumour spheroids. The inclusion 
of fibroblasts in the surrounding collagen I gel resulted in a contraction of this gel, even in the 
presence of endothelial cells, although in this case it was to a lesser extent, which resulted in 
smaller spheroids migrating out of the ACM at 21 days. As the hypoxic environment in the ACM 
was thought to be a large driving factor in the migration of the HT29 cells, the expression of VEGF 
in these cultures was examined and positive staining was observed via immunofluorescence at day 
14 and 21 of culture. 
These studies demonstrate that there is a move toward developing in vitro models which 
incorporate additional aspects of the tumour microenvironment, be it ECM proteins or 
supplementary cell types, which are better representative of the situation in vivo. Therefore the 3D 
in vitro model under development here will be assessed for it potential to allow the incorporation of 
ECM and co-culture components to better model the cancer microenvironment.  
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6.2 Chapter Aims 
This Chapter aims to assess the potential of including ECM and co-culture components in the 3D in 
vitro migration assay under development in this project by looking at protein coatings and co-
culture with a stromal equivalent. These basic assays will help to determine whether this system 
can be developed into a model of greater biological significance taking into account ECM and 
alternative cell types. This is an important step toward recreating a cancer tissue-like 
microenvironment in vitro. 
6.2.1 Objectives 
Overall, the aims of the assessment of assay adaptability in this Chapter will be investigated by: 
 Assessing the feasibility of the utilisation of ECM coatings of collagen I and fibronectin for 
the culture of colorectal cancer cells in the 3D model; 
 Assessing the impact that these coatings, if successful, have on the behaviour of the 
colorectal cancer cells in the 3D model; 
 Assessing the feasibility of the adaption of the 3D migration assay to include a stromal 
equivalent for co-culture; 
 Comparing the in vitro 3D cultures obtained with ECM coating and co-cultures to patient 
samples to investigate if the increased biological relevance of the 3D model produces 
cultures with protein expression patterns which are closer to those seen in tumour 
samples. 
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6.3 Results 
6.3.1 ECM coatings effect cell behaviour in a 3D model 
Collagen I and fibronectin have both been identified as the ECM proteins which have altered 
expression level and distribution in colorectal cancer progression [79, 378, 381, 382]. They have 
therefore been selected as ECM components to assess the impact of incorporating a protein 
coating into the 3D migration model herein. 
6.3.1.1 ECM coatings affected cellular distribution in 3D culture 
When cultured on 3D scaffolds which had been pre-coated which either 0.8μg/ml rat-tail collagen I 
or 1.0μg/ml bovine plasma fibronectin both the SW480 and SW620 cell lines demonstrated altered 
distribution on Alvetex
®
 Scaffold after 10 days of culture. As previously observed on uncoated 
scaffolds, the SW480 cell line was found to be distributed across the entire width of the scaffold, 
however the growth of these cells did not form a continuous layer across the material (Figure 6.2A). 
When cultured on either collagen I or fibronectin (Figure 6.2C & E), the SW480 cells maintained a 
distribution across the entire length of the material as seen with the cultures on uncoated scaffolds. 
In contrast, cell cultures on coated scaffolds produced a cellular distribution which was found to be 
more consistent over the width of the material. Interestingly, the depth of growth did not appear to 
differ from that observed in the cultures on uncoated scaffolds. 
The culture of the SW620 cell line on coated scaffolds demonstrated that this cell line was more 
sensitive to the presence of protein coatings than the SW480 cell line. As expected, on uncoated 
scaffolds the SW620 cell line mainly grew as single cells scattered throughout the width and depth 
of the material (Figure 6.2B). However, when a coating of collagen I was present, the behaviour of 
these cells was altered, with two distinct behaviours observed within each sample. On the collagen 
I coated scaffolds, the SW620 cells were observed as growing in tight clusters on top of the 
collagen I coating at the top of the material or they had grown through the collagen I and were seen 
to penetrate into the scaffold as previously observed (Figure 6.2D). In contrast, the pre-coating of 
Alvetex
®
 Scaffold with fibronectin did not lead to the SW620 cells growing in clusters at the top of 
the material and the cells were observed to be spaced more evenly within the material when 
compared to the uncoated scaffolds (Figure 6.2F). 
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Figure 6.2: Both the SW480 and SW620 cell lines displayed an altered cell distribution when cultured on 
collagen I or fibronectin coated scaffolds. H&E images of 10 day cultures on A and B: uncoated, C and D: 
collagen I coated and E and F: fibronectin coated scaffolds for both cells lines. Scale bars = 200µm for all 
images. 
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The observed differences in cellular distribution of the SW480 and SW620 cell lines when cultured 
on uncoated and coated scaffolds were reflected in the observed cell penetration achieved by each 
cell line over the 10 day culture period, with a significant difference seen between the two cell lines, 
ANOVA, F(1,12)=13.025, p=0.004. When the cell penetration achieved by the SW480 cell line was 
quantified, there was a small, but not significant, 20% decrease in cell penetration on the collagen I 
coated scaffolds, whereas the SW480 cells cultured on fibronectin coated scaffolds achieved a 
significant 27% increase in cell penetration (Figure 6.3A). In comparison, the depth of cell 
penetration attained by the SW620 cell line was not significantly affected by the protein pre-coating 
of the scaffold, with the cell penetration decreased by 14% on collagen I and increased by 13% on 
fibronectin coated scaffolds, compared to uncoated scaffolds (Figure 6.3B). The main variation to 
note between the three coating tested is that the cell penetration of the SW620 cell line measured 
on the collagen I coated scaffolds was found to be more variable than that measured on the 
uncoated or fibronectin coated scaffolds, as seen here by the increased size of the error bars for 
this data set compared to the other conditions. This variability is likely to be due to the two 
behaviours observed, with the collagen I restricting penetration into the scaffold in some areas and 
allowing penetration in others. 
6.3.1.2 ECM coatings affected the proliferation of colorectal cancer cells in a 3D model 
When the apparent cell viability of the 3D cultures was examined using the MTT Cell Viability 
Assay, the addition of an ECM pre-coating was seen to have a significant effect on viability overall, 
ANOVA, F(2,12)=33.866, p<0.001. It was also observed that a coating of collagen I negatively 
affected the viability of 3D cultures of both the SW480 and SW620 cell lines (Figure 6.4). With both 
cell lines, the cell viability was significantly decreased for cultures grown on scaffolds which had 
been pre-coated with collagen I, when compared to uncoated controls, whereas a pre-coating of 
fibronectin did not affect the viability of the 3D cultures of either cell line. 
The assessment of the number of cells present in the material after 10 days of culture also 
highlighted that the pre-coating of Alvetex
®
 Scaffold had a significant effect on cell number, 
ANOVA, F(2,12)=12.548, p=0.001. The number of SW480 cells found in the material was 
significantly reduced when the cultures had been maintained on ECM pre-coated scaffolds 
compared to uncoated control scaffolds, with a collagen I coating resulting in a greater decrease 
than a fibronectin coating (Figure 6.5A). However, there was no significant variation in cell number 
for the SW620 cell line cultured on uncoated and coated scaffolds, although a small, non-significant 
dip in cell number was observed with the collagen I coated scaffolds (Figure 6.5B), with the SW620 
cell line maintaining a higher cell number overall, ANOVA, F(1,12)=142.522, p<0.001. 
6.3.1.3 ECM coatings significantly affected cell attachment 
Coating of scaffolds with ECM components has been shown to affect the resulting viability and cell 
number of SW480 and SW620 cells cultured for 10 days. The attachment of cells was then 
investigated as a potential cause for this difference. The cells were seeded onto uncoated and 
coated scaffolds as before and assessed after 24 hours of culture to determine if the ECM coatings 
had an effect on the attachment of either the SW480 or SW620 cell lines to the material. 
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Figure 6.3: The 3D cell penetration of the SW480 cell line was increased when the scaffolds were 
fibronectin coated, while penetration of the SW620 cell line remained unaffected. Cell penetration in µm of 
A: SW480 and B: SW620 cells after 10 days of 3D culture, as determined by the linear measurement 
method. Data represent mean, n = 3, ±SEM for both graphs, * p < 0.05 by a Dunnett’s t-test. 
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Figure 6.4: The 3D cell viability of both the SW480 and SW620 cell lines was decreased following 
culturing on collagen I coated scaffolds. Absorbance at 570nm of A: SW480 and B: SW620 cells after 10 
days of 3D culture, as determined by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for 
both graphs, * p < 0.05 by a Dunnett’s t-test. 
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Figure 6.5: The number of SW480 cells in the 3D material was decreased both the presence of both 
collagen I and fibronectin, while the SW620 cell line remained unaffected. Cell number in millions of cells 
of A: SW480 and B: SW620 cells after 10 days of 3D culture, as determined by the Pico Green dsDNA 
Assay. Data represent mean, n = 3, ±SEM for both graphs, ** p < 0.01, *** p < 0.005 by a Dunnett’s t-test. 
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When samples which had been fixed and prepared for histological examination were imaged, a 
small number of cells were observed to be attached to the material for all conditions (Figure 6.6). 
The distribution of the SW480 cells appeared to be unaffected by the presence of ECM coating, 
with a small number of cells visible in the top quarter of the material regardless of the type of 
coating present (Figure 6.6A, C & E). The distribution of the SW620 appeared to be affected by a 
pre-coating of collagen I, but not by fibronectin, as the cells were observed on the top seeding 
surface of collagen I coated scaffolds (Figure 6.6D), but were seen distributed throughout a greater 
proportion of the depth of the material on either the uncoated or fibronectin coated scaffolds (Figure 
6.6B & F). Additionally, there appears to be a variation in the attachment of the two cell lines, with 
more SW480 cells visible on the material at 24 hours than SW620 cells. 
The observed variation in cell attachment between the SW480 and SW620 cell lines was also 
reflected in the cell viability data, as the SW480 cells produced a higher reading than the SW620 
cells after 24 hours (Figure 6.7), ANOVA, F(1,12)=11.106, p=0.006. As expected from the 
consistent cellular distribution seen in the SW480 cultures, the level of cell viability did not vary 
between cultures with the various protein coatings (Figure 6.7A). In contrast, the observed 
difference in the depth distribution of the SW620 cells on collagen I coated scaffolds was not 
reflected in the MTT data, with no significant variation seen between all cultures (Figure 6.7B). 
The assessment of the number of attached cells after 24 hours highlighted a significant difference 
between the cultures grown on different coatings, ANOVA, F(2,12)=8.396, p=0.005; in addition to a 
significant difference between the number of SW480 or SW620 cells attached to the scaffolds, 
ANOVA, F(1,12)=5.670, p=0.035 (Figure 6.8). For both cell lines, there was a non-significant drop 
in the number of cells attached to collagen I coated scaffolds when compared to either uncoated or 
fibronectin coated scaffolds, with a comparable number of cells attached to either of these 
scaffolds. 
Together these data show that the pre-coating of Alvetex
®
 Scaffold significantly affected the 
attachment of the SW480 or SW620 cell lines over a 24 hour period. Differences in the number of 
SW480 cells after 10 days of 3D culture may also be due to changes in the proliferative behaviour 
of the attached cells. This is further confirmed when the cell number data after 24 hours and 10 
days is used to calculate the population doubling times using the equations given by Hayflick in 
1973 [217]. On uncoated scaffolds, the SW480 cell line achieved a generation time of 55 hours. 
This was extended on collagen I and fibronectin coated scaffolds to 58 and 68 hours respectively, 
demonstrating that the SW480 cells proliferate at a slower rate on protein coated scaffolds. The 
SW620 cell line demonstrated a faster rate of proliferation than the SW480 cell line, with a 
generation time of 43 hours on uncoated scaffolds. Again, the rate of proliferation was altered when 
the cells were cultured on pre-coated scaffolds, with the cells cultured on collagen I coated 
scaffolds achieving a generation time of 40 hours, while those cultured on fibronectin scaffolds 
achieve a generation time of 45 hours. This data correlates with the 2D generation times for these 
cell lines, 28 and 26 hours for SW480 and SW620 respectively as shown in Chapter 3, with the 
SW620 cell line maintaining a quicker rate of cell proliferation than the SW480 cell line for all 
conditions, however it also highlights that subjecting these cells to 3D culture decreases the rate of 
proliferation, a phenomena which has been noted in many different systems [165].  
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Figure 6.6: Both the SW480 and SW620 cell lines displayed attachment to the scaffolds after 24 hours on 
uncoated and collagen I or fibronectin coated scaffolds. H&E images of 24 hours cultures on A and B: 
uncoated, C and D: collagen I coated and E and F: fibronectin coated scaffolds for both cells lines. Scale 
bars = 100µm for all images. 
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Figure 6.7: The 3D cell viability of both the SW480 and SW620 cell lines was unaffected by scaffold 
coating. Absorbance at 570nm of A: SW480 and B: SW620 cells after 24 hours of 3D culture, as 
determined by the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs, no 
significance by a Dunnett’s t-test. 
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Figure 6.8: The number of SW480 and SW620 cells in the 3D material was unaffected by scaffold coating. 
Cell number in millions of cells of A: SW480 and B: SW620 cells after 24 hours of 3D culture, as 
determined by the Pico Green dsDNA Assay. Data represent mean, n = 3, ±SEM for both graphs, no 
significance by a Dunnett’s t-test. 
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6.3.2 Characterisation of the growth of a stromal equivalent for the 3D 
model 
Following the demonstration that this model can be adapted to incorporate an ECM-like component 
by pre-coating Alvetex
®
 Scaffold with collagen I or fibronectin prior to culture of the SW480 or 
SW620 cell line, the potential of this model to incorporate a co-culture element will now be 
examined. As the seeding and culture of the murine embryonic fibroblast cell line NIH/3T3 on 
Alvetex
®
 Scaffold has already been established [278], this cell line will be used to provide a stromal 
equivalent for the assessment of co-cultures on Alvetex
®
 Scaffold. 
6.3.2.1 Alvetex
®
 Scaffold appeared to support the co-culture of colorectal cancer cell lines 
with NIH/3T3 fibroblasts 
When cultured on Alvetex
®
 Scaffold, the NIH/3T3 cell line adopts a cell distribution which differs 
greatly from the cell distribution observed with either the SW480 or SW620 cell lines. After 7 days 
of culture, the NIH/3T3 cells are seen to have a sparse distribution throughout the entire depth of 
the material, with the cells found at a higher density at the top and bottom surfaces of the material 
(Figure 6.9A) and this higher density of cells at the top and bottom surfaces does not appear to 
differ between the seeding and non-seeding surface. This distribution of cells is maintained across 
the diameter of the disc where the initial 100µl seeding dose was applied in a concentrated 
manner, with very few cells observed at the very edge of the material beyond the seeding area. 
When the colorectal cancer cell lines were seeded on top of this fibroblast culture and maintained 
for a further 7 days, an altered cell distribution was observed (Figure 6.9B & C). In the case of both 
the SW480 and SW620 cell lines, there appears to be a denser layer of cell growth at the seeding 
surface of the material. In the case of the SW480 cell line this additional cell growth took the form 
of dense groups of cells with apparent areas between where fewer cells are growing on top of the 
fibroblast layer (Figure 6.9B), while the SW620 cell line appeared to grow as rounded cells in a 
continuous layer across the fibroblast culture (Figure 6.9C). 
However, as this analysis was carried out on histologically stained samples, the distinction between 
the fibroblast and colorectal cancer cells was not clear and thus it was hard to determine the extent 
to which the cancer cell line had infiltrated into the stromal equivalent. To overcome the problem 
with identifying the colorectal cancer cell lines from the fibroblast cells, a commercially available 
variant of the NIH/3T3 cell line was obtained, the NIH3T3/GFP cell line, which has been transfected 
to stably express the GFP protein when cultured in media containing the selection antibiotic 
Blasticidin. These two cell lines were subsequently assessed to see if they retained comparable 
culturing properties in 2D and 3D culture with a view to culturing the NIH3T3/GFP cell line for 
culture on Alvetex
®
 Scaffold in the same manner that the NIH/3T3 cell line is cultured. 
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Figure 6.9: Alvetex
®
 Scaffold could support co-cultures of NIH/3T3 cells with both the SW480 and SW620 
cell lines. H&E stained images of scaffolds which had been cultured for 7 days with A: NIH/3T3 cells only or 
scaffolds which had been cultured for 7 days with NIH/3T3 cells and 7 days with B: SW480 and C: SW620 
cells, with the probable location of cancer cells indicated by arrows. Scale bars = 100µm for both images. 
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6.3.2.2 Both the NIH/3T3 and NIH3T3/GFP cell lines have a similar 2D morphology 
When maintained in standard 2D culture the NIH/3T3 cell line adopted the characteristic spindle-
like morphology which is commonly associated with fibroblasts (Figure 6.10A & B). The 
NIH3T3/GFP also adopted this morphology in 2D culture (Figure 6.10C & D); although the 
individual cells of this cell line appeared to be slightly smaller than the NIH/3T3 cell line. When the 
monolayer cultures of the NIH3T3/GFP cell line was imaged using a filter for GFP fluorescence, the 
GFP protein was clearly visible throughout the cytoplasm of the NIH3T3/GFP cells and no cells in 
these cultures were observed to be present without expressing the GFP protein (Figure 6.10E & F). 
In addition to the morphological similarities between these two cell lines, both exhibited contact 
inhibition of growth once the monolayer cultures reached a high level of confluency. However, while 
the NIH/3T3 cell line stopped proliferating at this point, the NIH3T3/GFP cell line lost adhesion to 
the culture flask and lifted off as a large sheet of cells into the culture media. This demonstrates 
that the NIH3T3/GFP cell line may be more sensitive to overgrowing in standard 2D cultures. 
6.3.2.3 The NIH3T3/GFP cell line had a faster rate of proliferation in 2D culture than the 
NIH/3T3 cell line 
The maintenance of the NIH/3T3 and NIH3T3/GFP cell lines in standard 2D culture for up to 7 days 
highlights further differences between these two cell lines. The counting of cells trypsinised from 
monolayer cultures demonstrated that the rate of proliferation is different for each of these cell 
lines. The NIH/3T3 cell line was seen to steadily increase in number from the initial 0.25 x 10
6
 
seeded into a T25 flask over the whole of the 7 day period, with an average of 6.73 x 10
6
 cells 
found by day 7 (Figure 6.11A). However, the NIH3T3/GFP cell line was seen to increase in number 
at a faster rate, with the population peaking at 7.96 x 10
6
 cells by day 5 of culture (Figure 6.11B). 
As this produced a monolayer culture which was nearly 100% confluent, these monolayers lifted off 
the culture plastic, such that very few cells were found remaining attached by 7 days of culture. 
When the cell counts for the NIH/3T3 and NIH3T3/GFP cell lines at day 5 were compared and 
subjected to Hayflick’s equations for calculating the rate of population doubling of cells in culture 
[217], the difference in proliferation rates is clearly seen. The NIH/3T3 cells were found to double 
once every 27 hours, whereas the NIH3T3/GFP cells were doubling once every 24 hours. 
This difference in proliferation between the two cell lines also had an effect on the viability of the 2D 
cultures of NIH/3T3 and NIH3T3/GFP cells. The viability of NIH/3T3 cell line was seen to steadily 
increase over the whole 7 day culture period (Figure 6.12A), in line with the increasing cell number 
previously noted. In contrast, the NIH3T3/GFP cell line exhibited a crash in cell viability after 3 days 
of culture (Figure 6.12B), demonstrating that the monolayer culture was losing viability as the 
culture became 100% confluent in the culture flask. 
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Figure 6.10: Phase contrast and fluorescence images of NIH/3T3 and NIH3T3/GFP cells in 2D culture. 
Both cell lines displayed similar characteristics in 2D culture. Phase images of A and B: NIH/3T3 and C 
and D: NIH3T3/GFP cell lines showing both have classic fibroblast morphologies. Fluorescence images of 
E and F: NIH3T3/GFP showing that all cells expressed GFP. Scale bars = 100µm for all images. 
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Figure 6.11: The NIH3T3/GFP cell line had a quicker proliferation rate than the standard NIH/3T3 cell line 
and experienced a population crash as it outgrew the plasticware. Cell counts for A: NIH/3T3 and B: 
NIH3T3/GFP cells. Data represent mean, n = 3, ±SEM for both graphs. 
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Figure 6.12: The NIH/3T3 cell line maintained an increasing level of cell viability when maintained in 2D 
culture over 7 days, while the NIH3T3/GFP cell line experienced a drop in viability before the cells 
overgrew the plasticware. Absorbance at 570nm of A: NIH/3T3 and B: NIH3T3/GFP cells as determined by 
the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for both graphs. 
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6.3.2.4 The NIH3T3/GFP produced a more dense 3D culture than the NIH/3T3 cell line 
With the NIH3T3/GFP cell line exhibiting a quicker rate of proliferation in 2D culture, it was 
expected that there were be a difference in the cell density of the 7 day 3D cultures of these two 
cell lines. As previously noted, the NIH/3T3 cell line was found to be sparsely distributed 
throughout the depth of the material after 7 days culture on Alvetex
®
 Scaffold (Figure 6.13A). In 
comparison, while the NIH3T3/GFP cell line exhibited a similar pattern of cell distribution, the cell 
growth was more dense than the NIH/3T3 cultures (Figure 6.13B). 
The 3D cultures were also assessed for GFP fluorescence to ensure that this was retained by all 
cells. Once fixed, embedded and sectioned samples of the NIH3T3/GFP cultures were stained with 
DAPI to highlight the cell nuclei, they were subjected to examination via fluorescence microscopy. 
The GFP (Figure 6.13C) and DAPI (Figure 6.13D) images obtained demonstrate that all cells within 
the 3D culture retained expression of GFP and therefore this tag is suitable for use to distinguish 
between the fibroblast and cancer compartments of any subsequent co-culture. 
6.3.2.5 Both the NIH/3T3 and NIH3T3/GFP cell lines can be maintained in 3D culture for up 
to 7 days 
As the 2D culture of the NIH3T3/GFP cell line demonstrated that the cells lost viability while still 
remaining attached to the culture flask, the viability of the 3D cultures of fibroblasts were compared 
to assess the suitability of the NIH3T3/GFP cell line. 
When the viability of the cultures was assessed using the MTT Cell Viability Assay, the viability of 
the 3D cultures of both the NIH/3T3 and NIH3T3/GFP cell lines was seen to significantly increase 
between 4 days and 7 days culture (Figure 6.14). By 4 days, the NIH3T3/GFP cell line appeared to 
exhibit a greater level of viability than the NIH/3T3 cell line, whereas, by 7 days, the viability of the 
cultures was comparable between the two cell lines. 
6.3.2.6 3D cultures of NIH3T3/GFP cells contained fewer cells than those of NIH/3T3 cells 
As the viability of 3D fibroblast cultures on Alvetex
®
 Scaffold was comparable by 7 days of culture, 
the amount of cell growth was assessed using the Bradford Assay to assess protein content and 
the Pico Green Assay to ascertain cell number. The 3D cultures of the NIH/3T3 did not significantly 
increase their protein content between 4 and 7 days of culture (Figure 6.15A), whereas the 
NIH3T3/GFP cultures did (Figure 6.15B). Additionally, it was observed that the NIH/3T3 cultures 
consistently had a higher protein content than the NIH3T3/GFP cultures for each time point 
assayed. 
A similar trend was observed when the cell number was quantified, with the NIH/3T3 cultures 
containing a larger number of cells at each time point compared to the NIH3T3/GFP cultures 
(Figure 6.16). However, in this case, there was no significant increase in cell number observed for 
either cell line between day 4 and day 7 of 3D culture. 
Together this data demonstrates that the NIH/3T3 and NIH3T3/GFP demonstrate broadly similar 
characteristics when maintained in 3D culture on Alvetex
®
 Scaffold for 7 days after the 
concentrated seeding of 0.5 x 10
6
 cells and could be used interchangeably in the protocols used 
here. 
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Figure 6.13: NIH3T3/GFP cells were more densely packed in Alvetex
®
 Scaffold than standard NIH/3T3 
cells. High magnification H&E images of scaffolds seeded with A: NIH/3T3 and B: NIH3T3/GFP cells and 
high magnification fluorescence images of NIH3T3/GFP cells showing C: GFP and D: DAPI. Scale bars = 
100µm for all images. 
258 
  
Figure 6.14: Both the NIH/3T3 and NIH3T3/GFP cell lines experienced an increase in viability from four to 
seven days in 3D culture. Absorbance at 570nm of A: NIH/3T3 and B: NIH3T3/GFP cells as determined by 
the MTT Cell Viability Assay. Data represent mean, n = 3, ±SEM for all graphs, * p < 0.05, ** p < 0.01 by a 
Student’s t-test. 
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Figure 6.15: The NIH3T3/GFP cell line showed a significant increase in protein content over an extended 
culture period, whereas the NIH/3T3 cell line did not. Protein content in mg/ml of A: NIH/3T3 and B: 
NIH3T3/GFP cells as determined by the Bradford Assay. Data represent mean, n = 3, ±SEM for both 
graphs, *** p < 0.005 by a Student’s t-test. 
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Figure 6.16: Neither the NIH/3T3 or NIH3T3/GFP cell lines displayed a significant increase in cell number 
over extended culture periods. Cell number in millions of cells of A: NIH/3T3 and B: NIH3T3/GFP cells as 
determined by the Pico Green dsDNA Assay. Data represent mean, n = 3, ±SEM for both graphs, no 
significance by a Student’s t-test. 
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6.3.3 Co-culture provides the opportunity for a more biologically 
relevant model 
With the NIH/3T3 and NIH3T3/GFP cell lines producing comparable 3D cultures after 7 days and 
with the NIH3T3/GFP able to maintain the GFP tag in 3D culture, it was concluded that the 
NIH3T3/GFP cell line could be used as a stromal equivalent in a co-culture model to provide a 
simple means of distinguishing between the fibroblast and cancer cells. 
6.3.3.1 Alvetex
®
 Scaffold could support co-cultures of colorectal cancer cell lines with the 
NIH3T3/GFP cell line 
The co-culture of both the SW480 and SW620 cell lines for 10 days on top of 7 day old 
NIH3T3/GFP cultures produced samples which contained both cell types. Sample histological 
images for each co-culture (Figure 6.17A & B) display a deviation from the organisation of 
NIH3T3/GFP cells previously observed in 7 day cultures (Figure 6.13B). When these co-cultures 
were stained for cell nuclei and examined under fluorescent microscopy, distinct populations of 
cells were observed within the cultures which did not have a GFP tag but did contain the DAPI 
stain for nuclei, highlighted using an arrow for the SW480 co-cultures (Figure 6.17C & E) and an 
arrowhead for the SW620 co-cultures (Figure 6.17D & F). As it has already been demonstrated that 
all cells in the NIH3T3/GFP 3D cultures retained the GFP tag (Figure 6.13C & D), these 
populations of cells were assumed to be the colorectal cancer cell lines. 
When higher magnification images of the co-cultures were examined (Figure 6.17G & H), the 
location of fibroblast and cancer cells is easily determined by the GFP tag. Cell nuclei seen in the 
absence of the GFP tag were assumed to be the cancer cells (closed-headed arrows, Figure 6.17G 
& H), while those seen with GFP expression were assumed to be the fibroblasts (open-headed 
arrows, Figure 6.17G & H). From these images, it was observed that while there was a build-up of 
cancer cells at the top of the scaffold, under a layer of fibroblast cells, there was also single 
infiltrating cell found within the scaffold which had migrated though the fibroblast cells found at the 
top of the scaffold. 
These images suggest that Alvetex
®
 Scaffold is capable of supporting the viable co-culture of the 
colorectal cancer cell lines SW480 and SW620 with the cell line NIH3T3/GFP acting as a stromal 
equivalent to ease cell type identification. 
6.3.4 The expression of proteins in in vitro cultured samples is 
comparable to that seen in pathological samples 
As the aim of this Chapter has been to assess the impact of the protein microenvironment on the 
migration of colorectal cancer cells and the feasibility of using the model developed here for co-
culture with fibroblasts to generate a stromal equivalent, the impact of these alterations to the 
culture environment on the expression of proteins in the colorectal cancer cell lines was assessed. 
  
262 
  
Figure 6.17: Alvetex
®
 Scaffold could support co-culture of the NIH3T3/GFP cell line with both the SW480 
and SW620 cell lines. H&E images of NIH3T3/GFP co-cultures with A: SW480 and B: SW620 cells, GFP 
images of NIH3T3/GFP co-cultures with C: SW480 and D: SW620 cells and DAPI images of NIH3T3/GFP 
co-cultures with E: SW480 and F: SW620 cells. The populations of colorectal cancer cells are highlighted 
by the open (SW480) and solid (SW620) arrow heads in images A-F. High magnification merged images 
NIH3T3/GFP co-cultures with G: SW480 and H: SW620 cells taken from the areas highlighted by dashed 
boxes in images C-F. Examples fibroblast nuclei, with associated GFP fluorescence, are shown by open-
headed arrows and examples of cancer cell nuclei, lacking associated GFP fluorescence, are shown by 
closed-headed arrows in images G and H. Scale bars = 100µm for images A-F, 50μm for images G and H. 
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6.3.4.1 The inclusion of an ECM coating did not alter the expression of proteins in the 
SW480 and SW620 cell lines 
When the expression of proteins in SW480 and SW620 cultures on uncoated and coated scaffolds 
was assessed, the inclusion of an ECM protein coating did not appear to effect the expression of 
proteins. All 3D SW480 cultures were found to be negative for E-cadherin (Figure 6.18A-C) and 
Slug (Figure 6.18J-L) expression, while positive for vimentin (Figure 6.18D-F) and β-catenin (Figure 
6.18G-I) expression, although the vimentin staining observed here was lower than previously 
observed. Similarly, all 3D SW620 cultures were also found to be negative for E-cadherin (Figure 
6.19A-C) and Slug (Figure 6.19J-L) expression, while positive for vimentin (Figure 6.19D-F) and β-
catenin (Figure 6.19G-I) expression. With both cell lines, the pre-coating of Alvetex
®
 Scaffold with 
either collagen I or fibronectin did not have an effect on the expression of these proteins. 
6.3.4.2 Protein expression in co-cultures varied between the cell compartments 
When the protein expression profiles of the 3D co-cultures were examined, a similar pattern of 
protein expression was seen between the co-cultures with the SW480 cell line and the SW620 cell 
line. In both cases, the cancer cells were seen to be negative for both E-cadherin (Figure 6.20A & 
B) and Slug (Figure 6.20G & H) and positive for vimentin (Figure 6.20C & D) and β-catenin (Figure 
6.20E & F), although the amount of β-catenin staining observed was less than seen in previous 
cultures with cancer cells only (Figure 6.18D and Figure 6.19D). This suggests that the interaction 
between the cancer cells and the fibroblasts had altered the expression of key proteins that directs 
the behaviour of the cancer cells. 
The co-cultures were also assessed for the expression of collagen I and collagen IV, with 
antibodies which detect both human and mouse proteins, to investigate the ECM environment that 
the fibroblasts were providing to the cancer cells. Collagen I expression was seen at low levels 
around both the cancer and fibroblast cells in the 3D culture (Figure 6.20I & J), whereas collagen 
IV expression was seen surrounding the fibroblast cells, not the cancer cells (Figure 6.20K & L). 
The E-cadherin and vimentin antibodies used were human specific and so did not react with the 
mouse fibroblasts (Figure 6.20A-D). The β-catenin and Slug antibodies used were able to detect 
both human and mouse proteins, but did not positive staining for these proteins was not seen in the 
fibroblast compartment of the co-cultures (Figure 6.20E-H). These data indicate that both cell types 
are capable of laying down ECM proteins on Alvetex
®
 Scaffold to modify the growth environment to 
suit their needs. It also suggests that the ECM generated by the fibroblasts is different to that 
generated by the cancer cells and, therefore, adds to the more complex microenvironment 
provided by co-culture. 
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Figure 6.18: The pre-coating of scaffolds with collagen I or fibronectin did not affect protein expression in the 
SW480 cell line, with the cells expressing vimentin and β-catenin in all cultures. Immunohistochemical 
images of antibody staining for A, B and C: E-cadherin, D, E and F: Vimentin, G, H and I: β-catenin, J, K and 
L: Slug and M, N and O: no primary control on 10 day cultures of SW480 on uncoated, collagen I coated and 
fibronectin coated scaffolds, where the brown precipitate (arrows) indicates positive staining. Scale bars = 
25µm for all images. 
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Figure 6.19: The pre-coating of scaffolds with collagen I or fibronectin did not affect protein expression in the 
SW620 cell line, with the cells expressing vimentin and β-catenin in all cultures. Immunohistochemical 
images of antibody staining for A, B and C: E-cadherin, D, E and F: Vimentin, G, H and I: β-catenin, J, K and 
L: Slug and M, N and O: no primary control on 10 day cultures of SW620 on uncoated, collagen I coated and 
fibronectin coated scaffolds, where the brown precipitate (arrows) indicates positive staining. Scale bars = 
25µm for all images. 
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Figure 6.20: Co-culture of fibroblasts with colorectal cancer cells produces cultures which express a variety of 
proteins, with the cancer cells expressing vimentin, β-catenin and collagen I and the fibroblasts expressing 
collagen I and IV. Immunohistochemical images of antibody staining for A and B: E-cadherin, C and D: 
Vimentin, E and F: β-catenin, G and H: Slug and I and J: Collagen I, K and L: Collagen IV, M and N: no 
primary control and O and P: merged GFP and DAPI on 10 day 3D co-cultures of NIH3T3/GFP with SW480 
and SW620 cells, where the brown precipitate (arrows) indicates positive staining. Scale bars = 25µm for all 
images. 
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6.3.4.3 The organised protein expression in healthy colonic tissue is disrupted in 
colorectal tumours 
Immunohistochemical staining of pathological samples highlighted the expression of the six 
proteins under investigation here in both healthy colonic tissue and colorectal tumours. In the 
healthy tissue, the expression of proteins was found to be confined to specific cell types within the 
tissue which corresponds to their documented location in the literature. Both E-cadherin and β-
catenin are localised to the colonic epithelium, with E-cadherin expression higher in cells which are 
exiting the crypts [437] and β-catenin in the cells at the base of the crypts [438], whereas vimentin 
is localised to the stromal compartment of healthy colonic tissue [439]. Collagen I is found to be 
expressed throughout colonic tissue, although staining was seen to be more intense in the stromal 
regions of the tissue, while collagen IV is found around the basement membrane and blood vessels 
of the colon [378]. Slug is expressed by adult colonic tissue [440], however no data could be found 
regarding the location of this protein in healthy tissue samples. 
The expression of E-cadherin was largely absent from the tissue and was only present in the 
uppermost section of the colon epithelium, where the epithelial cells had exited the proliferative 
crypts (Figure 6.21A & B). In contrast, while absent from the epithelial cells, the expression of 
vimentin was found to be widespread through most of the tissue (Figure 6.21C & D). 
The expression of β-catenin was seen to be confined to the nucleus of cells towards the base of 
the epithelial crypts (Figure 6.21E & F), while the expression of Slug was found to be absent in the 
samples analysed (Figure 6.21G & H). The common ECM component collagen I was found to be 
expressed at low levels throughout the tissue (Figure 6.21I & J), while the more specialised ECM 
protein collagen IV was found to be localised to the muscularis mucosa and to the walls of blood 
vessels within the tissue (Figure 6.21K & L). 
In contrast, this clear pattern of staining is not seen in pathological samples taken from either 
Dukes’ Stage B (Figure 6.22) or C (Figure 6.23) tumours. This data demonstrates the variability in 
the expression of proteins between separate tumours and between different regions of the same 
tumour. General trends are seen in the stained samples, with the upregulation of vimetin 
expression (Figure 6.22C & D and Figure 6.23C & D) in both the epithelial derived and stromal 
portion of the tumour, although the balance of this staining can vary from being more intense in the 
epithelial derived portion (Figure 6.22C) or the stromal portion (Figure 6.23D). 
Any E-cadherin staining visible within the samples is confined to the epithelial derived portion of the 
tumours, with the expression of this protein varying across the tumour samples (Figure 6.23A & B). 
The expression of the other proteins examined is also seen to vary both between and within the 
tumours samples (Figure 6.22E-L and Figure 6.23E-L), with no clear trends in terms of expression 
in relation to cell or tumour type clearly visible. 
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Figure 6.21: Proteins are expressed in specific compartments of healthy colonic tissue. Immunohistochemical 
images of antibody staining for A and B: E-cadherin, C and D: Vimentin, E and F: β-catenin, G and H: Slug 
and I and J: Collagen I, K and L: Collagen IV, M and N: no primary control and O and P: H&E on primary 
healthy human colon tissue at low and high magnification. Scale bars = 500µm for images A, C, E, G, I, K, M 
and O, 50µm for images B, D, F, H, J, L, N and P. 
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Figure 6.22: The expression of proteins varies between Dukes’ Stage B tumours. Immunohistochemical 
images of antibody staining for A and B: E-cadherin, C and D: Vimentin, E and F: β-catenin, G and H: Slug 
and I and J: Collagen I, K and L: Collagen IV, M and N: no primary control and O and P: H&E on two 
examples of Dukes’ Stage B colorectal carcinomas. Scale bars = 100µm for all images. 
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Figure 6.23: The expression of proteins varies between Dukes’ Stage C tumours. Immunohistochemical 
images of antibody staining for A and B: E-cadherin, C and D: Vimentin, E and F: β-catenin, G and H: Slug 
and I and J: Collagen I, K and L: Collagen IV, M and N: no primary control and O and P: H&E on two 
examples of Dukes’ Stage C colorectal carcinomas. Scale bars = 100µm for all images. 
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6.4 Discussion 
The Chapter has aimed to assess the feasibility of including an ECM protein coating or co-culture 
element in the 3D migratory model under development here in order to provide a culture 
microenvironment which reflects the tumour environment seen in pathological samples (Figure 
6.1A & B) better than standard 2D cultures (Figure 6.1C). While the use of a synthetic scaffold 
provides a 3D culturing environment, where the level of cell-cell interactions is increased over 
standard 2D monolayer cultures, which creates a culture environment which has an increased level 
of biological relevance, the format of this environment, a polystyrene scaffold, is still far removed 
from the protein rich multicellular tumour environment in vivo. 
The inclusion of an appropriate ECM coating provides the cancer cells with an environment which 
directs cell attachment, proliferation and migration in a manner which more closely reflects cancer 
cell behaviour seen in tumours. The two ECM protein coatings selected to investigate the role of 
cell-protein interactions on cell behaviour in a 3D model were collagen I, due to the upregulation of 
this protein in colorectal cancer tissue at all stages of the disease [386], particularly in the stromal 
portion of the tumours [378, 387], and fibronectin, which is upregulated in primary colorectal 
tumours [79, 386]. The data presented here demonstrated that the inclusion of an ECM coating on 
Alvetex
®
 Scaffold affected colorectal cancer cell migration, viability, proliferation and attachment in 
this 3D model and is summarised in Table 6.1. 
Coating SW480 SW620 
Collagen I − No significant effect on cell 
penetration 
 
 
− 33% decrease in cell viability 
− 43% decrease in cell number 
 
− Non-significant decrease in 
cell attachment after 24 hours 
− Increased population doubling 
time 
− No significant effect on cell 
penetration, although more 
cells were confined to the 
seeding surface 
− 37% decrease in cell viability 
− No significant effect on cell 
number 
− Non-significant decrease in 
cell attachment after 24 hours 
− Decreased population 
doubling time 
Fibronectin − 27% increase in cell 
penetration 
− No significant effect on cell 
viability 
− 28% decrease in cell number 
 
− Non-significant increase in cell 
attachment after 24 hours 
− Increased population doubling 
time 
− No significant effect on cell 
penetration 
− No significant effect on cell 
viability 
− No significant effect on cell 
number 
− No significant effect on cell 
attachment after 24 hours 
− Increased population doubling 
time 
Table 6.1: Summary of the primary effect of ECM coatings cell culture in the 3D migration assay. 
The cell penetration of the SW480 cell line, as a measure of cell migration, was found to be 
significantly increased when a fibronectin coating was present but not when a collagen I coating 
was present (Figure 6.3A). In contrast, the penetration of the SW620 cell line was unaffected 
(Figure 6.3B). Comparisons of this result to published data is difficult as many 3D migration models 
which utilise ECM gels are composed of either collagen I [209] or Matrigel [212], which may be 
supplemented with additional ECM components such as fibronectin [210], and these results are not 
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compared back to an uncoated 3D environment. However, the comparison of the invasion of the 
human fibrosarcoma cell line HT1080 into collagen I only and collagen I with fibronectin gels 
demonstrated that there was no difference observed when the gels were not mechanically 
stimulated [210]. 
The inclusion of a collagen I coating prior to 3D culture was also found to significantly decrease the 
viability of both the SW480 and SW620 cell lines (Figure 6.4). Again, no published data was found 
which compared the viability of SW480 or SW620 cultures on collagen I or fibronectin, either to 
each other or to tissue culture plasticware, for the data presented here to be compared to. 
The data presented here also demonstrated that the pre-coating of Alvetex
®
 Scaffold with either 
collagen I or fibronectin decreased the number of SW480 cells present after 10 days of culture 
(Figure 6.5A), a change which was assumed to be due to a decrease in cell proliferation. While 
there is no published data comparing the proliferation rate of SW480 cells cultured on ECM 
coatings to SW480 cells cultured on tissue culture plasticware, there is published data 
demonstrating that the proliferation rate of the SW480 cell line is comparable when the cells are 
cultured on thin ECM coatings of collagen I or fibronectin [441, 442]. This does not appear to be the 
case here; with the decreased number of SW480 cells present on the collagen I coated scaffolds 
after 10 days and the decreased generation time of 58 hours, as opposed to 68 hours, when 
compared to fibronectin coated scaffolds. However, as these experiments were carried out in a 3D 
culturing environment, this may account for the change in behaviour between collagen I coating 
and fibronectin coating which is not seen in 2D culture. 
In terms of cell attachment to Alvetex
®
 Scaffold over a 24 hour period, more SW480 cells were 
found to be attached than SW620 cells over the time period for all uncoated and coated scaffolds 
(Figure 6.8), and while there was no significant difference between uncoated and specific coated 
scaffolds, the inclusion of an ECM coating affected cell attachment overall. This correlates with 
some of the previously published data, as Del Buono et al. demonstrated that the SW480 cell line 
attached to thin collagen I or fibronectin gels than the SW620 cell line [443]. However, there is also 
published data demonstrating a lack of difference between the adhesion of the SW480 and SW620 
cell lines to thin collagen I or fibronectin gels [444, 445], although this may be due to the difference 
in conditions during the adhesion assay, as Del Buono et al. assessed adhesion after 2 hours at 
room temperature and the other papers assessed adhesion after 1 hour at 37
o
C. 
As it has been demonstrated that the expression of both collagen I and fibronectin is increased in 
colorectal cancer tumours relative to normal mucosa [386], the inclusion of these ECM coatings in 
the 3D model under development here provided the colorectal cancer cell lines with an in vitro 
culturing environment which reflects the tumour microenvironment more closely. As the inclusion of 
these coatings affected multiple aspects of the behaviour of the cells in this model, the data 
presented here suggests the importance of providing this relevant microenvironment to obtain 
experimental data which truly reflects the behaviour of tumours in vivo. 
As demonstrated in Figure 6.18 and Figure 6.19, the provision of an ECM coating does not affect 
the expression of E-cadherin, vimentin, β-catenin or Slug in either the SW480 or SW620 cell lines. 
This does not correlate with published data regarding the expression of E-cadherin and β-catenin in 
response to a thin ECM gel in 2D culture in a variety of cell types. It has been demonstrated that 
the expression of β-catenin is elevated in response to fibronectin as opposed to collagen I in both 
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pancreatic cancer cell lines [446] and primary dermal fibroblasts [447]. However, these papers 
disagree on how these levels relate to culture on standard tissue culture plasticware, with one 
demonstrating that the level of expression when cultured on fibronectin was comparable to 
expression when cultured on tissue culture plasticware [446], while the other demonstrated that the 
level of β-catenin expression was elevated in cells cultured on ECM coated plasticware, regardless 
of the ECM protein [447], although this difference may be due to the different cell types used by 
each study. Additionally, it was demonstrated that the expression of E-cadherin in pancreatic cell 
lines was decreased in cultures on collagen I when compared to cultures on uncoated or 
fibronectin coated plasticware [446]. The lack of alteration in protein expression seen in this model 
may be due to the increased dimensionality of the model or the use of different cell types. 
Together, these data demonstrate that the inclusion of an ECM substrate in the 3D culture system 
does have an effect on many aspects of cell behaviour and highlight that the inclusion of ECM 
proteins provides a simple means of increasing the biological relevance of in vitro cancer models. 
An alternative method to increase the biological relevance of in vitro cancer models is to introduce 
a secondary cell type to model the multicellular environment of the tumour microenvironment 
(Figure 6.1B). To achieve co-culture in the 3D migration model under development here, fibroblasts 
were selected as a secondary cell type as they have been shown to affect the migratory behaviour 
of cancer cells in in vitro models [273, 418]. The cell line NIH/3T3 was selected as the fibroblast 
cell line for use to achieve a co-culture as it has previously been used in co-culture with colorectal 
cancer cells [193] and decellularised ECM matrices generated from the culture of NIH/3T3 in vitro 
have been used as a 3D growth substrate for a variety of cancer types [184]. In addition, the 
NIH/3T3 cell line has previously been optimised for culture on Alvetex
®
 Scaffold [278], which 
removed the need for an extensive optimisation process, as carried out in Chapter 3 for the 
colorectal cancer cell lines. 
Initial experiments demonstrated that Alvetex
®
 Scaffold appeared to be able to support co-cultures 
of NIH/3T3 fibroblasts and colorectal cancer cells (Figure 6.9); however, the identification of the 
location of the individual cell lines within the cultures was difficult to establish. In order to ease the 
process of cell type identification, a GFP-tagged variant of the NIH/3T3 cell line was obtained. 
While there is no published data for the NIH3T3/GFP cell line, with many papers utilising a GFP-
tagged variant of the NIH/3T3 cell line relying on an in-house transfection which tags a specific 
protein of interest [448], which was not the aim in this study, as the use of GFP was to identify one 
cell type from another. Additionally, the use of a commercially available cell line allowed for the 
reduction of variability arising from transfections carried out by different research groups and to 
allow for the successful replication of results. 
The successful demonstration of the co-culture of the NIH3T3/GFP cell line with both the SW480 
and SW620 cell lines (Figure 6.17) illustrates that the 3D migration assay developed utilising 
Alvetex
®
 Scaffold can be further adapted to incorporate a secondary cell type to increase the 
biological relevance of the model by modelling a multicellular microenvironment in vitro. 
The utilisation of a co-culture model which relies on a synthetic scaffold base, as opposed to an 
ECM gel base, allows for the study of the effect that a secondary cell type has on the behaviour of 
cancer cells in the absence of signalling provided by the starting ECM gels. Many stratified 
organotypic migration models utilise fibroblasts encapsulated in collagen I gels to provide a stromal 
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equivalent to the cancer cells [76, 436], while others use fibroblast seeded decellularised tissue 
[216]. The use of decellularised tissue to provide the ECM architecture of a 3D model has the 
potential to provide an inappropriate microenvironment to the cancer cells, as the ECM 
organisation and characteristics of tissue is disrupted during cancer development [368, 386], and 
the provision of a ‘healthy’ microenvironment may alter the behaviour of the cancer cells from that 
seen if an ‘unhealthy’ microenvironment was provided. Additionally, the use of a collagen I gel as 
the ECM base of a 3D model may mask the protein environment produced by the fibroblasts, which 
alters with cancer progression [409], and provide a microenvironment which does not truly reflect 
the tumour microenvironment. 
The expression of E-cadherin, vimentin, β-catenin and Slug in the SW480 and SW620 cell lines 
was not seen to alter with the addition of a secondary cell type (Figure 6.20). In these cultures, the 
expression of collagen I and collagen IV was also examined to assess the ECM environment that 
the fibroblasts were providing to the colorectal cancer cells. The expression of collagen I in both the 
cancer and fibroblast cells in these cultures correlates with the ubiquitous expression of collagen I 
seen in colorectal cancers [378, 386], whereas the limited expression of collagen IV in the 
fibroblast portion of the co-cultures also correlates with the expression of collagen IV previously 
noted in the stromal portion colorectal cancers [378, 449] 
The co-culture work presented here is a proof of concept which demonstrates the feasibility of it 
when Alvetex
®
 Scaffold is used to provide the 3D environment for in vitro cell culture and also 
demonstrates, by the examination of collagen expression, that it adds environmental complexity to 
the 3D model by producing biologically relevant ECM proteins. However, the role of incorporating 
fibroblasts into the 3D migration model in altering the migratory behaviour of colorectal cancer cells 
has not been examined here and would need to be assessed to fully validate co-culture on 
Alvetex
®
 Scaffold as a viable 3D migration model to study the behaviour of colorectal cancer cells. 
The staining of pathology samples demonstrated that the internal structure of colorectal cancers 
represents a disrupted form of the healthy colonic epithelium [38], both in terms of the organisation 
of cells and the localisation of protein expression. The staining of Dukes’ Stage B and C tumours 
also highlights that the expression of proteins is highly variable both between patients and within 
the same sample, something that has been previously noted for E-cadherin [450, 451], vimentin 
[452, 453], β-catenin [451], Slug [450], collagen I [378] and collagen IV [378]. 
This high level of variability increases the difficulty of making an assessment about the accuracy of 
the protein expression achieved by the SW480 and SW620 cell lines in the 3D model developed 
here. While some comparisons can be drawn between the lack of E-cadherin expression in the cell 
lines (Figure 6.18A and Figure 6.18A) and some of the pathology samples (Figure 6.22A & B) and 
the high levels of vimentin in the cell lines (Figure 6.19D) and pathology samples (Figure 6.22C & 
D and Figure 6.23C & D), the lack of protein expression information of the original tumours from 
which the two cell lines were derived [48] allows for comparisons to unrelated tissue samples only, 
which limits the confidence in the interpretation of the data. The most accurate assessment of 
relationship the protein expression profile of colorectal cancer cells in 3D culture on Alvetex
®
 
Scaffold to the protein expression profile of the original tumour would be to use a cell line where 
expression information of the source tissue is available, or to use primary cells directly from the 
tumour taken for histological analysis.  
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7 Summary and General Discussion 
7.1 Thesis Background 
The tumour microenvironment, consisting of multiple cell types, ECM proteins and nutrient 
gradients, provides a complex signalling environment to direct the behaviour of the cancer cells 
[365, 366]. The interaction between the cancer cells and this tumour microenvironment can go on 
to impact patient survival, as seen by the correlation between the stromal content of tumours and 
survival rates [58]. The importance of these interactions is also seen when cancer cells 
metastasise to form secondary tumours, either in localised lymph nodes or more distant 
metastases in other organs. Paget’s (1889) paper alludes to the need for a permissive 
microenvironment for the establishment of a secondary tumour [64]. Due to the severe impact that 
the formation of metastatic tumours has on patient survival, understanding the effect that the 
microenvironment has on acquisition of migratory behaviour prior to metastasis is important to be 
able to target it for therapeutic treatment. 
While there have been numerous studies into the migratory behaviour of cancer cells using in vitro 
models, many of them are carried out using assays which enforce an unrealistic culturing 
microenvironment on the cells, such as scratch wound assays [199] and Transwell
®
 inserts 
[206].These models can give rise to behaviours which do not reflect behaviour of cancers in 
patients. This discrepancy in behaviours can be problematic for drug discovery as it leads to many 
compounds which show promise in early in vitro screening failing in in vivo or clinical trials. This is 
reflected by the low rate of success in bringing antineoplastic agents through to a marketable 
therapy [454, 455]. Consequently, there has been a recent push within the scientific community to 
develop more accurate, 3D models of the tumour microenvironment in order to study the behaviour 
of the cells and identify compounds of therapeutic interest which are more likely to make it past in 
vivo screening. While many of these models have been documented in the literature, many of 
those that are a good reflection of the tumour microenvironment are unsuitable for widespread use 
due to variability between sample sets [177, 216] or the need for highly specialist equipment in 
order to establish the 3D culture [193]. 
One emerging area which may be well placed to provide a culturing solution which is both 
reproducible and reflects an accurate tumour microenvironment is the use of synthetic scaffold 
technologies to provide the 3D culturing environment. One such commercially available, technology 
is Alvetex
®
, a polystyrene based membrane which comes in two pore sizes. These have already 
been demonstrated to support the culture of a variety of cell lines [232, 261]. Therefore this 
material was selected to assess its feasibility for use in investigating the migration of cancer cells 
by recreating a more biologically relevant culture microenvironment.  
The cancer type selected for this study was colorectal cancer, currently the fourth most diagnosed 
cancer type in England [9]. The importance of understanding the alteration in behaviour which 
gives rise to the formation of secondary tumours is of particular importance for this cancer because 
of the steep decline in patient survival seen between those patients diagnosed with and without 
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secondary tumours [59]. This is in addition to its overall poor prognosis rate in the UK relative to 
other Western countries [11, 12]. 
Further to the clear link between cancer progression and patient prognosis, the critical genetic 
mutations required for the initiation and progression of the disease are also well documented. First 
proposed by Fearon and Vogelstein [35], the adenoma-carcinoma progression of colorectal cancer 
demonstrates that the initial mutations required to change healthy colonic epithelium to an 
overproliferative pre-cursor and on to tumour formation rely on genetic mutations to key members 
of the Wnt signalling pathway as shown in Figure 1.1. These Wnt pathway mutations upset the 
usual control of proliferation vs differentiation seen in the healthy colonic epithelium [90] and can 
drive the cancer cells towards EMT resulting in an increase in the migratory behaviour of the cells 
[456]. 
In addition to the clear relationship between the Wnt signalling pathway and colorectal cancer, 
many other signalling pathways have been linked to promoting the migratory behaviour of 
colorectal cancer cells, including bone morphogenetic protein (BMP)-4 [457] and TGFβ [458]. One 
of these pathways which has been linked with the establishment of cancers in general is the IGF-I 
signalling pathway, which has known interactions with downstream mediators of Wnt signalling 
[138]. Inhibition of signalling within this pathway has been demonstrated to inhibit the migratory 
behaviour of colorectal cancer cell lines in vitro [334, 345], which suggests that targeting this 
pathway may be of some interest in the development of anti-migratory drugs. 
7.2 Summary of Experimental Findings 
7.2.1 Optimisation of a novel 3D in vitro migration model 
Through the optimisation of cell culture protocols carried out in Chapter 3, a protocol for the 3D 
culture of both the SW480 and SW620 colorectal cancer cell lines on Alvetex
®
 Scaffold was 
determined. This protocol was sufficient to allow for the growth of viable cultures of two cell lines 
with known differences in 2D culturing behaviour, in terms of cell morphology and cell proliferation 
rate [48], adding to the number of cell types that have successfully been cultured using this system 
[232, 260-263]. 
This optimisation process demonstrated the affect that the 3D culturing environment can have on 
the culture of cells, as the smaller void variant, Alvetex
®
 Strata, was found to be unable to support 
3D cultures of these cell lines due to poor adhesion to the material (Figure 3.19). As Alvetex
®
 
Scaffold and Alvetex
®
 Strata are composed of the same material and it is the physical properties 
that vary (Figure 3.1), this demonstrates that the physical characteristics of the culture environment 
can have a large impact on experimental outcomes. 
The assessment of protein expression in 3D cultures of different cell densities, obtained by different 
lengths of culturing, also demonstrated that the expression of the key EMT protein E-cadherin 
varied with culture density. The lack of E-cadherin expression, as detected via both 
immunohistochemical staining and Western blot analysis, in the lower density 7 day cultures, 
compared to the higher density 11 day cultures (Figure 3.21), correlates with the analysis of sparse 
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and dense 2D cultures of the SW480 cell line presented by Conacci-Sorrell et al. [223]. This 
suggests that under certain circumstances comparisons between 2D and 3D cultures can be made 
as they retain some similar culturing characteristics and this allows data obtained using this model 
to be compared to 2D counterpart studies. 
7.2.2 Inhibition of the Wnt signalling pathway reduces cell migration in 
colorectal cancer 
In Chapter 4, the effect of inhibiting Wnt signalling via small molecule inhibitors was assessed in 2D 
and 3D migration assays. This work highlighted two major results, firstly that the results obtained in 
the 2D and 3D models did not always correlate, with cardamonin causing a significant decrease in 
the amount of single cell migration of the SW620 cell line observed in a 2D scratch wound assay 
(Figure 4.25) but failing to significantly affect cell penetration in the 3D migration model (Figure 
4.19). 
Furthermore, this study highlighted a small molecule, IWR-1, with no previously published evidence 
supporting a role in the inhibition of cancer cell migration, which was found to decrease the cell 
penetration of the SW620 cell line in 3D (Figure 4.19) while having no observed affect in 2D (Figure 
4.23 and Figure 4.25). This molecule was shown to be effective at the commonly used 
concentration of 10μM in addition to the lower concentration of 1μM, without affecting the 
proliferation of either of the two colorectal cancer cell lines, in contrast to data previously 
demonstrated for a variety of human and murine lung cancer cell lines [321]. 
The immunohistochemical analysis of 3D SW620 cultures in the absence and presence of 10μM 
IWR-1 demonstrated that application of this small molecule reduced the level of β-catenin seen 
within the cells (Figure 4.34). This finding correlates with the findings of Chen et al. [313], who 
demonstrated that the application of 10μM IWR-1 decreased the amount of β-catenin which was 
not bound to E-cadherin in the colorectal cancer cell line DLD-1. 
7.2.3 Modulation of IGF-I signalling to alter the migration of colorectal 
cancer cells 
The findings presented in Chapter 5 broadly correlate with the previously published data regarding 
the relationship between IGF-I signalling and the migratory behaviour of colorectal cancer cells. 
While failing to induce a change in the observed cell migration, either collective (Figure 5.8) or 
single cell (Figure 5.10), in 2D scratch wound assays, the addition of exogenous IGF-I into the 
culture media of the 3D migration assay induced an increase in the migration of the SW480 cell line 
(Figure 5.4). This correlates with data presented by Bauer et al. [334], where the migration and 
invasion of the colorectal cancer cell line KM12L4 was significantly increased in the presence of 
IGF-I in uncoated and Matrigel coated Transwell
®
 assays, although IGF-I was used at a higher 
concentration in this study, 100ng/ml, than the effective concentration of 1ng/ml determined here. 
This data was not seen in conjunction with an increase in cell proliferation (Figure 5.6), which is not 
in agreement with previously published data showing that the injection of exogenous IGF-I into 
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mice with transplantation of colon 38 tissue resulted in a significant increase in tumour growth over 
a 6 week period compared to control mice [146]. 
Again, the data presented here for the work carried out using the IGF-IR inhibitor NVP-AEW541 
broadly correlated with previously published data for its effect on the migratory behaviour of cancer 
cells, but not the proliferative behaviour. The inhibition of migration by NVP-AEW541 in the 
absence and presence of IGF-I has previously been demonstrated in Transwell
®
 assays for 
Ewing’s sarcoma [351] and pancreatic cancer [348] cell lines, whereas the inhibition of migration 
was only seen in the presence of IGF-I in the model used here (Figure 5.12 and Figure 5.20). As 
seen with the inclusion of IGF-I in the culture media, the inclusion of NVP-AEW541 was not seen to 
affect cell proliferation at concentrations where cell migration was affected (Figure 5.14 and Figure 
5.22), whereas it has previously been shown to inhibit the proliferation of a variety of 
gastrointestinal tract cancer cell lines in the absence of IGF-I [345]. 
The mechanism of action for the IGF-I mediated increase in the cell migration of the SW480 cell 
line was determined to be via the action of PI3K leading into the Wnt signalling pathway, as 
opposed to via the action of Ras, as the application of the Wnt signalling inhibitor IWR-1, as 
identified in Chapter 4, was seen to return the IGF-I induced cell penetration levels back to control 
levels (Figure 5.28). As there is no published documentation of these compounds being used in 
conjunction to modulate the migratory behaviour of cancer cells, this result may provide an 
opportunity to target multiple signalling pathways simultaneously to reduce the migratory behaviour 
of cancers. This interaction between the Wnt and IGF-I pathways appears to be confirmed by the 
immunohistochemical staining of the 3D cultures, as the inclusion of IGF-I increased β-catenin 
expression (Figure 5.35 and Figure 5.38) whereas inclusion of either of the two inhibitors, NVP-
AEW541 or IWR-1, decreased the expression of β-catenin (Figure 5.36, Figure 5.37 and Figure 
5.38). The mechanism of action of the Wnt and IGF-I pathways and their inhibitors is demonstrated 
in Figure 7.1. 
7.2.4 Improvement of the 3D migration model by utilising ECM coating 
and co-culture 
In Chapter 6, the biological relevance of the model was increased by utilising ECM coating and co-
culture to provide a culturing microenvironment which was a more accurate reflection of the tumour 
microenvironment. The data presented in this Chapter demonstrated that both protocols produce 
viable cultures with colorectal cancer cell lines (Figure 6.1 and Figure 6.17), with further analysis of 
the cultures on coated scaffolds demonstrating that the provision of an ECM substrate affected 
cancer cell migration (Figure 6.3), proliferation (Figure 6.5) and attachment (Figure 6.8). 
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Figure 7.1: Schematic of the signalling interactions investigated by small molecule inhibitors in this thesis. 
In the control colorectal cancer cultures A: the Axin/APC/GSK-3β destruction complex is disrupted due to 
mutations to APC, leading to high levels of β-catenin, which translocates to the nucleus to mediate the 
transcription of EMT related genes. Additionally, IGF-I signalling can further inhibit the function of GSK-3β 
by the action of PI3K and PKB. In the presence of small molecules inhibitors B: IWR-1 stabilises the 
Axin/APC/GSK-3β destruction complex, even in the presence of a mutated APC protein, leading to the 
phosphorylation of β-catenin, targeting it for proteasomal degradation. Additionally, NVP-AEW541 binds to 
and blocks the IGF-IR, preventing the signalling cascade with inhibits GSK-3β function. 
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Immunohistochemical analysis of both in vitro 3D cultures and pathological samples demonstrated 
parallels between the protein expression profiles, with reduced E-cadherin expression and 
increased vimentin expression seen throughout (Figure 6.18, Figure 6.19, Figure 6.20, Figure 6.22 
and Figure 6.23) and the expression of the basement membrane component collagen IV confined 
to the stromal portion of both co-cultures and pathological samples (Figure 6.20, Figure 6.22 and 
Figure 6.23). This demonstrates that while the organisation of the cells in the 3D cultures does not 
reflect that seen in pathological samples, the expression of proteins relating the EMT and migration 
are comparable. 
For further detailed discussion of the findings generated in this thesis, refer to each of the primary 
results chapters. 
7.3 Conclusions 
In conclusion, the work presented in this thesis has demonstrated the application of modern cell 
culture technology to generate a 3D migration assay for colorectal cancer cells. While this model 
does not accurately replicate the tissue architecture of colorectal tumours, as seen from 
pathological samples, it provides the opportunity for a reproducible 3D model which does not rely 
on specialist equipment or protocols to provide insights into the behaviour of cancer cells in vitro, 
which allows it to be more accessible to a wider range of researchers. 
Investigations into the effect of Wnt and IGF-I signalling on the migratory behaviour of colorectal 
cancer using the model generated in this thesis has highlighted IWR-1 as a compound of interest 
for the inhibition of the migration, which has not currently been shown in the literature. This 
demonstrates that data produced by this model can provide information regarding the signalling 
pathways involved in the change of migratory behaviour of cancer cells, even with the basic 
methods of analysis employed here and it is suggested that with the application of more complex 
assays, this model could yield further information regarding the events surrounding cancer cell 
migration. 
7.4 Further Work 
The results presented here in this thesis highlight several areas of further work for consideration. 
Firstly, as the co-culture work presented in in Chapter 6 was a proof of concept study to 
demonstrate the capacity of Alvetex
®
 Scaffold to support the culture of colorectal cancer cells with 
a fibroblast-based stromal equivalent, the penetration of the two colorectal cancer cell lines should 
be quantified to assess the impact of co-culture on the migratory behaviour of these cells. While a 
limited amount of cell penetration would be expected relative to the amount seen in uncoated and 
coated assays, due to the physical barrier provided by the 3D fibroblast culture, there have been 
few examples in the literature of the changes in the behaviour of the SW480 and SW620 cell lines 
in response to fibroblasts, such as the demonstration of differing rates of proliferation in response 
to conditioned media from CAFs originating from either primary tumours or liver metastases [417]. 
Another area for further work which would follow on directly from data presented in this thesis 
should focus on investigation of the cumulative effect of media additives, as identified in Chapters 4 
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and 5, with the more biologically relevant 3D models utilising ECM coating and co-culture as 
presented in Chapter 6. While IWR-1, IGF-I and NVP-AEW541 have all been shown to be effective 
in modulating the migratory response of both the SW480 and SW620 cell lines in the uncoated 3D 
migration assay, inclusion of ECM coatings, which have also been shown to modulate cell 
behaviour in this model, or a secondary cell type may affect the efficacy of these additives in this 
model. 
Additionally, the assessment of the impact of migration modulating media additives and ECM 
coatings on the expression of the EMT related proteins E-cadherin, vimentin, β-catenin and Slug 
was carried out using immunohistochemical staining, which provides qualitative data. Assessment 
of these protein levels via Western blots would provide quantitative data regarding protein 
expression, which would highlight any alterations to protein expression which are too small to be 
picked up by immunohistochemical staining. Also, while the proteins identified for analysis have 
been shown to be key proteins involved in EMT in colorectal cancer cells [79, 223], they are only a 
small selection of the proteins that have been identified as markers of EMT [80, 459] and a wider 
analysis of further EMT marker proteins may provide further clues to the mechanism of action by 
which the media additives and ECM coatings are modulating the migratory behaviour of colorectal 
cancer cells. 
While the protein expression within the 3D migration model and pathological samples of colorectal 
cancer have been compared, there are problems with drawing conclusions between protein 
expression in cell lines and pathological samples, as discussed in Chapter 6. With the lack of 
pathological and protein expression information provided regarding the tumours from which the 
SW480 and SW620 cell lines were isolated [48], any alterations to protein expression may be 
artefacts of the extended period that these cells have been in in vitro culture and it is hard to 
determine if the protein expression pattern seen in the 3D model accurately reflects the protein 
expression in the original tumours. If pathological samples could be obtained such that part of the 
sample was histologically processed to determine the protein expression profile of the tumour and 
part of the tumour was processed for maintenance in both 2D and 3D in vitro cell culture, a 
comparison of protein expression profiles between the original tumour and in vitro cultures could be 
made to provide a more accurate assessment of the reliability of the 3D model in recreating a more 
accurate in vivo-like culturing environment. 
Finally, an assessment of the applicability of the procedure carried out within this thesis to generate 
a 3D migration assay should be made on other cancer types. This would validate the model 
presented here as one which presents an easily accessible method for investigating the migration 
of a range of cancer cell types. 
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